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 Abstract xvii 
  
Abstract 
Any lipoproteins and cells present in the inflammatory environment of atherosclerotic 
plaques are likely to be exposed to high levels of oxidative stress. As 7,8-dihydro-
neopterin (7,8-NP) is synthesized by interferon-γ (IFN-γ)-activated macrophages, this 
pteridine is also thought to exist at sites of inflammation. 7,8-NP’s in vivo role remains 
controversial, but numerous in vitro studies have identified a radical scavenging 
activity. The possibility of 7,8-NP protecting against oxidative damage in inflammatory 
environments like plaque was investigated in this thesis. Both human monocyte-derived 
macrophages (HMDMs) and low density lipoprotein (LDL) were used as substrates. 
The extent of protein hydroperoxide formation in each model, and 7,8-NP’s effect on 
this process, were specifically studied since most previous research has focussed on 
lipid rather than protein peroxidation.  
 For the first time, neopterin (including oxidized 7,8-NP) was also directly detected 
by high performance liquid chromatography in the inflammatory environments of 19 
pus and two atherosclerotic plaque samples. Peak concentrations even reached the low 
micromolar range. The positive correlation identified in the pus between neopterin and a 
well known antioxidant, vitamin E, further hinted at a potential antioxidant function. 
However, no significant association was noted between neopterin and markers of 
protein or lipid oxidation. 
 Exposure of HMDMs to the AAPH peroxyl radical generator resulted in significant 
quantities of lipid hydroperoxides but not protein hydroperoxides, as detected by the 
FOX assays. This is likely due to the large accumulation of polyunsaturated fatty acid-
rich lipid in the primary HMDMs during differentiation in 10% human serum and is of 
relevance to atherosclerotic plaque, where macrophages also become lipid-loaded. The 
addition of up to 200µM 7,8-NP failed to prevent AAPH-induced lipid peroxidation and 
was also unable to inhibit a loss of cellular thiols or viability. This lack of effect 
suggests the damaging peroxyl radicals are not being scavenged by 7,8-NP. The high 
lipid content of HMDM cells appears to cause the AAPH and/or 7,8-NP to localize to a 
cellular site, where they are unable to interact.  
 Macrophage-mediated oxidation of LDL in iron(II)-supplemented Hams F10 was 
associated with the formation of 30-40 moles of protein hydroperoxides per mole of 
LDL. The close parallel between protein and lipid peroxidation supports the theory that 
lipid-derived radicals are involved in protein hydroperoxide formation on LDL and 
 Abstract xviii 
  
indicates that protein hydroperoxides are an early product of LDL oxidation. Their 
detection during exposure of LDL to both the THP-1 macrophage cell line and primary 
HMDM cells confirms that protein hydroperoxides are also a normal consequence of 
macrophage-mediated LDL oxidation. 
 Incubation of LDL with micromolar 7,8-NP prevented macrophage-mediated 
protein hydroperoxide formation in a concentration-dependent manner. Lipid oxidation 
and vitamin E loss were similarly inhibited by 7,8-NP during the cell-mediated attack  
of LDL. Kinetic analysis revealed protection due to extension of the lag phase, with  
7,8-NP depletion and initiation of the propagation phase coinciding. This supports a 
radical scavenging activity for 7,8-NP, resulting in protection of the entire LDL particle. 
By contrast, the release of nanomolar quantities of 7,8-NP by IFN-γ-stimulated THP-1 
macrophages failed to prevent LDL oxidation. HMDMs activated by IFN-γ did 
significantly inhibit LDL oxidation, including protein hydroperoxide formation, for up 
to 48 hours but this antioxidant effect was not due to the de novo synthesis of 7,8-NP.  
 These results indicate that both the prevalence of protein hydroperoxides, and the 
ability of 7,8-NP to act as an antioxidant, depend on the system under investigation. 
Neopterin exists in inflammatory environments but, considering the lack of protection 
against AAPH-mediated HMDM oxidation and the 7,8-NP concentration required to 
inhibit macrophage-mediated LDL oxidation, strong evidence for an antioxidant activity 
of 7,8-NP in atherosclerotic plaque is currently lacking.  
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1 Introduction 
1.1 Overview 
As atherosclerotic plaques represent sites of chronic inflammation, the lipoproteins and 
cells present in such environments are likely to be exposed to high levels of oxidative 
stress. Oxidative damage to both cells and lipoproteins has been detected in 
atherosclerotic lesions (Yla-Herttuala et al., 1989; Martinet et al., 2001). In an attempt 
to protect themselves from this damage, macrophages have evolved a range of cellular 
responses including, but not limited to, antioxidant production. 7,8-Dihydroneopterin 
(7,8-NP) may be one of these antioxidants because, although its in vivo role remains 
controversial, numerous in vitro studies have provided evidence of antioxidant activity 
at micromolar concentrations (for review, see Oettl & Reibnegger, 2002). Interferon-γ 
(IFN-γ) stimulates human macrophages to synthesize 7,8-NP and, as this cytokine has 
been detected in atherosclerotic plaque (Geng et al., 1995; Frostegard et al., 1999), the 
potential exists for 7,8-NP to be present in these lesions as well. Consequently, 7,8-NP 
may be able to inhibit oxidative damage to both macrophages and LDL in the 
inflammatory environment of the plaque.  
 This hypothesis will be investigated in two separate studies. The first will model 
oxidative stress to human monocyte-derived macrophages (HMDMs) by exposure to a 
peroxyl radical generator. The second will promote cell-mediated LDL oxidation using 
both the THP-1 monocyte cell line and the more physiologically relevant HMDMs.   
7,8-NP’s presence in the inflammatory environments of pus and atherosclerotic plaque 
will also, ultimately, be confirmed.  
 
1.2 Atherosclerosis 
It is now widely recognized that atherosclerosis is not merely a problem of blocked 
arteries but is, in fact, a multifactorial disease. Oxidative stress and inflammation 
represent particularly critical components of the pathological process. Risk factors 
therefore range from hyperlipidemia, obesity, lack of exercise and hypertension to 
smoking, diabetes, hyperhomocysteinemia and even infection (Scott, 2004; Wu & Wu, 
2006). 
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 Atherosclerosis is also a slowly developing disease, spanning many decades in 
humans. Some of the earliest signs of atherosclerosis, termed fatty streaks, have been 
detected in adolescents (McGill et al., 2000) but the clinical events are predominantly 
observed only in people over 50 years of age (Milne et al., 2003).  
 
1.2.1 Development of the Plaque 
1.2.1.1 Lesion Initiation 
Atherosclerosis begins as sub-clinical fatty streaks within the intima of arteries. Arterial 
branch points are particularly susceptible sites because the turbulent blood flow in these 
regions alters the release of various endothelium-derived cytokines. This creates a more 
atherogenic profile by disrupting endothelium-dependent vasodilation (McLenachan et 
al., 1991) and increasing the adherence of cells to the endothelium (Ross, 1993). 
Turbulent blood flow is also likely to affect endothelial cell morphology (Lusis, 2000) 
and cause chronic injury to cells (Jang et al., 1993). The former provides one 
explanation for the increased permeability of LDL at these arterial branch sites  (Lusis, 
2000) and the latter would lead to chronic inflammation, a feature commonly associated 
with atherosclerosis (Jang et al., 1993). 
 Lipid-filled macrophages (foam cells) are the predominant component of fatty 
streaks, though small quantities of T lymphocytes have also been detected (Stary et al., 
1994). Despite many detailed analyses of fatty streak composition, controversy still 
surrounds the exact sequence of events during the early stages of formation. Some 
suggest a response to injury hypothesis, involving monocyte recruitment to the injured 
endothelium and subsequent migration into the intima (Jang et al., 1993). Lipoprotein 
entry into the intima would occur soon afterwards. Alternatively, the lipoproteins may 
enter first and initially become modified in the absence of any monocytes/macrophages. 
The appearance of these cells at a later stage would then promote the further progression 
of the atherogenic process. In support of the latter hypothesis, oxidized LDL (oxLDL) 
has been immunohistochemically identified in foetal aortae prior to the detection of any 
monocytes (Napoli et al., 1997). A similar result has been observed in rats following 
injection with native human LDL (Calara et al., 1998). 
 Whatever the initial sequence of events, monocyte recruitment is clearly an 
important step in atherogenesis (Figure 1.1). Macrophages are one of the most 
prominent cell types in plaque (Stary et al., 1994; Stary et al., 1995) and mice 
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genetically engineered to lack large numbers of macrophages develop atherosclerosis   
to a significantly less extent than control mice (Smith et al., 1995; Qiao et al., 1997). 
Entry into the arterial intima initially requires weak and rolling interactions between    
L-selectin on the monocytes and endothelial-associated P- and E-selectin (Dong et al., 
1998). Stronger interactions between the monocyte and endothelial cells are 
subsequently established and include recognition between the monocytic integrin very 
late antigen (VLA-4) and endothelial vascular cell adhesion molecule (VCAM-1). 
Interactions between the monocytic leukocyte function associated antigen (LFA-1) and 
endothelial intercellular adhesion molecule (ICAM-1) have also been reported (Lusis, 
2000). Firm attachment to endothelial cells is followed by migration of the monocytes 
into the intima through endothelial tight junctions. Platelet endothelial cell adhesion 
molecule (PECAM) is a prime candidate for mediating the monocyte-endothelial 
interactions required for this movement (Scott, 2004). Monocyte migration is further 
aided by chemotactic factors. Monocyte chemotactic protein (MCP-1) and its 
corresponding monocyte receptor, CCR2, appear to be particularly important because 
atherosclerotic lesions are reduced in MCP-1-/- (Gu et al., 1998; Gosling et al., 1999) or 
CCR2-/- (Boring et al., 1998) mice. Once in the intima, monocytes are ultimately 
induced to differentiate into macrophages by exposure to cytokines like monocyte 
colony stimulating factor (M-CSF) and IFN-γ (Glass & Witztum, 2001). 
 T lymphocyte recruitment is also critical to atherosclerosis, with the RAG-/- mice 
deficient in this cell type exhibiting retarded lesion development compared to controls 
(Song et al., 2001). These differences diminish over time, placing particular emphasis 
on the role of T cells during early stages of the disease. 
 LDL modification represents another important feature of atherogenesis. This 
modification is generally described as being oxidative in nature and it causes 
macrophages to endocytose the modified LDL via their scavenger receptors. Although 
scavenger receptor AI/AII (SRA) and CD36 are considered to be the most significant 
receptors (Suzuki et al., 1997; Febbraio et al., 2000), several others have been identified 
in recent years. These include CD68/macrosialin (van der Kooij et al., 1997), scavenger 
receptor BI (SR-BI) (Gillotte-Taylor et al., 2001), lectin-like oxLDL receptor (LOX-1) 
(Yoshida et al., 1998) and scavenger receptor that binds phosphatidylserine and oxLDL 
(SR-PSOX) (Shimaoka et al., 2000). Irrespective of the exact scavenger receptor, the 
unregulated nature of this oxLDL uptake appears to generate lipid-laden macrophage 
foam cells. OxLDL, itself (section 1.2.3), and mechanical stresses designed to mimic 
 Introduction 4 
 
  
the conditions of turbulent blood flow or hypertension (Sakamoto et al., 2001), are just 
two factors known to increase SRA and CD36 expression in human monocytes/ 
macrophages. Such mechanisms are likely to contribute to the further enhancement of 
foam cell formation, as will scavenger receptor-independent pathways of oxLDL 
uptake. In particular, aggregated oxLDL and antibody-tagged oxLDL can be taken up 
via non-specific phagocytosis (Steinbrecher & Lougheed, 1992) and the Fc-γ receptor 
(Morganelli et al., 2000), respectively. Conversely, homeostatic responses provide a 
limited means of reducing foam cell formation by promoting the efflux of cholesterol 
from macrophages to high density lipoprotein (HDL) (Glass & Witztum, 2001). 
 
 
Figure 1.1  Development of the fatty streak.  
Adapted from Glass & Witzum (2001) and Scott (2004). 
 
1.2.1.2 Lesion Progression 
The next stage of plaque development is characterized by the migration of smooth 
muscle cells (SMCs) from the vascular media into the intima (Figure 1.2). In contrast to 
the contractile phenotype associated with SMCs below the internal elastic lamina (IEL), 
the newly migrated cells possess a synthetic phenotype (Ross, 1993). This phenotype 
permits the expression of various growth regulatory cytokines and receptors, which, in 
combination with the cytokines and growth factors released from macrophages and T 
lymphocytes, results in SMC proliferation. It also permits the release of extracellular 
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matrix material, leading to the development of a fibrous cap over the plaque. 
Components of this extracellular matrix are composed primarily of type I collagen, but 
proteoglycans, elastin, glycoproteins, fibrin and other forms of collagen are also present 
(Jang et al., 1993; Stary et al., 1995).  
 The plaque may also become more complex, hardening the fibrous cap further via 
calcification of the fibrous material. Apatite is the major mineral in calcified lesions and 
tends to be found in the extracellular matrix associated with elastin and vesicles derived 
from dead cells (Stary et al., 1995). As a result, both these plaque components are 
suggested to serve as critical sites for calcification.  
 Foam cells continue to form during this stage of atherogenesis and, in addition to 
macrophages, some SMCs also develop a foam-like appearance (Figure 1.3). This has 
been suggested to occur, at least in part, by scavenging lipid released upon the death of 
the macrophage foam cells (Berliner et al., 1995). Ultimately, however, the predominant 
role for lipid and ceroid released from dead macrophages arises from their contribution 
to the development of an acellular necrotic core (Ball et al., 1995). Macrophages that 
participate in the formation of the necrotic core do not all die by necrosis. Apoptosis is 
just as plausible and, in fact, apoptotic nuclei have been directly detected within this 
core (Bjorkerud & Bjorkerud, 1996; Hegyi et al., 1996). The term necrotic core is, thus, 
rather misleading and many papers now refer to it as an acellular lipid core. 
 
 
Figure 1.2  Lesion progression from a fatty streak to a fibrous plaque. 
Adapted from Glass & Witzum (2001). 
 Introduction 6 
 
  
1.2.1.3 Plaque Rupture and Thrombosis  
The continued monocyte recruitment, foam cell formation, necrotic core expansion, 
SMC migration and proliferation, and extracellular matrix deposition, may eventually 
cause occlusion of the artery lumen. However, stenosis is generally a poor indicator of 
risk of an acute cardiovascular event (Libby, 1995). Heart attacks are, instead, 
predominantly caused by rupture of the fibrous cap and subsequent thrombosis. The 
likelihood of this occurring obviously depends on the stability of the fibrous cap and not 
on the extent of stenosis. A stable plaque is characterized by a thick fibrous cap, large 
amounts of SMCs and low levels of inflammatory cells (Scott, 2004). By contrast, 
unstable plaques are typified by a thin fibrous cap, with large quantities of lipid-filled 
macrophages, T lymphocytes and debris from dead cells. More specifically, plaque 
rupture is often localized to shoulder regions of the atherosclerotic lesion where 
macrophage cells are abundant (Bjorkerud & Bjorkerud, 1996).  
 As these observations suggest, inflammatory cells play a particularly critical role in 
destabilizing the fibrous cap (Figure 1.3). Activated T lymphocytes secrete IFN-γ 
(Libby & Hansson, 1991), which is directly responsible for many of the destabilizing 
effects (section 1.2.4.1). This cytokine also activates macrophages and thus, in 
combination with other stimuli, induces macrophages to secrete matrix 
metalloproteinase-1 (MMP-1) (Anderson et al., 2002). MMPs degrade extracellular 
matrix material, thereby thinning the fibrous cap and making it more susceptible to 
rupture. Considering that IFN-γ (Geng et al., 1995; Frostegard et al., 1999) and active 
MMPs (Galis et al., 1994) have both been detected at sites of plaque rupture, the 
likelihood of such reactions occurring in atherosclerotic lesions is certainly high.  
 Plaque stability may be further disrupted by the death of macrophages and SMCs, 
particularly if death occurs near the surface of the atherosclerotic lesion. It is therefore 
noteworthy that apoptotic macrophages and SMCs have been identified in the shoulder 
region and fibrous cap of plaques (Bjorkerud & Bjorkerud, 1996; Kolodgie et al., 2000). 
Moreover, the pro-apoptotic Fas receptor appears to be expressed on up to 66% of all 
cells in the fibrous cap (Haunstetter & Izumo, 1998).  
 Microvessel formation within atherosclerotic lesions also affects plaque stability. 
Such vessels are commonly detected in atherosclerotic lesions and are prone to rupture 
(Libby, 1995). These intra-plaque haemorrhages are often absorbed into the lesion, 
thereby contributing both to plaque growth and plaque instability (Kolodgie et al., 2003; 
Takaya et al., 2005). 
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 Tissue factor plays a central role in initiating coagulation and is yet another 
abundant component of atherosclerotic plaques (Wilcox et al., 1989). As a result, once 
the thinned fibrous cap ruptures, blood will be exposed not only to the thrombogenic 
necrotic core but also to this pro-coagulant tissue factor (Dickson & Gotlieb, 2003). In 
combination with platelets, these interactions quickly lead to the formation of a 
thrombus. Like intra-plaque haemorrhages, this thrombus is often absorbed into the 
existing, but now larger, plaque (Davies, 1996b). However, once a certain size is 
exceeded, the thrombus can block arteries, resulting in events such as coronary infarcts 
(heart attacks), cerebral infarcts (stroke) and death (Jang et al., 1993).  
 
 
Figure 1.3  Advanced plaque, with rupture and thrombosis. 
Adapted from Glass & Witzum (2001). 
 
 
1.2.2 Low Density Lipoprotein 
It has long been known that elevated plasma LDL levels are associated with an 
increased risk of atherosclerosis (Steinberg et al., 1989). Nevertheless, it is also 
understood that native LDL is incapable of promoting foam cell formation and must 
first be modified to a form recognized by the macrophage scavenger receptors for 
unregulated uptake. Acetylated LDL was one of the first such modifications identified 
(Brown et al., 1979) but is not physiologically relevant because it does not exist in vivo 
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(Steinberg et al., 1989). By contrast, oxLDL has been detected in vivo and is also 
recognized by scavenger receptors.  
 Support for oxLDL’s existence arises from several lines of evidence, including the 
finding that copper-oxidized LDL induces a response in T lymphocytes isolated from 
atherosclerotic plaque but not the corresponding peripheral blood (Stemme et al., 1995). 
Autoantibodies (Salonen et al., 1992; Shaw et al., 2001) and immunoglobulins (Yla-
Herttuala et al., 1994) reactive towards copper-oxidized LDL have also been isolated 
from human serum and plaque, respectively. Furthermore, human atherosclerotic lesions 
but not healthy arteries are clearly stained by antibodies designed against epitopes of 
oxLDL (Yla-Herttuala et al., 1991; Itabe et al., 1994). Unfortunately, such antibodies 
are not 100% specific for oxLDL (Chisolm & Chai, 2000). Thus, the direct detection of 
oxidation markers on plaque-derived lipoproteins provides more compelling evidence 
for the existence of oxLDL (Yla-Herttuala et al., 1989; Niu et al., 1999). It is also 
noteworthy that positive correlations exist between the severity of coronary 
atherosclerosis and the concentration of the cholesteryl ester hydro(pero)xide oxidation 
marker (Upston et al., 2002) or the susceptibility of LDL to in vitro oxidation 
(Regnstrom et al., 1992). Likewise, plasma lipid hydroperoxides (Kovacs et al., 1997) 
and plasma LDL baseline diene conjugation (Ahotupa & Asankari, 1999) tend to be 
elevated in patients with coronary artery disease.  
 
1.2.2.1 LDL Composition 
LDL has evolved to transport cholesterol to peripheral tissues in the body and its 
composition reflects this function. It is characterized by a core of triglycerides and 
cholesteryl esters, surrounded by a phospholipid monolayer containing free cholesterol 
and the apolipoprotein B100 (apoB100) protein (Esterbauer et al., 1992).  
 Interactions between this 4536 amino acid protein and the LDL receptor are critical 
for the normal, regulated receptor-mediated endocytosis of LDL by target cells (Brown 
& Goldstein, 1986). However, apoB100 also contributes to atherogenesis. Alterations to 
the apoB100 result in a loss of LDL receptor recognition but a gain of scavenger 
receptor recognition. This switch was found to be particularly dependent on the 
modification of apoB100 lysine residues rather than merely requiring a change in the 
net negative charge of the lipoprotein (Haberland et al., 1984). ApoB100 modification 
may occur via direct attack of susceptible amino acid residues or, indirectly, via 
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derivatization with the lipid aldehydes produced during lipid hydroperoxide 
decomposition (Haberland et al., 1984; Jurgens et al., 1986; Steinbrecher, 1987). 
 ApoB100’s interaction with proteoglycans further contributes to atherogenesis 
because it promotes retention of LDL in the intima and provides time for exposure to 
oxidative attack. A single point mutation to the histidine- and lysine-rich heparin 
binding domain of LDL produces a particle still recognizable by the LDL receptor but 
no longer able to interact with the negatively charged regions of proteoglycans (Boren 
et al., 1998). Mice expressing this mutated apoB100 were found to develop significantly 
less atherosclerosis than controls, even when fed a high cholesterol diet (Skalen et al., 
2002). 
 Lipids are abundant in LDL, with an estimated 2,200 cholesterol/cholesteryl ester 
molecules and 2,600 fatty acids (Esterbauer et al., 1995). As half these fatty acids are 
polyunsaturated, with a predominance of linoleic acid (Esterbauer et al., 1995), the LDL 
particle is highly susceptible to free radical attack (Parthasarathy et al., 1990b). 
Consequently, LDL also contains a variety of antioxidants for protection, most notably 
an average of six α-tocopherol molecules per lipoprotein (Esterbauer et al., 1992). The 
remaining antioxidants are each reported to be present at less than one mole per mole   
of LDL and include γ-tocopherol, carotenoids, retinoids and ubiquinol-10 (Esterbauer et 
al., 1992). 
 α-Tocopherol is the most effective form of vitamin E (Brigelius-Flohe & Traber, 
1999) and, during the lag phase of LDL oxidation, is generally the first antioxidant to  
be consumed while β-carotene is the last (Esterbauer et al., 1991). Traditionally,          
α-tocopherol (α-TocH) has been considered a chain breaking antioxidant that donates 
hydrogen to reactive lipid peroxyl (LOO•) radicals (reaction 1) (Burton & Ingold, 1986). 
Under conditions of suitably high radical flux, the resulting α-tocopheroxyl radical     
(α-Toc•) can then neutralize a second lipid peroxyl radical (reaction 2). When the radical 
flux is extremely low, however, α-tocopherol exhibits pro-oxidant rather than 
antioxidant activities (Bowry et al., 1992; Neuzil et al., 1997). This occurs despite       
α-tocopheroxyl radicals being considerably less reactive than lipid peroxyl radicals 
because, in the absence of any other substrate, α-tocopheroxyl radicals will ultimately 
extract hydrogen from lipid (Upston et al., 1999). While the abstraction regenerates     
α-tocopherol, it also creates a lipid radical (L•) (reaction 3) that can participate in the 
lipid peroxidation chain reaction. 
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(1) α-TocH  +  LOO•  →  α-Toc•  +  LOOH 
(2) α-Toc•  +  LOO•   →  Non-radical product  +  LOOH 
(3) α-Toc•  +  LH   →  α-TocH  +  L• 
This tocopherol-mediated peroxidation (TMP) can be prevented by co-antioxidants   
that neutralize the α-tocopheroxyl radical and transfer the newly created, damaging 
radical into the aqueous phase (Bowry et al., 1995; Thomas et al., 1996a; Upston et al., 
1999). Examples include endogenous co-antioxidants like ascorbate, ubiquinol-10     
and bilirubin. The detection of vitamin E and several co-antioxidants in all stages of 
atherosclerotic lesions (Suarna et al., 1995; Upston et al., 2002) has therefore raised 
questions about the in vivo relevance of TMP. Nevertheless, it remains possible that 
microenvironments deficient in co-antioxidants may exist and that TMP may occur in 
these regions. It is also suggested that, if LDL is in close proximity to free copper,       
α-tocopherol may act as a pro-oxidant by reducing this transition metal to its redox 
active state (Yoshida et al., 1994). 
 The importance of co-antioxidants, and their ability to act synergistically (Sato et 
al., 1990), provides one explanation for the relatively consistent protection observed 
against cardiovascular disease during epidemiological studies of dietary vitamin E.   
This is because an increased dietary intake of vitamin E is also suggested to represent  
an increased intake of dietary co-antioxidants (Stocker, 1999). By extension, the 
contradictory results obtained from vitamin E supplementation trials in humans may    
be caused by a lack of co-supplementation with appropriate co-antioxidants (Stocker, 
1999; Upston et al., 1999; Heinecke, 2001). Additional suggestions for the 
inconsistency observed in human antioxidant supplementation trials range from the 
generally advanced stage of atherosclerosis being investigated (Hazell & Stocker, 1997; 
Pryor, 2000; Steinberg & Witztum, 2002; Kaliora et al., 2006) to the use of 
inappropriate antioxidants, antioxidant doses, sample populations and trial lengths. 
Thus, a lack of efficacy in these studies should not necessarily be viewed as a negation 
of the oxidative theory of atherosclerosis. 
 
1.2.2.2 Kinetics of LDL Oxidation 
There are three characteristic phases of LDL oxidation and the first, the lag phase, 
represents a period of antioxidant consumption (Esterbauer et al., 1992). Once the 
antioxidants are consumed, lipid peroxidation commences and rapidly leads to a       
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self-propagating chain reaction that greatly amplifies the initial damage. More 
specifically, the free radical (R•)-mediated abstraction of a hydrogen atom from a 
polyunsaturated fatty acid (PUFA; LH) (reaction 4) generates a lipid radical that 
subsequently reacts rapidly with molecular oxygen (reaction 5) (Porter et al., 1995). The 
resulting peroxyl radical can then abstract an atom of hydrogen from a neighbouring 
lipid, producing a lipid hydroperoxide and a new lipid radical (reaction 6) that may 
participate in reaction 4. The length of the chain reaction depends on many factors 
(Esterbauer et al., 1993) but will, ultimately, be terminated by reaction with antioxidants 
or other radicals (reactions 1 & 7).  
(4) LH  +  R•  →  L•+  RH 
(5) L•  +  O2  →  LOO• 
(6) LOO•  +  LH  →  LOOH  +  L• 
(7) LOO•  +  R•/LOO•  →  LOOR/LOOOOL  →  Other non-radical products 
 PUFAs are not the only targets of attack during the propagation phase. Time course 
studies have confirmed that the apoB100 of LDL is also subject to oxidative 
modification (Giessauf et al., 1995; Knott et al., 2002; Gieseg et al., 2003). Likewise, 
the cholesterol associated with LDL is oxidized predominantly to oxysterols at the 
seven position. Analysis of plaque material and time course investigations have 
indicated that hydroperoxycholesterol is the principal oxysterol early in atherosclerosis, 
while 7-ketocholesterol and 7-hydroxycholesterol are later stage products (Brown et al., 
1997; Jessup & Kritharides, 2000; Upston et al., 2002). Enzymatically generated   
26/27-hydroxycholesterol has also been detected, particularly in more advanced lesions 
(Carpenter et al., 1995; Jessup & Kritharides, 2000; Upston et al., 2002). 
 Lipid hydroperoxides continuously break down during LDL oxidation but the final 
decomposition phase begins only once these reactions predominate (Esterbauer et al., 
1992). For copper-mediated LDL oxidation, this generally occurs once 70-80% of 
PUFAs have been oxidized (Esterbauer et al., 1992). The end products of 
decomposition include hydrocarbon gases, epoxides, alcohols and especially aldehydes 
(Esterbauer et al., 1995). This decomposition can occur spontaneously but is accelerated 
in the presence of transition metals, resulting in the initial formation of lipid peroxyl and 
lipid alkoxyl (LO•) radicals (Cheeseman & Slater, 1993). The thermodynamically 
unfavourable nature of reaction 9 ensures that it proceeds very slowly relative to 
reaction 8 (Burkitt, 2001). Whichever radical is generated, decomposition products are 
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ultimately formed and lipid peroxidation is further propagated via the radical-mediated 
abstraction of a PUFA hydrogen atom (reaction 10). Some of the aldehydes produced 
during this phase are cytotoxic (section 1.2.3) and may also conjugate to apoB100 
(section 1.2.2.1). Thus, LDL only becomes sufficiently modified for recognition and 
uptake by macrophage scavenger receptors at this late stage of oxidation (Jessup et al., 
1990). 
(8) LOOH  +  Fe2+/Cu+  →  LO•  +  Fe3+/Cu2+  +  OH- 
(9) LOOH  +  Fe3+/Cu2+  →  LOO•  +  Fe2+/Cu+  +  H+ 
(10) LO•/LOO•  + LH  →  LOH/LOOH + L• 
 Protein hydroperoxides will be discussed in greater detail in chapter 5 but it is worth 
noting now that this moiety is generated (reactions 4-6) and decomposed (reactions      
8-10) by mechanisms similar to the ones described for lipid hydroperoxides. As a 
consequence, protein hydroperoxide formation may also participate in peroxidation 
chain reactions (Neuzil et al., 1993) while the peroxyl and alkoxyl radicals produced 
during decomposition have the potential to contribute to additional oxidative damage 
(Davies et al., 1995; Gebicki et al., 1995). The occurrence of protein hydroperoxides in 
atherosclerosis is supported by the detection of valine hydroperoxide and leucine 
hydroperoxide break-down products in plaque samples (Fu et al., 1998). 
 
1.2.2.3 Location of LDL Oxidation 
Although the general sequence of events during LDL oxidation is rapidly being 
elucidated, the actual location of oxidation remains unclear. Plasma contains large 
quantities of antioxidants (Halliwell & Gutteridge, 1990) and as little as 5-6% human or 
foetal calf serum has been shown to inhibit macrophage-mediated LDL oxidation in 
vitro (Leake & Rankin, 1990; Dabbagh & Frei, 1995). Consequently, it has been 
hypothesized that LDL oxidation occurs predominantly in the arterial intima rather than 
the plasma. However, macrophage-mediated oxidation is also inhibited by the 
interstitial fluid that is expected to bathe the artery wall (Dabbagh & Frei, 1995). 
Moreover, antioxidants have been directly detected in atherosclerotic plaques (Suarna et 
al., 1995; Upston et al., 2002) and vitamin E even appears to be associated with the 
oxidized lipoproteins in these lesions (Niu et al., 1999). As a result, TMP and other 
oxidative mechanisms in the intima may be restricted to microenvironments low in 
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antioxidants and interstitial fluid. The creation of such an environment is plausible, 
particularly in close proximity to cells, because cellular secretions may alter the pH as 
well as oxygen and antioxidant availability of the immediate surroundings (Garner & 
Jessup, 1996).  
 
1.2.2.4 Mechanisms of LDL Oxidation 
While controversy also surrounds the initiating mechanism of LDL oxidation in vivo, 
cells in the atherosclerotic plaque are postulated to play a critical role. Smooth muscle 
cells (Heinecke et al., 1984; Muller et al., 1998), endothelial cells (Sparrow & 
Olszewski, 1993; Muller et al., 1998), macrophages (Carpenter et al., 1994; Muller et 
al., 1998), monocytes (Folcik et al., 1997) and lymphocytes (Lamb et al., 1992) have all 
been shown to promote LDL oxidation in vitro. Macrophages may be of particular 
relevance, both because of their ability to produce a range of oxidizing species and 
because of their abundance in the plaque relative to other cell types, especially during 
early stages of lesion development (Chisolm & Chai, 2000). 
 
i) Transition Metals in LDL Oxidation 
Numerous theories have been proposed to explain the underlying mechanism of cell-
mediated LDL oxidation and most include a requirement for transition metals. Copper is 
a particularly potent mediator of LDL oxidation due to its ability to bind histidine 
residues on the apoB100 (Wagner & Heinecke, 1997; Roland et al., 2001). Such close 
proximity permits both LDL-mediated reduction of copper to its redox active form and 
site-specific damage to the LDL. The former may be mediated by the α-tocopherol, lipid 
and/or protein components of LDL (Yoshida et al., 1994; Wagner & Heinecke, 1997; 
Batthyany et al., 2000) while the latter involves Fenton reactions (Lynch & Frei, 1993; 
Burkitt, 2001). Ultimately, however, the most important role for all transition metals 
may be propagation rather than site-specific initiation of the oxidative damage. The 
suggestion arises because metals decompose pre-existing lipid hydroperoxides to 
reactive alkoxyl/peroxyl radicals (reactions 8 & 9) and this process appears to be critical 
for metal-dependent lipid peroxidation (Thomas & Jackson, 1991; Pinchuk et al., 1998; 
Tang et al., 2000). Pre-existing lipid hydroperoxides may be derived from dietary lipids 
(Wilson et al., 2002), generated by autoxidation of α-tocopherol (Burkitt, 2001) or 
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transferred from peroxidized cell membrane lipid to the LDL (Parthasarathy et al., 
1990a). 
 When present in sufficient quantities, transition metals can oxidize LDL under cell 
free conditions (Parthasarathy et al., 1990a; Kritharides et al., 1995a). Cells accelerate 
the oxidative process by continually reducing the metals back to their redox active 
forms, either via the action of the transplasma membrane electron transport (TPMET) 
system or via the release of reducing agents such as superoxide and thiols. Glucose, 
likewise, represents a reducing agent of potential in vivo relevance (Mowri et al., 2000; 
Leoni et al., 2002). 
 Superoxide lacks the reactivity to induce lipid peroxidation in the absence of 
additional reagents (Bedwell & Jessup, 1987; Chisolm et al., 1999) but may do so more 
indirectly via transition metal reduction or participation in Fenton reactions. Despite this 
potential, THP-1 monocytes appear to reduce copper ions by a superoxide-independent 
mechanism (Wood & Graham, 1999) and clear evidence for the contribution of 
superoxide towards LDL oxidation is currently lacking (Jessup & Dean, 1993; Garner  
et al., 1994; Wilkins & Leake, 1994). Studies of atherosclerosis in nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase-deficient mice are similarly inconclusive. 
While Barry-Lane et al. (2001) observed a reduced lesion size compared to control 
subjects in this model, Kirk et al. (2000) detected no such difference. Nevertheless, it 
should be noted that the former study used mice lacking the gp47phox subunit of 
NADPH oxidase but the latter study used gp91phox knockouts. There is some 
suggestion that a gp91phox deficiency may not alter NADPH oxidases in vascular cells 
due to the existence of compensatory homologues (Griendling & Harrison, 2001). 
Furthermore, although NADPH oxidase represents a major pathway for superoxide 
production in monocytes/macrophages, it remains possible that alternative pathways 
may influence atherosclerotic development (Kirk et al., 2000). In an attempt to more 
broadly address the question of superoxide in atherosclerosis, mice were engineered to 
overexpress copper-zinc superoxide dismutase (CuZn SOD) (Tribble et al., 1997). 
These transgenic mice were just as prone to disease as controls but, because the 
relevance of intracellular CuZn SOD in atherosclerotic development is ambiguous, the 
data from this study also remains inconclusive. 
 The failure to identify a clear link between superoxide and atherosclerosis further 
suggests that the superoxide derived from thiol or glucose autoxidation may not play a 
critical role in LDL oxidation in vivo. Indeed, thiol-mediated LDL oxidation has been 
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correlated with susceptibility to autoxidation rather than superoxide generation (Wood 
& Graham, 1995). Additional products of thiol autoxidation include thiyl and thiyl-
peroxyl radicals, both of which are capable of initiating lipid peroxidation (Halliwell & 
Gutteridge, 1999). The most critical outcome of thiol autoxidation, however, may be  
the reduction of transition metals back to their redox active forms. Several studies    
have clearly demonstrated enhanced endothelial- and macrophage-mediated oxidation 
of LDL upon addition of extracellular cystine to transition metal-containing media 
(Sparrow & Olszewski, 1993; Graham et al., 1994; Garner et al., 1997b). Cells are 
suggested to promote LDL oxidation under these conditions by continual uptake of    
the L-cystine, with subsequent intracellular reduction and export. This ensures that     
the resulting cysteine is once more extracellularly available for autoxidation and 
concomitant reduction of transition metals. Wood & Graham (1999) provided support 
for this theory by confirming that increased cystine uptake and thiol export in THP-1 
macrophages correlates positively with rates of transition metal reduction.  
 The Wood & Graham (1999) study further indicated that a thiol-independent 
reduction of transition metals was also occurring, possibly via TPMET. This TPMET 
system is ubiquitous to all mammalian cells and functions by transferring electrons from 
intra-cellular nicotinamide adenine dinucleotide (NADH) to extracellular substrates. 
Cellular activities, ranging from cell growth and differentiation to iron uptake and 
defence, are all suggested to be modulated by TPMET (Ly & Lawen, 2003). 
Furthermore, it is suggested to participate in atherosclerosis by reducing extracellular 
transition metals to their redox active forms (Garner et al., 1997b; Baoutina et al., 
2000). One study has even identified a direct correlation between TPMET activity and 
the extent of cell-mediated LDL oxidation (Baoutina et al., 2001b). 
 Despite all this in vitro evidence for metal-mediated LDL oxidation, the role of 
transition metals in vivo remains controversial. Admittedly, free and redox active copper 
and iron have been detected in samples of advanced atherosclerotic plaque (Smith et al., 
1992; Lamb et al., 1995; Swain & Gutteridge, 1995; Stadler et al., 2004). Iron, in 
particular, has been found colocalized with ceroid (Lee et al., 1998) and apoptotic foam 
cells (Yuan, 1999). However, many researchers question the existence of free metals 
during early stages of the disease. The finding that various metal carrying proteins 
remain capable of promoting LDL oxidation under appropriate conditions may help to 
alleviate such concerns.  
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 Physiological levels of the blood’s major copper transporter, ceruloplasmin, have 
been shown to induce oxidation in vitro (Ehrenwald et al., 1994). Intact ceruloplasmin 
is required for this oxidation and it appears to involve only one of the seven bound 
copper ions (Ehrenwald et al., 1994; Mukhopadhyay et al., 1997). Ceruloplasmin also 
requires a reducing environment and, while LDL fulfils this prerequisite in phosphate 
buffered saline (PBS), cells or a superoxide generating system must provide it in culture 
medium (Fox et al., 2000). Of direct relevance to atherosclerosis, ceruloplasmin is 
synthesized by activated macrophages (Ehrenwald & Fox, 1996; Mazumder et al., 
1997) and has been immunohistochemically identified in samples of atherosclerotic 
plaque (Fox et al., 2000). In addition, ceruloplasmin becomes more catalytically active 
under acidic conditions (Lamb & Leake, 1994b) and the atherosclerotic plaque is 
considered to provide just such an environment (Leake, 1997). 
 Iron carrying proteins may also contribute to LDL oxidation, with ferritin and 
transferrin both exhibiting pro-oxidant properties under conditions that promote iron 
release. Superoxide radicals and an acidic pH are each suggested to provide this kind of 
environment (Abdalla et al., 1992; Lamb & Leake, 1994a). Another iron carrier, hemin, 
exhibits pro-oxidant activity even at neutral pH and in the presence of human serum 
(Tribble et al., 1996; Camejo et al., 1998). Such activity has been attributed to hemin’s 
ability to intercalate with the surface monolayer of LDL. Co-incubation of this 
haemoglobin degradation product with hydrogen peroxide further accelerates LDL 
oxidation, presumably by inducing the release of iron from the hemin (Camejo et al., 
1998) (Balla et al., 1991). Additional support for a pro-atherogenic effect of hemin 
arises from the discovery that atherosclerotic lesions are reduced in mice overexpressing 
the heme oxygenase enzyme (Ishikawa et al., 2001). 
 An alternative source of metal may be provided by macrophages that have 
previously phagocytosed iron-rich cellular debris and erythrocytes. Exocytosis of this 
lysosomal iron after macrophage entry into the atherosclerotic lesion would then ensure 
that the iron was readily available for promoting LDL oxidation (Yuan et al., 1995). 
 Although these studies once again support the potential for metal-mediated LDL 
oxidation, they fail to confirm the significance of such reactions in humans. Fu et al. 
(1998) examined protein extracted from atherosclerotic plaque and did find evidence of 
hydroxyl radical attack and Fenton chemistry. However, only advanced lesions were 
sampled in this study. By contrast, Leeuwenburgh et al. (1997b) analyzed protein 
isolated from lesions of all stages. They observed patterns specific to metal-catalyzed 
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oxidation only in the advanced plaque, suggesting that metals are more important at 
later stages of the disease.  
 Copper levels are significantly elevated in people afflicted with Wilson’s disease  
but this increase fails to correlate with atherosclerosis (Heinecke, 1999). Nevertheless,  
it is possible that an increased atherosclerotic risk is masked by the decrease in 
ceruloplasmin that is also associated with these individuals (Heinecke, 1999). 
Epidemiological studies correlating atherosclerotic risk to iron levels have also proved 
contradictory, even when studying a disease associated with excessive iron deposition 
like haemochromatosis (You & Wang, 2005). Reasons for this disparity are unclear but 
may be due, at least partly, to an inappropriate choice of markers. For instance, 
combining measurements of elevated LDL with transferrin saturation is suggested to 
provide a more accurate indication of atherosclerotic risk than either parameter alone 
(Wells et al., 2004). Likewise, the labile iron pool may represent a more relevant source 
of the iron available for promoting LDL oxidation than many other iron markers.         
In support of this, Gackowski et al. (2001) noted a significant correlation between 
atherosclerotic risk and elevated levels of the labile iron pool in lymphocytes.  
 
ii) Lipoxygenase-Mediated LDL Oxidation 
Cells, particularly monocytes/macrophages, may promote LDL oxidation by pathways 
that are independent of their metal reducing activities. Lipoxygenases (LOs) selectively 
catalyze the peroxidation of PUFAs (Cathcart & Folcik, 2000) and, as such, this class of 
enzymes has long been studied for their role in atherogenesis. It is now generally 
accepted that 5LO does not significantly participate in macrophage-mediated LDL 
oxidation but 15LO remains a potential candidate (Chisolm et al., 1999). The 
intracellular nature of 15LO has, in turn, raised some important questions about its 
relevance in LDL oxidation. Several mechanisms of action have been proposed to 
overcome this issue, including the transfer of cell-derived 15LO products to LDL 
(Cathcart & Folcik, 2000). A direct interaction between 15LO and LDL might also 
occur after lipoprotein uptake. Alternatively, by altering the balance of PUFA oxidation 
products, this enzyme may affect signal transduction and/or alternative metabolic 
pathways involved in LDL oxidation. Obtaining definitive evidence of LO-mediated 
LDL oxidation in cell culture is hindered by the fact that, similar to many superoxide 
inhibitors, LO inhibitors often possess additional non-specific antioxidant functions 
 Introduction 18 
 
  
(Chisolm et al., 1999). Nevertheless, mouse models have shown that an absence of 
functional 12/15LO activity significantly reduces the extent of atherosclerosis compared 
to controls (Cyrus et al., 1999; George et al., 2001). 15LO has also been detected, 
colocalized with oxLDL, in rabbit and human atherosclerotic plaque (Yla-Herttuala      
et al., 1990; Yla-Herttuala et al., 1991). Of course, colocalization does not necessarily 
indicate a causative role for LO in LDL oxidation. It remains possible that the oxLDL is 
present first and merely induces an upregulation of macrophage 15LO levels (Garner & 
Jessup, 1996). More direct evidence for LO-mediated oxidation is therefore provided by 
identification of 15LO-associated stereospecific chirality in lipids extracted from human 
atherosclerotic lesions (Folcik et al., 1995). While another study detected significant 
chirality only in early lesions (Kuhn et al., 1997), this finding has since been attributed 
simply to a lower sample size (Cathcart & Folcik, 2000). Nevertheless, these results 
must still be interpreted with caution, because stereospecific lipid peroxidation products 
may be generated via other enzymatic pathways (Heinecke, 1998).  
 
iii) Nitric Oxide- and Hypochlorite-Mediated LDL Oxidation 
The subendothelial space of the vessel wall is reported to contain relatively high 
concentrations of nitric oxide (Westhuyzen, 1997). While nitric oxide, itself, is unable 
to oxidize LDL under physiological conditions, several of the reactive nitrogen species 
(RNS) derived from this radical are known to be potent oxidants (Carr et al., 2000a). 
Peroxynitrite, in particular, is formed by the reaction between superoxide and nitric 
oxide (Squadrito & Pryor, 1998) and has been shown both to nitrate the tyrosyl residue 
on the apoB100 of LDL and to promote lipid peroxidation in vitro (Hazen et al., 1999). 
By contrast, cell culture studies have demonstrated an overall anti-atherogenic effect    
of nitric oxide in mouse macrophages (Jessup et al., 1992; Jessup & Dean, 1993; Niu et 
al., 2000). Inducible nitric oxide synthase (iNOS) (Luoma et al., 1998) and 3-
nitrotyrosine (Leeuwenburgh et al., 1997a; Ischiropoulos, 1998) have been detected in 
human atherosclerotic plaque. However, a direct comparison between tyrosine nitration 
and oxidation has revealed that the former accounts for less than 3% of tyrosine 
modifications in atherosclerotic lesions (Morton et al., 2003). Oxidative products like 
dityrosine were found to be considerably more abundant. 
 Furthermore, 3-nitrotyrosine is not a specific marker of peroxynitrite attack. The 
myeloperoxidase (MPO) enzyme can also nitrate tyrosyl residues, as confirmed by both 
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in vitro and mouse in vivo studies (Hazen et al., 1999; Carr et al., 2000a; Gaut et al., 
2002). MPO is a heme protein of phagocytic cells that is detectable during inflammation 
(Heinecke, 2002) and, in addition to promoting nitration, this enzyme also catalyzes 
other reactions. Incubating MPO with hydrogen peroxide and tyrosine results in the 
production of tyrosyl radicals. These radicals can then induce lipid peroxidation 
(Savenkova et al., 1994) or dityrosine formation and subsequent cross-linkage of 
proteins (Heinecke et al., 1993b). Alternatively, incubating MPO in the presence of 
hydrogen peroxide and chlorine ions generates hypochlorite, a reactive product known 
to oxidize cholesterol to chlorohydrins and to particularly attack protein (Berliner & 
Heinecke, 1996). Not surprisingly, therefore, apoB100 is the primary target of 
hypochlorite-mediated LDL oxidation (Hazell & Stocker, 1993). The ensuing lipid 
peroxidation is attributed to secondary reactions between chloramine break-down 
products and the lipid (Hazell et al., 1999). MPO’s atherogenic effect is likely to be 
aided by its ability to bind LDL, thereby permitting site-directed oxidation of the 
lipoprotein and reducing the effectiveness of antioxidants (Carr et al., 2000b). The 
potential for this interaction in vivo is high because active MPO has been isolated from 
atherosclerotic plaque, where it is found predominantly colocalized with macrophages 
in the shoulder region of the fibrous cap or adjacent to cholesterol clefts in lipid-rich 
areas and microvessels (Daugherty et al., 1994; Sugiyama et al., 2001). Moreover, 
markers of MPO-mediated oxidation have been detected on lipoproteins isolated from 
human atherosclerotic lesions. These markers include 3-chlorotyrosine (Hazen & 
Heinecke, 1997), protein-bound p-hydroxyphenylacetaldehyde (Hazen et al., 2000) and 
even plaque protein that cross-reacts with antibodies raised against hypochlorite-
modified LDL (Hazell et al., 1996). In contrast to markers of metal-catalyzed oxidation, 
MPO markers appear to be present at all stages of lesion development, suggesting a  
role for MPO from the initial fatty streak to the advanced plaque (Leeuwenburgh et al., 
1997b; Heinecke, 1998). Paradoxically, mice deficient in MPO develop larger 
atherosclerotic lesions than controls (Brennan & Hazen, 2003). The relevance of this 
finding is doubtful because lesions from control mice contain no detectable MPO or     
3-chlorotyrosine anyway (Brennan & Hazen, 2003). Corresponding human studies may 
be more appropriate and have, in fact, highlighted a correlation between patients with 
reduced MPO expression and a decreased risk of cardiovascular disease (Nikpoor et al., 
2001).  
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An alternative pathway for LDL oxidation involves endocytosis of minimally modified 
LDL (mmLDL) by the macrophage LDL receptor, with subsequent oxidation only upon 
entering the acidic environment of endosomes and lysosomes (Jessup & Kritharides, 
2000).  
 Thus, multiple pathways are likely to be involved in LDL oxidation in vivo, with 
some displaying a cell- and/or stage-specificity. Whichever mechanism(s) are involved 
in LDL modification in vivo, the end product is ultimately a heterogeneous population 
of LDL that is oxidized to varying degrees. At one end of the spectrum is minimally 
modified LDL (mmLDL) and, as the name suggests, such particles have only been 
oxidized to a small extent. At the other end of the spectrum, by contrast, is the heavily 
oxLDL that has been extensively modified.  
 
1.2.3 Atherogenicity of oxLDL 
As a heterogeneous population, oxLDL is able to promote a range of atherogenic 
effects. All contribute further to the development of atherosclerosis but the exact 
biological activity differs depending on the extent of oxidation. Thus, the properties of 
mmLDL differ from those of the more heavily oxLDL, with the former still being 
recognized by the LDL receptor but also playing a critical role in the induction of 
various pro-inflammatory cytokines. Continued oxidation reduces this activity and 
ultimately produces a particle that is both rapidly taken up by scavenger receptors and is 
cytotoxic to cells (Berliner et al., 1995).  
 OxLDL-mediated cytotoxicity is directed not only towards oxidizing macrophage 
cells themselves (Marchant et al., 1996) but also towards other cells subsequently 
exposed to the oxLDL. Cell types tested under these conditions include SMCs (Nishio 
et al., 1996), endothelial cells (Li et al., 1998a), macrophages (Kinscherf et al., 1998),  
T cells (Alcouffe et al., 1999) and fibroblasts (Chisolm et al., 1994). Depending on the 
cell type and extent of damage, this cell death may occur via caspase-dependent or          
-independent apoptosis or via necrosis (Vicca et al., 2000; Yuan et al., 2000; Asmis     
& Begley, 2003; Baird et al., 2004). While the cytotoxic activity of oxLDL is 
predominantly attributed to 7β-hydroperoxy-cholesterol (Chisolm et al., 1994; Colles   
et al., 1996), other oxysterols like 7-ketocholesterol and 7β-hydroxycholesterol can also 
contribute to cell death (Colles et al., 1996; Nishio et al., 1996). These cholesterol 
oxidation products are reported to destabilize macrophage lysosomes, leading to  
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leakage of lysosomal contents and subsequent induction of apoptosis or necrosis (Yuan 
et al., 2000). 7β-hydroperoxy-cholesterol decomposition further contributes to oxysterol 
toxicity due to the formation of reactive alkoxyl, peroxyl and lipid radicals that can 
propagate peroxidation of cellular lipids (Coffey et al., 1995). Other hydroperoxides and 
their aldehyde break-down products have also been suggested to contribute to the 
cytotoxicity of oxLDL (Siow et al., 1999; Uchida, 2000; Choudhary et al., 2002), as 
have phospholipid hydrolysis products like lysophosphatidylcholine (Carpenter et al., 
2001).  
 Components of oxLDL and ceroid are known to accumulate in macrophage 
lysosomes (Mander et al., 1994; Brown et al., 2000; Jessup & Kritharides, 2000) and 
this is caused, at least in part, by inactivation of some of the lysosomal proteases and 
hydrolases (Kritharides et al., 1998; Li et al., 1998b). This accumulation clearly 
contributes to cytotoxicity but it also has the potential to impair other cellular activities, 
including endocytic and secretory macrophage functions (Bolton et al., 1997). 
 Several pro-atherogenic consequences arise from oxLDL-mediated cytotoxicity. In 
particular, damaged endothelial cells may enhance entry of LDL and/or monocytes into 
the arterial intima (Steinberg et al., 1989) while macrophage death may contribute to 
growth of the necrotic core (Bjorkerud & Bjorkerud, 1996). Plaque instability may be 
promoted at later stages of atherosclerosis due to endothelial denudation (Steinberg      
et al., 1989) or macrophage and SMC death (section 1.2.1.3).  
 
OxLDL promotes atherogenesis via additional non-cytotoxic pathways, particularly 
when present as mmLDL. It is known to act as a chemoattractant towards both T cells 
and monocytes (Young & McEneny, 2001) and, while some of this activity is directly 
attributable to mmLDL, it is further aided by the mmLDL-mediated induction of 
chemoattractant cytokines like P-selectin, GRO, VCAM-1 and MCP-1 (Berliner et al., 
1995; Berliner & Heinecke, 1996). Once recruited to the intima, monocytes are then 
subject to an additional array of actions mediated by oxidized components of LDL.      
In particular, monocyte differentiation is promoted by the oxLDL-induced release        
of endothelial-derived M-CSF (Rajavashisth et al., 1990). Subsequent macrophage 
proliferation (Martens et al., 1999) and retention in the intima (Quinn et al., 1987)      
are also enhanced by this modified lipoprotein. Likewise, macrophage cholesterol 
metabolism is influenced by oxLDL at all stages, from uptake to degradation (as 
described above) and even efflux. While evidence for uptake is provided by increased 
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SRA and CD36 expression (Nakagawa et al., 1998; Glass & Witztum, 2001), 
cholesterol efflux studies have proved more contradictory. One group observed 
increased cholesterol export due to the oxLDL-mediated upregulation of ATP binding 
cassette transporter-1 (ABC1) (Tang et al., 2004) but others have noted inhibition of 
efflux (Kritharides et al., 1995b; Gelissen et al., 1996). Such disparity may be due to 
cell-specific effects or to differences in the nature of the oxLDL being studied.  
 The pro-atherogenic activity of oxLDL also extends to other cells, ranging from 
enhanced SMC proliferation (Auge et al., 2002) and SMC migration (Gorog & Kovacs, 
1998) to activation of T lymphocytes (Frostegard et al., 1992) but inhibition of 
endothelial cell migration (Murugesan & Fox, 1996). Conversely, oxLDL may promote 
endothelial proliferation via upregulation of vascular endothelial growth factor (VEGF) 
expression (Inoue et al., 2001). This proliferation exerts an anti-atherogenic effect early 
in atherosclerosis but is pro-atherogenic at later stages due to microvessel formation. 
OxLDL further influences endothelial cell activity by inhibiting nitric oxide production 
(Huang et al., 1999) but stimulating endothelin synthesis (Berliner & Heinecke, 1996). 
The net result is a loss of vasodilatory activity in the artery wall.  
 Likewise, oxLDL adversely affects plaque stability. It promotes a net increase in 
macrophage-mediated matrix degradation by down-regulating the tissue inhibitor of 
metalloproteinase-1 (TIMP-1) but upregulating matrix metalloproteinase-9 (MMP-9) 
(Xu et al., 1998). OxLDL also stimulates the production of tissue factor (Berliner et al., 
1995) and promotes platelet aggregation (Volf et al., 2000), further raising the 
likelihood of thrombus formation. 
 It is therefore clear that oxLDL induces a wide range of biological activities.    
While most of these activities are attributed to its oxidized phospholipids, including 
lysophosphatidylcholine (Chisolm & Chai, 2000; Subbanagounder et al., 2000), other 
components of oxLDL are also postulated to play a contributory role. For instance, 
oxLDL’s protein moiety appears to stimulate interleukin-1 (IL-1) production (Lipton    
et al., 1995) and respiratory burst activity in macrophages (Nguyen-Khoa et al., 1999) 
while lipid hydroperoxides inhibit nitric oxide synthesis (Huang et al., 1999). 
Furthermore, inhibition of cholesterol efflux is primarily ascribed to 7-ketocholesterol 
and the accumulation of undegradable cholesteryl esters in lysosomes (Jessup et al., 
2004). 
 OxLDL’s capacity to influence so many seemingly disparate biological functions is 
ultimately attributed to an increase in secondary messengers, like cyclic adenosine 
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monophosphate (cAMP) (Parhami et al., 1993), and to the induction of various 
cytokines and signal transduction pathways (Berliner & Heinecke, 1996). Signal 
transduction occurs through the oxLDL-mediated activation of protein kinase C (PKC), 
nuclear factor-κβ (NF-κβ), activator protein-1 (AP-1) and peroxisome proliferator-
activated receptor-γ (PPARγ) (Parhami et al., 1993; Berliner & Heinecke, 1996; Li       
et al., 1998a; Nagy et al., 1998; Tontonoz et al., 1998; Inoue et al., 2001; Whatling et 
al., 2004). 
 
1.2.4 Inflammation in Atherosclerosis 
The atherosclerotic plaque is clearly an environment of chronic inflammation. T 
lymphocytes and macrophages are numerous and activated, as demonstrated by the 
immunohistochemical detection of pro-inflammatory cytokines in plaque lesions and by 
the expression of various receptors and major histocompatability complexes (MHCs) on 
cell surfaces (Libby & Hansson, 1991; Wick et al., 1995). These T cells are primarily of 
the pro-inflammatory Th1 type rather than the anti-inflammatory Th2 cells (Frostegard 
et al., 1999) and it is suggested that oxLDL may help drive the T lymphocytes in       
this direction (Varadhachary et al., 2001). The diminished anti-inflammatory response 
observed in monocytes/macrophages isolated from acute coronary syndrome patients 
ensures further enhancement of the pro-atherogenic environment (van Haelst et al., 
2004). 
 Antibodies represent another aspect of the inflammatory reaction and, given 
oxLDL’s highly immunogenic nature (Horkko et al., 2000), it is not surprising that 
autoantibodies to oxLDL have been detected in the plasma of atherosclerotic patients 
(Salonen et al., 1992; Shaw et al., 2001). However, the relationship between antibody 
levels and atherosclerotic risk remains complex and often contradictory. Despite this 
complexity, Hulthe (2004) suggests that the extent of atherosclerosis generally 
correlates positively with IgG titres but negatively with IgM titres. 
 Studies of the complement system have proved similarly complex. Rabbits deficient 
in complement C6 were found to develop significantly less atherosclerosis than wild-
type controls (Schmidt et al., 1998) but a deficiency of complement C5 in mice afforded 
no protection against the disease (Patel et al., 2001). Rabbits may be more 
representative of humans in this case because the C5b-9 terminal complement complex 
has been detected in human atherosclerotic plaque, colocalized with apoptotic cells 
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(Niculescu et al., 2004). Furthermore, elevated levels of C5a are associated with an 
increased risk of future adverse cardiovascular events in patients with advanced 
atherosclerosis (Speidl et al., 2005). 
 Various infectious agents have also been implicated in atherosclerosis, most notably 
Chlamydia pneumonia, Helicobacter pylori and cytomegalovirus (Torgano et al., 1999) 
(Osterud & Bjorklid, 2003). Whether these infectious agent(s) promote atherosclerosis 
through some direct mechanism or indirectly via the promotion of an inflammatory state 
is currently unclear. Nevertheless, it should be noted that lipopolysaccharide (LPS) is 
capable of enhancing both cell- and copper-mediated LDL oxidation (Maziere et al., 
1999). 
 The detection of numerous inflammatory markers in patients provides additional 
support for the inflammatory nature of the atherosclerotic lesion (Erren et al., 1999; Van 
Lente, 2000). Some markers, particularly heat shock protein 65 (hsp65) (Xu et al., 
1993) and C reactive protein (CRP) (Patrick & Uzick, 2001; Wilson et al., 2006), even 
correlate with the extent of atherosclerosis. Rather than serving as simple diagnostic 
markers, these two parameters are also suggested to be directly pro-atherogenic (Wick 
et al., 1995; Wilson et al., 2006). 
 
1.2.4.1 Interferon-γ 
IFN-γ is currently reported to regulate over 500 genes (Leon & Zuckerman, 2005), 
ensuring that the effects of this cytokine are complex, multifactorial and associated with 
both pro- and anti-atherogenic activities. Potential pro-atherogenic functions include    
the IFN-γ-mediated upregulation of antigen presenting components like MHCs 
(Hansson et al., 2006); activation of macrophages and stimulation of the respiratory 
burst (Hansson et al., 2006); and induction of ceruloplasmin synthesis (Mazumder        
et al., 1997). Its ability to promote T lymphocyte and monocyte recruitment is also 
considered pro-atherogenic. The former involves an enhanced release of endothelial-
derived T cell α-chemoattractant (Cole et al., 1998) while the latter is associated       
with increased expression of the VCAM-1, ICAM-1 and MCP-1 chemokines (Leon     
& Zuckerman, 2005). Conversely, IFN-γ has been reported to inhibit induction of            
E-selectin, P-selectin, PECAM-1 and the MCP-1 receptor, CCR2 (Leon & Zuckerman, 
2005). IFN-γ’s inhibition of 15-LO synthesis is, likewise, described as antiatherogenic 
(Folcik et al., 1997). 
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 The pro-atherogenic properties of IFN-γ also extend to plaque instability and 
thrombus formation. Expression of the multifunctional CD40 and its ligand (CD40L) 
are enhanced in the presence of IFN-γ (Schonbeck & Libby, 2001), as are cathepsin S 
(Beers et al., 2003), MMP-1 (Anderson et al., 2002; Zhou et al., 2003) and the pro-
coagulant tissue factor (Collins et al., 1995). By contrast, IFN-γ is reported to inhibit 
synthesis of MMP-9 (Zhou et al., 2003) and cathepsin L (Beers et al., 2003). 
Nevertheless, because IFN-γ also inhibits SMC proliferation (Hansson et al., 1989; 
Warner et al., 1989), collagen synthesis (Weitkamp et al., 1999; Xu et al., 2004) and   
α-actin expression (Hansson et al., 1989), the net effect of this cytokine is likely to be 
one of plaque destabilization in advanced lesions.  
 The influence of IFN-γ on cholesterol metabolism is rather complex and, as such, 
the net result will depend on the balance between various conflicting actions. Although 
the human macrophage CD36 (Nakagawa et al., 1998; Panousis & Zuckerman, 2000a) 
is down-regulated by IFN-γ, its SR-PSOX receptor is paradoxically upregulated 
(Wuttge et al., 2004). Likewise, SRA expression is inhibited in macrophages (Geng & 
Hansson, 1992; Grewal et al., 2001) but stimulated in monocytes (Grewal et al., 2001) 
and SMCs (Li et al., 1995). IFN-γ has been theorized to limit foam cell  formation via 
its reduction of macrophage very low density lipoprotein (VLDL) receptor expression 
(Kosaka et al., 2001), lipoprotein (a) (Lp(a)) expression (Skiba et al., 1994), LDL 
receptor-related protein (LRP) activity (LaMarre et al., 1993; Garner et al., 1997a) and 
lipoprotein lipase (LPL) secretion (Jonasson et al., 1990; Garner et al., 1997a). 
Conversely, IFN-γ stimulates acyl-CoA: cholesterol-O-acyl-transferase (ACAT) activity 
(Panousis & Zuckerman, 2000a) and inhibits ABC1 expression (Panousis & 
Zuckerman, 2000b), apolipoprotein E (ApoE) production (Brand et al., 1993; Garner et 
al., 1997a) and cholesterol 27-hydroxylase production (Reiss et al., 2004). These 
activities would all be expected to diminish cholesterol efflux, thereby promoting foam 
cell formation.  
 The stage of atherosclerosis may play an equally critical role in determining IFN-γ’s 
overall effect. A prime example of this is highlighted by the inhibition of collagen 
synthesis and SMC proliferation, which would be considered anti-atherogenic during 
early atherosclerosis but pro-atherogenic in advanced plaques. 
 Attempts to address IFN-γ’s pro- versus anti-atherogenic effect in cell culture or 
animal models have produced contradictory results. Mice engineered to lack either a 
functional IFN-γ receptor (Gupta et al., 1997b) or gene (Buono et al., 2003) developed 
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significantly less diet-induced atherosclerosis than controls, while the intraperitoneal 
administration of exogenous IFN-γ enhanced atherogenesis (Whitman et al., 2000). This 
pro-atherogenic effect was observed in mice even in the absence of leukocytes (Tellides 
et al., 2000). By contrast, rabbits subjected to intramuscular injections of IFN-γ 
exhibited a reduction in lesion size and frequency (Wilson et al., 1990). On a cellular 
level, IFN-γ’s net effect also appears anti-atherogenic (Fong et al., 1994). It is suggested 
to inhibit mouse macrophage-mediated LDL oxidation by stimulating iNOS to generate 
nitric oxide (Jessup & Dean, 1993; Niu et al., 2000). The protection against oxidative 
attack observed when incubating LDL with human macrophages, IFN-γ and tryptophan 
has been attributed to IFN-γ’s ability to upregulate indoleamine 2,3-dioxygenase (IDO) 
(Christen et al., 1994). This enzyme participates in tryptophan degradation and one of 
the final break-down products in the pathway, 3-hydroxyanthranilic acid (3-HAA), 
exhibits strong antioxidant activity (Christen et al., 1990; Thomas et al., 1996b). 
Likewise, the IFN-γ-mediated induction of heme oxygenase ultimately generates 
bilirubin, another compound with known antioxidant activity (Neuzil & Stocker, 1994; 
Bowry et al., 1995). 
 
1.3 Neopterin and 7,8-Dihydroneopterin 
In addition to all the activities discussed above, IFN-γ is also responsible for stimulating 
the synthesis of 7,8-dihydroneopterin (7,8-NP) and neopterin (Huber et al., 1984). 
These molecules belong to a class of compounds called pteridines. All pteridines are 
characterized by a pyrazino-2,3-pyrimidine bicyclic nitrogen-containing ring system 
and can be further described as either conjugated or unconjugated, depending on the 
size of the substituent groups (Wachter et al., 1992). Additional subclassification of 
unconjugated pterdines is based on their oxidation states, ranging from fully reduced 
tetrahydropterins to partially reduced dihydropterins and aromatic pterins (Oettl & 
Reibnegger, 2002). 7,8-NP is an unconjugated partially reduced dihydropterin while 
neopterin is one of its oxidation products.  
 
1.3.1 Synthesis 
All pteridines, including 7,8-NP and neopterin, are synthesized from a guanosine        
triphosphate (GTP) precursor (Figure 1.4). IFN-γ promotes this initial step, ensuring the 
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efficient conversion of GTP to 7,8-NP triphosphate via upregulation of GTP     
cyclohydrolase I expression (Werner et al., 1990). Phosphatases then generate 7,8-NP 
by hydrolysing the 7,8-NP triphosphate (Wachter et al., 1992). Neopterin may be 
produced either by oxidation of 7,8-NP triphosphate, with subsequent phosphatase-
mediated hydrolysis of the newly formed neopterin triphosphate, or by oxidation of  
7,8-NP (Hoffmann et al., 2003). 
 
 
 
Figure 1.4  Biosynthetic pathway for 7,8-NP formation. 
Adapted from Wachter et al. (1992). 
 
 
 
 An alternative pathway for 7,8-NP triphosphate generates a fully reduced pteridine, 
5,6,7,8-tetrahydrobiopterin (BH4), and requires the sequential action of 6-pyruvol tetra-
hydropterin synthase (6-PTPS) and sepiapterin reductase (Wachter et al., 1992). Both 
enzymes are constitutively expressed but, in human macrophages, 6-PTPS activity is 
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very low (Werner et al., 1990). This is attributed to a cell-specific transcriptional skip  
of the 23bp exon 3, thereby creating a premature stop codon in human macrophage      
6-PTPS mRNA (Leitner et al., 2003). The rate limiting effect of 6-PTPS ensures that   
7,8-NP is synthesized in macrophages while BH4 is the predominant product in cells 
like fibroblasts and T lymphocytes (Werner et al., 1990). BH4 serves as a cofactor not 
only for aromatic amino acid monoxygenases but also for nitric oxide synthase (Walter 
et al., 2001). Thus, in contrast to other cells, nitric oxide production is not a significant 
consequence of the upregulation of GTP cyclohydrolase I in macrophages (Padgett & 
Pruett, 1992; Thomas et al., 1994c). 
 Although IFN-γ is the strongest inducer of 7,8-NP/neopterin production in 
macrophages, co-stimulation with tumour necrosis factor-α (TNFα), dexamethasone or 
LPS has also been shown to enhance synthesis (Werner-Felmayer et al., 1990; Werner-
Felmayer et al., 1995). Likewise, neopterin levels are elevated upon co-incubation of 
IFN-γ with increasing concentrations of extracellular tryptophan (Werner et al., 1989; 
Werner-Felmayer et al., 1990). By contrast, neopterin production was found to be 
down-regulated after the exposure of THP-1 monocytes to α-melanocyte-stimulating 
hormone (α-MSH) (Rajora et al., 1996), transferrin-bound or free iron (Weiss et al., 
1992) or histamine (Gruber et al., 2000). While the latter is suggested to involve a 
histamine-H2-receptor interaction (Gruber et al., 2000), the effect of iron has more 
specifically been ascribed to transcriptional and post-transcriptional disruption of GTP 
cyclohydrolase I expression (Oexle et al., 2003). More indirect influences on neopterin 
synthesis are observed in cultures of peripheral blood mononuclear cells (PBMCs), with 
the pro-inflammatory IL-12 cytokine enhancing T lymphocyte activity and IFN-γ 
release (Weiss et al., 1999). The anti-inflammatory IL-4 and IL-10 cytokines inhibit 
these processes, and there is some suggestion that they may also directly down-regulate 
IFN-γ’s effect on macrophages (Weiss et al., 1999). 
 These findings are all of potential relevance to atherosclerosis because histamine 
(Sasaguri & Tanimoto, 2004), iron (Smith et al., 1992; Swain & Gutteridge, 1995; Lee 
et al., 1998; Yuan, 1999) and cytokines (Geng et al., 1995; Berliner & Heinecke, 1996; 
Frostegard et al., 1999) have all been detected in lesions. Furthermore, serum neopterin 
levels appear to be elevated in patients with atherosclerosis (Tatzber et al., 1991; Weiss 
et al., 1994; Erren et al., 1999). 
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1.3.2 Neopterin as a Marker of Inflammation 
Neopterin levels in serum, urine and/or cerebrospinal fluid are also elevated in diseases 
ranging from endometriosis (Kondera-Anasz et al., 2004) and various cancers (Murr    
et al., 1999) to neurodegenerative and autoimmune disorders (Wirleitner et al., 2005). 
In many cases, the disease stage and/or disease prognosis have been correlated to the 
extent of neopterin production (Hamerlinck, 1999) (Hoffmann et al., 2003).  
 Elevated neopterin levels can often be associated with the severity of viral, bacterial, 
protozoic, fungal and parasitic infections too (Hamerlinck, 1999; Hoffmann et al., 
2003). While much of the viral research has focussed on the predictive value of 
neopterin in human immunodeficiency virus (HIV) patients (Tsoukas & Bernard, 1994), 
neopterin has also been seriously considered as a marker for other viral infections. 
Severe acute respiratory syndrome (SARS) (Zheng et al., 2005) and hepatitis B (Kalkan 
et al., 2005) are just two examples.  
 Neopterin and immune activation are, without a doubt, closely correlated. Thus, it is 
not surprising that elevated neopterin also serves as a useful marker of infection and/or 
allograft rejection following organ transplantation (Hoffmann et al., 2003). Of particular 
significance, neopterin measurements were indicative of transplant rejection an average 
of two days prior to confirmation by conventional diagnosis (Hamerlinck, 1999). 
 
1.3.3 Physiological Function of Neopterin and 7,8-NP  
Although neopterin’s suitability as a marker of inflammation has long been 
acknowledged, the biological function of this pteridine and its reduced counterpart 
remains an issue of contention. Numerous in vitro studies have provided evidence of 
both pro- and anti-oxidative activities as well as roles in apoptosis, signal transduction 
and gene expression. 
 
1.3.3.1 Enzyme Inhibition 
Neopterin was initially hypothesized to act as an antimicrobial agent via inhibition of 
folate biosynthesis (Nathan, 1986). However, in the absence of evidence for a direct 
effect of neopterin on bacterial cultures, support for this theory has since waned 
(Hoffmann et al., 2003). By contrast, neopterin has been specifically confirmed to 
inhibit the activity of at least two other enzymes in vitro – the superoxide generators, 
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NADPH oxidase and xanthine oxidase. Inhibition of the former occurs via competitive 
inhibition of the NADPH substrate (Kojima et al., 1993) while inhibition of the latter 
involves a reversible, non-competitive mechanism (Oettl et al., 1997; Oettl & 
Reibnegger, 1999). It has also recently been suggested that neopterin may inhibit 
myeloperoxidase, leading to an increase in singlet oxygen but a decrease in all other 
reactive oxygen species (ROS) (Razumovitch et al., 2004).  
 The in vivo relevance of such findings has been questioned because of the 
micromolar quantities of neopterin required for enzyme inhibition. Oettl & Reibnegger 
(2002) counteract this argument by noting that high concentrations of neopterin may 
accumulate intracellularly and in close proximity to enzymes like NADPH oxidase. 
Furthermore, the intravenous administration of neopterin was shown to inhibit ischemic 
paw edema in mice and gastric ischemic injury in rats (Icho et al., 1995). As superoxide 
is suggested to significantly contribute to the development of both diseases, neopterin 
may provide protection by directly inhibiting the superoxide generating enzymes. 
Alternatively, it may enter cells and be intracellularly reduced to dihydroneopterin or 
tetrahydroneopterin, both of which have strong radical scavenging activity (Kojima      
et al., 1992; Weiss et al., 1993; Icho et al., 1995; Oettl & Reibnegger, 2002).  
 
1.3.3.2 Radical Scavenging 
7,8-NP is unable to directly inhibit NADPH oxidase activity but still limits radical 
production by scavenging the superoxide generated by this enzyme (Oettl et al., 1997). 
This radical scavenging activity was initially demonstrated using hydroxyl radicals 
generated from an iron/hydrogen peroxide Fenton system (Heales et al., 1988). 
Additional confirmation arose from 7,8-NP’s ability to inhibit the luminol-dependent 
chemiluminescence induced by hydrogen peroxide, oxidase systems, the chloramine T 
free radical generator and the SIN-1 nitric oxide generator (Weiss et al., 1993; Shen, 
1994; Reibnegger et al., 1995; Murr et al., 1996). Some of the reduced pterins tested in 
the Shen (1994) study were even found to be more effective than the classical 
antioxidants, ascorbic acid and glutathione. Likewise, spin trap studies yielded a rate 
constant of 107 M-1s-1 for the reaction between 7,8-NP and peroxyl radicals (Oettl et al., 
1997). This is close to the rate constant for the reaction between peroxyl radicals       
and α-tocopherol. 7,8-NP is also an efficient scavenger of non-physiological radicals 
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like 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2’-azino-di-[3-ethylbenzthaizoline 
sulphonate] (ABTS+) (Oettl & Reibnegger, 2002). 
 On a larger scale, the radical scavenging activity of 7,8-NP has been shown to 
protect Escherichia coli from chloramine T- and hypochlorite-induced growth inhibition 
and cytotoxicity (Weiss et al., 1993; Horejsi et al., 1996; Wede et al., 1999). Similarly, 
radical scavenging explains the inhibition of lipid peroxidation observed for both 
linoleate and native LDL in the presence of 7,8-NP (Gieseg et al., 1995; Gieseg & Cato, 
2003; Gieseg et al., 2003; Greilberger et al., 2004). This inhibition occurred whether the 
oxidative stress was derived from copper ions or the peroxyl radical generator, 2,2’-
azobis (2-amidinopropane) dihydrochloride (AAPH). Low micromolar concentrations 
of 7,8-NP were further found to inhibit ROS-mediated damage to a variety of other 
substrates, including bovine serum albumin (BSA) (Duggan et al., 2001), erythrocytes 
(Gieseg et al., 2001a) and the U937 monocytic cell line (Gieseg et al., 2001b; Duggan 
et al., 2002). These studies noted protection against damage that ranged from dityrosine 
and protein hydroperoxide formation to haemolysis, cell death and thiol oxidation. The 
7,8-NP-mediated inhibition of protein hydroperoxide formation will be discussed in 
greater detail in chapter 5. It is worth noting now, however, that although 7,8-NP has 
been shown to decompose protein hydroperoxides on BSA, the degradation half-life is 
120 minutes (Duggan et al., 2001). Thus, 7,8-NP’s scavenging activity is a more 
significant form of protection against the AAPH-mediated peroxidation of BSA. 
Similarly, 7,8-NP appears to prevent copper- and AAPH-induced protein hydroperoxide 
formation on LDL by scavenging the lipid-derived radicals that are suggested to 
promote protein peroxidation (Gieseg et al., 2003). 
 7,8-NP also appears to efficiently scavenge reactive nitrogen species (RNS), 
inhibiting 3-nitrotyrosine formation in a simple system of 7,8-NP, tyrosine and 
peroxynitrite (Widner et al., 1998; Oettl et al., 2004).  
 
1.3.3.3 Pro-oxidant/Antioxidant Balance and Apoptosis 
Although 7,8-NP is clearly a potent radical scavenger, under certain circumstances this 
pteridine can also exhibit pro-oxidant activity. LDL oxidation serves as a useful model 
of this pro-oxidant/antioxidant balance because co-incubating 7,8-NP with copper and 
native LDL is strongly antioxidative. However, a 20 minute pre-incubation was found to 
inhibit LDL conjugated diene formation only after an initial 30 minutes of weak but 
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significant pro-oxidant activity (Herpfer et al., 2002). This result was attributed to the 
7,8-NP-mediated reduction of copper to its redox active form, with antioxidant activity 
then dominating reactions once the reduction was complete. It is therefore unsurprising 
that 7,8-NP has been directly confirmed to reduce another transition metal, iron, to the 
redox active ferrous ion state (Wirleitner et al., 2005). 7,8-NP’s strong reducing activity 
is also suggested to promote the oxidation of both minimally and moderately oxidized 
LDL in the presence or absence of copper ions (Greilberger et al., 2004).  
 The fully reduced tetrahydrobiopterins have been shown to generate superoxide 
upon autoxidation (Walter et al., 2001). Autoxidation of the partially reduced 7,8-NP is 
expected to yield similarly reactive products. This provides an alternative pathway for 
7,8-NP-mediated oxidative stress and is supported by the work of Oettl et al. (1999) and 
Wirleitner et al. (2001). These groups used two different detection systems to confirm 
the formation of oxygen radicals in solutions containing 7,8-NP, and noted that radical 
production was further enhanced in the presence of transition metals. Additional support 
for radical production arises from the detection of pterin-derived radicals upon the      
co-incubation of 7,8-NP with SIN-1 and the TMIO spin trap (Oettl et al., 2004).  
 These reactions highlight a parallel to the pro-oxidant/antioxidant balance of 
ascorbic acid and potentially explain the biphasic effects observed in some 7,8-NP 
studies. This pteridine inhibits hydrogen peroxide-induced chemiluminescence at lower 
concentrations but, by 5mM 7,8-NP, an enhancing effect is observed (Murr et al., 
1996). Likewise, micromolar concentrations of 7,8-NP generally inhibit cell death. 
Anti-Fas-induced apoptosis was inhibited in Jurkat T cells under these conditions 
(Wirleitner et al., 1998), as was TNFα-induced apoptosis (Baier-Bitterlich et al., 1995) 
and oxLDL- and AAPH-induced death (Baird et al., 2005) in U937 cells. In the absence 
of any other apoptotic inducers, micromolar quantities of 7,8-NP neither promote nor 
inhibit death in a range of neuronal cells (Spottl et al., 2000; Enzinger et al., 2002b), 
monocytes (Baird et al., 2005) and T lymphocytes (Wirleitner et al., 1998). By contrast, 
5mM 7,8-NP alone has been shown to directly promote apoptosis in astrocyte-like cells 
(Spottl et al., 2000), neuronal cells (Spottl et al., 2000; Enzinger et al., 2001; Enzinger 
et al., 2002b) and T lymphocytes (Baier-Bitterlich et al., 1996a; Wirleitner et al., 1998; 
Wirleitner et al., 2001; Enzinger et al., 2002a). Apoptosis in the U937 (Baier-Bitterlich 
et al., 1995) and rat PC12 (Enzinger et al., 2001) cells appears to be further enhanced by 
co-incubating 5mM 7,8-NP with TNFα. 
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 A few exceptions to this biphasic trend do exist, with micromolar 7,8-NP 
concentrations inducing apoptosis in both the rat alveolar epithelial L2 cell line 
(Schobersberger et al., 1996) and in human peripheral blood T cells (Wirleitner et al., 
2003). Nevertheless, this susceptibility has been attributed to species-, cell- and tumour-
specific differences.  
 Antioxidants ranging from N-acetylcysteine (NAC) to pyrollidine dithiocarbamate 
(PDTC), catalase and SOD have been demonstrated to significantly inhibit 7,8-NP-
mediated apoptosis (Baier-Bitterlich et al., 1995; Baier-Bitterlich et al., 1996a; 
Wirleitner et al., 1998; Spottl et al., 2000; Enzinger et al., 2002b; Wirleitner et al., 
2003). It therefore appears that the presence of excess 7,8-NP results in ROS generation, 
disrupting the oxidant/antioxidant balance and ultimately leading to cell death. 
 
In contrast to 7,8-NP, neopterin tends to exhibit only pro-oxidant activity during studies 
of chemiluminescence and bacterial cytotoxicity (Weiss et al., 1993; Murr et al., 1994; 
Reibnegger et al., 1995; Horejsi et al., 1996; Murr et al., 1996; Wede et al., 1999), as 
well as nitration (Widner et al., 1998) and LDL oxidation (Herpfer et al., 2002; 
Greilberger et al., 2004). The neopterin-mediated LDL oxidation occurred whether 
native, minimally or moderately oxidized LDL was used, but the enhancement was 
small and dependent on the presence of another oxidizing source (Herpfer et al., 2002; 
Greilberger et al., 2004). Unlike 7,8-NP, the effects of neopterin were also generally 
dependent on pH. 3-Nitrotyrosine formation was promoted by neopterin only between 
pH4 to pH5.5 (Widner et al., 1998), while its enhancement of chloramine T- and 
hydrogen peroxide-induced chemiluminescence and cytotoxicity required a neutral or 
slightly alkaline pH (Weiss et al., 1993). Additionally, hydrogen peroxide-induced 
chemiluminescence was shown to be dependent on the presence of iron chelator 
complexes (Murr et al., 1994; Murr et al., 1996). 
 Neopterin’s pro-oxidant nature was found to extend to the enhancement of an 
NADPH-independent release of ROS from adhesive neutrophils (Razumovitch et al., 
2003) and to the promotion of UV-A irradiation-induced DNA damage in B-16 
melanoma cells (Kojima et al., 1995). Furthermore, apoptosis in the rat alveolar 
epithelial L2 cell line was increased by neopterin, either alone or in combination with 
IFN-γ and TNFα (Schobersberger et al., 1996). Neopterin also enhanced apoptosis in rat 
vascular SMCs (Hoffmann et al., 1998b). By contrast, the presence of up to 1mM 
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neopterin slightly inhibited TNFα-induced apoptosis in U937 cells (Baier-Bitterlich      
et al., 1995). 
 7,8-NP is oxidized to 7,8-dihydroxanthopterin in the presence of oxidants like 
chloramine T, AAPH, hydrogen peroxide and oxygen (Murr et al., 1996; Oettl et al., 
1999; Gieseg et al., 2001a; Duggan et al., 2002). Conversely, co-incubating 7,8-NP 
with hypochlorite produces neopterin (Widner et al., 2000; Gieseg et al., 2001a). Both 
modifications contrast with the lack of chemical alteration observed for neopterin upon 
enhancement of chemiluminescence and this has led to the suggestion that neopterin 
promotes oxidative damage via an unidentified catalytic mechanism (Murr et al., 1996). 
Nevertheless, pterin radicals have been detected during neopterin-mediated 
enhancement of photodamage to DNA (Ito & Kawanishi, 1997). Neopterin’s mode of 
action therefore remains unclear and seems likely to vary between experimental 
conditions. Under some circumstances neopterin can even be neutral (Oettl & 
Reibnegger, 2002), as was observed when studying the effect of neopterin on apoptosis 
in rat PC12 cells (Enzinger et al., 2002b) or human neuronal NT2 cells (Spottl et al., 
2000).  
 
1.3.3.4 Gene Expression and Signal Transduction 
While disruption of the cellular redox balance promotes apoptosis, it is also suggested to 
account for the neopterin- and 7,8-NP-mediated activation of various redox-sensitive 
transcription factors. A two hour incubation with 20µM neopterin enhanced NF-κB 
translocation to the nucleus of rat vascular SMCs but could be inhibited by pre-
incubation with the antioxidant PDTC (Hoffmann et al., 1996). As NF-κB is postulated 
to participate in iNOS stimulation, it is unsurprising that the same quantity of neopterin 
has also been observed to upregulate iNOS transcription and nitric oxide release in these 
cells (Schobersberger et al., 1995; Hoffmann et al., 1996). Another study investigated 
NF-κB activation in Jurkat T cells transfected with a NF-κB promoter-chloramphenicol 
acetyltransferase (CAT) reporter gene construct (Baier-Bitterlich et al., 1997). 
Transcription of this reporter gene construct was significantly upregulated upon the    
co-incubation of 7,8-NP with TNFα. In the same paper, 7,8-NP alone was shown to 
enhance transcription of an AP-1-CAT promoter-reporter gene construct. More 
specifically, the activity of AP-1’s c-fos subunit has been studied in transfected NIH3T3 
fibroblasts (Uberall et al., 1994). 7,8-NP and, to a lesser extent, neopterin were both 
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able to transactivate a c-fos-CAT promoter-reporter gene construct. Further upregulation 
was observed by co-incubating the pteridines with cyclic guanosine monophosphate 
(cGMP). 
 The downstream consequences of pteridine-induced transcription factor activation 
are not merely restricted to host cells. NF-κB is a known enhancer element of the HIV-1 
long terminal repeat (LTR) promoter (Baier-Bitterlich et al., 1997) and, accordingly, a 
study of Jurkat T cells transiently transfected with an HIV-1-CAT promoter-reporter 
gene construct has confirmed that 7,8-NP enhances HIV-1 expression (Wirleitner et al., 
2005). This pteridine also transactivates the type 1 human T-cell leukaemia virus 
(HTLV-1) LTR promoter when incubated with Jurkat T cells at a concentration of 5mM 
(Baier-Bitterlich et al., 1996a). 
 Even second messengers like calcium appear susceptible to the effects of pteridines, 
thereby providing an alternative route for neopterin and 7,8-NP to influence cellular 
signalling. Both compounds, but especially 7,8-NP, were found to elevate intracellular 
calcium levels in the THP-1 monocyte cell line (Woll et al., 1993). These increases 
were attributed to the activation of a pteridine-induced calcium channel and, for 7,8-NP, 
it required as little as 10nM pteridine. 
 Two cytokines, IFN-γ and TNFα, are also upregulated by pteridines. Incubation 
with 7,8-NP was reported to transactivate an IFN-γ-CAT promoter-reporter construct   
in transfected Jurkat T cells (Baier-Bitterlich et al., 1996b). This upregulation was 
inhibited by NAC and, as a result, is theorized to occur via a ROS-dependent 
mechanism. Considering IFN-γ’s central role in stimulating 7,8-NP synthesis, the      
7,8-NP-mediated transactivation also suggests the existence of a positive feed-back 
loop. Meanwhile, TNFα release was enhanced by neopterin in both human peripheral 
blood mononuclear cells (Barak & Gruener, 1991) and vascular SMCs (Hoffmann et al., 
1998a). Although the former cell type involved co-incubation with IL-2, IFN-γ and 
LPS, the latter cell type was susceptible to TNFα synthesis in the presence of neopterin 
alone. Upregulating both these cytokines is expected to promote a pro-inflammatory 
environment. Such conditions are clearly of significance in atherosclerosis, as is the 
presence of ICAM-1. It is therefore of relevance that 7,8-NP has been shown to induce 
ICAM-1 expression in type II-like alveolar epithelial cells (Hoffmann et al., 1999).  
 
Neopterin could potentially contribute to tumour progression, either by preventing nitric 
oxide-mediated apoptosis or by promoting angiogenesis (Reider et al., 2003). The 
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former pathway is suggested because ovarian cancer cells are susceptible to nitric oxide 
and, unlike rat vascular SMCs, neopterin inhibits nitric oxide synthesis in this cell type. 
Neopterin has also been shown to induce the expression of erythropoietin (EPO) and 
vascular endothelial growth factor (VEGF) in ovarian cancer cells. Both these proteins 
are postulated to participate in angiogenesis during tumour development. Neopterin- 
and 7,8-NP-induced expression of the c-fos proto-oncogene provides yet another 
pathway for pteridine promotion of tumour growth (Reider et al., 2003).  
 Conversely, 7,8-NP’s modulation of the cellular redox balance in Jurkat T cells was 
found to promote apoptosis by inducing expression of the Fas ligand (Wirleitner et al., 
2001). Similarly, 7,8-NP enhanced apoptosis in rat PC12 cells by upregulating 
signalling cascades associated with mitogen-activated protein kinases (MAPKs) 
(Enzinger et al., 2001; Enzinger et al., 2002b). Activation of p44/42 ERK was mediated 
by 7,8-NP alone, while strong activation of SAPK required co-incubation with TNFα. 
 
It is clear that both neopterin and 7,8-NP influence a broad range of cellular functions. 
In many cases, the exact mechanism(s) of action remain to be elucidated. Nevertheless, 
a critical and recurring feature appears to be a neopterin- and 7,8-NP-induced 
disturbance of the cellular redox balance.  
 
1.4 Research Programme 
Two major aims define the following research: 
• To determine the extent of protein hydroperoxide formation on HMDM cells and 
LDL exposed to oxidative stress. 
• To determine the potential of 7,8-NP to protect HMDM cells and LDL against 
oxidative stress, whether supplied exogenously or endogenously. 
These aims were developed because atherosclerosis results in an environment of 
oxidative stress. Macrophages and LDL have both been detected in atherosclerotic 
plaques and are known to be susceptible to oxidative damage. However, to date, most 
studies have focussed on peroxidation of the lipid components rather than the protein 
components of these substrates. The role of 7,8-NP in vivo remains controversial but, 
given the inflammatory nature of atherosclerosis, this pteridine is expected to co-exist in 
atherosclerotic plaque with the cells and LDL. A number of studies have identified an 
antioxidant activity for 7,8-NP in vitro, raising the possibility that macrophages may 
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synthesize this pteridine to protect themselves and/or other substrates from oxidative 
damage. 
 Chapter 3 will therefore describe protein hydroperoxide and lipid hydroperoxide 
formation in HMDMs exposed to the AAPH peroxyl radical generator. The kinetics of 
peroxidation will be compared to HMDM viability loss before determining the ability  
of 7,8-NP to inhibit AAPH-induced oxidative damage and cell death. 7,8-NP will be 
provided both exogenously and via stimulation of HMDMs with IFN-γ. 
 The extent of protein hydroperoxide formation during macrophage-mediated      
LDL oxidation will be described in Chapter 5 and correlated to a range of other LDL 
oxidation markers. (Chapter 4 will be devoted to resolving the variable rate of cell free 
LDL oxidation in Ham’s F10, thereby enabling accurate conclusions to be drawn in 
Chapter 5.) Attention will then turn to the efficacy of 7,8-NP in preventing macrophage-
mediated oxidation of LDL’s protein, lipid and antioxidant components. These 
experiments will be conducted using both the THP-1 cell line and the more 
physiologically relevant HMDMs. An attempt will also be made to identify 7,8-NP’s 
mode of action and to confirm whether the IFN-γ-induced effect can be attributed to 
7,8-NP or is caused by some other, unspecified, IFN-γ-mediated activity.  
 The in vivo relevance of 7,8-NP will ultimately be described in Chapter 6 by 
measuring the levels of neopterin and various markers of oxidation in two examples of 
inflammatory material – pus and atherosclerotic plaque. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Reagents 
Water was deionized and ultrafiltered using a Milli-Q filtration system and, unless 
otherwise stated, all solutions were prepared in this nanopure water. All reagents used 
were of analytical grade or better. 
 
α-Naphthyl acetate esterase staining kit Sigma Chemical Co; St. Louis, MO, USA 
α-Tocopherol Sigma Chemical, Co. 
1,1,3,3-Tetramethoxypropane (TMP) Sigma Chemical Co. 
2,2’-Azobis (2-amidinopropane) dihydrochloride Aldrich Chemical Co; Sydney, Australia 
(AAPH)   
2,4-Dinitrophenyl hydrazine (DNPH) Sigma Chemical Co. 
2-Thiobarbituric acid (TBA) Sigma Chemical Co. 
3,4-Dihydroxyphenylalanine (DOPA) Sigma Chemical Co. 
5,5’-Dithiobis (2-nitrobenzoic acid) (DTNB) Sigma Chemical Co. 
7,8-Dihydroneopterin (7,8-NP) Schircks Laboratory; Switzerland 
Ammonium ferrous sulphate Hopkins & Williams Ltd; Essex, England 
Acetic acid Merck Ltd; Poole, England 
Acetone Merck Ltd 
Argon gas BOC Gasses; NZ 
Ascorbic acid Sigma Chemical Co. 
Bathocuproine disulphonic acid (BCS) Sigma Chemical Co. 
Bathophenanthroline disulphonic acid (BPS) Sigma Chemical Co. 
Bicinchoninic acid (BCA) protein determination  Pierce; Illinois, USA 
kit  
Bovine serum albumin (BSA) Sigma Chemical Co. 
Butylated hydroxytoluene (BHT) Sigma Chemical Co. 
Chelex 100 resin Bio-Rad Laboratories; CA, USA 
Chloroform Merck Ltd and Asia Pacific Speciality  
  Chemicals Ltd; Auckland, NZ 
Cholesterol reagent Roche Diagnostics; USA 
Citric acid BDH Chemicals Ltd; Palmerston North, 
  NZ 
Copper chloride  BDH Chemicals Ltd 
Cytochrome C Sigma Chemical Co. 
Dialysis tubing Biolab Scientific; Auckland, NZ 
Di-ammonium hydrogen orthophosphate BDH Chemicals Ltd  
Diethyl ether Merck Ltd 
Dimethyl sulphoxide (DMSO) BDH Chemicals Ltd 
Ethanol BDH Chemicals Ltd 
Ethyl acetate Merck Ltd   
Ethylenediaminetetraacetic acid (EDTA) BDH Chemicals Ltd 
Ferricyanide Sigma Chemical Co. 
Formaldehyde Merck Ltd  
Guanidine hydrochloride (GuHCl) Sigma Chemical Co.  
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HEPES Sigma Chemical Co. 
n-Hexane Merck Ltd 
Hydrochloric acid (HCl) BDH Chemicals Ltd 
Iodine BDH Chemicals Ltd 
Interferon-γ (IFN-γ)  Imukin®; Boehringer Ingelheim Pty Ltd;  
   NSW, Australia 
Iron sulphate  Ajax Chemicals; NSW, Australia 
Iron chloride  Sigma Chemical Co. 
Lymphoprep Axis-Shield PoC AS; Oslo, Norway 
Neopterin Schircks Laboratory 
Nitrogen gas BOC Gasses 
Mercaptoacetic acid Sigma Chemical Co. 
Methanol  Merck Ltd 
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyl- Sigma Chemical Co. 
tetrazolium bromide (MTT) 
Nitroblue tetrazolium (NBT) Sigma Chemical Co. 
Orthophosphoric acid (85%) BDH Chemicals Ltd 
Perchloric acid (PCA) BDH Chemicals Ltd 
Phenol Sigma Chemical Co. 
Phorbol 12-myristate 13-acetate (PMA) Sigma Chemical Co. 
Potassium bromide  Merck Ltd 
Potassium hydroxide Merck Ltd 
Potassium iodide May & Barker Ltd; Dagenham, England 
Sodium acetate Merck Ltd 
Sodium borohydride Sigma Chemical Co. 
Sodium chloride BDH Chemicals Ltd 
Sodium dihydrogen orthophosphate Merck Ltd 
Sodium dodecyl sulphate (SDS) Sigma Chemical Co. 
Sodium hydrogen carbonate (NaHCO3) Merck Ltd 
Sodium hydroxide  Merck Ltd 
Sucrose Chelsea Sugar Refinery; Auckland, NZ 
Sulphuric acid BDH Chemicals Ltd 
Superoxide dismutase, bovine erythrocyte (SOD) Sigma Chemical Co. 
Trichloroacetic acid (TCA) Sigma Chemical Co. 
Trifluoroacetic acid (TFA) Sigma Chemical Co. 
Trypan blue solution (0.4%) Sigma Chemical Co. 
Xylenol orange, sodium salt Sigma Chemical Co. 
 
2.1.2 Media 
Earle’s balanced salt solution (EBSS) Sigma Chemical Co. 
Ham’s F10 Sigma Chemical Co. and Gibco BRL; 
  Auckland, NZ 
Hanks’ balanced salt solution (HBSS) Sigma Chemical Co. 
Heat-inactivated foetal calf serum (HIFCS) Gibco BRL 
Penicillin/streptomycin (100 units/ml penicillin G  Gibco BRL 
and 100µg/ml streptomycin, final concentration) 
Roswell Park Memorial Institute 1640 (RPMI) Sigma Chemical Co. 
RPMI 1640, without phenol red Sigma Chemical Co. 
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2.1.3 General Solutions, Buffers and Media 
2.1.3.1 Phosphate Buffered Saline (PBS) 
Phosphate buffered saline (150mM sodium chloride and 10mM sodium dihydrogen 
orthophosphate, pH 7.4) was stirred with 1g of Chelex residue for at least four hours to 
remove contaminating metal ions before being vacuum filtered through a 0.45µm 
membrane. If required for cell culture, the PBS was autoclaved (15 minutes, 121°C and 
15psi) and then warmed to 37°C immediately prior to use with cells.  
 
2.1.3.2 HPLC Mobile Phases 
HPLC mobile phases that contained salt were vacuum filtered through a 0.45µm 
membrane and degassed via sonication.  
 
2.1.3.3 Cell Culture Media 
Powdered medium was dissolved in water, before adding sodium bicarbonate and 
adjusting the solution to pH 7.4, as per the manufacturer’s instructions. Sterilization was 
accomplished using a peristaltic pump (CP-600, Life Technologies) and a 0.22µm 
Millex®-GP50 filter (Molsheim, SA). Once transferred into sterile bottles, media was 
stored at 4°C but warmed to 37°C before use. 
 
2.1.3.4 7,8-Dihydroneopterin Solution 
A 2mM stock of 7,8-dihydroneopterin (7,8-NP) was prepared fresh prior to each 
experiment by dissolving in degassed media (Ham’s F10 for LDL oxidation 
experiments; EBSS for AAPH experiments; and RPMI for TPMET experiments) during 
a five to ten minute sonication. This antioxidant was subsequently sterilized by filtration 
through a 0.22µm membrane filter. 
 
2.2 Methods 
2.2.1 LDL preparation 
Ethics approval for the use of human blood was granted by the Canterbury Ethics 
Committee (protocol number 98/07/069). After an overnight fast, and obtaining written 
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consent, blood was collected from donors by venipuncture using a 21G x ¾ inch winged 
infusion set. The blood was drained directly into 50ml Falcon tubes, containing 0.5ml of 
10% (w/v) EDTA (pH 7.4), and centrifuged in a swing-out rotor at 4°C for 20 minutes at 
4,100g with the brake off. The resulting plasma was transferred to centrifuge tubes for a 
30 minute spin at 11,000g in a fixed angle rotor to remove any remaining trace of cells. 
Plasma from all donors was pooled to minimize inter-individual variation and stored in 
the presence of 0.6% sucrose in 20ml aliquots at -80°C for a maximum of six months 
(Gieseg & Esterbauer, 1994). 
 Plasma was thawed, as required, and centrifuged at 4,100g for ten minutes at 4°C to 
remove any precipitated fibrinogen. The density of the plasma was then adjusted to 
1.41g/ml, by dissolving potassium bromide (410mg/ml) in the ice-cold plasma, before 
being distributed evenly between six Beckman ultracentrifuge tubes.  
 Three different density gradients of sodium chloride were prepared in a 1mg/ml 
EDTA (pH 7.4) solution. The densities ranged from 1.08g/ml (solution A) to 1.05g/ml 
(solution B) and 1g/ml (solution C), with 3ml of each being layered into the 
untracentrifuge tubes. Solution A was placed immediately above the plasma, followed 
by solution B and finally solution C (top layer), to establish a discontinuous gradient of 
decreasing densities. The tubes were then transferred to a Beckman 41-Ti rotor and 
centrifuged at 10°C and 40,000rpm for 22 hours to ensure isolation of an orange band of 
LDL in the density range of 1.019g/ml to 1.063g/ml. This band was collected by syringe 
and, in order to remove all trace of EDTA, was dialysed for 24 hours at 4°C against four 
changes of degassed PBS containing Chelex 100 resin. Freshly dialysed LDL was 
stored under argon and filter sterilized through a 0.22µm membrane filter immediately 
prior to the start of an experiment. 
 
The cholesterol content of LDL was determined by incubating 10µl of LDL with 1ml of 
cholesterol reagent at room temperature for ten minutes and subsequently measuring the 
absorbance at 500nm against a cholesterol reagent blank. An LDL concentration was 
calculated from this absorbance, based on an estimate of cholesterol accounting for 
31.64% of the LDL particle by weight and LDL having a molecular weight of 2.5MDa 
(Gieseg & Esterbauer, 1994). 
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2.2.2 Cell Culture 
A Class II biological safety cabinet (Clyde-Apex BH 200) was used under aseptic 
conditions for all cell experiments. Sterile plasticware was supplied by Bector 
Dickinson & Co., Nunc, Nalge Nunc International or Falcon. All other materials were 
sterilized either by autoclaving (15 minutes, 121°C and 15psi) or by filtration through a 
0.22µm membrane filter. 
 Experiments were conducted on both the THP-1 monocyte-like cell line and primary 
HMDMs. Cells were stored at 37°C in a humidified incubator, with an atmosphere 
calibrated to 5% carbon dioxide:95% air (Nuaire™ IR Autoflow).   
 
2.2.3 THP-1 Cell Line 
The THP-1 cell line was originally obtained from a patient with acute monocytic 
leukaemia and has been confirmed to possess monocytic properties (Tsuchiya et al., 
1980). Suspensions of the cells were grown in 75cm2 tissue culture flasks, in RPMI 
1640 containing phenol red and L-glutamine and supplemented with 5% (v/v) heat-
inactivated foetal calf serum, 100 units/ml penicillin G and 100µg/ml streptomycin. Cell 
concentrations were maintained between 2x105 cells/ml and 1x106 cells/ml by passaging 
every two to four days. Adverse effects associated with excessive passaging were 
minimized by removing a fresh stock of THP-1s from liquid nitrogen storage every 
three to four months.  
 Trypan blue exclusion staining (Moldeus et al., 1978) provided a quick measure of 
viability for these suspension cells. Stain was mixed with cell suspension before using a 
light microscope to count the number of opaque (alive) cells in defined regions of a 
haemocytometer.  
 Although THP-1 monocytes were maintained in suspension, all experiments were 
conducted on THP-1s in their adherent macrophage-like form. Prior to an experiment 
cells were therefore incubated with PMA, a compound previously shown to promote 
THP-1 differentiation (Tsuchiya et al., 1982; Graham et al., 1994). Unless otherwise 
stated, THP-1s were adjusted to a concentration of 1x105 cells/ml in RPMI, and PMA 
(dissolved in DMSO) was added to a final concentration of 100ng/ml. Cells were then 
plated at 3ml/well in six well adherent plates (for LDL oxidation experiments) or 
1ml/well in 12 well adherent plates (for TPMET experiments) and incubated for one 
week. Fresh medium, supplemented with PMA, was supplied after three to four days.  
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2.2.4 Human Monocyte-Derived Macrophages 
Ethics approval for the use of human blood was granted by the Canterbury Ethics 
Committee (protocol number 98/07/069). The isolation procedure for human monocyte-
derived macrophages (HMDMs) was modified from Christen et al. (1994) by Dr Mark 
Hampton (personal communication) and the Free Radical Biochemistry Laboratory. 
Once isolated, the cells were maintained in RPMI 1640 containing phenol red and       
L-glutamine, supplemented with 10% (v/v) heat-inactivated human serum, 100 units/ml 
penicillin G and 100µg/ml streptomycin. 
 
2.2.4.1 Preparation of Human Monocyte-Derived Macrophages 
Unlinked blood from consenting haemochromatosis patients was collected into 600ml 
autologous bags by the NZ Blood Bank (Riccarton Road, Christchurch). On arrival at 
the Free Radical Biochemistry Laboratory, the blood was aseptically transferred to 50ml 
Falcon tubes and centrifuged at 3000g, with the brake off, for 30 minutes at room 
temperature. The resulting buffy coat was isolated and mixed with Hanks’ Balanced 
Salt Solution (HBSS) in a ratio of 15ml:20ml before underlaying this mixture with 15ml 
of Lymphoprep. (Both solutions had previously been warmed to room temperature.) 
After centrifuging at room temperature at 1000g for 20 minutes with the brake off, a 
white layer of monocytes/lymphocytes was visible approximately half-way down the 
Falcon tube. This layer was transferred to new Falcon tubes and washed four times in 
45ml HBSS, with a 15 minute room temperature centrifugation at 500g between each 
wash step. Cells were subsequently resuspended in serum-free RPMI 1640 (warmed to 
room temperature), at a concentration of 5x106 cells/ml, and then 7ml per well was 
aliquoted into six well suspension plates. A small quantity of heat-inactivated human 
serum (5µl/ml of cell suspension) was added to each well before incubating the plates           
for approximately 40 hours. Under these conditions, any T cells contaminating the     
cell suspension are unable to survive while platelets adhere to the surface of the      
plate. By contrast, monocytes remain both viable and in suspension. After the 40 hour 
incubation period they were therefore resuspended in fresh RPMI 1640, supplemented 
with 10% heat-inactivated human serum, at a concentration of either 3x106 cells/ml      
or 5x106 cells/ml (depending on experimental requirements) and plated at 1ml/well in 
12 well adherent plates. 
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 Fresh medium (RPMI 1640 containing 10% heat-inactivated human serum) was 
supplied every three to four days and experiments were conducted once the majority of 
monocytes had matured to macrophages, usually 14 days after the initial isolation of the 
cells. Excess monocytes were greatly reduced in number at the start of an experiment by 
washing all wells three times in warm, sterile PBS.  
 
2.2.4.2 Preparation of Heat-Inactivated Human Serum 
Unlinked blood from consenting haemochromatosis patients was collected into 600ml 
dry bags by the NZ Blood Bank (Riccarton Road, Christchurch). An overnight 
incubation, at 4°C, provided time for the serum to completely separate from the blood 
clot. A sterile mixing canula and syringe were then used to transfer the serum from the 
bag to 50ml Falcon tubes. The tubes were spun at 400g for 15 minutes to pellet any 
remaining blood cells and the serum was decanted into new Falcon tubes. 
 All serum was heat inactivated in a water bath at 56°C for 30 minutes before being 
cooled and stored at -80°C until required. 
 
2.2.4.3 α-Naphthyl Acetate Esterase Staining Procedure 
Cellular esterases are ubiquitous but do exhibit cell-specific differences, thereby 
providing a convenient means of determining the purity of HMDM preparations. The  
α-naphthyl acetate esterase enzyme is primarily expressed in monocytes and 
macrophages and, upon incubation with α-naphthyl acetate, these cells will hydrolyse 
the ester linkage and release naphthyl. This free naphthyl readily reacts with a 
diazonium salt, forming a blue-black compound that is clearly visible at the site of      
the enzyme activity (Moloney et al., 1960). 
 Before seeding the monocytes at 5x106 cells/ml, sterile glass coverslips (1cm x 1cm) 
were placed into the wells of 12 well adherent plates. This ensured that the monocytes 
adhered to, and differentiated directly on, the coverslip. Fourteen days later the 
coverslips were removed and the cells were fixed by a 30 second immersion in a citrate-
acetone-formaldehyde solution (25:65:8), followed by a gentle rinse in water for 60 
seconds. The fixed slides were subsequently incubated in the dark for 30 minutes at 
37°C in a mixture containing 40ml pre-warmed water, 1ml 0.1M sodium nitrite, 1ml 
Fast Blue BB Base solution, 5ml TRIZMAL 7.6 buffer concentrate and 1ml α-naphthyl 
acetate solution (all supplied in the Sigma α-naphthyl acetate staining kit). The slides 
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were then rinsed thoroughly in water for two minutes before counterstaining in 
Hematoxylin solution for a further two minutes. Following a final rinse in water, the 
coverslips were dried and examined microscopically to determine the percentage of 
cells exhibiting α-naphthyl acetate esterase activity. Cells stained a blue-black colour 
were considered to be positive for α-naphthyl acetate esterase activity and, 
consequently, were described as monocytes/macrophages. 
 
2.2.5 AAPH Experimental Set-up 
All experiments investigating the effect of AAPH on HMDMs were conducted at a 
concentration of 5x106 cells/ml and in a total volume of 1ml/well. Cells were washed 
three times in PBS before the addition to each well of the minimal medium, Earle’s 
Balanced Salt Solution (EBSS), and 0-50mM AAPH. After incubating for the required 
length of time, HMDM samples were analyzed for cell viability, protein 
hydroperoxides, lipid hydroperoxides or thiol loss. 
 When studying the protective capacity of 7,8-NP or IFN-γ, slight modifications to 
the above protocol were required. 7,8-NP was pre-incubated in EBSS with the HMDMs 
for ten minutes before initiating the experiment upon addition of AAPH. Experiments 
investigating IFN-γ required a 48 hour pre-incubation of the HMDMs in fresh RPMI, 
supplemented with 10% heat-inactivated human serum and up to 1000U/ml of the 
cytokine. After 48 hours, cells were washed three times in PBS and then incubated in 
EBSS with appropriate concentrations of IFN-γ and AAPH.  
 
2.2.6 Cell-Mediated LDL Oxidation Experimental Set-up 
Ham’s F10 has previously been shown to be permissive for cell-mediated LDL 
oxidation (Graham et al., 1994; Wood & Graham, 1995) and, as such, oxidation 
experiments using THP-1 macrophage-like cells (1x105/ml) or HMDMs (3x106/well) 
were all conducted in this medium. Some studies required chelexed Ham’s F10, which 
was prepared immediately prior to an experiment by mixing Ham’s F10 and Chelex 100 
resin (¼ teaspoon per 50ml media) at 4°C for at least four hours. The Chelex was 
subsequently pelleted by centrifugation and the Ham’s F10 was filter sterilized through 
a 0.22µM membrane filter. 
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 After washing the cells three times in PBS, Ham’s F10 (chelexed or non-chelexed) 
was aliquoted into each well in sufficient quantities to ensure a final volume of 3ml 
once all reagents were added. Depending on experimental requirements, each well was 
then supplemented with additional ferrous sulphate, ferric chloride and/or copper 
chloride and a pre-incubation period of five minutes was allowed before the inclusion of 
0.1mg/ml LDL. A control, lacking cells but containing all other reagents, was also 
prepared. At various time points, the supernatant was removed from the wells and 
centrifuged at 400g and 4°C for five minutes to pellet any dislodged cells. The resulting 
LDL supernatant was then analyzed for the level of dienes, thiobarbituric acid reactive 
substances (TBARS), vitamin E, dityrosine, protein bound 3,4-dihydroxyphenylalanine 
(PB-DOPA) or protein hydroperoxides.  
 All 7,8-NP and IFN-γ experiments required additional pre-incubations, with 7,8-NP 
supplementation occurring five minutes after the addition of the transition metals and 
requiring an additional five minute pre-incubation before the inclusion of LDL. 
 Ham’s F10 is more nutrient rich than EBSS and therefore, in contrast to the AAPH 
experiments, it was possible to study the effect of IFN-γ by washing the cells three 
times in PBS and then pre-incubating 500U/ml of this cytokine for 48 hours in Ham’s 
F10. The incubation was subsequently initiated by removing excess Ham’s F10 and 
replacing it with transition metals, LDL and a small amount of IFN-γ to ensure retention 
of a final IFN-γ concentration of 500U/ml and a total experimental volume of 3ml. 
 
2.2.7 Cell-Mediated BSA Oxidation Experimental Set-up 
Adherent THP-1s (1x105 cells/ml) were washed in PBS three times before the addition 
of non-chelexed Ham’s F10 to each well and supplementation with 1.5µM ferrous 
sulphate. A five minute pre-incubation was followed by the inclusion of bovine serum 
albumin (BSA), with concentrations ranging from 0-5mg/ml. The incubation was halted 
at various times by removal of the 3ml of supernatant. Dislodged cells were eliminated 
by centrifugation at 400g for five minutes at 4°C, and the supernatant was then analyzed 
for protein hydroperoxide formation. A cell free control was included at every time 
point for comparison. 
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2.2.8 Pus Preparation 
Pus was collected from patients by staff at the Digital Subtraction Angiography (DSA) 
Unit in Christchurch Hospital’s Radiography Department, with ethics approval granted 
by the Upper South B Regional Ethics Committee (protocol number CTY/0104036) and 
written consent given by all patients. The pus was subsequently transported to the Free 
Radical Biochemistry Laboratory on ice and stored at -80°C until required.  
 After thawing samples under cold running water, 2ml of pus was homogenized in a 
tissumizer (Tekmar Ltd, USA) with 2ml of water and 50µl each of 20mg/ml BHT (in 
methanol) and 100mg/ml EDTA (pH 7.4). The total volume was recorded and samples 
were aliquoted in preparation for the analysis of PB-DOPA, dityrosine, carbonyls, 
pterin, vitamin E, TBARS and protein content. 
 
2.2.9 Plaque Preparation 
The carotid artery was obtained from patients in Christchurch Hospital’s Department of 
Surgery, with ethics approval granted by the Upper South B Regional Ethics Committee 
(protocol number CTY/0104036). Provided patients had given written consent, it was 
placed on ice and transported to the Free Radical Biochemistry Laboratory to be 
weighed and then stored at -80°C. 
 When ready for analysis, the plaque was thawed and photographed. It was 
subsequently dissected into sections approximately 3-5mm in length, with the sample 
furthest away from the bifurcation being labelled as section number one. Transverse 
views of each fragment were photographed, and weights were also recorded, before 
homogenizing each section in a tissumizer in the presence of 5ml water and 50µl each 
of 100mg/ml EDTA (pH 7.4) and 20mg/ml BHT (in methanol). The total volume was 
noted and samples from each section were then aliquoted for PB-DOPA, dityrosine, 
carbonyls, pterin, vitamin E, TBARS, protein and cholesterol analysis. 
 
2.2.10 Viability Assays 
2.2.10.1 Trypan Blue Exclusion Staining 
Trypan blue exclusion staining monitors cell viability via analysis of membrane 
integrity (Moldeus et al., 1978). Viable cells have intact membranes that are 
impermeable to the dye and, as a consequence, appear opaque when viewed under a 
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microscope. By contrast, dead cells possess disrupted membranes and are no longer able 
to pump the dye out, resulting in a blue appearance. 
 Cells in suspension can be easily counted on a haemocytometer (section 2.2.3) but 
adherent cells remain attached to the surface of the plate. Thus, the viability of adherent 
THP-1s or HMDMs was determined at various time points by removing the incubation 
medium and submerging the cells in trypan blue. (Approximately 200µl ensured full 
coverage of the surface area in a 12 well plate.) Interference from all the excess stain 
was minimized by removal of the dye after 30 seconds and replacement with 1ml of 
warm PBS. An inverted microscope (40x magnification with a 10x eyepiece), was 
subsequently used to randomly examine five fields of view across each well. The 
proportion of viable cells in that well was calculated by dividing the number of viable 
cells from all five fields of view by the total number of cells (both alive and dead) from 
all five fields of view.  
 
2.2.10.2 MTT Assay 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay 
provides an alternative, indirect measure of viability. It is based on the ability of cells to 
endocytose the yellow MTT compound and subsequently metabolize it, via the action of 
cellular NAD(P)H dehydrogenases, into a purple MTT-formazan product that can be 
quantified spectrophotometrically (Mosmann, 1983). As a result, the intensity of the 
colour provides an indication of both the concentration of cells and their metabolic 
activity. 
 After removal of the incubation medium at selected time points, the adherent cells 
were washed twice in PBS. To each well was added 900µl of non-phenol red RPMI 
1640 plus 100µl of 5mg/ml MTT. Samples were then incubated for one to four hours, 
allowing sufficient time for significant quantities of purple compound to form in the 
control wells. This range of time is due to the metabolic activity of HMDMs differing 
from one preparation to the next. Nevertheless, while the incubation period did change 
between experiments, it was kept constant throughout each individual experiment. All 
insoluble MTT-formazan crystals were dissolved by mixing 1ml of 10% (w/v) SDS (in 
0.01M HCl) in each well and incubating for a further 15 minutes. The absorbance was 
read at 570nm, against a blank lacking cells but containing all other reagents. 
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2.2.11 Thiol Determination by the DTNB Assay 
Thiol concentrations were analyzed using an assay described by Ando & Steiner (1973) 
and modified by Soszynski et al. (1997). It relies on the 1:1 stoichiometry of the 
reaction between 5,5’-dithiobis (2-nitrobenzoic acid) (DTNB) and thiols, and the fact 
that the resulting product is 3-carboxylato-4-nitrothiophenolate (CNTP), a coloured 
anion with a peak absorbance at 412nm.  
 
2.2.11.1 Total Cellular Thiols 
Experiments were halted by washing the wells twice in warm PBS before adding 1ml 
cold PBS (pH 7.4) and scraping the HMDMs from the surface of the well. Any cells 
dislodged during the washing steps were collected in 1.8ml microtubes by centrifuging 
the wash solution for five minutes at 400g. The resulting pellet was mixed with the   
1ml scraped cell suspension and all cells were lysed with 0.5ml of 10% (w/v) SDS. 
Following the addition of 15µl of 3mM DTNB (final concentration 30µM), a 30 minute 
room temperature incubation was conducted in a heated shaking block (Eppendorf 
Thermomixer 5436). The absorbance was then measured at 412nm, against blanks 
containing PBS with DTNB and also against cell suspension samples lacking DTNB. 
Absorbance values were converted into thiol concentrations using an extinction 
coefficient of 13,600 M-1.cm-1 (Boyne & Ellman, 1972). 
 
2.2.11.2 Supernatant Thiols 
Supernatant thiols were analyzed during macrophage-like THP-1 transplasma 
membrane electron transport (TPMET) experiments using a simplified version of the 
above method. Dislodged cells were removed from the incubation medium by 
centrifugation at 400g for five minutes. 900µl of the centrifuged HBSS was transferred 
to a new microtube and incubated with 100µl of 300µM DTNB in a shaking block at 
room temperature for 30 minutes. The absorbance was then read at 412nm, against both 
a HBSS blank containing DTNB and a blank containing supernatant with 100µl 
phosphate buffer (pH 7.4) rather than 100µl DTNB.  
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2.2.12 FOX Assays 
Numerous variations of the FOX assay have been described in the literature, with some 
designed to detect lipid hydroperoxides (LOOHs) and others more suited to protein 
hydroperoxide (PrOOH) measurement. The suitability of each assay also depends on the 
substrate being studied. Despite the differences, all forms of the FOX assay indirectly 
measure hydroperoxides due to their ability to oxidize ferrous ions (Fe2+) to ferric ions 
(Fe3+) (reaction 11). Xylenol orange (XO) subsequently reacts with the ferric ions to 
form a complex (Fe-XO) that possesses a maximum absorbance at 560nm (reaction 12). 
(11) Fe2+  +  PrOOH  →  Fe3+  +  OH-  +  PrO• 
(12) Fe3+  +  XO  →  Fe-XO 
 
2.2.12.1 Protein Hydroperoxide Detection on BSA (FOX-1) 
The supernatant was removed at selected times from the wells and centrifuged as 
explained in section 2.2.6. Using a variation of the FOX assay described by Gay et al. 
(1999), the supernatant was then transferred to clean glass tubes and vortexed in the 
presence of 420µl of 72% (w/v) TCA. Protein in the samples was precipitated by storage 
on ice for ten minutes, with a subsequent centrifugation at 4100g at 4°C for a further       
15 minutes. The resulting pellet was resuspended in 1ml of 5% TCA, transferred to 
1.8ml microcentrifuge tubes and spun at 10,300g and 4°C for seven minutes. Following 
a second 5% TCA wash and centrifugation, the dry pellet was resuspended in 900µl of 
25mM sulphuric acid (H2SO4) and mixed first with 50µl of 5mM xylenol orange (in 
25mM H2SO4) and then 50µl of 5mM ferrous ammonium sulphate (in 25mM H2SO4).   
Samples were subsequently incubated at room temperature in the dark for 30 minutes 
before measuring the absorbance at 560nm, against a blank containing 900µl of 25mM 
sulphuric acid and 50µl each of xylenol orange and ferrous ammonium sulphate.  
Protein hydroperoxide concentrations were determined using an extinction coefficient 
of 35,500 M-1.cm-1 (Gay et al., 1999).  
 
2.2.12.2 Protein Hydroperoxide Detection on LDL (FOX-2) 
The LDL-containing supernatant was removed from cell culture wells at selected times 
and centrifuged (section 2.2.6) before being analyzed for protein hydroperoxides using  
a FOX assay protocol described by Gieseg et al. (2003). Protein was precipitated during 
a ten minute incubation on ice with 72% TCA and then centrifuged at 4°C for 15 
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minutes at 4100g. The resulting pellet was resuspended (still in glass tubes) in 1ml of 
1:1 methanol:chloroform and centrifuged for a further 15 minutes. After being air dried, 
the transparent pellet was dissolved in 900µl of 1:1 acetic acid:water, 50µl of 5mM 
xylenol orange and 50µl of 5mM ferrous ammonium sulphate. Blanks, lacking LDL   
but containing all other reagents, were also prepared. A 30 minute incubation in the dark 
at room temperature was followed by a five minute centrifugation at 4,100g to pellet 
any debris. The absorbance was recorded at 560nm and an extinction coefficient of 
48,000 M-1.cm-1 was used to convert absorbance units to protein hydroperoxide 
concentrations (Gay et al., 1999). 
 
2.2.12.3 Hydroperoxide Detection on HMDMs 
HMDMs were analyzed for both lipid and protein hydroperoxides using a method 
developed by Gay & Gebicki (2003).  
 Experiments were halted at selected times by removing the supernatant, then 
washing the adherent cells twice with warm PBS. The PBS and supernatant were 
combined and centrifuged at 400g for five minutes to pellet any cells dislodged during 
the incubation and washing steps. Meanwhile, the cells still attached to the bottom of 
the wells were exposed to 1ml of ice cold water and scraped off the plate. This cell 
suspension was mixed with the previously pelleted cells, thereby ensuring that all cells 
were analyzed for either lipid or protein hydroperoxides. 
 
i) Protein Hydroperoxide Detection on HMDMs (FOX-3) 
HMDM protein was precipitated in microcentrifuge tubes by incubating 1ml of cell 
suspension with 90µl of 2M perchloric acid (PCA) on ice for ten minutes. Samples  
were then centrifuged at 4°C for seven minutes at 10,300g, and the resulting protein 
pellet was resuspended in 1ml of 0.2M PCA. After centrifuging and discarding the 
supernatant again, the pellet was dissolved in 1.2ml of 6M guanidine hydrochloride, 
transferred to glass test tubes and mixed with an equal volume of chloroform 
(containing 4mM BHT). Phase separation was achieved by centrifuging at 4°C for ten 
minutes at 4,100g. The upper aqueous layer (950µl) was then transferred to a microtube 
and washed with 650µl of chloroform (containing 4mM BHT) before the layers were 
once again separated by centrifugation. This enabled 700µl of the upper aqueous phase 
to be isolated and subsequently mixed with 40µl of 0.5M PCA, 25µl of 5mM xylenol 
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orange (in 110mM PCA), 25µl water and 10µl of 5mM ferrous ammonium sulphate (in 
110mM PCA). A 60 minute incubation at room temperature, in the dark, was followed 
by centrifugation for five minutes at 10,300g to pellet any cell debris. Absorbances were 
measured at 560nm, against controls containing untreated cells, and were ultimately 
converted to protein hydroperoxide concentrations using an extinction co-efficient of 
35,900 M-1.cm-1 (Gay & Gebicki, 2003). 
 
ii) Lipid Hydroperoxide Detection on HMDMs (L-FOX) 
HMDM lipid was extracted into solvent by vortexing 1ml of cell suspension with 4.5ml 
of 2:1 (v/v) chloroform:methanol (containing 4mM BHT). Samples were briefly stored 
on ice before separating the phases via centrifugation at 4°C and 4,100g for ten minutes. 
After drying 2ml of the lower organic phase under argon, the residue was dissolved in 
250µl chloroform (containing 4mM BHT) and 460µl methanol (containing 4mM BHT). 
This solution was transferred to sealable tubes and incubated in the dark at room 
temperature for 60 minutes with 41µl of 2M PCA, 30µl of 5mM xylenol orange (in 
110mM PCA) and 20µl of 5mM ferrous ammonium sulphate (in 110mM PCA). 
Samples were subsequently centrifuged to pellet any cell debris and absorbances were 
recorded at 560nm, against a control of untreated cells. An extinction co-efficient of 
51,200 M-1.cm-1 was used to calculate the concentration of lipid hydroperoxides (Gay & 
Gebicki, 2003). 
 
2.2.13 TBARS Assay 
The TBARS assay provides an alternative means of monitoring lipid peroxidation and  
is based on a modification of the method described by Draper et al. (1993). It relies     
on the ability of 2-thiobarbituric acid (TBA) and the malondialdehyde (MDA) lipid 
hydroperoxide break-down product to readily react, with the resulting pink TBA-MDA 
adduct being fluorometrically detectable via HPLC.  
 The method of sample collection varied depending on the type of material being 
evaluated. Plaque and pus analysis required 100µl of plaque homogenate (section 2.2.9) 
and 100µl of pus supernatant, with the latter being collected after centrifuging 
previously prepared pus homogenate (section 2.2.8) at 400g for five minutes. HMDM 
and LDL samples were obtained from cell extracts (section 2.2.12.3) and supernatants 
(section 2.2.6), respectively. 
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 Once collected, the 100µl samples were mixed with 50µl of 150mM phosphoric 
acid and any further oxidation was inhibited by the addition of 10µl of 20mg/ml BHT 
(in methanol). These samples were then stored at -80°C until required for HPLC 
analysis. 
 Upon thawing, 50µl of 42mM TBA reagent was added to each tube and a 30 minute 
incubation was conducted at 95°C in a heated shaking block. Samples were then cooled 
on ice and all debris was pelleted by centrifuging at 4°C for ten minutes at 10,300g.  
The HPLC (Shimadzu RF-10AXL, Shimadzu corporation, Japan) injected 20µl of this 
supernatant through a Phenosphere reverse phase C-18, 4.6 x 150mm, 5µm column 
(Phenomenex; Auckland, NZ), heated to 30°C. TBARS were fluorometrically detected 
using excitation and emission wavelengths of 525nm and 550nm, respectively. The 
mobile phase, consisting of 55% 50mM sodium dihydrogen phosphate buffer (pH 6.8) 
and 45% methanol, was pumped through the system at a flow rate of 1ml/minute. 
 TBARS concentrations in all samples were quantified by comparison with the peak 
areas of 0µM and 1µM MDA standards. Fresh MDA was prepared before each assay by 
hydrolysis of 1,1,3,3-tetramethoxypropane (TMP) in 2:3 ethanol:water, with subsequent 
dilution in water to the appropriate concentration. Phosphoric acid and BHT were then 
added, as per the experimental samples. 
 
2.2.14 Conjugated Diene Assay 
Lipid peroxidation can also be monitored by the increase in absorbance at 234nm. This 
increase has previously been found to correlate with the production of both lipid 
hydroperoxides and TBARS and is attributed to the formation of conjugated dienes 
(Esterbauer et al., 1989).  
 During LDL oxidation experiments the supernatant was removed from the wells and 
centrifuged, as described in section 2.2.6, before quickly recording the absorbance at 
234nm against a blank of Ham’s F10 medium only. The sample was then returned to the 
test tube for subsequent analysis of protein hydroperoxide, vitamin E and TBARS 
levels. Conjugated diene concentrations were calculated from the absorbance values 
using an extinction co-efficient of 29,500 M-1.cm-1 (Esterbauer et al., 1989).  
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2.2.15 Vitamin E Assay 
Vitamin E levels in pus, plaque and in LDL subjected to cell-mediated oxidation were 
analyzed using 100µl of pus homogenate (section 2.2.8), plaque homogenate (section 
2.2.9) or centrifuged supernatant (section 2.2.6), respectively. Samples were mixed in 
glass screw-topped test tubes with 400µl water, 10µl of 100mg/ml EDTA (pH 7.4) and 
25µl of 20mg/ml BHT (in methanol). Protein precipitation was induced with 500µl of 
ice cold ethanol and vitamin E was subsequently extracted into 1ml of hexane during a 
60 second vortex. Samples were then stored at -80°C and, when required, were thawed 
and re-vortexed for a further 60 seconds. Phase separation was maximized by 
centrifugation at 4°C and 1,600g for five minutes before drying 700µl of the upper 
hexane phase under nitrogen gas. The resulting residue was then dissolved in 50µl cold 
methanol in preparation for a 20µl injection onto the HPLC (Gieseg et al., 1995). 
 Vitamin E was detected using excitation and emission wavelengths of 292nm and 
335nm, respectively. The mobile phase of 100% methanol was pumped at 1ml/minute, 
through an Econosphere reverse phase C18, 4 x 125mm, 5µm column (Alltech 
Associates Inc; USA), warmed to 35°C in the column oven.  
 A vitamin E stock solution was prepared by diluting approximately 1mg/ml vitamin 
E in nitrogen-degassed methanol that was overlayed with argon. Using a wavelength of 
294nm and an extinction coefficient of 3086 cm-1.M-1, the molar concentration could be 
spectrophotometrically determined (O'Neil et al., 2001). Stock vitamin E was stored at  
-20°C until required, at which time it was further diluted in methanol to 3µM for use as 
an HPLC standard. 
 
2.2.16 PB-DOPA and Dityrosine Assay 
DOPA and dityrosine are two products of tyrosine oxidation and both were measured in 
pus (section 2.2.8), plaque (section 2.2.9) and LDL-containing supernatants (section 
2.2.6). All samples were collected into glass Durham tubes but pus analysis required 
50µl (diluted in 50µl water) of homogenate and plaque analysis required 100µl of 
homogenate. By contrast, cell-mediated LDL oxidation was halted at various time 
points and 900µl of the LDL-containing supernatant was collected and centrifuged. 
Plaque and pus homogenate already contained antioxidants in the homogenate mix 
(sections 2.2.8 and 2.2.9) but further oxidation in the LDL supernatants had to be 
prevented by the addition of 10µl each of 20mg/ml BHT (in methanol) and 100mg/ml 
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EDTA. LDL samples were subsequently mixed with 140µl of 72% TCA, while plaque 
and pus were mixed with 900µl of ice cold acetone. All were stored on ice for ten 
minutes, followed by a 15 minute centrifugation at 4°C and 7000g. The resulting protein 
pellet was washed in 500µl of -20°C diethyl ether and centrifuged as before. Once 
drained of all residual diethyl ether, the pellets were stored at -80°C until required or 
subjected to acid hydrolysis immediately (Gieseg et al., 2003). 
 In preparation for acid hydrolysis, the Durham tubes were placed into Pico-Tag 
reaction vials (Millipore, USA) that contained 1ml of 6M hydrochloric acid with 1% 
(w/v) phenol and 50µl mercaptoacetic acid (Gieseg et al., 1993). Air was removed by 
flushing with argon gas for ten minutes and then evacuating each vial using a vacuum 
pump. Acid hydrolysis was initiated by incubating at 110°C for 16 hours and the 
resulting hydrolysis residue was then dried in a speed vac. Once dry, it was dissolved in 
either 200µl (for plaque and pus) or 50µl (for LDL) of 0.1% TFA and the suspensions 
were centrifuged to pellet any excess material.  
 Ultimately, 10µl was injected through a Phenomenex reverse phase C18,               
250 x 4.6mm, 5µm column (heated to 35°C), with fluorometric detection using an 
excitation wavelength of 280nm and an initial emission wavelength of 320nm. After 13 
minutes, the emission wavelength was increased to 410nm for dityrosine detection. The 
0.1% TFA (pH 2.5) mobile phase was run at 1ml/minute in an acetonitrile gradient, 
beginning at 0% but rising to 5% after ten minutes; 10% after 14 minutes; and 50% after 
16 minutes. By 23 minutes, the acetonitrile concentration was reduced to 1% and this 
dropped to 0% at the end of the run (30 minutes). 
 DOPA and tyrosine standards were prepared fresh, dissolving the powder in water 
via sonication, and then diluting to an appropriate concentration in 0.1% TFA. A 
dityrosine stock had previously been prepared in the Free Radical Biochemistry 
Laboratory by a technique involving horseradish peroxidase-mediated oxidation of 
tyrosine and subsequent purification on DEAE-sephacel (Sigma). The concentration of 
this dityrosine stock was determined spectrophotometrically at 315nm, using an 
extinction co-efficient of 5080 cm-1.M-1 (Pichorner et al., 1995). It was then stored at     
-20°C and, when required, aliquots were thawed and diluted to 1µM in 0.1% TFA.  
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2.2.17 Cholesterol Determination  
Cholesterol levels in plaque homogenate were measured as described for LDL 
cholesterol (section 2.2.1). However, it was important to first dilute the plaque 
homogenate to ensure that the colour was fully developed after a 30 minute incubation. 
(This contrasts with the 10 minute period required for LDL). Once colour development 
was complete, the absorbance was recorded at 500nm against a cholesterol reagent 
blank. 
 
2.2.18 Carbonyl Assay 
Protein hydroperoxide levels in plaque and pus could not be accurately measured using 
the FOX assay due to the tendency of hydroperoxides to degrade. Carbonyls also    
serve as a general marker of protein oxidation and, in contrast to hydroperoxides,       
are significantly more stable. Furthermore, a good correlation between protein 
hydroperoxide and carbonyl formation has been demonstrated during AAPH-induced 
oxidation of plasma (Ling, 2003). A protocol described by Quinlan et al. (1994) was 
therefore used to detect carbonyls in plaque and pus homogenate and during cell-
mediated LDL oxidation studies. It relies on the ability of carbonyls to react with 2,4-
dinitrophenyl hydrazine (DNPH), forming a carbonyl-DNPH derivative with maximum 
absorbance at 360nm. 
 Homogenate (200µl) was mixed in screw-topped glass tubes with either 1ml of 
10mM DNPH (prepared in 2M HCl) or, in the case of blanks, with 1ml of 2M HCl.    
All samples (blanks included) were shaken gently at 37°C for 90 minutes before     
being cooled on ice in the presence of 1ml of 28% TCA. A ten minute centrifugation    
at 4,100g and 4°C pelleted the precipitated protein, which was then washed twice in  
5ml of 1:1 ethanol:ethyl acetate. Once dry, the pellets were resuspended in 1ml of      
6M guanidine hydrochloride (in 2M HCl) and colour was allowed to develop during a 
one hour darkened incubation at room temperature. Excess material was subsequently 
removed by a five minute centrifugation at 4,100g and absorbances were recorded at 
360nm. The HCl blank absorbances were subtracted from the corresponding DNPH 
treatments before calculating carbonyl concentrations using an extinction co-efficient of 
21,000 cm-1.M-1 (Quinlan et al., 1994) 
 Carbonyls on LDL were similarly detected, though protein in the centrifuged 
supernatant (section 2.2.6) was first precipitated by a ten minute incubation on ice with 
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72% TCA and then a 15 minute centrifuge at 4°C and 5000rpm. The resulting pellet 
was washed once in 5% TCA before being dissolved in 1ml of either 10mM DNPH (in 
2ml HCl) or 2M HCl and subsequently treated as described for homogenate samples. 
 
2.2.19 Protein Determination 
Protein levels were investigated in pus homogenate (section 2.2.8), plaque homogenate 
(section 2.2.9) and cell suspensions. These cell suspensions consisted of either THP-1s 
or HMDMs and were prepared as described in section 2.2.12.3, but using only 0.5ml of 
cold water.  
 Protein analysis was conducted using a bicinchoninic acid (BCA) protein 
determination kit from Sigma, with working reagent freshly prepared by mixing 
Reagent A (sodium carbonate, sodium bicarbonate, BCA and sodium tartrate in 0.1M 
sodium hydroxide) and Reagent B (4% hydrated copper sulphate) in a ratio of 50:1. 
Thus, once samples were suitably diluted, 50µl was mixed with 1ml of working reagent 
and incubated at 60°C for 30 minutes in a heated shaking block. The reaction was 
subsequently halted by placing samples on ice and absorbances were recorded at 562nm 
against a water blank incubated with the working reagent. Protein concentration was 
quantitatively determined from a standard curve prepared by the incubation of known 
concentrations of BSA (0-250µg/ml) in 1ml of working reagent. 
 
2.2.20 Pterin Assay 
Neopterin and total pterin (neopterin plus 7,8-NP) levels were measured in pus 
homogenate (section 2.2.8) and plaque homogenate (section 2.2.9), as well as during 
studies investigating the IFN-γ-induced production of 7,8-NP in both macrophage-like 
THP-1s and HMDMs. These IFN-γ experiments monitored pterin levels in the cell-
conditioned medium, and in the cells themselves, by collecting centrifuged supernatant 
(section 2.2.6) and by washing cells in PBS before lysing them in 0.5ml of ice cold 
water (section 2.2.12.3).  
 Irrespective of the method of sample collection, a 200µl sample was ultimately 
aliquoted into microcentrifuge tubes and mixed with 20µl of 50% TCA (Gieseg et al., 
2000b). When measuring total pterin, the oxidation of all 7,8-NP to neopterin was 
ensured by the additional inclusion of 16µl of an acidic iodide solution (5.4% w/v iodine 
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and 10.8% w/v potassium iodide in 3.7% w/v TCA). After incubating in the dark for 60 
minutes, a few crystals of ascorbate were added to remove excess iodine. All samples 
(whether measuring total pterin or just neopterin) were centrifuged at 4°C and 10,300g 
for ten minutes, with 100µl of the resulting supernatant then being mixed with 5µl of 
2M ammonium phosphate (pH 6). The HPLC injected 20µl of this mixture through a 
reverse phase Develosil C18, 250 x 4.6mm, 5µm column (Nomura Chemicals; Japan), 
heated to 35°C. The mobile phase consisted of 20mM ammonium phosphate (pH 6) 
with 5% methanol and was pumped at 1ml/minute. Neopterin was fluorometrically 
detected using excitation and emission wavelengths of 353nm and 438nm, respectively. 
When present in sufficient quantities, 7,8-NP was directly monitored via the HPLC 
electrochemical detector (ECD) using a voltage setting of +0.6V. 
 A stock of neopterin was prepared by sonication in 10mM phosphoric acid and 
stored at -20°C. When required, it was thawed and diluted to a 1µM standard in 10mM 
phosphoric acid. By contrast, the 7,8-NP standard was prepared by sonication in 
degassed water and then diluted in 10mM phosphoric acid for immediate use. 
 
2.2.21 Transplasma Membrane Redox Activity Assays 
Transplasma membrane electron transport (TPMET) systems are expressed in every 
living cell (Ly & Lawen, 2003) and can be monitored via assays that measure the degree 
of transition metal reduction induced by both the cells and the cell-conditioned medium. 
The latter activity is attributed to reductants released from cells while the difference 
between the two accounts for TPMET activity. Two such assays were used in this study 
to monitor the TPMET activity of macrophage-like THP-1s. They are based on a 
protocol described by Baoutina et al. (2001b) and measure the reduction of cupric ions 
and ferricyanide to cuprous ions and ferrocyanide, respectively. 
 
2.2.21.1 TPMET Reduction of Copper 
THP-1 macrophages were washed three times in PBS and then incubated at 37°C     
with 900µl HBSS in the presence or absence of 50µl each of 1mM copper chloride    
and 2.5mM bathocuproine disulphonic acid (BCS). After two hours, the medium       
was removed and any dislodged cells were eliminated by centrifuging at 400g for      
five minutes. The absorbance of medium incubated in the presence of copper chloride 
and BCS was read immediately at 482nm, against controls incubated in the absence     
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of cells. Cuprous ion concentrations were quantified using an extinction co-efficient of 
12,200 cm-1.M-1 (Baoutina et al., 2001b). 
 Medium incubated in the absence of copper chloride and BCS served as the cell-
conditioned medium and, once centrifuged, cell-conditioned medium was therefore 
transferred to cell-free wells and incubated with copper chloride and BCS for a further 
two hours. Absorbances were then measured at 482nm, against a control incubated in 
the absence of cells. 
 
2.2.21.2 TPMET Reduction of Ferricyanide 
After THP-1 macrophages were washed three times in PBS, these cells were incubated 
in 900µl HBSS at 37°C for two hours in the presence or absence of 100µl of 1mM 
potassium ferricyanide. The medium was subsequently centrifuged at 400g for five 
minutes and 0.5ml of the supernatant mixture was then combined with 0.1ml each        
of 3M sodium acetate (pH 6.5), 0.2M citric acid, 3.3mM ferric chloride (in 0.1M    
acetic acid) and 3.3% (w/v) bathophenanthroline disulphonic acid (BPS). A ten minute 
incubation at room temperature in the dark provided time for colour development  
before recording the absorbance at 535nm, against controls incubated in the absence of 
cells but containing all other reagents. Absorbances were converted to ferrocyanide 
concentrations using an extinction co-efficient of 21,600 cm-1.M-1 (Baoutina et al., 
2001b). 
 The centrifuged cell-conditioned medium was ultimately transferred to cell-free 
wells and incubated with potassium ferricyanide for a further two hours before 0.5ml 
was treated with 0.1ml each of the reagents listed above, incubated for ten minutes and 
read at 535nm. 
 
2.2.21.3 TPMET Experiments Studying the Effect of 7,8-NP, IFN-γ and 
Superoxide 
7,8-NP interferes with both TPMET assays and, as such, it was necessary to modify   
the above protocols by including a pre-incubation step during 7,8-NP studies.            
Pre-incubation involved maintaining the cells in RPMI at 37°C, but in the presence of 
50µM 7,8-NP for two or six hours. The TPMET assays were subsequently initiated by 
washing all wells three times in PBS and then monitoring either ferricyanide or cupric 
ion reduction.  
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 Unlike 7,8-NP, IFN-γ doesn’t interfere with either TPMET assay. Thus, after pre-
incubating cells in RPMI with 500U/ml IFN-γ for 24 or 48 hours, fresh IFN-γ (diluted 
in HBSS) was added at the start of the TPMET assay to replace that lost during the PBS 
washing steps. 
 The effect of superoxide on ferricyanide and cupric ion reduction was also directly 
measured. TPMET experiments were set up as above, but the two hour incubation was 
conducted in the presence and absence of 40µg/ml superoxide dismutase (SOD). 
 
2.2.22 Reducing Activity Associated with Cell-Conditioned Medium 
Reducing activity detected in the cell-conditioned medium during the ferricyanide and 
cupric ion reduction assays has been suggested to be due to reductants released from 
cells, particularly thiols and superoxide (Garner et al., 1997a; Baoutina et al., 2001b). 
Supernantant thiols were measured as previously described (section 2.2.11b), while 
superoxide production was investigated via both the cytochrome C and nitroblue 
tetrazolium (NBT) reduction assays.  
2.2.22.1 Superoxide Measurement via Cytochrome C Reduction Assay 
The ability of THP-1 macrophages to reduce cytochrome C was measured using          
an assay described by Jessup et al. (1993). Cells were washed three times in PBS       
before being incubated for two hours in a 1ml solution, containing HBSS and 80µM 
cytochrome C in the presence or absence of 40µg/ml SOD. The supernatant was then 
centrifuged for five minutes at 400g before measuring the absorbance at 550nm, against 
a cell free control. Concentrations of reduced cytochrome C were determined using an 
extinction co-efficient of 21,000 cm-1.M-1 (Niu et al., 2000), with the difference 
between the level of reduced cytochrome C in the presence and absence of SOD being 
attributed to superoxide. 
 
2.2.22.2 Superoxide Measurement via NBT Reduction Assay 
A protocol based on the Rook et al. (1985) method was used to monitor THP-1-
macrophage-mediated reduction of NBT. This required washing the cells three times in 
PBS, followed by a two hour incubation in a 1ml solution of HBSS with 1mg/ml NBT 
in the presence or absence of 40µg/ml SOD. All wells were subsequently washed three 
times in 70% methanol, both to fix the cells and remove any unreduced NBT, before air 
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drying the wells and dissolving the insoluble formazan in 450µl of 2M potassium 
hydroxide and 525µl DMSO. The absorbances of the resulting solutions were read at 
630nm, against identically treated cell free controls, and the concentrations of reduced 
NBT were calculated using a standard curve that had been prepared by dissolving 
known concentrations of NBT (0-20nM) in an 18:21 ratio of 2M potassium 
hydroxide:DMSO. Superoxide levels were calculated as the difference in reduced NBT 
between samples incubated in the presence and absence of SOD. 
 
2.2.23 Statistical Analysis 
Data was graphed and statistically analyzed using the software program, Prism (version 
4.0; GraphPad Software, USA). Significance was confirmed by either a one-way 
analysis of variance (ANOVA) or a multiple analysis of variance (MANOVA), 
followed by Tukey’s multiple comparison test to provide a more quantitative indication 
of significance between treatments and/or time points. Where appropriate, linear 
regression and correlation analyses were also applied, with r2 values calculated 
assuming a Gaussian distribution. Significance levels are indicated in the following 
manner: * p < 0.05; ** p < 0.01; *** p< 0.001.  
 
Results displayed in this thesis are taken from one experiment, which is representative 
of three separate experiments. The means and standard errors of the mean (SEM) shown 
within each experiment were calculated from triplicate samples. 
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3 7,8-NP and AAPH-Induced Damage to 
HMDM Cells 
3.1 Introduction 
AAPH has been used to induce oxidative stress in a variety of experimental systems, 
ranging from pure protein solutions to lipid micelle suspensions, lipoproteins, plasma, 
erythrocyte membranes and even living cells (Lissi et al., 1991; Gieseg et al., 1995; 
Sato et al., 1995; Nourooz-Zadeh et al., 1996; May et al., 1998; Ma et al., 1999; Gieseg 
et al., 2000b; Park et al., 2002; Gieseg et al., 2003; Yoshida et al., 2004). It has also 
been utilized in vivo as a source of free radicals during animal studies (Dooley et al., 
1990; Niki, 1990). While AAPH is not a physiologically relevant compound, it does 
decompose to two carbon-centred radicals (reaction 13) which each react almost 
instantaneously with oxygen to produce peroxyl radicals (reaction 14). 
(13) R-N=N-R      37°C        N2  +  2R•          
(14) 2R•  +  O2                   2ROO• 
This allows AAPH to serve as an appropriate model of oxidative stress because peroxyl 
radicals are known to form in vivo, particularly during peroxidation reactions. 
Moreover, the rate and extent of radical generation can be carefully controlled when 
using AAPH, greatly aiding kinetic analysis. The rate of decomposition for this water-
soluble azo compound depends predominantly on temperature, with solvent and pH 
playing only a minor role (Niki, 1990). In addition, the half-life for AAPH 
decomposition is 175 hours, ensuring that the rate of radical generation is constant for 
the first several hours (Niki, 1990). Thus, at 37°C and in the presence of oxygen, the 
rate of radical generation is determined by the following equation:  
  Rate = 3.19x10-7 x [AAPH] 
where [AAPH] is the molar concentration of AAPH and the units for rate are molar per 
second (Yamamoto et al., 1985). 
 While AAPH-induced damage has been studied in both the U937 and THP-1 
monocytic cell lines (Duggan et al., 2002; Baird et al., 2005; Kappler, 2005), there is a 
distinct lack of research on AAPH-induced damage to HMDMs. This paucity of 
knowledge is largely due to the fact that primary cells are more difficult and time 
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consuming to work with than cell lines. Donor variability and finite life-time are other 
negative aspects associated with primary cells. However, by their very nature, cell lines 
are not completely representative of the corresponding cells in the body. The effect of 
this on experimental results has recently been highlighted with the discovery that 
oxLDL-induced cell death occurs by different mechanisms in U937 and THP-1 cells 
(Baird et al., 2004). While both cell lines undergo apoptosis, THP-1s do so via 
activation of the caspase enzymes but U937s enter a less conventional apoptotic 
pathway. Of more relevance to the current research, it has also been found that 7,8-NP’s 
ability to protect monocytes against AAPH-induced damage varies depending on the 
cell line (Baird et al., 2005). 7,8-NP significantly inhibited thiol loss and cell death in 
U937s (Duggan et al., 2002; Baird et al., 2005) but had no effect on thiol levels and 
only a limited impact on viability in THP-1s (Baird et al., 2005). This disparity makes  
it very difficult to determine which cell line provides the most accurate model of cells  
in vivo. Primary cells are generally considered more physiologically relevant than cell 
lines and, as such, this section of research will extend the findings of Baird et al. (2005) 
by investigating the influence of AAPH and 7,8-NP on viability and total cellular thiol 
loss in HMDMs.  
 The effect of AAPH and 7,8-NP on HMDM hydroperoxide formation will also be 
studied. Protein rather than lipid is the most significant site of AAPH-induced 
hydroperoxide generation on both U937s (Gieseg et al., 2000a) and red blood cell 
membranes (Firth, 2001). Furthermore, protein hydroperoxides have been detected on 
THP-1s at levels comparable to those measured in U937s (Cassidy, 2003; Kappler, 
2005). The current research will therefore determine whether a similar trend is obtained 
upon incubation of AAPH with HMDMs. It will also investigate the effectiveness of 
7,8-NP in preventing HMDM hydroperoxide formation because this antioxidant has 
previously been found to inhibit the generation of protein hydroperoxides on U937s 
exposed to AAPH (Duggan et al., 2002). 
 
3.2 Results 
3.2.1 Concentration-Dependent Effect of AAPH on Cellular Viability 
Before beginning time course and 7,8-NP studies, a suitable concentration of AAPH 
first needed to be identified by incubating 14 day cultures of HMDMs (5x106 cells/ml) 
in EBSS for 12 hours in the presence of a range of AAPH concentrations. Loss of 
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viability was measured by MTT and trypan blue exclusion staining and exhibited a clear 
dependence on AAPH concentration, with r2 values of 0.90 and 0.99, respectively 
(Figure 3.1). For ease of comparison, results from both assays were displayed as 
percentages of the control. Nevertheless, it should be noted that cells in control 
treatments consistently exceeded 98% viability prior to any data manipulation, as 
determined by trypan blue exclusion staining (data not shown). 
 Subsequent experiments were conducted using 20mM AAPH because this 
concentration reduced viability to approximately 50% (44.4 ± 3.4% and 58.0 ± 1.4% by 
MTT and trypan blue assays, respectively). This result was reproducible, though inter-
experimental variation did account for a few exceptions when viability loss was as little 
as 65% or, conversely, as low as 40% (data not shown).  
 The discovery of a 50% HMDM mortality rate being reached after 12 hours in the 
presence of 20mM AAPH was unexpected because a previous study had indicated that 
10mM AAPH was sufficient to produce such an effect (Duggan, 2000). This disparity 
may simply be due to inter-experimental variation or, alternatively, the cells used in the 
Duggan study may have been less differentiated. To resolve this issue, the above 
experiment was repeated but three day rather than 14 day cultures were tested (Figure 
3.2). A concentration-dependent effect of AAPH on cell viability was once again 
observed. However, in contrast to Figure 3.1, cell death reached approximately 50% 
with only 10mM AAPH (59.0 ± 5.1% and 52.1 ± 5.1% by MTT and trypan blue assays, 
respectively). By 20mM AAPH, the percentage of dead cells had climbed to almost 
90%. 
 All subsequent experiments investigated the effects of AAPH and 7,8-NP using the 
more differentiated 14 day HMDM cultures. 
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Figure 3.1  Loss of HMDM viability in 14 day cultures with increasing 
concentrations of AAPH. 
14 day cultures of HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS with increasing 
concentrations of AAPH. After 12 hours, HMDMs were analyzed for cell viability via (a) MTT and 
(b) trypan blue exclusion staining. Significance is indicated from 0mM AAPH. Results are displayed 
as mean ± SEM of triplicates from a single experiment, representative of three separate experiments. 
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Figure 3.2  Loss of HMDM viability in three day cultures with increasing 
concentrations of AAPH. 
Three day cultures of HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS with increasing 
concentrations of AAPH. After 12 hours, the human monocytes were analyzed for cell viability via 
(a) MTT and (b) trypan blue exclusion staining. Significance is indicated from 0mM AAPH. Results 
are displayed as mean ± SEM of triplicates from a single experiment, representative of three separate 
experiments. 
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3.2.2 AAPH-Induced Hydroperoxide Formation on HMDMs 
The FOX-1 assay lacks a lipid extraction step but has been successfully used to measure 
protein hydroperoxides in U937s due to the absence of significant quantities of lipid 
hydroperoxides forming in this cell line after AAPH treatment (Gieseg et al., 2000a). 
Whether the FOX-1 assay would also accurately detect protein hydroperoxides was 
unclear and needed to be tested. Thus, hydroperoxides were generated on HMDMs by 
exposure to 20mM AAPH for 16 hours. Lipids were then completely eliminated from 
72% TCA-precipitated pellets, using either an acetone followed by a diethyl ether 
extraction (Figure 3.3a) or a methanol then hexane extraction (Figure 3.3b), and 
samples were analyzed by the FOX-1 assay. Some variability in hydroperoxide 
concentrations is apparent between the two experiments but this is most likely due to 
donor variability and does not detract from the fact that both lipid extraction procedures 
reduced hydroperoxide levels. The acetone/diethyl ether extraction reduced 
hydroperoxides to the extent that, while the level was not significantly different from 
the 5% TCA washed sample, it was also not significantly different from the baseline 
value recorded in the absence of any AAPH (Figure 3.3a). Hydroperoxide loss was  
even more pronounced using the methanol/hexane wash (Figure 3.3b), with levels 
dropping considerably below the TCA treatment (p<0.001). As any hydroperoxides   
still detectable after lipid extraction are associated with protein, these results imply    
that protein hydroperoxides were present at levels of only 0.28 ± 0.13µM and           
0.39 ± 0.16µM after lipid extraction by acetone/diethyl ether and methanol/hexane, 
respectively. A similarly low level of 0.27 ± 0.02µM protein hydroperoxides was 
detected after extracting lipids using a methanol/chloroform wash (data not shown). 
Including a 5% TCA wash step, subsequent to lipid extraction with solvents, also failed 
to prevent the sudden drop in hydroperoxides (data not shown). 
Protein hydroperoxide formation on HMDMs is clearly limited, suggesting that lipid 
rather than protein may be the primary target of peroxyl radical attack on this cell type. 
TBARS provides a measure of lipid peroxidation and, as such, was used to investigate 
this theory. However, while TBARS levels did increase significantly by 12 hours in the 
presence of 20mM AAPH (p<0.001), the concentration remained low and plateaued at 
106.9 ± 3.1nM (equivalent to 21.4 pmole/million cells) after 18 hours (Figure 3.4).  
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Figure 3.3  Effect of lipid extraction from HMDMs on hydroperoxide detection. 
HMDMs (5x106 cells/ml) were incubated at 37°C for 16 hours in EBSS in the presence or absence 
of 20mM AAPH. Hydroperoxides were measured in half the samples by the FOX-1 assay (with    
5% TCA washes) while hydroperoxides in the remaining samples were measured using a 
modification of the FOX-1 assay, with washes of the 72% TCA-precipitated samples in either        
(a) acetone followed by diethyl ether or (b) methanol then hexane. The micromolar values refer to 
concentrations in the original cell suspension. * indicates significance between the wash treatments. 
# indicates significance from 0mM AAPH. Results are displayed as mean ± SEM of triplicates from 
a single experiment, with (a) and (b) representing different donors. 
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Figure 3.4  AAPH-induced TBARS formation on HMDMs. 
HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS in the presence or absence (control) of 
20mM AAPH. Samples were removed at various time points and analyzed for the level of TBARS 
associated with HMDMs. The nanomolar value refers to the concentration in the original cell 
suspension. Significance is indicated from time zero. Results are displayed as mean ± SEM of 
triplicates from a single experiment, representative of three separate experiments. 
 
 
 A more sensitive and direct method for detecting lipid hydroperoxides was reported 
soon afterwards by Gay & Gebicki (2003) and is derived from previous lipid FOX 
assays. This most recent L-FOX protocol has the added advantage of being convenient 
for use in parallel with the FOX-3 assay when measuring lipid and protein 
hydroperoxides from the same experiment. HMDMs exposed to 20mM AAPH for 16 
hours were therefore analyzed for both lipid and protein hydroperoxides by the L-FOX 
and FOX-3 assays, respectively. A general measure of hydroperoxides provided a 
further comparison to the FOX-1 assay results in Figure 3.3 and was obtained by using 
a modified version of the FOX-3 assay, consisting of two PCA washes and no 
chloroform washes. Blanks were included in each assay and comprised reagents in the 
absence of any cells. Although similar blanks have successfully yielded absorbance 
values close to control sample values for the FOX-1 and FOX-2 assays, this was not the 
case for the FOX-3 and L-FOX assays (Figure 3.5a). In particular, the absorbance for 
the FOX-3 blank was higher than both control and AAPH-treated samples. A further 
contrast with the FOX-1 and FOX-2 assays was provided by the observation that 
baseline absorbance readings varied dramatically between 0.15 to 0.4 absorbance units 
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from one experiment to the next (data not shown). This instability did not affect the 
degree of AAPH-induced hydroperoxide formation, so reproducible data could still be 
obtained simply by subtracting control absorbances from AAPH-treated absorbances 
(Figure 3.5b). These data manipulations enabled protein and lipid hydroperoxides to be 
calculated at concentrations of 0.66 ± 0.36µM and 2.46 ± 0.54µM, respectively, with 
lipid hydroperoxides accounting for 79% of all hydroperoxides. In comparison, the 
general PCA washing protocol yielded a hydroperoxide concentration of 1.66 ± 0.23µM 
(Figure 3.5b). This value differed from the protein hydroperoxide and lipid 
hydroperoxide results but was comparable to levels detected by the FOX-1 assay prior 
to lipid extraction (Figure 3.3). Some lipid was likely lost during the acid washing steps 
associated with both the general PCA protocol and the FOX-1 assay. Thus, the total 
(protein plus lipid) hydroperoxide content was not accurately measured in either of 
these two variations of the FOX assay and neither one was suitable for measuring 
hydroperoxide formation on HMDMs. 
 
3.2.3 Time Course of AAPH-Induced Damage to HMDMs 
Having identified appropriate assays for monitoring lipid and protein hydroperoxide 
formation, a time course of AAPH-mediated damage was then conducted. HMDMs 
were incubated with 20mM AAPH and, after an initial four hour lag, loss of cell 
viability was observed by both the MTT (Figure 3.6a) and trypan blue (Figure 3.6b) 
assays. Contrasting with the almost complete survival of control cells (particularly when 
monitored by trypan blue exclusion staining), virtually 100% of AAPH-treated cells 
were dead after 24 hours of exposure. 
 A lag phase of approximately four hours was also observed during AAPH-induced 
lipid oxidation (Figure 3.4 & Figure 3.6c). Similar trends were observed for both 
TBARS and lipid hydroperoxide formation, with a rapid increase in lipid peroxidation 
after the lag and a subsequent plateau in oxidation levels after 18 hours. Lipid 
hydroperoxide concentrations were consistently larger and, following an 18 hour 
incubation with 20mM AAPH, were at least 20 times greater than TBARS levels. 
 Lipid hydroperoxide formation was relatively linear between four and 18 hours, but 
occurred at a rate of only 0.15µM/hour, which is significantly below the concomitant 
rate of 22.97µM/hour for the generation of peroxyl radicals during AAPH 
decomposition. Nevertheless, lipid hydroperoxides are clearly a significant event of 
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HMDM exposure to AAPH, with concentrations becoming statistically different from 
zero hour levels within 12 hours (p<0.01). By contrast, protein hydroperoxides did not 
increase significantly above the zero hour measurement, even though their trend of 
formation was similar to that observed for lipid hydroperoxides (Figure 3.6c).  
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Figure 3.5  Characterization of hydroperoxides formed on HMDMs during AAPH-
induced oxidation. 
HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS in the presence or absence (control) of 
20mM AAPH. After 16 hours HMDMs were analyzed for lipid hydroperoxide (LOOH) and protein 
hydroperoxide (PrOOH) content using the L-FOX and FOX-3 assays, respectively. Blanks contained 
FOX reagents but no cells. A general measure of hydroperoxides was obtained using a modified 
version of the FOX-3 assay, with PCA washes but no chloroform washes. (a) Absorbances, 
measured at 560nm, were subsequently converted to (b) an AAPH-induced micromolar 
hydroperoxide concentration increase above the controls. Results are displayed as mean ± SEM of 
triplicates from a single experiment, representative of three separate experiments. 
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Figure 3.6  Time course of AAPH-induced damage to HMDMs. 
HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS in the presence or absence (control) of 
20mM AAPH. At various times, HMDMs were analyzed for cell viability by both (a) MTT and     
(b) trypan blue exclusion staining, with data expressed as a percentage of zero hour levels. (c) The 
AAPH-induced increase in LOOHs and PrOOHs above the controls was also examined, using the  
L-FOX and FOX-3 assays, respectively. Significance is indicated from time zero. Results are 
displayed as mean ± SEM of triplicates from a single experiment, representative of three separate 
experiments. In a separate experiment, cell viability was reduced to 81.0 ± 7.5% and 85.5 ± 1.1% via 
MTT and trypan blue exclusion staining, respectively, after six hours. This confirms that the lag 
phase ends after a four hour exposure to 20mM AAPH. 
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3.2.4 Effect of 7,8-NP on AAPH-induced damage to HMDMs 
7,8-NP’s potential antioxidant effect was studied by pre-incubating the HMDMs for ten 
minutes in EBSS with various concentrations of 7,8-NP. AAPH (20mM) was 
subsequently added and cells were incubated at 37°C for 12 hours before analyzing   
7,8-NP’s effect on viability and hydroperoxide formation (Figure 3.7). In agreement 
with Figure 3.1, 20mM AAPH reduced viability to approximately 50% after 12 hours. 
However, as determined by both MTT and trypan blue exclusion staining, the addition 
of up to 200µM 7,8-NP did not significantly protect against this AAPH-mediated      
cell death (Figure 3.7a & Figure 3.7b). 7,8-NP was also unable to prevent lipid 
hydroperoxide formation, although it did reduce protein hydroperoxide levels (Figure 
3.7c). Despite this trend, the protection was not significant because protein 
hydroperoxides were not raised significantly above the control even in the absence of 
any 7,8-NP. 
 It is possible that the high flux of peroxyl radicals generated by 20mM AAPH 
overwhelmed any ability of 7,8-NP to inhibit cell death. This theory was investigated by 
incubating the HMDMs with a lower AAPH concentration of 10mM (Figure 3.8). 
Although the lower radical flux did ensure that 70-80% of HMDMs remained viable 
after a 12 hour incubation, 7,8-NP still failed to exert any protective effect against 
AAPH-mediated cell death.  
 Previous studies have found a correlation between 7,8-NP’s ability to inhibit cell 
death and its prevention of cellular thiol loss (Duggan et al., 2002; Baird et al., 2004). 
Based on the above data (Figure 3.7 & Figure 3.8), it could therefore be theorized that 
7,8-NP has no effect on the AAPH-induced oxidation of HMDM thiols. This potential 
association was investigated by using the DTNB assay to measure total cellular thiols 
following a 12 hour incubation of 5x106 HMDMs/ml with 20mM AAPH and 7,8-NP 
(Figure 3.9). Control HMDMs contained approximately 25µM thiols and this level was 
reduced by 67% after exposure to 20mM AAPH. As observed for the cell viability 
studies, co-incubation with concentrations of up to 200µM 7,8-NP did not provide a 
significant protective effect against this thiol loss. 
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Figure 3.7  Effect of 7,8-NP on AAPH-induced oxidation of HMDMs. 
HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS with 20mM AAPH and increasing 
concentrations of 7,8-NP. Controls were conducted in the absence of AAPH. After 12 hours, 
HMDMs were analyzed for cell viability by both (a) MTT and (b) trypan blue exclusion staining.  
(c) LOOH and PrOOH levels were also monitored, using the L-FOX and FOX-3 assays, 
respectively, with controls subtracted from the AAPH-treated samples. ANOVA analysis revealed 
no statistical significance from 0µM 7,8-NP. Results are displayed as mean ± SEM of triplicates 
from a single experiment, representative of three separate experiments. 
 7,8-NP and AAPH-Induced Damage to HMDM Cells 75 
  
0 50 100 150 200
50
60
70
80
90
100
(a)
7,8-NP (µM)
Vi
ab
ili
ty
 (%
 o
f c
on
tr
ol
)
 
0 50 100 150 200
50
60
70
80
90
100
(b)
7,8-NP (µM)
Vi
ab
ili
ty
 (%
 o
f c
on
tr
ol
)
 
Figure 3.8  Effect of 7,8-NP on HMDM viability loss in the presence of 10mM 
AAPH. 
HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS with 10mM AAPH and increasing 
concentrations of 7,8-NP. Controls were conducted in the absence of AAPH. After 12 hours, 
HMDMs were analyzed for cell viability via (a) MTT and (b) trypan blue exclusion staining. 
ANOVA analysis revealed no statistical significance from 0µM 7,8-NP. Results are displayed as 
mean ± SEM of triplicates from a single experiment, representative of three separate experiments. 
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Figure 3.9  Effect of 7,8-NP on AAPH-induced thiol loss on HMDMs. 
HMDMs (5x106 cells/ml) were incubated at 37°C in EBSS with 20mM AAPH and increasing 
concentrations of 7,8-NP. Controls were conducted in the absence of AAPH. After 12 hours, the 
total thiol content of HMDMs was analyzed by the DTNB assay. ANOVA analysis revealed no 
statistical significance from 0µM 7,8-NP. Results are displayed as mean ± SEM of triplicates from a 
single experiment, representative of three separate experiments. 
 
 
3.2.5 Effect of IFN-γ on AAPH-induced damage to HMDMs 
While the results in section 3.2.4 clearly suggested that 7,8-NP offered no significant 
protection against AAPH-mediated damage to HMDMs, it remained possible that     
7,8-NP would exert some effect when provided as an endogenous continuous supply 
rather than the exogenous bolus approach used above. IFN-γ is known to stimulate 
synthesis of 7,8-NP in macrophages (Huber et al., 1984; Werner et al., 1990), and a    
48 hour pre-incubation was found to be optimal for 7,8-NP production (Figure 5.29). 
Thus, HMDMs were pre-incubated with various concentrations of IFN-γ for 48 hours 
before being washed and incubated in EBSS with fresh IFN-γ and 20mM AAPH. In 
agreement with the 7,8-NP experiments, no significant effect on cell viability or lipid 
hydroperoxide formation was observed (Figure 3.10). IFN-γ also did not inhibit 
generation of the minimal levels of protein hydroperoxides that were detected (Figure 
3.10c).  
 
 
 7,8-NP and AAPH-Induced Damage to HMDM Cells 77 
  
0 250 500 750 1000
20
30
40
50
60
70
(a)
IFN−γ (U/ml)
Vi
ab
ili
ty
 (%
 o
f c
on
tr
ol
)
 
0 250 500 750 1000
20
30
40
50
60
70
(b)
IFN−γ (U/ml)
Vi
ab
ili
ty
 (%
 o
f c
on
tr
ol
)
 
0 250 500 750 1000
0.0
0.5
1.0
1.5
2.0
2.5
LOOH
PrOOH
0.0
0.2
0.4
0.6
0.8
1.0
IFN−γ (U/ml)
LO
O
H
 (µ
M
) PrO
O
H
 (µM
)
(c)
 
Figure 3.10  Effect of IFN-γ on AAPH-induced oxidation of HMDMs. 
Following a 48 hour pre-incubation in RPMI at 37°C with increasing concentrations of IFN-γ, 
HMDMs (5x106 cells/ml) were washed and incubated for a further 12 hours in EBSS with 20mM 
AAPH and fresh IFN-γ. Controls were conducted in the absence of AAPH. HMDMs were analyzed 
for cell viability by both (a) MTT and (b) trypan blue exclusion staining. (c) LOOH and PrOOH 
levels were also monitored, using the L-FOX and FOX-3 assays, respectively, with controls 
subtracted from the AAPH-treated samples. ANOVA analysis revealed no statistical significance 
from 0U/ml IFN-γ. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments.  
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 The lack of a concentration-dependent effect is not so surprising once the level of 
total pterin (neopterin and 7,8-NP) at each IFN-γ concentration is taken into account. 
Pterin, detected in both the supernatant and in the HMDM cellular extracts, did not vary 
significantly between 250 and 1000U/ml IFN-γ (Figure 3.11). Furthermore, the pterin 
levels dropped dramatically after replacing the RPMI medium with EBSS. This is 
partially due to the less nutrient rich nature of EBSS and the short incubation time of   
12 hours, but exposure of the HMDMs to AAPH also accounts for the decrease. A        
48 hour incubation with 500U/ml IFN-γ in RPMI, followed by 12 hours in EBSS 
without AAPH, yielded 36.3 ± 2.1nM and 62.6 ± 7.0pmole/mg protein of supernatant 
and cell extract pterin, respectively (data not shown). The supernatant concentration is 
twice as large as that obtained in the presence of 20mM AAPH, while the quantity of 
pterin measured in the cell extract is six times greater. 
 It should be noted that pterin concentrations showed some variability from one 
donor to the next. Most had pterin levels in the range displayed in Figure 5.29, with 
minimal or even no detectable pterins in the absence of IFN-γ and levels of up to 30nM 
of supernatant pterin and 35pmole/mg protein of cell extract pterin upon stimulation 
with IFN-γ for 48 hours. Concentrations shown in Figure 3.11 are significantly higher 
than this but were still unable to protect HMDMs from AAPH-induced cell death and 
hydroperoxide formation. 
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Figure 3.11  Pterin production by HMDMs exposed to increasing concentrations of 
IFN-γ. 
HMDMs (5x106 cells/ml) were incubated at 37°C in RPMI with various concentrations of IFN-γ. 
After 48 hours, the supernatant and HMDM cell lysate in half the samples were analyzed for the 
presence of total pterin (neopterin plus 7,8-NP). HMDMs in the remaining samples were washed and 
incubated for a further 12 hours in EBSS with 20mM AAPH and fresh IFN-γ before measuring 
supernatant and cell lysate total pterin levels. Results are displayed as mean ± SEM of triplicates 
from a single experiment, representative of three separate experiments. 
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3.3 Discussion 
3.3.1 Three Day Culture Versus 14 Day Culture 
AAPH induced a dose-dependent decrease in cell viability and this susceptibility was 
considerably more pronounced for the three day cultures (Figure 3.2) than the 14 day 
cultures (Figure 3.1). Similarly, tissue macrophages are more resilient towards ionizing 
radiation than circulating monocytes (Munn et al., 1995). Differences between 
differentiated and undifferentiated cells have also been observed for the THP-1 cell line, 
with THP-1 macrophage-like cells consistently displaying an increased resistance 
towards oxidative stress compared to undifferentiated THP-1 monocytes when exposed 
to AAPH (Baird, 2003), oxLDL (Vicca et al., 2000), and even hydrogen peroxide or a 
nitric oxide donor (Ferret et al., 2000).  
 Differentiation of monocytes into macrophages involves not just a change in 
appearance but also a change in metabolism. Numerous studies have therefore been 
devoted to identifying genes that are either up-regulated or down-regulated during      
the differentiation process (for example, Asseffa et al., 1993; Hart et al., 1999; Kohro et 
al., 2004; Whatling et al., 2004). In particular, because macrophages have evolved to 
combat infection at sites of inflammation, it is not surprising that damaging reactive 
oxygen species are released in greater quantities from macrophages than monocytes 
(Mouithys-Mickalad et al., 2001). A corresponding increase in endogenous antioxidants 
during differentiation is just as critical if macrophages are to survive under such 
oxidative conditions. Manganese SOD (Mn SOD) and copper-zinc SOD (CuZn SOD) 
are examples of antioxidant enzymes induced during differentiation (Ferret et al., 2000; 
Pietarinen-Runtti et al., 2000), while the vitamin E to total cholesterol ratio was also 
found to rise as HMDMs matured under in vitro conditions (Asmis & Jelk, 2000a). 
More extensive studies have revealed that glutathione levels are three-fold higher in 
THP-1 macrophages than monocytes, with depletion of this intracellular glutathione 
increasing the rate of oxLDL-induced cell death (Gotoh et al., 1993). Differentiated 
THP-1 cells were also shown to produce 70% and 120% more thioredoxin and 
thioredoxin reductase mRNA, respectively, compared to undifferentiated cells (Ferret  
et al., 2000). The same paper established a causal relationship between this antioxidant 
system and protection of the cells, by up-regulating thioredoxin expression via 
transfection, and subsequently observing increased resistance to oxidative stress.  
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 In contrast to the above studies, some research has indicated that differentiation does 
not always lead to increased protection from oxidative stress. The PC12 rat neuronal 
cell line was more sensitive to oxidative stress once differentiated (Sasaki et al., 2001), 
while U937 cells displayed no change either before or after differentiation (Ferret et al., 
2000). This apparent discrepancy was explained by a decrease in glutathione peroxidase 
activity and glutathione concentration upon differentiation in the PC12 cells and by a 
lack of any significant change in antioxidant activity in the U937s. These findings, 
therefore, ultimately provide further confirmation that resistance towards oxidative 
stress is correlated with cellular antioxidant activity. As such, the enhanced resistance of 
the 14 day cultures towards AAPH cytotoxicity when compared to the three day 
cultures is likely due to the increase in antioxidant activity that has previously been 
described upon differentiation.  
 
Duggan (2000) reported that the exposure of mature macrophages to 10mM AAPH 
caused a 50-75% reduction in viability after 12 hours. This is comparable to the 10mM 
AAPH-induced drop in viability observed for three day cultures (Figure 3.2) but not for 
14 day cultures (Figure 3.1), suggesting that the cells used in the Duggan study were not 
mature macrophages as initially stated. Indeed, later analysis of cells obtained using the 
methods described by Duggan (2000) showed that the majority were not fully 
differentiated (Gieseg & Duggan, personal communication). 
 
Further support for the degree of AAPH-induced loss of viability observed in this study 
arises from the use of two distinct viability assays. The MTT assay measures the 
metabolic activity of cells (Mosmann, 1983), while the trypan blue assay monitors 
membrane integrity and is generally considered to be a less sensitive measure of a cell’s 
state (Gieseg et al., 2001b). Irrespective of their different mechanisms for detecting cell 
death, these two assays consistently yielded similar trend and percentage value data, and 
therefore provided strong corroboration of all viability results obtained. 
 
3.3.2 Hydroperoxide Formation 
Incubation with AAPH resulted not only in cell death but also in the generation of 
hydroperoxides on the HMDMs. Initial attempts to monitor hydroperoxide formation 
relied on the FOX-1 assay because this had been successfully used to monitor      
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AAPH-induced protein hydroperoxide formation in the U937 cell line (Gieseg et al., 
2000a). However, doubts were soon raised about the suitability of this assay for HMDM 
research, when it became apparent that the inclusion of a lipid extraction step 
dramatically lowered hydroperoxide levels (Figure 3.3). Similar results were obtained 
with all three solvent combinations tested (acetone/diethyl ether, methanol/hexane and 
methanol/chloroform), indicating that the decrease in absorbance was unlikely to be due 
to the use of a specific solvent combination. It was also unlikely to be due to trace 
amounts of solvent inhibiting the FOX assay because the incorporation of a 5% TCA 
wash after the solvent wash steps did not prevent the drop in absorbance. 
 The FOX-1 assay is suitable for detecting protein hydroperoxides only under 
conditions of minimal lipid hydroperoxide production and the above results suggested 
that this was not the case during exposure of HMDMs to AAPH. Although TBARS 
remained at low levels of approximately 0.1µM after 18 hours (Figure 3.4), this assay 
measures an end-product of lipid peroxidation rather than the lipid hydroperoxides 
themselves. In comparison, the L-FOX and FOX-3 assays are designed to directly detect 
lipid and protein hydroperoxides, respectively. The use of these assays revealed that 
approximately 79% of all hydroperoxides were located on the lipid rather than the 
protein component of HMDMs after a 16 hour incubation with 20mM AAPH (Figure 
3.5). This contrasts with research exposing the U937 monocyte cell line (Gieseg et al., 
2000a) and red blood cell membranes (Firth, 2001) to AAPH, and it also contrasts with 
results obtained during gamma irradiation of both mouse myeloma Sp2/0 and U937 
cells (Gebicki et al., 2000b; Du & Gebicki, 2004). In all these studies, protein 
hydroperoxides rather than lipid hydroperoxides were detected.  
 Eukaryotic cells generally contain 74% protein versus 21% lipid and 4% DNA (Du 
& Gebicki, 2004). Thus, considering the abundance of protein in cells and also their 
susceptibility to free radicals, it is not surprising that cellular protein was the primary 
target of attack in these studies. Conversely, HMDMs are expected to be associated with 
large amounts of lipid because differentiation from blood-derived monocytes to 
macrophages has been reported to cause a 77-fold increase in total neutral lipid mass 
(Asmis & Jelk, 2000b). Such a dramatic accumulation of lipid during the culture of 
HMDMs produces cells with a foam-like appearance and has been attributed to the 
triglyceride-rich lipoprotein fraction of human serum (Garner et al., 1997a). As the 
HMDMs in this study were cultured for a minimum of 14 days in the presence of 10% 
heat-inactivated human serum, they too were expected to become foam-like. This trait 
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was, indeed, microscopically observed. Of further relevance to this study, the 
peroxidizability of membrane lipids positively correlates with PUFA content 
(Alexander-North et al., 1994). As a result, peroxidation is likely to be increased in 
HMDMs because the elevated lipid content is predominantly ascribed to long chain 
PUFAs of the n-3 series (Visioli et al., 2000b). Thus, reasons similar to those used to 
explain the preferential attack of protein in U937s and mouse myeloma cells, can also 
be used to account for the current results. More specifically, this means hydroperoxides 
were predominantly detected on the lipid rather than the protein component of HMDMs 
due to the susceptibility of PUFAs to oxidative attack and their abundance in 
differentiated primary macrophages. 
 Primary cells are generally considered to be more physiologically relevant than cell 
lines but, because of their contrasting states of differentiation, direct comparisons 
between the U937 monocytes studied by Gieseg et al. (2000a) and the HMDMs are not 
entirely appropriate. Nevertheless, since blood-derived monocytes possess significantly 
lower levels of lipids than HMDMS, it can be speculated that protein may be the 
preferential target of attack prior to the differentiation of these primary cells. 
 This research also offers a note of warning against extrapolating directly to the       
in vivo situation. While primary cells may be more physiologically relevant than cell 
lines, the lipid profile of the HMDMs is nevertheless highly dependent on the 
conditions of culture. HMDMs cultured in media supplemented with human serum 
amass large quantities of lipid but HMDMs cultured in the presence of foetal calf serum 
do not (Garner et al., 1997a). Whether AAPH-induced lipid hydroperoxide production 
would be reduced in HMDMs exposed to foetal calf serum is not currently known but 
could be investigated in future studies.  
 Unlike human serum, foetal calf serum is relatively deficient in triglycerides. By 
extension, it can be postulated that HMDMs cultured in human serum will accumulate 
lipid to a greater or lesser extent depending on the exact composition of the donor 
serum. The general in vivo significance of this serum-induced lipid accumulation in 
macrophages remains uncertain. It may, however, serve as a reasonable model for more 
specific situations, particularly those involving macrophage foam cells in the 
atherosclerotic plaque. Lipid profiles do differ slightly between foam cells isolated from 
plaque and HMDMs cultured in human serum (Garner et al., 1997a). As plaque is 
considered to be a site of chronic inflammation and high oxidative stress (Van Lente, 
2000; Scott, 2004), the detection of lipid hydroperoxides on HMDMs exposed to an 
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oxidant like AAPH raises the possibility of a similar scenario occurring in the 
atherosclerotic plaque. Lipid hydroperoxide formation on HMDMs in such an 
environment may be of significance to the atherogenic process for several reasons. For 
instance, macrophage foam cells are suggested to contribute to the necrotic core via the 
release of their lipids into the extracellular environment upon death (Ball et al., 1995; 
Martinet et al., 2001). Macrophages bearing peroxidized lipids on their membranes may 
also possess an additional means to promote the oxidation of LDL, with one study 
indicating that such macrophages promote LDL oxidation even in the absence of 
transition metals (Fuhrman et al., 1994).  
 
The specific location of the HMDM-associated lipid hydroperoxides was not 
investigated. However, it should be noted that AAPH is hydrophilic and has previously 
been shown to induce protein hydroperoxide formation on the cellular membrane rather 
than the intracellular components of U937 cells (Cassidy, 2003). While a similar 
hydroperoxide distribution may occur in HMDMs, the prospect of a lipid peroxidation 
chain reaction means that some damage may ultimately be transferred to the 
intracellular contents. Future studies could investigate this possibility by analyzing the 
various proportions of lipid hydroperoxides formed either in the HMDM cell extract or 
on the membrane following incubation with AAPH.  
 
Kinetic analysis revealed that 20mM AAPH had no detectable effect on lipid 
hydroperoxide formation during the first four hours of incubation (Figure 3.6). 
Oxidation subsequently proceeded at a rate of 0.15µM lipid hydroperoxides per hour 
and then plateaued at 2.27 ± 0.12µM after 18 hours. By contrast, the equation described 
in section 3.1 indicates that 20mM AAPH incubated at 37°C generated peroxyl radicals 
at a steady rate of 22.97µM/hour. Thus, only one lipid hydroperoxide was formed per 
152 peroxyl radicals. This is comparable to the ratio of one protein hydroperoxide per 
200 peroxyl radicals calculated by Gieseg et al. (2000a) for U937 cells.  
 Any hydroperoxides detected do represent a balance between formation and 
degradation, so it should be noted that the lipid hydroperoxide to peroxyl radical ratio 
may be a slight underestimate. Furthermore, a low hit rate is not entirely unexpected 
because peroxyl radicals are likely to react not only with the HMDMs but with other 
peroxyl radicals and with any molecules in the medium as well. Other cellular 
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components also represent alternative targets, so even a reaction between peroxyl 
radicals and the cell will not necessarily generate lipid hydroperoxides.  
 Protein peroxidation is not a major outcome of peroxyl radical attack under the 
conditions of this study (Figure 3.6). The possibility remains that protein 
hydroperoxides were formed and then rapidly degraded but, considering that samples 
were collected throughout the incubation period, this seems unlikely.  
 By contrast, thiols appear to be important scavengers of peroxyl radicals. Only one 
third of total cellular HMDM thiols remained after a 12 hour incubation with 20mM 
AAPH (Figure 3.9). Antioxidants like thiols are certainly valid alternative cellular 
targets, with many exhibiting strong peroxyl radical scavenging activity. A reaction 
between peroxyl radicals and antioxidants would limit the extent of lipid hydroperoxide 
formation and could also explain the four hour lag phase observed prior to the 
acceleration of lipid peroxidation on HMDMs. A lag period observed during the AAPH-
induced membrane oxidation of erythrocyte ghosts was attributed to α-tocopherol 
(Yamamoto et al., 1985). The presence of ascorbate in sealed erythrocyte ghosts was 
also shown to provide antioxidant protection by regenerating the membrane-bound α-
tocopherol (May et al., 1998). Though conducted on a different cell type, these studies 
are of potential relevance because the α-tocopherol to total cholesterol ratio is known to 
increase in HMDMs during differentiation (Asmis & Jelk, 2000a). A lag in protein 
hydroperoxide formation has also been observed during AAPH-induced oxidation of the 
THP-1 monocyte cell line (Kappler, 2005). This protection was suggested to be 
mediated by glutathione because protein peroxidation and cell death were only initiated 
once the glutathione had been largely depleted. Considering the increase in glutathione 
that occurs during differentiation (Gotoh et al., 1993), a similar scenario could account 
for the lag during AAPH-mediated damage to HMDMs. Likewise, thioredoxin levels 
also increase during macrophage differentiation (Ferret et al., 2000), and this 
antioxidant system has been shown to inhibit apoptosis in glutathione-depleted 
lymphoid cells through maintenance of the cellular redox status (Iwata et al., 1997).  
 Future studies could investigate the existence of such correlations in the HMDMs 
during AAPH-induced oxidative stress by analyzing the kinetics of antioxidant loss. 
Subsequent modulation of these antioxidant systems would then provide more direct 
evidence for their role in the lag phase.  
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A comparison of Figure 3.4 and Figure 3.6c confirmed that TBARS and lipid 
hydroperoxide formation yielded similar trends. In each case, a lag phase of 
approximately four hours was followed by a propagation phase and finally a plateau by 
18 hours. This similarity is not surprising considering that both provide an indication of 
lipid oxidation, with lipid hydroperoxides directly monitoring the peroxidation process 
and TBARS measuring MDA, one of the aldehyde break-down products of lipid 
peroxidation. As such, it is also not surprising that TBARS levels are significantly lower 
than the lipid hydroperoxides themselves. In particular, by the time a plateau was 
reached at 18 hours, 2.27 ± 0.12µM lipid hydroperoxides but only 107 ± 3nM TBARS 
were detectable. Although it must be acknowledged that the lipid hydroperoxide 
concentration represents a balance between formation and break-down, it is still 
possible to obtain an approximate estimate of 5% of lipid hydroperoxides being 
decomposed to MDA. 
 
In addition to elucidating the kinetics of AAPH-induced lipid oxidation on HMDMs, 
time course studies also highlighted a correlation between lipid and protein 
hydroperoxides, with protein hydroperoxides displaying a trend similar to that observed 
for lipid peroxidation (Figure 3.6c). Despite this, it should be noted that the protein 
hydroperoxide concentration on HMDMs never rose significantly above control levels.  
 Of more importance, therefore, may be the correlation observed between lipid 
hydroperoxide formation and loss of cell viability (Figure 3.6). In accord with the four 
hour lag observed during lipid peroxidation, both the MTT and trypan blues assays 
revealed an identical lag phase prior to any detectable cell death. This observation, 
combined with previous research, raises the possibility that these AAPH-induced lipid 
hydroperoxides contribute to the loss of viability in HMDMs. For instance, lipid 
hydroperoxides on oxLDL were shown to induce death in a variety of cell types, 
including human fibroblasts (Chisolm et al., 1994; Coffey et al., 1995) and human 
vascular smooth muscle cells (Siow et al., 1999). Meanwhile, tert-butyl hydroperoxide 
(Masaki et al., 1989) and 13-L-hydroperoxylinoleic acid (Aoshima et al., 1987) 
triggered loss of viability in cultured hepatocytes and Xenopus oocytes, respectively, by 
a mechanism dependent on the lipid peroxidation of cellular membranes. This mode of 
cell death was suggested to be due to lipid hydroperoxides disrupting the membrane 
lipid bilayer and thereby increasing membrane permeability. Other studies have 
attributed lipid hydroperoxide-induced apoptosis to disruption of the cellular redox 
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balance, either via increased ROS production (Aoshima et al., 1997) or a decrease in 
glutathione and the glutathione-to-oxidized glutathione ratio (Wang et al., 2000). Lipid 
hydroperoxides have also been suggested to increase cytosolic calcium levels, thereby 
participating in the activation of a calcium-dependent apoptotic pathway (Sandstrom    
et al., 1995; Li et al., 2001). Such findings could be related to membrane disruption or 
to lipid hydroperoxide involvement in various signal transduction pathways (Girotti, 
1998). Lipid hydroperoxides can also participate in damaging chain reactions, 
explaining why some studies have found apoptosis to be more directly linked to iron-
dependent lipid peroxidation than to either calcium or glutathione levels (Tzeng et al., 
1995; Chiou et al., 2003). The toxicity of lipid peroxidation end-products provides 
another means of inducing cell death, with 4-hydroxynonenal (HNE) able to directly 
induce apoptosis in human lens epithelial cells (Choudhary et al., 2002).  
 The above studies indicate that lipid peroxidation can induce cell death in numerous 
ways, with the exact mechanism depending on the experimental conditions and cell type 
under investigation. A direct causal relationship between HMDM lipid hydroperoxides 
and loss of viability remains to be established but, once it is, additional research will 
clearly be required to identify their exact role in AAPH-mediated HMDM death.  
 
3.3.3 Effect of 7,8-NP 
Despite 7,8-NP’s known ability to scavenge peroxyl radicals (Gieseg et al., 1995; Oettl 
et al., 1997), the addition of up to 200µM 7,8-NP failed to protect HMDMs from the 
cytotoxicity induced by 20mM AAPH (Figure 3.7a & b). This contrasts with the ability 
of micromolar quantities of 7,8-NP to significantly inhibit cell death in erythrocytes 
(Gieseg et al., 2001a) and in U937 monocytes (Gieseg et al., 2001b; Duggan et al., 
2002) during exposure of the cells to a range of oxidative insults.  
 Duggan et al. (2002) observed protection by seeding the U937s at a concentration of 
5x106 cells/ml (identical to the HMDM seeding concentration in this current study) but 
adding only 10mM rather than 20mM AAPH to the incubation medium. Although 
HMDMs display increased resistance towards AAPH compared to U937s, the use        
of different oxidant concentrations nonetheless raised the possibility of 7,8-NP’s 
antioxidant activity simply being overwhelmed by the increased peroxyl radical flux. 
Incubating HMDMs for 12 hours with 10mM AAPH did reduce the radical flux by half, 
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leading to a corresponding decrease in HMDM death. However, 7,8-NP still failed to 
exert any protective effect under these conditions (Figure 3.8).  
 Although macrophages are known to release increased quantities of ROS    
compared to monocytes (Mouithys-Mickalad et al., 2001), cellular antioxidants are 
correspondingly up-regulated too. As a consequence, 7,8-NP’s lack of protective effect 
is unlikely to be due to any inability to offset the increased levels of oxidative stress 
associated with HMDMs. Of more significance, therefore, may be additional changes in 
metabolic response that are caused either by differentiation or by slight contrasts 
between the cell types. Several studies have discussed the influence of 7,8-NP on gene 
expression and cell signalling and it is possible that this compound’s effect will vary 
depending on the metabolic state of the cell (for example, Woll et al., 1993).  
 The structural changes that occur during differentiation in 10% human serum 
provide a more likely explanation for 7,8-NP’s lack of effect during AAPH-mediated 
oxidation of HMDMs. Unlike U937s, HMDM cells are differentiated and lipid-loaded. 
Such differences may cause 7,8-NP and/or AAPH to interact or partition with the two 
cell types in distinct ways. One or the other may bind directly to, or be absorbed by, the 
HMDM cells in such a way that the 7,8-NP is unable to effectively scavenge radicals. In 
the absence of such interactions, the water soluble 7,8-NP would be expected to 
effectively scavenge the water soluble peroxyl radicals. This certainly appeared to occur 
when exposing BSA (Duggan et al., 2001) or U937 cells (Duggan et al., 2002) to 
AAPH and 7,8-NP, but was not observed during the current HMDM study. In further 
support of the interaction/partitioning theory, 7,8-NP provided some protection against 
AAPH-induced cytotoxicity in the presence of the less lipid-loaded and less 
differentiated primary macrophages studied by Duggan (2000). 
 In contrast with the protection mediated by 7,8-NP towards U937s, 7,8-NP had no 
effect on cellular thiols and only a limited impact on loss of viability in THP-1 cells 
(Baird et al., 2005). THP-1 and U937 monocytes do not possess significant structural 
differences, so it is uncertain whether the interaction/partitioning theory is sufficient to 
account for the diverging results observed with these two cell lines. Regardless of this, 
the concept of an interaction between 7,8-NP and its substrates remains worthy of 
consideration. It has, in fact, already been discussed during LDL oxidation studies, with 
Gieseg et al. (1995) suggesting that 7,8-NP interacts with LDL in or on its lipid 
environment. This interaction enabled 7,8-NP to efficiently scavenge the LDL lipid 
peroxyl radicals that form and explains why 7,8-NP afforded similar levels of protection 
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against AAPH and copper attack, despite these compounds generating different types of 
radicals. 
 Whatever the precise mechanism(s) accounting for 7,8-NP’s contrasting 
protectiveness towards a range of monocyte/macrophage cells, it is clear from AAPH 
and oxLDL studies on U937s that a positive correlation exists between 7,8-NP’s ability 
to inhibit cellular thiol loss and its ability to inhibit cell death (Duggan et al., 2002; 
Baird et al., 2005). This correlation can be explained by considering the importance of 
glutathione, and thiols in general, for maintaining a healthy redox state within the cells. 
Given 7,8-NP’s failure to prevent HMDM death, it was not surprising to discover that 
7,8-NP also failed to inhibit AAPH-mediated oxidation of the total HMDM cellular 
thiols (Figure 3.9). Likewise, because lipid hydroperoxides are postulated to play a 
critical role in the AAPH-mediated death of HMDMs (section 3.3.2), it was anticipated 
that 7,8-NP would not prevent the generation of lipid hydroperoxides. A co-incubation 
with up to 200µM 7,8-NP caused no change in lipid hydroperoxide levels (Figure 3.7c), 
verifying this hypothesis and lending further support to the contribution of lipid 
hydroperoxides in HMDM death.  
 By contrast, 100µM 7,8-NP was sufficient to almost completely inhibit protein 
hydroperoxide formation after a 12 hour incubation with 20mM AAPH (Figure 3.7c). 
Due to the non-significant levels of protein hydroperoxides formed even in the absence 
of any 7,8-NP, this protection against AAPH is not statistically significant and it 
becomes difficult to make any strong conclusions. Nevertheless, the inhibition of 
protein hydroperoxides does agree with a previous study where 7,8-NP prevented 
AAPH-induced protein hydroperoxide formation on the U937 monocyte cell line 
(Duggan et al., 2002). Furthermore, if 7,8-NP was scavenging AAPH-derived peroxyl 
radicals in the aqueous solution only, a similar level of inhibition would be expected for 
both lipid and protein hydroperoxides. Thus, the differential effect of 7,8-NP towards 
AAPH-mediated protein and lipid hydroperoxide formation supports the notion that  
7,8-NP may interact with the HMDMs. This interaction may occur intracellularly and/or 
on the cell’s surface but, irrespective of the location, it ultimately appears to place the 
7,8-NP in a better position to scavenge the cells’ protein peroxyl radicals and not the 
lipid peroxyl radicals.  
  
The above results demonstrated an inhibition of protein hydroperoxide formation but no 
effect on thiol oxidation, lipid hydroperoxide formation or cell viability when 7,8-NP 
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was added in a single exogenous dose. Stimulation of HMDMs with IFN-γ was 
designed to ensure an endogenous and continuous supply of 7,8-NP. This, too, failed to 
prevent AAPH-mediated cell death and the generation of lipid hydroperoxides (Figure 
3.10). Under these conditions there was also no inhibition of protein hydroperoxide 
formation, indicating that insufficient quantities of 7,8-NP were produced to provide the 
required protection.  
 Pterin (neopterin and 7,8-NP) levels were certainly lower following the 12 hour 
incubation with 20mM AAPH in EBSS compared to the preceding 48 hour incubation 
in RPMI (Figure 3.11). Several reasons account for this dramatic drop, including the 
fact that EBSS is less nutrient rich than RPMI and would have contributed to a slower 
rate of 7,8-NP synthesis. Furthermore, all 7,8-NP released into the RPMI was lost once 
the incubation medium was changed to EBSS. As cells were subsequently incubated in 
EBSS for only 12 hours, there was less time for the 7,8-NP levels to build up again. 
Although pterin levels may have been higher if the entire pre-incubation and incubation 
were conducted in EBSS, this is not feasible when using EBSS. Sixty hours in minimal 
medium is likely to adversely affect the health of cells even in the absence of AAPH.  
 Ultimately, AAPH may play the largest role in accounting for the dramatic decrease 
in pterins. While transferral to EBSS did reduce supernatant and intracellular pterin 
levels, the addition of 20mM AAPH decreased the yields even further. Thus, the stress 
and cell death caused by AAPH was clearly more than sufficient to adversely affect  
7,8-NP synthesis. Whether HMDMs would be better able to synthesize 7,8-NP, and 
provide protection, in the presence of a lower level of oxidative stress is unclear. 
However, with respect to AAPH, this seems unlikely. Halving the dose of AAPH to 
10mM did reduce the extent of cell death to approximately 25% but the bolus addition 
of up to 200µM 7,8-NP still failed to protect against this lower level of oxidative 
damage (Figure 3.8). Moreover, the lack of protection observed in this study with IFN-γ 
may not be restricted to an oxidant like AAPH. Baird (2003) showed that IFN-γ was 
also unable to prevent oxLDL-induced death in a range of cell lines, including U937 
monocytes, THP-1 monocytes and THP-1 macrophage-like cells. This lack of protection 
was observed despite the entire experiment (including a 24 hour pre-incubation) being 
conducted in RPMI supplemented with 300U/ml IFN-γ. 
 The absence of any concentration-dependent effect of IFN-γ on AAPH-mediated 
damage is, in itself, not unexpected because pterin levels displayed no reliance on IFN-γ 
between the range of 250-1000U/ml (Figure 3.11). This range of concentrations was 
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chosen based on findings by previous studies of a positive correlation between IFN-γ 
and pterin levels (Werner-Felmayer et al., 1990; Gruber et al., 2000). The apparent 
disparity between these results and the current study may simply be due to cell type-
specific differences, with the THP-1 cell line being used previously compared to 
HMDMs now. Pterins released from human macrophages have been reported to exhibit 
a concentration-dependence towards IFN-γ. However, this effect was only observed up 
to 100U/ml IFN-γ, with pterin levels reaching a plateau thereafter (Huber et al., 1984). 
This agrees with the plateau detected between 250 and 1000U/ml IFN-γ in Figure 3.11,     
and provides another cautionary tale against extrapolating directly from cell line data   
to primary cells. The result does not detract from the fact that, under the conditions of 
this study, stimulation with IFN-γ failed to protect HMDMs from AAPH-mediated 
damage.  
 
3.4 Summary 
The differentiation of blood-derived monocytes produced HMDMs possessing an 
increased resistance towards AAPH-induced oxidative stress. Double the dose of AAPH 
was required to kill 50% of 14 day cultures compared to three day cultures under 
otherwise identical experimental conditions. Kinetic analysis revealed that the AAPH-
mediated death of HMDMs was closely correlated to lipid hydroperoxide formation. 
Both parameters displayed a lag of approximately four hours before the initiation of any 
detectable damage and, given the findings of previous studies, it seems likely that lipid 
peroxidation contributes to the death of HMDMs. This theory is further supported by 
the inability of up to 200µM 7,8-NP to prevent both loss of viability and lipid 
hydroperoxide formation. Protein hydroperoxides are unlikely to play a major role in 
HMDM death because, although a similar kinetic trend was observed, protein 
hydroperoxide levels remained low and never reached significance. Furthermore, 
100µM 7,8-NP was sufficient to inhibit protein hydroperoxide formation, while having 
no effect on cell viability.  
 Lipid rather than protein appears to be the primary target of peroxyl radical attack 
on HMDMs, presumably due to the fact that HMDMs accumulate PUFA-rich lipid    
and become foam-like in appearance. This structural change is also postulated to    
affect the way 7,8-NP interacts with the HMDMs, limiting its effectiveness as a radical 
scavenger and thereby preventing 7,8-NP from inhibiting AAPH-mediated thiol loss, 
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lipid hydroperoxide formation and, ultimately, cell death. This lack of effect by 7,8-NP 
towards HMDMs exposed to AAPH bears more resemblance to the THP-1 cell line than 
to the U937 cell line. 
 Stimulation with IFN-γ also failed to inhibit hydroperoxide formation and cell death 
in the presence of 20mM AAPH. Thus, under the conditions of this study, both a single 
exogenous addition and a continuous endogenous supply of 7,8-NP were incapable of 
protecting HMDMs from AAPH-mediated damage. 
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4 Ham’s F10 Medium and LDL Oxidation 
4.1 Introduction 
Ham’s F10 is a popular choice of medium for experiments studying cell-mediated LDL 
oxidation (for example, Sparrow & Olszewski, 1993; Maziere et al., 1995; Wood & 
Graham, 1995; Halvorsen et al., 1996; Marchant et al., 1996; Carpenter et al., 1997; 
Muller et al., 1998; Gieseg & Cato, 2003) and has several advantages when compared 
to other types of media. It is more nutrient-rich than the minimal media, HBSS and 
EBSS, but less enriched than RPMI. This balance enables Ham’s F10 to effectively 
maintain cells in a healthy state for several days but, conversely, limits the level of 
potential antioxidant compounds (amino acids, thiols and vitamins) that could inhibit 
the pro-oxidant activity of the incubating cells (Faure et al., 2004). For this reason, 
Ham’s F10 requires supplementation with a lower level of transition metal ions than 
RPMI 1640 to achieve an equivalent level of cell-mediated LDL oxidation (van Reyk   
et al., 1999). It is also less likely than RPMI to interfere with the antioxidant activity of 
any compounds studied (Faure et al., 2004). 
 These features make Ham’s F10 ideal for the current research; an investigation of 
7,8-NP’s capacity to inhibit macrophage-mediated LDL oxidation. Unfortunately, the 
quality of commercially available Ham’s F10 media appears to have diminished in 
recent years. Problems in LDL oxidation studies coincided with the depletion of a batch 
of Gibco BRL’s Ham’s F10 liquid medium. Gibco BRL had, by this point, halted the 
manufacture of Ham’s F10 for a couple years so the media had to be replaced with what 
was assumed to be the powdered equivalent from Sigma. Of particular concern was the 
detection of sudden inconsistency in the rates of cell free LDL oxidation. By contrast, 
cell-mediated rates of LDL oxidation remained relatively constant. Although there were 
no obvious changes in the chemical composition of Ham’s F10, informal discussions 
with other labs supported the idea of an intrinsic but unidentified inconsistency in the 
media (A. Baoutina; K. Carpenter, personal communications). 
 A cell free (LDL only) control is important because a basal level of oxidation occurs 
whenever transition metals are present. Cells are considered to enhance this process. 
Consequently, an ideal experimental set-up for monitoring cell-mediated LDL oxidation 
should result in minimal cell free oxidation while still maintaining a significant level of 
cell-mediated oxidation. Unpredictable changes in the rate of cell free LDL oxidation 
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make it difficult to systematically study cell-mediated LDL oxidation and any ensuing 
inhibition that occurs during 7,8-NP or IFN-γ treatment.  
 This section of work therefore highlights the problems experienced during cell free 
LDL oxidation and provides an overview of the steps taken to identify the cause of the 
inconsistency and alleviate the problem. 
 
4.2 Results 
4.2.1 Variability in the Rate of Cell Free LDL Oxidation 
Inconsistencies between experiments became apparent when monitoring the rate of cell 
free LDL oxidation, with the lag phase varying from anywhere between three hours to 
over 24 hours (Figure 4.1 & Figure 4.2). This variability was observed whether 
measuring protein oxidation, lipid oxidation or even vitamin E loss. Meanwhile, cell-
mediated LDL oxidation maintained relatively consistent rates between experiments. 
This led to large variations in the length of time that cell free samples remained 
significantly less oxidized than the cell plus LDL samples, with only one time point of 
significance in Figure 4.1 versus all time points between six and 24 hours in Figure 4.2. 
In some experiments, the cell free oxidation proceeded so fast that there was no 
significant difference between incubations in the presence and absence of cells (data not 
shown). 
 Initial observations indicated that the rate of oxidation was generally slower when 
using fresher batches of media. The addition of 25mM N-[2-hydroxyethyl]piperazine-
N’-[2-ethanesulfonic acid] (HEPES) also appeared to delay the sudden onset of 
variability observed between experiments. However, even these trends could not be 
guaranteed. Some of the fastest cell free LDL oxidations were observed when using 
HEPES-supplemented Ham’s F10, prepared only a few days prior to the experiment 
(data not shown). 
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Figure 4.1  Rapid cell free LDL oxidation in Ham’s F10 medium. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10, supplemented with 25mM HEPES and 
1.5µM FeSO4, in the presence or absence of adherent THP-1 macrophage-like cells (1x105 cells/ml). 
Samples were analyzed at various time points for an increase in (a) protein hydroperoxides and      
(b) TBARS and (c) a loss of vitamin E. Significance is indicated between treatments. Results are 
displayed as mean ± SEM of triplicate samples. 
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Figure 4.2  Slow cell free LDL oxidation in Ham’s F10 medium. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10, supplemented with 25mM HEPES and 
1.5µM FeSO4, in the presence or absence of adherent THP-1 macrophage-like cells (1x105 cells/ml). 
Samples were analyzed at various time points for an increase in (a) protein hydroperoxides and      
(b) TBARS and (c) a loss of vitamin E. Significance is indicated between treatments. Results are 
displayed as mean ± SEM of triplicate samples. 
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 The role of media in the cell free oxidation inconsistency was more rigorously tested 
by setting up four LDL oxidation treatments that differed only in the Ham’s F10 (Figure 
4.3). Two month old Medium 1a lacked HEPES, while one month old Medium 2a was 
supplemented with 25mM HEPES at the time of media preparation. Despite the lack of 
any other differences, a large discrepancy in the degree of cell free LDL oxidation was 
observed between the two treatments. The addition of fresh HEPES to the two month 
old Medium 1a served as the basis for Medium 1b but this had only a limited impact on 
the level of cell free LDL oxidation at 12 and 24 hours. By contrast, Medium 2b 
permitted significantly more TBARS formation on LDL than Medium 2a after a 24 hour 
incubation. Both were prepared on the same day and from the same batch of powdered 
Ham’s F10 but merely stored in different bottles. Medium 2b’s exposure to oxygen and 
light was also limited by leaving it undisturbed in an unopened, darkened bottle for the 
entire month after preparation. (All other bottles were partially empty.) The low level of 
cell free LDL oxidation in Medium 2a differs not only from that obtained with Medium 
2b but also with the trend observed using Medium 2a two weeks earlier. In that 
experiment, TBARS concentrations of 13.41 ± 1.79 and 42.22 ± 1.07 moles/mole LDL 
were detected after 12 and 24 hours, respectively (data not shown). 
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Figure 4.3  Effect of different Ham’s F10 media on cell free LDL oxidation. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10 supplemented with 1.5µM FeSO4. After 12 
and 24 hours, samples were analyzed for an increase in TBARS. Medium 1a: Two month old Ham’s 
F10, lacking HEPES. Medium 1b: Same batch as medium 1a but with 25mM HEPES added 
immediately prior to the experiment. Medium 2a: One month old Ham’s F10, containing 25mM 
HEPES. Medium 2b: Same batch as medium 2a, containing 25mM HEPES, but stored in an 
unopened, darkened bottle for the entire month. Results are displayed as mean ± SEM of triplicate 
samples. 
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4.2.2 Medium Modifications 
Variable rates of cell free LDL oxidation continued to be observed after preparation of 
the Ham’s F10 in water sourced from an alternative filtration system (data not shown). 
Even purchasing the medium from an alternative supplier failed to solve the 
inconsistency problem, as was confirmed when Gibco BRL began reselling Ham’s F10 
(Table 4.1). A 12 hour incubation in Gibco BRL Ham’s F10 yielded concentrations of 
LDL-associated protein hydroperoxides that differed significantly between April and 
July 2004 (p<0.001). The variability associated with this Gibco BRL medium contrasts 
with the consistent cell free results obtained when using Ham’s F10 purchased from 
Gibco BRL a few years before the current problems. However, it agrees with the 
inconsistency observed during cell free LDL oxidation in Sigma Ham’s F10. This 
similarity to Sigma Ham’s F10 occurs despite the two sources of media having 
distinctly different preparation and storage procedures. Ham’s F10 from Gibco BRL 
was purchased in liquid form and stored in sterile plastic containers supplied by the 
medium manufacturer. Sigma Ham’s F10 was purchased as a powder and then prepared 
and stored in sterile glass bottles sourced from the Free Radical Biochemistry 
Laboratory.  
 
 
Table 4.1  Cell free LDL oxidation in Ham’s F10 medium sourced from Gibco 
BRL. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10, sourced from Gibco BRL, and supplemented 
with 1.5µM FeSO4 and 25mM HEPES. After 12 hours, samples were analyzed for an increase in 
protein hydroperoxides. The experiment was conducted on two different occasions (April 2004 and 
July 2004) but using the same bottle of Ham’s F10 medium. Significance is indicated between dates. 
Results are displayed as mean ± SEM of triplicate samples. 
 April 2004 July 2004 
Protein hydroperoxide 
(mole/mole LDL) 3.84 ± 0.64     33.54 ± 2.26 
*** 
 
 
 
 
Dr Keri Carpenter (personal communication) has also experienced a lack of consistency 
during LDL oxidation in Ham’s F10 but was largely able to solve the instability            
by supplementing phenol red to a concentration of 12mg/L. Sigma and Gibco BRL 
Ham’s F10 currently contain low quantities of 1.3mg/L and 1.2mg/L phenol red, 
respectively, but prior to 1994, contained the much higher concentration of 12mg/L 
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(Wilkins & Leake, 1994). However, increasing the phenol red concentration to pre-1994 
levels failed to reproduce Dr Carpenter’s result (Figure 4.4). No inhibition was observed 
compared to unsupplemented Sigma Ham’s F10. The supplemented treatment actually 
appeared to promote a slightly faster rate of cell free LDL oxidation, though this was 
not significant for protein hydroperoxide formation and only significant for vitamin E 
loss at six hours (p<0.05). 
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Figure 4.4  Effect of phenol red on cell free LDL oxidation. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10, containing 25mM HEPES and either 
1.3mg/L or 12mg/L phenol red. All media were supplemented with 1.5µM FeSO4. After both six and 
nine hours, samples were analyzed for (a) an increase in protein hydroperoxides and (b) a loss of 
vitamin E. Significance is indicated between treatments. Results are displayed as mean ± SEM of 
triplicate samples. 
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Having failed to eliminate the cell free inconsistency by antioxidant supplementation, an 
attempt was then made to identify and subsequently modify the component(s) in Ham’s 
F10 responsible for the variability. Thiols in the media were initially studied because of 
their ability to contribute to LDL oxidation but, regardless of this potential, no clear 
correlation was found to exist between Ham’s F10 thiol levels and the extent of cell free 
LDL oxidation (Figure 4.5). While Medium 1 did contain the lowest quantities of both 
thiols in the Ham’s F10 and protein hydroperoxides on the incubated LDL, the other 
media contradicted this trend. Protein hydroperoxide formation was considerably more 
pronounced when LDL was incubated in Medium 3 compared to Medium 2 (p<0.001) 
even though these two media exhibited no significant difference in thiol concentrations. 
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Figure 4.5  Comparison between thiol levels in Ham’s F10 media and cell free 
protein hydroperoxide formation on LDL. 
Thiol levels were measured in each of three batches of Ham’s F10 media before supplementing with 
1.5µM FeSO4 and incubating with 0.1mg/ml LDL at 37°C. After nine hours, samples were analyzed 
for an increase in protein hydroperoxides. Medium 1: Five month old Ham’s F10, containing 25mM 
HEPES. Medium 2: Four month old Ham’s F10, lacking HEPES. Medium 3: One week old Ham’s 
F10, lacking HEPES. * indicates significance from Medium 1. # indicates significance from Medium 
2. Results are displayed as mean ± SEM of triplicate samples.  
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Like thiols, glutamine also deserved consideration as a source of the cell free 
instability. Admittedly, the literature does not refer to a role for glutamine in LDL 
oxidation but, at a concentration of 1mM, it is the most abundant amino acid present in 
Ham’s F10. Just as critically, it has been shown to degrade over time (Sigma product 
information sheet). Ham’s F10 was therefore supplemented with 1mM glutamine 
immediately before the initiation of a cell free LDL oxidation experiment (Figure 4.6). 
The supplemented treatment failed to show any significant difference in LDL-associated 
TBARS compared to the unsupplemented control after either six or nine hours of cell 
free oxidation. 
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Figure 4.6  Effect of supplementation with fresh glutamine on cell free LDL 
oxidation. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10, containing 25mM HEPES. All media was 
supplemented with 1.5µM FeSO4 but only half was supplemented with 1mM fresh glutamine. After 
both six and nine hours, samples were analyzed for an increase in TBARS. ANOVA analysis 
revealed no statistical significance between treatments. Results are displayed as mean ± SEM of 
triplicate samples. 
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 Iron plays a critical role in LDL oxidation under the conditions of this study, raising 
the possibility that it may somehow contribute to the inconsistent rates of cell free   
LDL oxidation. Initial studies had indicated that a supplemental ferrous sulphate 
concentration of 1.5µM was required for optimal results (Figure 5.1 to Figure 5.3). 
However, ferrous sulphate is not the only suitable source of supplemental iron for LDL 
oxidation studies. Ferric chloride also has the potential to promote LDL oxidation      
and has, in fact, been used by another research group without any major problems     
(W. Jessup, personal communication). Thus, the stability of cell free LDL oxidation 
after supplementation with 1.5µM ferric chloride was investigated over a period of five 
days and compared to oxidation in the presence of 1.5µM ferrous sulphate (Figure 4.7). 
Despite such a short time frame, supplementation with ferric chloride showed dramatic 
variations in the extent of cell free LDL oxidation (p<0.001). The values differed so 
widely that, although a significant difference in the extent of TBARS formation was 
apparent between ferric chloride and ferrous sulphate treatments after the first 
experiment (p<0.001), this difference was no longer significant after the second 
experiment.  
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Figure 4.7  Effect of different iron oxidation states on cell free LDL oxidation. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10, containing 25mM HEPES, and supplemented 
with either 1.5µM FeSO4 or 1.5µM FeCl3. After 24 hours, samples were analyzed for an increase in 
TBARS. The experiment was conducted on two different occasions (day 1 and day 5) but using the 
same bottle of Ham’s F10 medium. * indicates significance between the different iron treatments.    
# indicates significance between dates. Results are displayed as mean ± SEM of triplicate samples. 
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 Supplementary iron is not the only source of metal in these LDL oxidation 
experiments because the Ham’s F10 is formulated with 3µM ferrous sulphate. This 
iron(II) is likely to oxidize over time, providing an alternative means by which iron 
could contribute to the variability in cell free LDL oxidation. The extent of oxidation to 
the iron(III) state was quantified using the basic FOX assay protocol. It required 900µl 
of media to be adjusted to a pH between 1.7 and 1.8 with sulphuric acid, before being 
mixed with 50µl of 5mM xylenol orange (in 25mM H2SO4) and 50µl of either water or 
1mM hydrogen peroxide. Samples were subsequently incubated in the dark for 30 
minutes, providing adequate time for all iron(III) to react with xylenol orange and form 
a coloured complex with a peak absorbance at 560nm. The water blank was used when 
measuring iron(III) concentrations (reaction 15), while hydrogen peroxide oxidizes any 
iron(II) present and was therefore required for the detection of any iron in this reduced 
oxidation state (reaction 16 followed by reaction 15). Iron(II) levels could then be 
quantified as the difference between absorbances in the presence and absence of the 
hydrogen peroxide.  
(15) Ham’s F10 Fe(III)  +  XO  +  H2O  →  Ham’s F10 Fe(III)-XO 
(16) Ham’s F10 Fe(II)  +  H2O2  →  Ham’s F10 Fe(III)  +  OH-  +  •OH 
 Despite iron(III) not being listed as a constituent of Ham’s F10, high concentrations 
were detected in each of the four Ham’s F10 media tested (Table 4.2). This contrasted 
with the discovery of low levels of iron(II) and results in a ratio of one iron(II) molecule 
for every 2.2 to 2.9 iron(III) molecules. Although Ham’s F10 is formulated with 3µM 
ferrous sulphate, the combined iron(II) and iron(III) levels in the four media never 
exceeded 2.27µM. These lower than expected readings could have been caused by the 
formation of complexes between various components of the medium and iron in such a 
way that the latter was no longer available for reaction in the FOX assay. Alternatively, 
it may simply be due to insensitivity in the detection method. Nevertheless, mixing    
the Ham’s F10 with Chelex 100 resin for at least four hours at 4°C did appear to remove 
both iron(II) and iron(III) from the medium, with significant levels no longer being 
detectable by the FOX assay (Table 4.2).  
 A series of experiments therefore investigated the effect of chelexed Ham’s F10 on 
cell-mediated and cell free LDL oxidation after fresh supplementation with a range of 
ferrous sulphate concentrations (Figure 4.8). As expected, when non-chelexed Ham’s 
F10 was supplemented with the usual 1.5µM ferrous sulphate, cell free oxidation 
displayed a fast rate of reaction and was no longer significantly different from the level 
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of cell-mediated LDL oxidation by 12 hours (Figure 4.8). Conversely, chelexed Ham’s 
F10 supported no oxidation when supplemented with only 1.5µM ferrous sulphate 
(Figure 4.8a). This was observed even in the presence of THP-1 macrophages and after 
24 hours of incubation. Supplementation with 2µM ferrous sulphate also prevented cell 
free LDL oxidation in chelexed Ham’s F10 but did permit a limited degree of cell-
mediated oxidation (Figure 4.8b). The addition of 2.5µM ferrous sulphate to chelexed 
Ham’s F10 further maximized this effect (Figure 4.8c). Cell free oxidation was still 
prevented but cell-mediated LDL oxidation was promoted at a reasonable rate and was 
almost comparable to that observed when using non-chelexed Ham’s F10.  
 For this reason, subsequent experiments tested the consistency of LDL oxidation 
using freshly chelexed Ham’s F10 supplemented with 2.5µM ferrous sulphate. Cell free 
LDL oxidation was found to consistently give base-line readings under these conditions 
(Figure 4.9). However, the rate of cell-mediated LDL oxidation now varied dramatically 
from one experiment to the next. On some occasions there was an absence of any 
apparent oxidation, as supported by the complete retention of LDL-associated vitamin E 
(Figure 4.9a). At other times cell-mediated oxidation was significantly different from 
the cell free LDL oxidation (p<0.001) and proceeded, as expected, with a complete loss 
of vitamin E and maximal levels of protein hydroperoxides (Figure 4.9b). 
 
 
 
Table 4.2  Iron concentrations in different bottles of Ham’s F10 media.  
The FOX assay was used to measure the quantity of iron(II) and iron(III) in two bottles each of 
Gibco BRL Ham’s F10 and Sigma Ham’s F10. Concentrations were determined against a standard 
curve that had been prepared by dissolving known concentrations of iron(II) in 25mM H2SO4 and 
incubating for 30 minutes with 50µl each of xylenol orange and 1mM hydrogen peroxide. Iron levels 
were also assessed in freshly chelexed Sigma Ham’s F10. Results are displayed as mean ± SEM of 
triplicate samples. 
 Fe(II) 
concentration
(µM) 
Fe(III) 
concentration
(µM) 
Total 
concentration
(µM) 
Fe(II):Fe(III) 
Ratio 
Gibco BRL 1 
Gibco BRL 2 
Sigma 1 
Sigma 2 
Chelexed Sigma 
0.56 ± 0.06 
0.54 ± 0.06 
0.54 ± 0.05 
0.59 ± 0.06 
0.00 ± 0.00 
1.27 ± 0.04 
1.19 ± 0.05 
1.50 ± 0.04 
1.68 ± 0.03 
0.00 ± 0.02 
1.83 ± 0.07 
1.73 ± 0.08 
2.04 ± 0.06 
2.27 ± 0.07 
0.00 ± 0.02 
1 : 2.3 
1 : 2.2 
1 : 2.8 
1 : 2.9 
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Figure 4.8  Combined effects of different iron concentrations and chelexed Ham’s 
F10 on LDL oxidation. 
LDL (0.1mg/ml) was incubated at 37°C in Ham’s F10 in the presence or absence of adherent THP-1 
macrophage-like cells (1x105 cells/ml). The Ham’s F10 was chelexed, contained 25mM HEPES, and 
was supplemented with (a) 1.5µM FeSO4, (b) 2µM FeSO4 and (c) 2.5µM FeSO4. For comparison, 
each graph also includes data obtained during LDL oxidation in non-chelexed Ham’s F10, 
supplemented with 1.5µM FeSO4. All samples were analyzed at multiple time points for an increase 
in TBARS. Significance is indicated, at each iron concentration, between cell-containing and cell 
free treatments. Results are displayed as mean ± SEM of triplicate samples. 
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Figure 4.9  Inconsistent cell-mediated LDL oxidation using chelexed Ham’s F10 
and 2.5µM FeSO4. 
LDL (0.1mg/ml) was incubated in Ham’s F10 at 37°C in the presence or absence of adherent THP-1 
macrophage-like cells (1x105 cells/ml). Ham’s F10 contained 25mM HEPES and was freshly 
chelexed and supplemented with 2.5µM FeSO4. After 24 hours, samples were analyzed for an 
increase in protein hydroperoxides and a loss of vitamin E. The experiments were conducted on two 
different occasions: (a) 15 March 2005 and (b) 29 March 2005. Significance is indicated between 
treatments. Results are displayed as mean ± SEM of triplicate samples. 
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 In an attempt to gain consistency during both cell free and cell-mediated LDL 
oxidation, chelexed Ham’s F10 was supplemented with 4.5µM ferrous sulphate and 
0.01µM cupric chloride. These concentrations mimic the initial levels used before 
variability became a problem, representing the transition metals normally present in 
Ham’s F10 plus the supplemental 1.5µM ferrous sulphate. Cell free LDL oxidation was 
still limited under these conditions, with no protein hydroperoxide formation and 
significant vitamin E loss (p<0.05) beginning only at 24 hours (Figure 4.10). By 
contrast, cell-mediated LDL oxidation occurred at a reasonable rate. This rate was, 
admittedly, slower than that previously observed when using similar concentrations of 
transition metals (Figure 4.1 or Figure 4.2). However, it was to be expected because the 
cells had been pre-incubated in Ham’s F10 for 48 hours prior to the start of the 
experiment. This was done in conjunction with an experiment designed to investigate 
the effect of IFN-γ on THP-1 macrophage-mediated LDL oxidation (see section 5.25 for 
more details). Ham’s F10 is a less nutrient-rich medium than RPMI but this pre-
incubation was required to provide adequate time for IFN-γ to induce the THP-1 
macrophages to synthesize 7,8-NP. A similar incubation was conducted in non-chelexed 
Ham’s F10, supplemented with 1.5µM ferrous iron, and was also associated with a 
slower rate of cell-mediated LDL oxidation (data not shown).  
 Subsequent experiments confirmed consistency in the rate of cell-mediated LDL 
oxidation but indicated that some variability persisted during cell free oxidation 
(compare the different rates in Figure 4.10 and Figure 5.31). Nevertheless, this 
variability was considerably less pronounced than that experienced when using non-
chelexed Ham’s F10. Cell free LDL oxidation in the latter medium produced lag phases 
ranging anywhere from three to 24 hours. Detecting maximal levels of cell free 
oxidation products by 12 hours was also not uncommon. Contrary to these results in 
non-chelexed media, a lag phase of less than 12 hours was never observed during cell 
free LDL oxidation using chelexed Ham’s F10. Casual observations also suggested that 
any cell free variation occurred less frequently than had been encountered when using 
non-chelexed media.  
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Figure 4.10  Slow cell free LDL oxidation using chelexed Ham’s F10 with 4.5µM 
FeSO4 and 0.01µM CuCl2. 
LDL (0.1mg/ml) was incubated in Ham’s F10 at 37°C in the presence or absence of adherent THP-1 
macrophage-like cells (1x105 cells/ml). Ham’s F10 contained 25mM HEPES and was freshly 
chelexed and supplemented with 4.5µM FeSO4 and 0.01µM CuCl2. Samples were analyzed at 
various time points for (a) an increase in protein hydroperoxides and (b) a loss of vitamin E. 
Significance is indicated from time zero. Results are displayed as mean ± SEM of triplicates from a 
single experiment, representative of three separate experiments. 
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4.3 Discussion 
LDL can become oxidized via multiple pathways, with the precise mechanism 
depending both on the LDL particle and the surrounding environment. This vast array of 
potential interactions and modulating factors made it difficult to identify the cause of 
the problem when sudden instability was observed in the rate of cell free LDL oxidation 
(Figure 4.1 & Figure 4.2). Despite this confusion, it soon became apparent that the 
variability was real. It was not an artefact of the protocols used to monitor oxidative 
damage because the same result was observed whether measuring protein 
hydroperoxides, TBARS or vitamin E levels (Figure 4.1 & Figure 4.2). Three general 
theories regarding the cause of this inconsistency therefore remained to be investigated: 
1) Non-media related effects 
2) Contaminants in the media 
3) Changes in the media’s chemical constituents 
 
4.3.1 Non-Media Related Effects 
LDL composition is known to be a critical determinant of the susceptibility of these 
particles to oxidative modification (Jessup et al., 1990; Esterbauer et al., 1991; Thomas 
& Jackson, 1991; Thomas et al., 1994a; Thomas et al., 1994b; Visioli et al., 2000a).     
It was possible to minimize any interference arising from differences in LDL’s 
composition simply by pooling LDL from multiple donors. Variation due to 
compositional changes also seemed unlikely given the consistent rates observed for 
macrophage-mediated LDL oxidation. Furthermore, large variations in the level of 
oxidation were observed for the four cell free treatments in Figure 4.3. This occurred 
despite setting up the treatments simultaneously and incubating with LDL from the 
same preparation. 
 Testing all four treatments at the same time also indicated that the problem was not 
related to some minor change in experimental protocol from one experiment to the next. 
The sources of supplemental iron and tissue culture plasticware were identical for all 
treatments, as were the atmospheric conditions. This latter point is of relevance because 
oxygen can serve as a rate limiting factor during LDL oxidation (Raveh et al., 2002).  
 Ultimately, the source of the Ham’s F10 medium provided the only point of 
difference between the four treatments shown in Figure 4.3.  
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4.3.2 Contaminants in the Media 
Contaminants were most likely to enter the media either as impurities in the water or by 
leaching from the bottles used to store the Ham’s F10. Neither option was categorically 
disproved, but contamination seemed unlikely considering that variability was observed 
whether the medium was sourced from Sigma or Gibco BRL (Figure 4.1, Figure 4.2    
& Table 4.1). Not only were these media obtained from different companies, but they 
were stored and prepared in distinctly different ways. Ham’s F10 from Gibco BRL was 
pre-made and supplied as a liquid in plastic containers. By contrast, Sigma medium was 
purchased in powder form and prepared using nanopure, ultrafiltered water. The 
inability to stop variable rates of cell free oxidation after preparing Sigma Ham’s F10 in 
water sourced from an alternative filtration system provided further evidence against the 
effect of any impurities in the water.  
 
4.3.3 Changes in the Media’s Chemical Constituents 
The variability in cell free LDL oxidation was clearly medium-dependent and caused by 
one or more of the chemical constituents in Ham’s F10. Given that a general trend of 
increasing instability was observed as the Ham’s F10 aged, it appeared that the 
component(s) may be degrading, oxidizing, reducing or reacting with other compounds 
over time. However, the complexity of the Ham’s F10 medium made it a difficult and 
time-consuming process to identify and correct the cause. Initial attempts were therefore 
made to identify the problem without directly identifying the compounds responsible.  
 HEPES and riboflavin are known to synergistically generate hydrogen peroxide in 
the presence of light (Halliwell & Butt, 1972). Both are components of Ham’s F10, but 
light-dependent oxidative stress reactions did not play a pivotal role in the cell free 
inconsistency. The storage of some Ham’s F10 in darkened bottles, with minimal 
handling, failed to prevent cell free LDL oxidation from occurring at a rapid rate 
(Figure 4.3).  
 HEPES and phenol red were each added to Ham’s F10 in an attempt to resolve the 
inconsistency issue through antioxidant supplementation. While HEPES is generally 
considered as a buffer, it can also exhibit radical scavenging activity under certain 
circumstances (Hicks & Gebicki, 1986; Simpson et al., 1988; Ermilov et al., 1999; Van 
Eden & Aust, 2001). Adding HEPES at the time of media preparation delayed the onset 
of variability, thereby stabilizing cell free oxidation for a brief time. By contrast, the 
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addition of 25mM HEPES to pre-made Ham’s F10 immediately prior to an experiment 
failed to have a major impact on the extent of cell free LDL oxidation (Figure 4.3). In 
this experimental system, HEPES therefore appears to stabilize some component in 
Ham’s F10 rather than exerting a direct antioxidant effect on the cell free LDL 
oxidation. HEPES ultimately failed to solve the problem for extended periods of time, 
or even consistently from one batch of medium to the next. Nevertheless, all future 
preparations of Ham’s F10 (including those used for experiments in chapter 5) were 
supplemented with 25mM HEPES at the time of preparation because of the limited 
stabilization it did provide. 
 Phenol red has also been reported to exhibit antioxidant activity (Fujiwara et al., 
1998; Ermilov et al., 1999; Dugas et al., 2000; Faure et al., 2004) but, despite this, 
phenol red was unable to efficiently scavenge radicals under the conditions of the 
current study (Figure 4.4). The reason for the lack of antioxidant effect is unknown but 
it does support a previous study of LDL oxidation in RPMI, where both the cell-
mediated and cell free oxidation rates remained unchanged whether phenol red was 
present or absent (van Reyk et al., 1999). 
 
Having failed to resolve the instability issue either by supplementing the medium with 
additional antioxidant components or by varying physical parameters, the only 
remaining solution was to try and identify the component(s) in the medium responsible 
for the variability in cell free LDL oxidation rates. Ham’s F10 is a complex medium, 
consisting of amino acids, vitamins, inorganic salts and a variety of other components 
(glucose, HEPES, hypoxanthine, lipoic acid, phenol red, sodium pyruvate and 
thymidine). One of these additional components, glucose, is known to enhance cell free 
LDL oxidation in the presence of transition metals (Hunt et al., 1994; Kawamura et al., 
1994; Mowri et al., 2000; Leoni et al., 2002; Gallego-Nicasio et al., 2003). Many of the 
other constituents could also potentially contribute to either the promotion or inhibition 
of LDL oxidation. Considering the general trend of increasing instability as the Ham’s 
F10 aged, it seemed likely that the compound(s) responsible were somehow changing 
over time. Despite the complexity of Ham’s F10, most of the constituents are actually 
relatively stable. Three notable exceptions do exist – cysteine, glutamine and ferrous 
ions.  
 Thiols can exhibit antioxidant or pro-oxidant activity, with the exact outcome 
largely depending on conditions in the surrounding environment. Thiols incubated in the 
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presence of iron, as occurs in Ham’s F10, have generally been associated with a pro-
oxidant activity (Parthasarathy, 1987; Graham et al., 1994; Lynch & Frei, 1997; Dugas 
et al., 2000). Wood et al. (1995) noted a strong positive correlation between the 
susceptibility of thiols to iron-mediated autoxidation and the extent of cell free LDL 
oxidation. Despite the detection of all medium thiols between the range of 1.8µM and 
3.0µM, large variations in the extent of cell free LDL oxidation continued to be 
observed (Figure 4.5). The loss of 99% of the Ham’s F10 cysteine is in agreement with 
other studies, which also commented on the relative instability of cysteine in Ham’s F10 
and its ultimate autoxidation to cystine (Sparrow & Olszewski, 1993; Lynch & Frei, 
1997; Niu et al., 2000). Cystine is unlikely to contribute to the fast rates of oxidation 
because previous research has indicated that cystine is unable to promote cell free 
oxidation on fresh LDL even in the presence of transition metals (Heinecke et al., 
1993a; Sparrow & Olszewski, 1993; Graham et al., 1994; Santanam & Parthasarathy, 
1995). Furthermore, the lack of a correlation between thiols and the extent of LDL 
oxidation also suggests, by extension, a lack of a correlation with cystine or any radical 
by-products of the autoxidation. 
 Glutamine has also been reported to be unstable in media (Sigma product 
information sheet), and many researchers supplement media with additional glutamine 
immediately prior to an experiment to overcome this issue (Leist et al., 1996; van Reyk 
et al., 1999; Wood & Graham, 1999; Carpenter et al., 2001). Glutamine is not generally 
regarded as an antioxidant, but like other amino acids, could potentially serve as an 
alternative target of oxidative attack. This may be of particular relevance in Ham’s F10 
because glutamine is present at a concentration of 1mM. All other amino acid residues 
were added at concentrations of 200µM or less. Sanatnam & Parthasarathy (1995) noted 
that copper-mediated oxidation of LDL was inhibited during co-incubation with the 
amino acids glutamate, lysine, glycine, alanine, methionine, serine or histidine. 
Although glutamine was not studied in this paper, it is possible that it could have 
exerted similar effects and that these effects decreased in the Ham’s F10 over time       
as the glutamine degraded. This theory was disproved when it became apparent that 
supplementation with additional fresh glutamine failed to change the extent of cell free 
LDL oxidation (Figure 4.6). 
 Metal ion dependent oxidative modification of LDL has been extensively studied, 
but the exact mechanism of action still remains to be elucidated. Nevertheless, it is clear 
that copper and iron promote LDL oxidation by slightly different mechanisms (Lynch  
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& Frei, 1993; Tribble et al., 1996) and that redox chemistry plays a pivotal role in the 
oxidative process (Tang et al., 2000).  
 Copper is a more potent inducer of LDL oxidation than iron (Lynch & Frei, 1993; 
Kritharides et al., 1995a; Lynch & Frei, 1995) but is present in the Ham’s F10 medium 
at a concentration of only 0.01µM. Redox cycling provides a mechanism for 
minimizing the limitations of this low concentration, with both LDL (Lynch & Frei, 
1995) and ferrous ions (Kritharides et al., 1995a) reported to reduce copper to its redox 
active cuprous ion state. The speed of the reduction mediated by LDL (Lynch & Frei, 
1995) suggests that any change in the copper redox status during Ham’s F10 storage is 
unlikely to directly account for the variability associated with the cell free LDL 
oxidations. Copper reduction may do so indirectly, however, by enhancing the oxidation 
of iron over time.  
 Iron is the predominant transition metal in Ham’s F10, with an initial formulation of 
3µM ferrous sulphate and an additional 1.5µM included immediately prior to an 
experiment. Iron chemistry can be quite complex and is further complicated by the 
tendency of any ferrous sulphate present in Ham’s F10 to autoxidize to the iron(III) 
state (Wood & Graham, 1995; Dugas et al., 2000). Changes in the Ham’s F10 iron 
redox state were also observed in the current study (Table 4.2) and are likely to be of 
consequence to the medium problem. Iron-mediated LDL oxidation has been reported to 
occur at a significant rate only when both iron(II) and iron(III) are present. Some studies 
suggest a requirement for an, as yet unidentified, iron(II)-iron(III) complex (Minotti & 
Aust, 1987; Tang et al., 1997; Welch et al., 2002b). Others have argued against this and, 
instead, suggested that all observations could be explained by the balance between 
iron(II)’s decomposition of pre-existing lipid hydroperoxides (reaction 17) and its 
scavenging of the resulting lipid alkoxyl and peroxyl radicals (reactions 18 & 19) (Tang 
et al., 2000). A further decomposition reaction, mediated by iron(III), is described in 
reaction 20 but may be of little relevance in vivo because it is expected to proceed 
slowly relative to reaction 17. Based on the above theory, the lipid peroxidation chain 
reaction (reactions 21 & 22) would begin only once iron(II) has been oxidized to such 
an extent that it can no longer effectively compete with lipid for the alkoxyl/peroxyl 
radicals (reactions 18 & 19).  
(17) Fe2+  +  LOOH  →  Fe3+  +  LO•  +  OH- 
(18) Fe2+  +  LO•  +  H+  →  Fe3+  +  LOH 
(19) Fe2+  +  LOO•  +  H+  →  Fe3+  +  LOOH 
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(20) Fe3+  +  LOOH  →  Fe2+  +  LOO•  +  H+ 
(21) LO•/LOO•  +  LH  →  L•  +  LOH/LOOH 
(22) L•  +  O2  →  LOO• 
 Whatever the mechanism, changes in the relative amounts of iron(II), iron(III) and 
lipid obviously have the potential to modulate the rate of cell free LDL oxidation. 
Differences in these parameters from one batch of medium to the next could account for 
the variable rates observed both over time and between bottles of media. The lipid 
concentration was kept constant throughout all experiments, while altering the iron(II) 
to iron(III) ratio by supplementation did not stabilize the rate of cell free LDL oxidation 
(Figure 4.1, Figure 4.2 & Figure 4.7). A more comprehensive means of modulating iron 
levels, and the corresponding redox states, involved chelexing the Ham’s F10 and then 
standardising the medium by adding a known concentration of fresh ferrous sulphate 
immediately prior to an experiment. 
 The use of Chelex certainly removed all iron detectable by the FOX assay (Table 
4.2) and, accordingly, chelexed medium was not permissive for either cell-mediated or 
cell free LDL oxidation even after resupplementation with 1.5µM iron (Figure 4.8). 
Increasing the iron concentration to 2.5µM maintained cell free LDL oxidation at 
consistently minimal rates but resulted in sudden variability for cell-mediated oxidation 
(Figure 4.9). Macrophages can exhibit either antioxidant or pro-oxidant activity towards 
LDL, with the net effect depending on the exact conditions of study (Baoutina et al., 
2001a). As a result, a 2.5µM iron concentration may have represented a threshold value 
under the current experimental conditions. Depending on the metabolic state of the 
THP-1s at the time of PMA-induced conversion to macrophages, the cells may have 
been either more or less successful at counteracting the pro-oxidant effects of this iron. 
One potential mechanism involves cell-dependent sequestration of the iron (van Reyk  
et al., 1999), with successful sequestration inhibiting LDL oxidation. Failure to 
sequester sufficient amounts would permit the competing reaction, macrophage-
mediated reduction of the remaining iron and subsequent LDL oxidation. An increased 
iron concentration should therefore consistently overwhelm the cell’s metal 
sequestering activity (and all other antioxidant activity), leading to stable rates of cell-
mediated LDL oxidation. This was, indeed, observed once the chelexed Ham’s F10 was 
supplemented with 4.5µM ferrous sulphate and 0.01µM copper chloride (Figure 4.10).  
 Standardising the medium in this way also ensured minimal, and relatively 
consistent, rates of cell free LDL oxidation from one experiment to the next. The overall 
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iron(II) concentration, and its rate of autoxidation, are therefore critical in accounting 
for the variable rates of cell free LDL oxidation observed both over time and between 
bottles of media. 
 Throughout this entire study, the relative stability of cell-mediated LDL oxidation 
provided a direct contrast to the inconsistent rates of cell free LDL oxidation. Such a 
discrepancy can also be explained by the iron autoxidation theory because cells possess 
an inherent ability to reduce iron to the iron(II) state (Garner et al., 1997a; Baoutina et 
al., 2001b). This, in turn, minimizes the consequences of any iron autoxidation that may 
or may not have occurred in the medium during storage. 
 Finally, the apparent ability of HEPES to delay the onset of variability can now be 
accounted for by the fact that iron autoxidation is significantly slower in HEPES buffer 
than in the phosphate and bicarbonate buffers that provide buffering capacity to Ham’s 
F10 lacking HEPES (Welch et al., 2002a).  
 
4.3.4 Summary 
Inconsistency in the rate of cell free LDL oxidation was quickly attributed to some 
unidentified variable in the Ham’s F10 medium. The addition of 25mM HEPES 
provided a degree of stabilization, but the problem could be more comprehensively 
resolved by completely removing all transition metals in the Ham’s F10 via chelexing. 
Immediately prior to an experiment, the medium could then be standardised by 
resupplementing with a known concentration of fresh transition metals (4.5µM ferrous 
sulphate and 0.01µM cupric chloride). 
 The requirement for freshly prepared transition metal solutions indicates that the 
variable rates of cell free LDL oxidation were caused by iron autoxidation during 
storage of the non-chelexed media. As HEPES is reported to stabilize ferrous ions, and 
therefore slow their rate of autoxidation (Welch et al., 2002a), this theory also accounts 
for the stabilizing effect of HEPES supplementation. 
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5 7,8-NP and Macrophage-Mediated LDL 
Oxidation 
5.1 Introduction 
Macrophage-mediated oxidation of LDL is postulated to play a critical role in the 
development of the atherosclerosis. Until recently, however, most attention has focussed 
on lipid peroxidation, antioxidant depletion and/or late stage protein modification. Early 
peroxidation of the apoB100 protein can be just as critical and has, in fact, been 
confirmed under cell free conditions (Gieseg et al., 2003). Preliminary research arising 
from this PhD thesis was also included in the Gieseg et al. (2003) paper and 
demonstrates the formation of protein hydroperoxides on LDL in the presence of THP-1 
macrophages (Figure 5, re-printed in Appendix II). Chapter 5 will therefore extend this 
initial finding by further monitoring the kinetics of macrophage-mediated protein 
hydroperoxide formation and correlating these kinetics to a range of other LDL 
oxidation markers. 
 The generation of protein hydroperoxides is of particular significance because this 
oxidation product is not inert. Protein hydroperoxide formation on bovine serum 
albumin (BSA) has been associated with peroxidation chain reactions (Neuzil et al., 
1993) and it seems reasonable to expect that such reactions may also occur on the 
apoB100 of LDL. Once formed, these protein hydroperoxides also possess sufficient 
reactivity to promote additional damage. Their decomposition to reactive free radicals 
appears to be promoted by both metal-mediated (Davies et al., 1995; Gebicki et al., 
1995) and cell-mediated (Headlam & Davies, 2003) processes. Such decomposition is 
known to enhance the oxidation of nucleotides (Luxford et al., 1999), formation of 
protein-DNA cross-links (Gebicki & Gebicki, 1999) and inactivation of various 
oxidized enzymes (Hampton et al., 2002; Morgan et al., 2002). Protein fragmentation 
has also been attributed to hydroperoxide degradation, specifically when the 
hydroperoxide is located at the α-carbon position of the peptide backbone (Davies, 
1996a). Additionally, protein hydroperoxides can reduce the surrounding environment’s 
antioxidant capacity by consuming thiols (Soszynski et al., 1996) and antioxidants like 
GSH and ascorbate (Simpson et al., 1992; Fu et al., 1995).  
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 Although protein hydroperoxides are reactive, they also possess a degree of stability 
(Simpson et al., 1992). This contrasts with the short-lived, initiating free radicals and 
enables diffusion some distance from their site of formation. As a consequence, protein 
hydroperoxides may contribute to both localized and widespread oxidative damage, and 
their generation could have critical implications in atherogenesis.  
 Inhibiting protein hydroperoxide formation clearly represents an important area of 
research. Direct cellular defence against protein hydroperoxides appears limited as 
peroxidases are generally inefficient at degrading protein hydroperoxides, particularly 
when those hydroperoxides are associated with larger proteins (Gebicki et al., 2002). By 
contrast, the macrophage-synthesized pteridine, 7,8-NP, has been shown to be a potent 
inhibitor of protein hydroperoxide formation during studies exposing U937 cells and 
bovine serum albumin to a range of oxidative insults (Duggan et al., 2001; Duggan et 
al., 2002; Gieseg et al., 2003). 7,8-NP has also been observed to inhibit LDL oxidation 
(Gieseg et al., 1995; Gieseg & Cato, 2003; Gieseg et al., 2003). Protection against lipid 
peroxidation was noted whether the LDL was oxidized by AAPH, copper ions or THP-1 
monocytes and THP-1 macrophages. Protection against protein peroxidation was 
studied, and confirmed, only under the cell free conditions.  
 The current research will therefore complement the above work by investigating 
7,8-NP’s efficacy, and its mode of action, in protecting the LDL particle from 
macrophage-mediated oxidation. Specific emphasis will be placed on 7,8-NP’s 
inhibition of protein hydroperoxide formation. 7,8-NP will be supplied both 
exogenously and via de novo synthesis, upon stimulation of macrophages with IFN-γ. 
Several studies have previously used mouse cells to investigate the effect of IFN-γ on 
macrophage-mediated LDL oxidation (Jessup et al., 1992; Jessup & Dean, 1993; Fong 
et al., 1994; Niu et al., 2000). Although LDL oxidation was inhibited in all these mouse 
studies, the results are not applicable to human macrophages. Protection was attributed 
to nitric oxide but, in human macrophages, IFN-γ induces 7,8-NP synthesis rather than 
nitric oxide production (Werner et al., 1990). Thus, differentiated THP-1s will be used 
as one source of macrophages for the current research. As cell lines are not completely 
representative of cells in the body, an additional investigation will use primary HMDMs 
to more conclusively indicate whether 7,8-NP could inhibit LDL oxidation in vivo. 
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5.2 Results 
5.2.1 Protein Hydroperoxide Formation on LDL During Oxidation 
Mediated by THP-1 Macrophages  
Conjugated dienes on LDL can be rapidly measured at 234nm without any need for 
prior lipid extraction, thereby providing a convenient means of monitoring lipid 
peroxidation. Although the Ham’s F10 culture medium contains components that also 
absorb at 234nm (Esterbauer et al., 1992), Beer’s Law still applies up to an absorbance 
value of at least 2.15 units (data not shown). The formation of conjugated dienes could 
therefore be monitored when investigating the iron(II) concentration required for 
optimal cell-mediated LDL oxidation. TBARS provided an additional indication of lipid 
peroxidation while protein hydroperoxides highlighted the extent of protein oxidation. 
These initial studies were conducted in non-chelexed Ham’s F10 and, as such, contained 
a transition metal baseline of 3µM ferrous sulphate and 0.01µM cupric chloride. 
 A lack of additional iron(II) resulted in minimal levels of both cell free and THP-1 
macrophage-mediated LDL oxidation, whether monitored via protein hydroperoxides, 
TBARS or conjugated dienes (Figure 5.1). By contrast, supplementing the Ham’s F10 
with 1.5µM (Figure 5.2) or 3µM (Figure 5.3) iron(II) yielded clear kinetic data. LDL 
oxidized by THP-1 macrophages in the 1.5µM iron(II)-supplemented medium exhibited 
a longer lag phase than LDL oxidized in the corresponding 3µM iron(II)-supplemented 
medium. This led to peaks or plateaux in concentration for all three assayed oxidation 
parameters at nine hours rather than the six hours observed using the 3µM iron(II)-
supplemented treatment. It also ensured that the decomposition phase was strongly 
detected only at the higher iron concentration during these 12 hour time courses. Such a 
limitation was deemed to be of little relevance to the current research because 
antioxidant efficacy studies generally centre on the lag and propagation phases rather 
than advanced stages of decomposition. Of more importance was the confirmation    
that the peak in protein hydroperoxides corresponded to a concentration between 
approximately 30-40 moles/mole LDL. This concentration was attained irrespective of 
supplementing with 1.5µM or 3µM iron(II). Furthermore, a comparison of iron 
treatments indicated that the difference between cell-mediated and cell-free LDL 
oxidation levels was more pronounced after the addition of 1.5µM iron(II). Future 
experiments in non-chelexed Ham’s F10 were therefore conducted by supplementing 
the medium with 1.5µM iron(II).  
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Figure 5.1  Effect of no iron supplementation on THP-1 macrophage-mediated 
LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml LDL in 
Ham’s F10 in the absence of any iron supplementation. Controls included cells only and LDL only. 
Samples were analyzed at various time points for an increase in (a) protein hydroperoxides 
(PrOOH), (b) TBARS and (c) conjugated dienes. Significance is indicated between LDL treatments. 
Results are displayed as mean ± SEM of triplicate samples. 
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Figure 5.2  Effect of supplementation with 1.5µM iron on THP-1 macrophage-
mediated LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml LDL in 
Ham’s F10 supplemented with 1.5µM FeSO4. Controls included cells only and LDL only. Samples 
were analyzed at various time points for an increase in (a) protein hydroperoxides, (b) TBARS and 
(c) conjugated dienes. Significance is indicated between LDL treatments. Results are displayed as 
mean ± SEM of triplicates from a single experiment, representative of three separate experiments. 
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Figure 5.3  Effect of supplementation with 3µM iron on THP-1 macrophage-
mediated LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml LDL in 
Ham’s F10 supplemented with 3µM FeSO4. Controls included cells only and LDL only. Samples 
were analyzed at various time points for an increase in (a) protein hydroperoxides, (b) TBARS and 
(c) conjugated dienes. Significance is indicated between LDL treatments. Results are displayed as 
mean ± SEM of triplicates from a single experiment, representative of three separate experiments. 
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 Supplementing non-chelexed Ham’s F10 with 1.5µM iron(II) also promoted the loss 
of LDL’s vitamin E in a time-dependent manner (Figure 5.4). In the presence of cells, 
this resulted in the complete consumption of vitamin E within six hours. Cell free 
oxidation was significantly slower, with 100% loss of the antioxidant only by 12 hours. 
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Figure 5.4  Loss of vitamin E during THP-1 macrophage-mediated LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml LDL in 
Ham’s F10 supplemented with 1.5µM FeSO4. Controls included cells only and LDL only, and all 
samples were analyzed at various time points for the loss of vitamin E. Significance is indicated 
between LDL treatments. Results are displayed as mean ± SEM of triplicates from a single 
experiment, representative of three separate experiments. 
 
 
 In an attempt to complement the protein hydroperoxide data, PB-DOPA and 
dityrosine were chosen to serve as additional markers of apoB100 modification and, 
more specifically, of tyrosine oxidation. However, neither was identified as a major 
product during the oxidative modification of LDL (Figure 5.5). Dityrosine was 
undetectable during the entire 12 hour time course, whether monitored in the presence 
or absence of THP-1 macrophages. PB-DOPA was measurable, but levels remained low 
and no significant difference between cell free and cell-mediated LDL oxidation was 
noted at any time point. The plateau attained after 12 hours, by both the cell free and 
cell-containing treatments, resulted in PB-DOPA concentrations of less than 0.3 
moles/mole of LDL.  
 As expected, dityrosine and PB-DOPA remained undetectable in supernatant 
isolated from the cell only controls over the 12 hour incubation period (Figure 5.5). This 
finding agrees with the lack of change in the cell only control when monitoring protein 
hydroperoxides, conjugated dienes, TBARS and vitamin E (Figure 5.2 & Figure 5.4).  
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Figure 5.5  THP-1 macrophage-mediated oxidation of tyrosine residues on LDL. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml LDL in 
Ham’s F10 supplemented with 1.5µM FeSO4. Controls included cells only and LDL only. Samples 
were analyzed at various time points for an increase in (a) PB-DOPA and (b) dityrosine. ANOVA 
analysis revealed no statistical significance between LDL treatments. Results are displayed as mean 
± SEM of triplicates from a single experiment, representative of three separate experiments. 
 
 
 The parameters of cell-mediated LDL oxidation described above were subsequently 
compared to the kinetics of protein hydroperoxide formation and analyzed for any 
significant correlations (Figure 5.6). Specifically, protein peroxidation was shown to 
strongly and positively correlate with lipid peroxidation. This was observed whether 
monitoring TBARS (r2=0.99) or conjugated diene (r2=0.99) formation and it ensured 
that the protein hydroperoxide lag, propagation and decomposition phases paralleled the 
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corresponding TBARS and conjugated diene phases. While not as strong as the protein 
peroxidation/lipid peroxidation relationship, protein hydroperoxides were also observed 
to correlate with PB-DOPA (r2=0.76) and protein carbonyls (r2=0.65). The rate of 
protein hydroperoxide formation occurred faster in Figure 5.6d than previously 
observed. It is thought to be caused by an unexpected increase in the oxidation potency 
of THP-1s over time (possibly due to the creation of an unidentified mutation after 
numerous cell passages) and does not negate the existence of the carbonyl/protein 
hydroperoxide correlation. 
 A relationship was also confirmed between protein hydroperoxide formation and 
vitamin E loss, with the protein peroxidation lag phase ending and propagation 
beginning only once vitamin E was completely consumed (Figure 5.6e). 
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Figure 5.6  Correlations with protein hydroperoxide formation during THP-1 
macrophage-mediated LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml LDL      
in Ham’s F10 supplemented with 1.5µM FeSO4. Samples were analyzed at various time points      
for an increase in protein hydroperoxides and (a) TBARS, (b) conjugated dienes, (c) PB-DOPA,    
(d) carbonyls and (e) a loss of vitamin E. The data is paired and from five separate experiments. 
 7,8-NP and Macrophage-Mediated LDL Oxidation 126 
  
5.2.2 Protein Hydroperoxides and THP-1 Macrophage-Mediated BSA 
Oxidation 
A previous study had suggested that, under cell free conditions, radical intermediates of 
lipid peroxidation were required to initiate the formation of protein hydroperoxides on 
LDL (Gieseg et al., 2003). Thus, although protein hydroperoxides were produced in 
significant quantities on LDL during macrophage-mediated oxidation, it was unclear 
whether pure proteins would be just as susceptible to cell-mediated peroxidation. This 
was investigated by incubating THP-1 macrophages with a pure protein, BSA, under 
conditions identical to those described for the LDL oxidation experiments. Despite 
testing BSA concentrations between 0.1mg/ml and 5mg/ml, the presence of 1x105/ml 
THP-1 macrophages failed to elevate protein hydroperoxide levels above cell free 
controls after 12 hours (Figure 5.7).  
 It remained possible that the cells were oxidizing the BSA but that any protein 
hydroperoxides were simply degraded by the end of the 12 hour incubation period. 
BSA, at 0.1mg/ml (Figure 5.8) and 5mg/ml (Figure 5.9), was incubated under the same 
conditions as above but samples were instead collected at multiple time points. Once 
again, protein hydroperoxide formation remained insignificant and this was observed 
for both cell-mediated and cell free conditions at all time points tested. 
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Figure 5.7  THP-1 macrophage-mediated protein hydroperoxide formation on 
BSA. 
Various concentrations of BSA (0.1, 0.5, 1, 3 and 5mg/ml) were incubated at 37°C in the presence or 
absence of adherent THP-1 macrophage-like cells (1x105/ml) in Ham’s F10 supplemented with 
1.5µM FeSO4. After 12 hours, samples were analyzed for an increase in protein hydroperoxides by 
the FOX-1 assay. ANOVA analysis revealed no statistical significance between BSA treatments. 
Results are displayed as mean ± SEM of triplicates from a single experiment, representative of two 
separate experiments. 
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Figure 5.8  Time course of THP-1 macrophage-mediated protein hydroperoxide 
formation on 0.1mg/ml BSA.  
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 0.1mg/ml BSA in 
Ham’s F10 supplemented with 1.5µM FeSO4. Controls included cells only and BSA only. Samples 
were analyzed at various time points for an increase in protein hydroperoxides by the FOX-1 assay. 
ANOVA analysis revealed no statistical significance between LDL treatments. Results are displayed 
as mean ± SEM of triplicates from a single experiment, representative of two separate experiments. 
 
 
0 12 24 36
-0.2
0.0
0.2
0.4
0.6 Cells + BSA
BSA
Cells
Time (hours)
Pr
O
O
H
 (µ
M
)
 
Figure 5.9  Time course of THP-1 macrophage-mediated protein hydroperoxide 
formation on 5mg/ml BSA.  
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C with 5mg/ml BSA in 
Ham’s F10 supplemented with 1.5µM FeSO4. Controls included cells only and BSA only. Samples 
were analyzed at various time points for an increase in protein hydroperoxides by the FOX-1 assay. 
ANOVA analysis revealed no statistical significance between LDL treatments. Results are displayed 
as mean ± SEM of triplicates from a single experiment, representative of two separate experiments. 
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5.2.3 7,8-NP Inhibits Protein Hydroperoxide Formation During   
THP-1 Macrophage-Mediated LDL Oxidation 
Like Ham’s F10, 7,8-NP also interferes at the 234nm wavelength (data not shown). The 
combined interference from Ham’s F10 and 7,8-NP ultimately made reliable collection 
of conjugated dienes data impossible. Further complicating matters was the likely 
impact of 7,8-NP oxidation on the extent of interference. As a result, TBARS rather 
than conjugated dienes became the preferred marker of lipid peroxidation in the 
presence of 7,8-NP. Vitamin E and protein hydroperoxides were chosen as additional 
indicators of oxidation, thereby ensuring a comprehensive understanding of 7,8-NP’s 
impact on the entire LDL particle during THP-1 macrophage-mediated LDL oxidation. 
 Gieseg & Cato (2003) noted that protection against cell-mediated LDL oxidation 
was consistent only when 7,8-NP was pre-incubated with the cells. Consequently, a five 
minute pre-incubation of THP-1 macrophages in Ham’s F10, freshly supplemented with 
1.5µM iron(II), was followed by a further five minute pre-incubation with various 
concentrations of 7,8-NP. Samples were then incubated in the presence of 0.1mg/ml 
LDL at 37°C. A nine hour incubation was chosen because it had previously been shown 
to represent the end of the propagation phase and, as such, a time of peak protein 
hydroperoxide and TBARS concentrations (Figure 5.2). Under these conditions, 7,8-NP 
was found to protect LDL from THP-1 macrophage-mediated protein hydroperoxide 
formation in a concentration-dependent manner (Figure 5.10). A similar pattern of 
inhibition was observed for TBARS formation and vitamin E loss. Thus, 30µM 7,8-NP 
afforded almost complete protection against the formation of both protein 
hydroperoxides and TBARS while concurrently permitting the retention of significant 
quantities of vitamin E. 
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Figure 5.10  7,8-NP inhibits THP-1 macrophage-mediated LDL oxidation in a 
concentration-dependent manner. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C, with 0.1mg/ml LDL and 
various concentrations of 7,8-NP, in Ham’s F10 supplemented with 1.5µM FeSO4. After nine hours, 
samples were analyzed for (a) protein hydroperoxides, (b) TBARS and (c) vitamin E. Significance is 
indicated from 0µM 7,8-NP. Results are displayed as mean ± SEM of triplicates from a single 
experiment, representative of three separate experiments. 
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 Additional experiments were conducted over 24 hours and indicated that 7,8-NP 
was able to extend the lag phase during THP-1 macrophage-mediated LDL oxidation in 
a concentration-dependent manner (Figure 5.11). This extension was observed whether 
monitoring protein hydroperoxide or TBARS formation and was most noticeable at 
lower 7,8-NP concentrations. A three hour lag phase, in the absence of 7,8-NP, doubled 
to six hours in the presence of 10µM 7,8-NP and then nine hours upon incubation with 
20µM 7,8-NP. By contrast, the much larger concentration of 50µM 7,8-NP produced a 
lag phase that lasted only nine to twelve hours. Irrespective of the 7,8-NP incubation 
concentration or lag phase length, the subsequent propagation phase was associated with 
oxidation of both the lipid and protein components of LDL. This oxidation proceeded at 
rates similar to those observed in the absence of any 7,8-NP. 
 In agreement with the concentration-dependent extension of the protein 
hydroperoxide and TBARS lag phases, 7,8-NP was observed to delay the cell-mediated 
loss of LDL’s vitamin E in a similar manner (Figure 5.11c). This effect was, once again, 
more prominent at the lower concentrations of 10µM and 20µM 7,8-NP. Even so, the 
7,8-NP-mediated protection was so efficient at earlier time points that an almost 
complete retention of vitamin E was initially recorded for all 7,8-NP treatments. By the 
final stages, vitamin E oxidation occurred rapidly and at comparable rates, largely 
independent of the starting 7,8-NP concentration. 
 To complement the kinetic data obtained during these LDL oxidation studies, the 
oxidation of the exogenously added 7,8-NP to 7,8-dihydroxanthopterin (7,8-XP) was 
also monitored (Figure 5.12). 7,8-NP levels at the zero hour time point were always 
slightly lower than the stated preparation concentration. This is likely due to 
autoxidation during the preparation of the antioxidant solution and does not alter the 
general trends described below. As expected, neither 7,8-NP nor 7,8-XP were detectable 
in samples lacking exogenous 7,8-NP (data not shown) but the 10µM, 20µM and   
50µM treatments all showed a time-dependent loss of 7,8-NP. In contrast to 7,8-NP, the 
concentration of 7,8-XP was difficult to determine. A 7,8-XP standard was obtained, but 
this compound was labile and had partially degraded during transport to New Zealand. 
Although this prevented 7,8-XP from being quantified to a micromolar value, an 
increase in the chromatographic area corresponding to 7,8-XP nevertheless confirmed 
that the depletion of 7,8-NP and the formation of 7,8-XP occurred concomitantly. 
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Figure 5.11  7,8-NP extends the lag phase during THP-1 macrophage-mediated 
LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C, with 0.1mg/ml LDL and 
various concentrations of 7,8-NP, in Ham’s F10 supplemented with 1.5µM FeSO4. Samples were 
analyzed at various time points for an increase in (a) protein hydroperoxides and (b) TBARS and   
(c) a loss of vitamin E. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
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Figure 5.12  Oxidation of 7,8-NP during THP-1 macrophage-mediated LDL 
oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C in 1.5µM FeSO4-
supplemented Ham’s F10, with 0.1mg/ml LDL and either (a) 10µM 7,8-NP, (b) 20µM 7,8-NP or   
(c) 50µM 7,8-NP. Samples were analyzed at various time points for the loss of 7,8-NP (displayed as 
a micromolar concentration) and the formation of 7,8-XP (displayed as area on the HPLC 
chromatograph). Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
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 Just as critically, 7,8-NP loss was also found to correlate with the cell-mediated 
oxidation of LDL. Figure 5.13 represents an incubation with 20µM 7,8-NP and provides 
an example of this relationship, with the almost complete consumption of 7,8-NP by 
nine hours corresponding to the end of the protein hydroperoxide and TBARS lag 
phase. A comparison of 7,8-NP and vitamin E oxidation indicated that loss of the 
former began almost immediately while loss of the latter was delayed until almost      
six hours. Both were ultimately 100% depleted at the same time point of 12 hours. 
 7,8-NP oxidation in iron(II)-supplemented Ham’s F10 was further investigated by 
monitoring the impact of the presence and absence of both THP-1 macrophages and 
LDL on this process (Figure 5.14). In the absence of either of these components, a slight 
decrease in the level of 7,8-NP occurred over 12 hours. An identical trend was observed 
upon incubation of the 20µM 7,8-NP with THP-1 macrophages. In both cases, a small 
but corresponding increase in the amount of 7,8-XP was also noted. Co-incubation with 
LDL rather than cells produced more extensive 7,8-NP oxidation and 7,8-XP formation, 
with such reactions being most apparent between nine and twelve hours. An even    
more enhanced rate of 7,8-NP oxidation was observed upon addition of cells to the   
7,8-NP/LDL incubation mixture. This oxidation was evident at all time points and 
corresponded to an increased rate of 7,8-XP formation. 
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Figure 5.13  Correlation between the oxidation of 7,8-NP and THP-1 macrophage-
mediated LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105/ml) were incubated at 37°C, with 0.1mg/ml LDL and 
20µM 7,8-NP, in Ham’s F10 supplemented with 1.5µM FeSO4. At various time points, 7,8-NP 
oxidation was compared to (a) the formation of protein hydroperoxides and TBARS and (b) the loss 
of vitamin E. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
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Figure 5.14  Effect of THP-1 cells and LDL on the oxidation of 7,8-NP. 
20µM 7,8-NP was dissolved in Ham’s F10 supplemented with 1.5µM FeSO4. The 7,8-NP was 
incubated at 37°C, either alone or in combination with 0.1mg/ml LDL and/or 1x105/ml THP-1 
macrophage-like cells. Samples were analyzed at various time points for the (a) loss of 7,8-NP 
(displayed as a micromolar concentration) and (b) formation of 7,8-XP (displayed as area on         
the HPLC chromatograph). Results are displayed as mean ± SEM of triplicates from a single 
experiment, representative of three separate experiments. 
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5.2.4 7,8-NP, IFN-γ and TPMET 
Consistent protection against cell-mediated LDL oxidation requires a pre-incubation of 
7,8-NP with THP-1s not the lipoprotein (Gieseg & Cato, 2003). 7,8-NP-mediated 
protection of vitamin E also yielded different kinetics in the presence of THP-1 
macrophages (Figure 5.11) compared to cell free conditions (Gieseg et al., 1995). These 
observations raised questions regarding 7,8-NP’s mechanism of inhibiting macrophage-
mediated LDL oxidation and whether it involved some, as yet unidentified, direct 
interaction with the cells. The transplasma membrane electron transport (TPMET) 
system is suggested to play a critical role in atherosclerosis, transferring electrons from 
intracellular NADH to the extracellular transition metals that can subsequently promote 
the oxidation of LDL (Garner et al., 1997b; Baoutina et al., 2000; Baoutina et al., 
2001b). As such, it was deemed important to investigate whether any interaction 
between 7,8-NP and the TPMET system was responsible for this pteridine’s effective 
inhibition of THP-1 macrophage-mediated LDL oxidation. 
 Two assays were used to monitor the extent of cellular reduction, with one based on 
the reduction of ferricyanide to ferrocyanide and the second based on the reduction of 
cupric ions to cuprous ions. The latter assay is susceptible to falsely low readings 
because, unlike ferricyanide, cupric ions are not impermeable to cells (Baoutina et al., 
2001b). Subjecting cupric ions to a control incubation in the presence and absence of 
THP-1 macrophages before initiating ascorbate-mediated reduction alleviated this 
concern by confirming a cuprous ion recovery of over 98% (data not shown). 
 Total cellular reducing activity was measured for both assays after a two hour 
incubation of cells in HBSS. This activity represents the combined reduction of both the 
TPMET system and any cellular reducing equivalents released into the medium. 
Assaying the reducing potential of cell-conditioned medium enables more direct 
measurement of the latter. Thus, TPMET activity can be indirectly determined by 
calculating the difference between the total cellular reduction and the activity in the 
conditioned medium. Initial studies simply monitored the total cellular reduction, 
confirming that both the ferricyanide and cupric ion reducing assays yielded similar 
trends (Figure 5.15). Reducing activity and cell concentration were shown to be 
positively associated, with 5x105 cells/ml representing a suitable THP-1 macrophage 
concentration for subsequent experiments. 
 The extent of total cellular reduction was found to remain relatively constant, from 
one experiment to the next, using THP-1 macrophages at this concentration of 5x105/ml. 
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Reducing activity directly attributed to the cell-conditioned medium was also generally 
consistent. Reduction in the cell-conditioned medium accounted for between 10-25% 
and 40-60% of the total cellular reduction that occurred, as measured by the ferricyanide 
and copper assays, respectively (for example, Figure 5.16 & Figure 5.17). Exceptions to 
this general trend were occasionally observed. In these instances, total cellular reduction 
levels were unchanged but reduction in the cell-conditioned medium varied anywhere 
between 0% and 85% of the total activity (data not shown). 
 Both thiol-containing compounds and superoxide have been suggested as likely 
reductants to be released into the medium (Garner et al., 1997b; Baoutina et al., 2001b). 
However, thiol levels in the supernatant remained constant between experiments while 
superoxide was not produced by THP-1 macrophages, as measured by both the 
cytochrome C reduction and nitroblue tetrazolium (NBT) assays (data not shown). This 
inability to identify the cause of the occasional variability in the activity of cell-secreted 
reductants was ultimately determined to have little consequence for subsequent 
experiments investigating the impact of 7,8-NP and IFN-γ on TPMET activity. 
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Figure 5.15  TPMET activity of THP-1 macrophage cells. 
Adherent THP-1 macrophage-like cells were incubated at 37°C at various concentrations in HBSS 
for two hours in the presence of either ferricyanide or cupric chloride and BCS. Samples were then 
analyzed spectrophotometrically for reduction to ferrocyanide or cuprous ions, respectively, by the 
TPMET assays. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
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 Micromolar concentrations of 7,8-NP were found to strongly interfere with both 
reduction assays (data not shown) and this problem could only be resolved by the 
introduction of a 7,8-NP pre-incubation step. Cells were subsequently washed in PBS to 
remove all traces of 7,8-NP before initiating the two hour TPMET assay. Irrespective of 
the inclusion of the pre-incubating step with 50µM 7,8-NP, the level of reduction due to 
reductants in the conditioned medium or to TPMET remained unchanged (Figure 5.16). 
This lack of effect was observed whether pre-incubating for two or six hours and was 
associated with both the ferricyanide reduction and cupric ion reduction assays. 
 In contrast to 7,8-NP, neopterin’s interference during the reduction assays was 
minimal (data not shown). This ensured that the low nanomolar quantities of 7,8-NP 
and neopterin detected during IFN-γ incubations would not strongly interfere with 
TPMET analysis. Following a pre-incubation with 500U/ml IFN-γ, THP-1 macrophages 
were therefore washed and incubated during the two hour ferricyanide and cupric ion 
reduction assays in the presence of fresh IFN-γ. Despite continuous exposure to IFN-γ, 
no significant difference was observed between incubations conducted in the presence 
and absence of this cytokine (Figure 5.17). This lack of effect was observed whether 
monitoring TPMET activity or the activity of reductants in the cell-conditioned 
medium. It was also independent of the assay system, with similar results obtained for 
both ferricyanide and cupric ion reduction. 
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Figure 5.16  Effect of 7,8-NP on the TPMET activity of THP-1 macrophage cells. 
Adherent THP-1 macrophage-like cells (5x105 cells/ml) were pre-incubated at 37°C in RPMI for 
either two or six hours with or without 50µM 7,8-NP. Wells were subsequently washed and 
incubated in HBSS for two hours in the presence of (a) ferricyanide or (b) cupric chloride and BCS. 
Samples were then analyzed spectrophotometrically for reduction to ferrocyanide or cuprous ions, 
respectively, by the TPMET assays. Cell-conditioned medium was similarly monitored for each 
assay. ANOVA analysis revealed no statistical significance between the presence and absence of 
7,8-NP. Results are displayed as mean ± SEM of triplicates from a single experiment, representative 
of three separate experiments.  
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Figure 5.17  Effect of IFN-γ on the TPMET activity of THP-1 macrophage cells. 
Adherent THP-1 macrophage-like cells (5x105 cells/ml) were pre-incubated at 37°C in RPMI for 
either 24 or 48 hours with or without 500U/ml IFN-γ. Wells were subsequently washed and 
incubated in HBSS for two hours in the presence of fresh IFN-γ  and (a) ferricyanide or (b) cupric 
chloride and BCS. Samples were then analyzed spectrophotometrically for reduction to ferrocyanide 
or cuprous ions, respectively, by the TPMET assays. Cell-conditioned medium was similarly 
monitored for each assay. ANOVA analysis revealed no statistical significance between the presence 
and absence of IFN-γ. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
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5.2.5 Effect of IFN-γ on THP-1 Macrophage-Mediated LDL Oxidation 
In an attempt to identify optimal conditions for monitoring the effect of endogenous  
7,8-NP on THP-1 macrophage-mediated LDL oxidation, cells were incubated in the 
presence of 500U/ml IFN-γ and monitored for total pterin (neopterin plus 7,8-NP) 
production at various times (Figure 5.18). Levels of total pterin reached significance    
in the supernatant after 36 hours while pterin in the cell extract became significant at   
24 hours. This provides reasonable agreement with the approximately 30 hours required 
by GTP cyclohydrolase I for maximal activation (Wachter et al., 1992). While a plateau 
in cell extract pterin concentrations was noted after 36 hours, supernatant levels 
continued to increase at least up to 48 hours. As a result, an incubation time of 48 hours 
was chosen as a suitable and convenient period of IFN-γ pre-incubation during 
subsequent experiments.  
 An additional control confirmed that LDL had no significant effect on pterin levels 
in either the supernatant or cell extract (Table 5.1).  
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Figure 5.18  Time course of pterin production by THP-1 macrophages. 
Adherent THP-1 macrophage-like cells (1x105 cells/ml) were incubated at 37°C in RPMI with 
500U/ml IFN-γ. At various time points, total pterin (neopterin plus 7,8-NP) levels were measured in 
the supernatant and cell lysate. Significance is indicated from time zero. Results are displayed as 
mean ± SEM of triplicates from a single experiment, representative of three separate experiments. 
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Table 5.1  Effect of LDL oxidation on THP-1 macrophage pterin levels. 
Adherent THP-1 macrophage-like cells (1x105 cells/ml) were incubated at 37°C in RPMI with 
500U/ml IFN-γ. After 48 hours, the cells were washed and LDL oxidation was initiated by the 
addition of Ham’s F10 supplemented with 1.5µM FeSO4, 0.1mg/ml LDL and fresh IFN-γ. Controls 
included LDL only and cells only, either in the presence or absence of IFN-γ. After 24 hours, total 
pterin (neopterin plus 7,8-NP) levels were measured in the supernatant and cell lysate of all samples. 
ANOVA analysis revealed no statistical significance between the presence and absence of LDL. 
Results are displayed as mean ± SEM of triplicates from a single experiment, representative of three 
separate experiments. 
 Cell extract 
(pmole/mg protein) 
Supernatant 
(nM) 
LDL + FeSO4 
LDL + FeSO4 + IFN-γ 
Cells 
Cells + LDL + FeSO4 
Cells + IFN-γ 
Cells + IFN-γ + LDL + FeSO4 
N/A 
N/A 
0 ± 0 
0 ± 0 
48.21 ± 2.32 
54.62 ± 7.05 
0 ± 0 
0 ± 0 
0 ± 0 
0 ± 0 
6.54 ± 1.03 
5.27 ± 0.48 
 
 
 
 Initial experiments monitoring the role of IFN-γ on THP-1 macrophage-mediated 
LDL oxidation followed the protocol of Gieseg & Cato (2003). After a pre-incubation in 
the RPMI with 500U/ml IFN-γ, the stimulated THP-1 macrophages were washed and 
subjected to a nine hour incubation in Ham’s F10 supplemented with ferrous ions, LDL 
and fresh IFN-γ. These conditions failed to prevent the formation of protein 
hydroperoxides and TBARS on LDL, irrespective of whether the THP-1 macrophages 
were pre-incubated with IFN-γ for 24 or 48 hours (Figure 5.19). Similarly, vitamin E 
was completely depleted after subjecting the LDL to cell-mediated oxidation and 
neither a 24 hour nor a 48 hour pre-incubation with IFN-γ prevented its loss (data not 
shown). 
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Figure 5.19  THP-1 macrophage-mediated LDL oxidation after a pre-incubation in 
RPMI with IFN-γ. 
Adherent THP-1 macrophage-like cells (1x105 cells/ml) were pre-incubated in RPMI for 24 or 48 
hours in the presence or absence (control) of 500U/ml IFN-γ. The experiment was subsequently 
initiated by removal of RPMI and replacement with Ham’s F10 supplemented with 1.5µM FeSO4, 
0.1mg/ml LDL and fresh IFN-γ. Samples were analyzed after nine hours for an increase in             
(a) protein hydroperoxides and (b) TBARS. ANOVA analysis revealed no statistical significance 
from the control. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of two separate experiments. 
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It remained possible that the change of media between the pre-incubation and 
incubation steps obscured any potential protective effect of IFN-γ. The chances of 
observing inhibition were also likely to be lessened at faster rates of cell-mediated LDL 
oxidation. Provided the THP-1 macrophages survived for extended periods in Ham’s 
F10, these issues could be resolved by continuous exposure to Ham’s F10 during both 
the pre-incubation and incubation steps. Viability in the presence and absence of IFN-γ 
was confirmed during 48 and 72 hour incubations of THP-1 macrophages in Ham’s 
F10, with the latter time point representing the combined pre-incubation and incubation 
period. A comparison against the control incubation in RPMI indicated that a small drop 
in viability did occur over time (Figure 5.20). After 72 hours in Ham’s F10, this had 
approached 86.8 ± 1.7% and 90.9 ± 0.5% of control values according to the MTT and 
trypan blue exclusion assays, respectively. Viability loss was slightly reduced in the 
presence of IFN-γ, but this effect failed to reach significance for either viability assay. 
Thus, THP-1 macrophages retained a reasonable level of viability during prolonged 
incubations in Ham’s F10, and the addition of IFN-γ had little impact on this cell 
survival.  
 These cells were then investigated once more for their ability to inhibit LDL 
oxidation when stimulated with 500U/ml IFN-γ. This time the entire experiment was 
conducted in Ham’s F10, incorporating a 48 hour pre-incubation followed by a 36 hour 
incubation in the presence of transition metals and LDL. As expected, the rate of THP-1 
macrophage-mediated LDL oxidation was slowed by the inclusion of a 48 hour pre-
incubation in Ham’s F10 (Figure 5.21). The lag phase was extended from three to six 
hours and LDL peroxidation products did not reach maximal levels until 18-24 hours. 
Stimulating THP-1 macrophages with IFN-γ appeared to marginally slow protein 
hydroperoxide and TBARS formation on LDL, but this never approached significance. 
Furthermore, the effect was not consistently observed, with some repeats of the 
experiment showing no detectable difference between treatments (data not shown). 
Likewise, the rate of vitamin E oxidation was unchanged when incubating THP-1 
macrophages with IFN-γ compared to the unstimulated control. 
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Figure 5.20  THP-1 macrophage viability in Ham’s F10 medium. 
Adherent THP-1 macrophage-like cells (1x105 cells/ml) were incubated in Ham’s F10, 
supplemented with 1.5µM FeSO4, in the presence or absence of 500U/ml IFN-γ. Controls incubated 
in RPMI for the entire experiment were also prepared. After 48 and 72 hours, cell viability was 
analyzed via (a) MTT and (b) trypan blue exclusion staining. ANOVA analysis revealed no 
statistical significance between treatments. Results are displayed as mean ± SEM of triplicates from 
a single experiment, representative of three separate experiments.  
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Figure 5.21  IFN-γ does not inhibit THP-1 macrophage-mediated LDL oxidation. 
Adherent THP-1 macrophage-like cells (1x105 cells/ml) were pre-incubated in chelexed Ham’s F10 
for 48 hours in the presence or absence of 500U/ml IFN-γ. The experiment was subsequently 
initiated by the addition of 4.5µM FeSO4, 0.01µM CuCl2 and 0.1mg/ml LDL. An LDL only 
treatment was also included. Samples were analyzed at various time points for an increase in          
(a) protein hydroperoxides, (b) TBARS and (c) the loss of vitamin E. ANOVA analysis revealed no 
statistical significance between cell treatments. Results are displayed as mean ± SEM of triplicates 
from a single experiment, representative of three separate experiments. 
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5.2.6 Protein Hydroperoxide Formation on LDL During Oxidation 
Mediated by HMDMs 
While THP-1 macrophages had clearly been shown to promote the formation of protein 
hydroperoxides on LDL, it remained to be confirmed whether this was specific to the 
THP-1 cell line or whether it was a general feature of macrophage-mediated LDL 
oxidation. To answer this question, the more physiological HMDMs were incubated in 
the presence of transition metals and LDL. HMDMs were initially plated at four 
different densities in 12 well plates and allowed to mature over 14 days. TBARS 
formation during HMDM-mediated LDL oxidation was subsequently monitored in 3ml 
of Ham’s F10 to provide an indication of the most suitable cell concentration for 
additional experiments (Figure 5.22). All cell concentrations were found to promote 
LDL oxidation but 1x106 cells/ml (3x106 cells/well) was ultimately chosen for future 
studies. This concentration promoted a rate of oxidation that provided adequate time   
for sampling and for the detection of all critical kinetic phases in the process of        
LDL modification. Just as critically, 3x106 cells/well was the lowest density regularly 
observed to yield a healthy monolayer of cells in the 12 well Falcon plates (data not 
shown). 
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Figure 5.22  Effect of increasing cell concentrations on HMDM-mediated LDL 
oxidation  
Increasing concentrations of HMDMs were incubated at 37°C with 0.1mg/ml LDL in 3ml of 
chelexed Ham’s F10. The medium was supplemented with 4.5µM FeSO4 and 0.01µM CuCl2, and 
samples were analyzed at various time points for an increase in TBARS. Results are displayed as 
mean ± SEM of triplicate samples. 
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 When LDL was exposed to this concentration of HMDMs, protein hydroperoxides 
were clearly detectable, reaching a maximum level of 30.8 ± 1.2 moles/mole LDL after 
24 hours (Figure 5.23). As with THP-1 macrophage-mediated LDL oxidation, HMDMs 
promoted protein hydroperoxide formation in a manner that paralleled the generation of 
TBARS. Both parameters possessed a 12 hour lag phase and this corresponded to the 
complete loss of vitamin E between 12 and 18 hours. In agreement with the THP-1 
macrophages, HMDMs were also confirmed to promote a significantly faster rate of 
protein hydroperoxide formation on LDL than the corresponding cell free treatments.  
 As expected, protein hydroperoxides, TBARS and vitamin E levels in the 
supernatant removed from cell only controls remained unchanged throughout the 
experiment. 
 Contrasting with the relative consistency of THP-1 macrophage-mediated LDL 
oxidation, variable rates of HMDM-mediated oxidation were commonly noted between 
batches of HMDMs. Thus, lag phases in the presence of 1x106 HMDMs/ml were found 
to vary anywhere between three and 12 hours from one macrophage preparation to the 
next. Figure 5.22 and Figure 5.23 provide an example of this, with lag phases of 
approximately six hours and 12 hours, respectively, despite otherwise identical 
incubation conditions. 
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Figure 5.23  HMDM-mediated LDL oxidation. 
HMDMs (1x106/ml) were incubated at 37°C with 0.1mg/ml LDL in Ham’s F10 supplemented with 
4.5µM FeSO4 and 0.01µM CuCl2. Controls included cells only and LDL only. Samples were 
analyzed at various time points for an increase in (a) protein hydroperoxides, (b) TBARS and (c) the 
loss of vitamin E. Significance is indicated from time zero. Results are displayed as mean ± SEM of 
triplicates from a single experiment, representative of three separate experiments. 
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5.2.7 7,8-NP Inhibits Protein Hydroperoxide Formation During LDL 
Oxidation Mediated by HMDMs 
The effect of 7,8-NP on cell-mediated LDL oxidation was studied using a similar 
protocol for both THP-1 macrophages and HMDMs. A five minute pre-incubation of 
HMDMs in chelexed Ham’s F10, freshly supplemented with 4.5µM ferrous ions and 
0.01µM cupric ions, was therefore followed by a further five minute pre-incubation 
with various concentrations of 7,8-NP. Samples were then incubated in the presence of 
0.1mg/ml LDL for a period of time that corresponded to a peak in TBARS and protein 
hydroperoxide levels in the 0µM 7,8-NP control treatment. Due to the variable rates of 
HMDM-mediated LDL oxidation obtained between blood donors, a time course was 
conducted prior to each one of these 7,8-NP experiments to enable proper identification 
of this time point. An 18 hour incubation was required to reach this peak when using the 
HMDM preparation in Figure 5.24 (data not shown). Under these incubation conditions, 
protection against HMDM-mediated protein hydroperoxide and TBARS formation on 
LDL only became significant between 85-95µM 7,8-NP (Figure 5.24). In support of the 
almost complete retention of vitamin E at 100µM 7,8-NP, lipid and protein oxidation 
was also almost completely inhibited at this pteridine concentration.  
 While 100µM 7,8-NP provided strong inhibition in the current study, LDL 
incubated with other HMDM preparations appeared to require anywhere between     
100-200µM 7,8-NP for a similar level of protection. Thus, the variability between 
HMDM donors is associated not only with differing rates of cell-mediated LDL 
oxidation but also with the concentration of 7,8-NP required for complete prevention of 
oxidation. However, no correlation between these two factors could be identified. For 
instance, HMDMs from two separate donors promoted a peak in LDL oxidation 
products after nine hours and 18 hours, but 100µM 7,8-NP was similarly effective in 
preventing the LDL oxidation induced by both these cells (data not shown). 
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Figure 5.24  7,8-NP inhibits HMDM-mediated LDL oxidation. 
HMDMs (1x106/ml) were incubated at 37°C, with 0.1mg/ml LDL and various concentrations of  
7,8-NP, in chelexed Ham’s F10 supplemented with 4.5µM FeSO4 and 0.01µM CuCl2. After 18 
hours, samples were analyzed for (a) protein hydroperoxides, (b) TBARS and (c) vitamin E. 
Significance is indicated from the 0µM 7,8-NP treatment. Results are displayed as mean ± SEM of 
triplicates from a single experiment, representative of three separate experiments. 
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5.2.8 IFN-γ Inhibits HMDM-Mediated LDL Oxidation 
Werner-Felmayer et al. (1990) have previously noted that the THP-1 cell line and 
HMDMs display a similar pattern of pterin production, and this observation has been 
further confirmed in the current study (Figure 5.18 & Figure 5.25). Total HMDM pterin 
levels did not reach significance in both the supernatant and cell extract until 36 hours 
and, in the presence of 1x106 cells/ml, pterin subsequently plateaued at approximately 
17-20nM and 50-55pmole/mg protein in the supernatant and cell extract, respectively 
(Figure 5.25).  
 In further similarity to the THP-1 results, HMDM pterin production was not 
significantly affected by co-incubation with LDL or transition metals (Table 5.2).  
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Figure 5.25  Time course of pterin production by HMDMs. 
HMDMs (1x106 cells/ml) were incubated at 37°C in RPMI with 500U/ml IFN-γ. At various time 
points, total pterin (neopterin plus 7,8-NP) levels were measured in the supernatant and cell lysate. 
Significance is indicated from time zero. Results are displayed as mean ± SEM of triplicates from a 
single experiment, representative of three separate experiments. 
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Table 5.2  Effect of LDL oxidation on HMDM pterin levels. 
HMDMs (1x106/ml) were incubated at 37°C in chelexed Ham’s F10 in the presence or absence of 
500U/ml IFN-γ. After 48 hours, 4.5µM FeSO4, 0.01µM CuCl2 and 0.1mg/ml LDL were added to 
half the samples. Neopterin levels were subsequently measured in the supernatant and cell lysate of 
all samples after a further 24 hours. Significance is indicated between LDL oxidation samples and 
the corresponding LDL- and transition metal-free treatments. ANOVA analysis revealed no 
statistical significance between LDL oxidation samples and the corresponding LDL- and transition 
metal-free treatments. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
 Cell extract 
(pmole/mg protein) 
Supernatant 
(nM) 
Cells 
Cells + LDL + Metals 
Cells + IFN-γ 
Cells + IFN-γ + LDL + Metals 
0 ± 0 
0 ± 0 
48.95 ± 3.59 
41.12 ± 5.43 
2.75 ± 0.26 
0 ± 0 
23.18 ± 1.14 
23.40 ± 1.97 
 
 
 Like THP-1 macrophages, HMDMs were also able to survive for extended periods 
in Ham’s F10 (Figure 5.26). As determined by trypan blue exclusion staining, viability 
in this medium remained at almost 100% compared to control cells incubated for up     
to 78 hours in the more nutrient rich RPMI. This lack of cell death was also observed   
in the presence of IFN-γ. Although the MTT assay did show a reduction in viability to 
72.7 ± 1.7% after 78 hours in Ham’s F10, the difference between cells incubated in the 
presence and absence of IFN-γ remained insignificant. 
 Given the viability of HMDMs in Ham’s F10 over prolonged periods and the 
detection of neopterin under these conditions, the effect of IFN-γ on HMDM-mediated 
LDL oxidation could consequently be studied. Cells were stimulated with IFN-γ during 
a 48 hour pre-incubation in chelexed Ham’s F10 before additional exposure to LDL and 
transition metals. In the absence of IFN-γ, HMDM-mediated LDL oxidation was 
associated with a lag phase of eight hours (Figure 5.27). The addition of IFN-γ extended 
this lag for both protein hydroperoxide and TBARS formation to 18-24 hours, with 
vitamin E being completely consumed between 24 and 36 hours. This contrasts with the 
total loss of vitamin E by 18 hours during LDL oxidation mediated by unstimulated 
HMDMs. The presence of IFN-γ actually retarded LDL oxidation to such an extent that 
the rate was even slower than that observed during cell free LDL oxidation.  
 A direct effect of IFN-γ on the oxidative process was eliminated by confirming that 
the presence of this cytokine had no effect on the rate of LDL oxidation under cell free 
conditions (data not shown).  
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 The extent of inhibition mediated by IFN-γ-activated HMDMs during LDL 
oxidation showed some variability between donors. In general, this appeared to be 
independent of any changes in the rate of LDL oxidation mediated by unstimulated 
HMDMs. Although unstimulated HMDMs from two separate donors were both 
associated with a nine hour lag phase, the corresponding IFN-γ-stimulated HMDM 
treatments extended that lag phase to 18-24 hours in one experiment (Figure 5.27) and 
over 36 hours in the second experiment (data not shown). 
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Figure 5.26  HMDM viability in Ham’s F10 medium. 
HMDMs (1x106 cells/ml) were incubated in Ham’s F10, supplemented with 4.5µM FeSO4 and 
0.01µM CuCl2, in the presence or absence of 500U/ml IFN-γ. Controls incubated in RPMI for the 
entire experiment were also prepared. After 48 and 78 hours, cell viability was analyzed via (a) MTT 
and (b) trypan blue exclusion staining. ANOVA analysis revealed no statistical significance between 
treatments. Results are displayed as mean ± SEM of triplicates from a single experiment, 
representative of three separate experiments. 
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Figure 5.27  IFN-γ inhibits HMDM-mediated LDL oxidation. 
HMDMs (1x106 cells/ml) were pre-incubated in chelexed Ham’s F10 for 48 hours in the presence or 
absence of 500U/ml IFN-γ. The experiment was subsequently initiated by the addition of 4.5µM 
FeSO4, 0.01µM CuCl2 and 0.1mg/ml LDL. An LDL only treatment was also included. Samples  
were analyzed at various time points for an increase in (a) protein hydroperoxides, (b) TBARS and 
(c) a loss of vitamin E. Significance is indicated between cell treatments. Results are displayed as 
mean ± SEM of triplicates from a single experiment, representative of three separate experiments. 
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 Irrespective of inter-experimental variability, the discovery of such a significant 
IFN-γ-mediated impact raised questions about the source of this inhibition and whether 
it required the continual presence of HMDMs or was caused by a cellular secretion. To 
test this, cell-conditioned Ham’s F10 medium was prepared by incubating the HMDMs 
in the presence or absence of IFN-γ for 48 hours. LDL and 3µM cupric ions were then 
exposed to this conditioned medium for an additional incubation in the absence of cells 
(Figure 5.28). LDL oxidation in the unstimulated HMDM-conditioned medium 
exhibited kinetics identical to those observed during the corresponding cell free LDL 
oxidation. Both these treatments were associated with a lag phase of 12 hours, a similar 
rate of propagation and a decomposition phase that began after approximately 24 hours. 
This indicates that cell-mediated oxidation only occurs upon the continual exposure of 
LDL to macrophages. A completely different LDL oxidation trend was observed upon 
exposure of LDL to the conditioned medium derived from IFN-γ-stimulated HMDMs. 
Under these conditions, the TBARS lag phase was extended to 36 hours and the peak in 
LDL oxidation levels had not quite been attained by 48 hours. 
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Figure 5.28  Conditioned medium removed from IFN-γ-treated HMDMs inhibits 
LDL oxidation. 
HMDMs (1x106 cells/ml) were pre-incubated in chelexed Ham’s F10 for 48 hours in the presence or 
absence of 500U/ml IFN-γ. The experiment was subsequently initiated by removing media from 
half the cells and incubating this cell-conditioned medium with 3µM CuCl2 and 0.1mg/ml LDL. The 
remaining medium was kept with the HMDMs but treated similarly. An LDL only treatment was 
also included. Samples were analyzed at various time points for an increase in TBARS. Significance 
is indicated between cell-conditioned treatments. Results are displayed as mean ± SEM of triplicates 
from a single experiment, representative of three separate experiments. 
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5.3 Discussion 
5.3.1 Transition Metals in LDL Oxidation 
Transition metals have previously been shown to play a critical role in macrophage-
mediated LDL oxidation (Leake & Rankin, 1990; Kritharides et al., 1995a; Lamb et al., 
1995), and the current study further confirms these findings. While THP-1 macrophage-
mediated LDL oxidation was minimal in the absence of any ferrous ion supplementation 
(Figure 5.1), increasing concentrations of ferrous ions were associated with increasing 
rates of oxidation (Figure 5.2 & Figure 5.3). This requirement for transition metals has 
led to the suggestion that cells accelerate a metal-dependent oxidative process via the 
continuous reduction of these transition metals back to redox active forms (Garner & 
Jessup, 1996). Thus, it is not surprising that cell free LDL oxidation was similarly 
dependent on the supplemental iron concentration but that it simply proceeded at a 
slower rate than the corresponding cell-containing treatment (Figure 5.1 to Figure 5.3). 
 
5.3.2 Protein Hydroperoxide Formation on LDL During Oxidation 
Mediated by Macrophages 
5.3.2.1 Protein Hydroperoxide Formation and Lipid Peroxidation Are Correlated 
THP-1 macrophages promoted the formation of 30-40 moles of protein hydroperoxides 
per mole of LDL, and this maximum level was observed whether the Ham’s F10 
medium was supplemented with 1.5µM or 3µM ferrous ions (Figure 5.2 & Figure 5.3). 
TBARS also peaked at a similar mole per mole scale, but the yield of conjugated   
dienes was approximately six to seven times larger. The disparity between these two 
markers of lipid peroxidation is explained by the fact that the TBARS assay detects 
malondialdehyde, an end-product of lipid peroxidation, while conjugated dienes provide 
a direct measure of conjugated lipid hydroperoxides (Esterbauer et al., 1989). Using this 
more direct indication of lipid hydroperoxides, protein hydroperoxides can therefore   
be determined to account for 12-15% of the total LDL hydroperoxide content. This       
is comparable to the value of 16% calculated during copper-mediated LDL oxidation 
(Gieseg et al., 2003) and is to be expected, especially considering that protein 
constitutes only 21.9% of the LDL by weight (Esterbauer et al., 1992). It also confirms 
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for the first time that protein hydroperoxides are a significant product of THP-1 
macrophage-mediated LDL oxidation.  
 Given sufficient time, similar levels of protein hydroperoxides were ultimately 
detected in the iron-containing cell free incubations (Figure 5.2 & Figure 5.3). Likewise, 
comparable quantities of protein hydroperoxides were generated on each LDL particle 
during both AAPH- and copper-mediated oxidation (Gieseg et al., 2003). Such strong 
similarity between different oxidizing conditions indicates that apoB100’s sensitivity   
to protein peroxidation is a general phenomenon. A common mechanism of apoB100 
oxidation may exist, irrespective of the initial oxidizing agent. 
 The close parallel consistently observed between protein hydroperoxide formation 
and lipid peroxidation provides further support for a common mechanism of protein 
oxidation (Figure 5.6a & Figure 5.6b). This same correlation was previously noted 
during both AAPH- and copper-mediated LDL oxidation, and was further shown to 
remain undisturbed in the presence of either hydrophilic or hydrophobic antioxidants 
(Gieseg et al., 2003). It has therefore been suggested that protein peroxidation and lipid 
peroxidation are linked, with protein hydroperoxides likely to be generated by a radical 
intermediate of the lipid peroxidation process. The theory appears equally relevant to 
cell-mediated LDL oxidation because the linkage between protein hydroperoxides and 
lipid peroxidation products was not broken by the incubation of THP-1 macrophages 
and LDL with a water soluble antioxidant like 7,8-NP (Figure 5.11). Moreover, the 
close linkage between the two ensured that the end of the protein hydroperoxide lag 
phase corresponded to the complete consumption of vitamin E (Figure 5.6e). This 
correlation occurs despite the fact that vitamin E is a lipid soluble antioxidant and, as 
such, is not expected to directly protect the apoB100.  
 The suggestion that protein oxidation can be initiated by lipid-derived radicals is 
certainly not new. In 1966 peroxidizing lipids were demonstrated to cause the loss of 
amino acids and of solubility in a variety of proteins (Roubal & Tappel, 1966a). The 
same authors also attributed the induction of protein polymerization to lipid 
peroxidation products (Roubal & Tappel, 1966b). Fluorescent products generated by a 
direct interaction between lipid peroxyl radicals and amino acids have been deteccted 
upon incubation of polypeptides with linoleoyl hydroperoxide (Fruebis et al., 1992). 
More recently, an antibody has been described that is specific for protein damaged by 
lipid hydroperoxides and not aldehyde-modified or AAPH-damaged protein (Kim et al., 
1997). This same antibody also immunostained atherosclerotic lesions and LDL 
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oxidized by copper but did not cross-react with a native LDL control. Another group 
has demonstrated that the metal-catalyzed oxidation of PUFAs enhances carbonyl 
formation on pure proteins, with the extent of carbonyl formation increasing as the 
degree of lipid unsaturation increases (Refsgaard et al., 2000). A strong correlation 
between LDL lipid peroxidation and apoB100 carbonyl formation in the presence of 
copper has, similarly, been attributed to protein oxidation induced by radical 
intermediates of lipid peroxidation (Yan et al., 1997). Lipid-derived radicals are 
therefore likely to be responsible not only for protein hydroperoxide formation but also 
for production of the apoB100 carbonyls detected during macrophage-mediated LDL 
oxidation in the current study (Figure 5.6d).  
 
5.3.2.2 A Comparison Between Protein Hydroperoxides and Additional Markers 
of Protein Oxidation 
In comparison to the 30-40 moles of protein hydroperoxides generated per mole of LDL 
during THP-1 macrophage-mediated LDL oxidation, protein carbonyls peaked at eight 
moles/mole LDL (Figure 5.6d). A similar predominance of protein hydroperoxides over 
carbonyls has been noted in plasma after exposure to AAPH (Ling, 2003).  
 Specific markers of tyrosine oxidation were produced at even lower levels than 
carbonyls during LDL oxidation. Dityrosine remained undetectable, whether the LDL 
was incubated in the presence or absence of THP-1 macrophages, while the maximum 
PB-DOPA concentration only reached 0.29 moles/mole LDL (Figure 5.5). Thus, despite 
LDL containing 152 tyrosine residues (Esterbauer et al., 1992), neither PB-DOPA nor 
dityrosine were found to be major products of macrophage-mediated or cell free LDL 
oxidation during the current incubation period. Other metal-dependent oxidation 
systems appear equally poor at inducing dityrosine formation on either LDL or 
alternative substrates, including tyrosine-containing tripeptides and lens proteins (Bruce 
et al., 1999; Kato et al., 2001; Gieseg et al., 2003). In these studies, dityrosine 
formation only became significant upon the co-incubation of copper with hydrogen 
peroxide. PB-DOPA was at least detectable in a range of oxidizing systems, but 
concentrations remained low and were comparable to those recorded on LDL during 
THP-1 macrophage-mediated oxidation (Bruce et al., 1999; Knott et al., 2002; Gieseg  
et al., 2003). While a range of incubation times was required to ultimately reach such 
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similar levels of PB-DOPA, this is likely to simply be due to the use of different LDL 
donors, oxidants, oxidant concentrations and LDL concentrations between the studies.  
 
5.3.2.3 Protein Hydroperoxides are a General Consequence of Macrophage-
Mediated LDL Oxidation 
Lipid peroxidation products like conjugated dienes are widely recognized to form early 
during the oxidative modification of LDL. Thus, the correlation between these lipid 
peroxidation products and protein hydroperoxides (Figure 5.6b) not only supports the 
concept of protein being oxidized by lipid-derived radicals but also confirms that 
protein hydroperoxides are an early product of LDL oxidation. Combined with the 
significant quantities that have been detected during THP-1 macrophage-mediated LDL 
oxidation, protein hydroperoxides can therefore be considered a useful marker of 
apoB100 damage. However, it remained to be confirmed whether cell-mediated protein 
hydroperoxide formation was specific to the THP-1 macrophage cell line or whether it 
was a more general feature of all macrophage-mediated LDL oxidation. The finding that 
the primary HMDMs were also able to promote the formation of approximately 30 
moles of protein hydroperoxides per mole of LDL (Figure 5.23a) confirms that the latter 
expectation is, indeed, correct. Protein hydroperoxides represent a general, and 
significant, consequence of macrophage-mediated LDL oxidation. Furthermore, the 
continued parallel between protein hydroperoxide and TBARS formation (Figure 5.23) 
suggests that a lipid-derived radical is likely to promote protein hydroperoxide 
formation during cell free oxidations and all macrophage-mediated LDL oxidations. 
Just as critically, these findings suggest that LDL will be vulnerable to protein 
hydroperoxide formation in the atherosclerotic plaque. There is some in vivo support for 
this claim because hydroxyleucine and hydroxyvaline are the break-down products of 
leucine hydroperoxide and valine hydroperoxide, respectively, and both have been 
detected in atherosclerotic samples (Fu et al., 1998). 
 The variable rates of LDL oxidation observed in the presence of HMDMs contrast 
with the relative stability of THP-1 macrophage-mediated oxidation but do not 
invalidate any conclusions regarding protein hydroperoxide formation. This variability 
has been noted by other laboratories studying HMDM-mediated LDL oxidation (for 
example, Carpenter et al., 1997) and, considering that each batch of HMDM cells is 
prepared using blood isolated from different donors, is to be expected.  
 7,8-NP and Macrophage-Mediated LDL Oxidation 161 
  
5.3.3 Protein Hydroperoxides and Macrophage-Mediated Oxidation 
of BSA  
Although macrophages are clearly capable of promoting significant protein 
hydroperoxide formation on LDL, this ability does not necessarily extend to other     
protein-containing compounds. Incubating a pure protein like BSA with THP-1 
macrophages failed to produce any protein hydroperoxides detectable by the FOX assay 
(Figure 5.7 to Figure 5.9). BSA is susceptible to peroxidation when exposed to peroxyl 
radicals or irradiation (Duggan et al., 2001) and, although albumin serves as an 
important transport protein in circulation, it has also been described as a sacrificial 
antioxidant (Frei et al., 1988; Halliwell, 1988).  
 The absence of protein hydroperoxide formation in the current study occurred 
despite incubating under conditions known to be permissive for LDL oxidation, and 
despite testing a range of BSA concentrations and incubation times. Another group has 
reported a similar result when monitoring tryptophan levels in the presence of copper, 
with an early loss of tryptophan being measured on LDL but never BSA (Knott et al., 
2002). In an attempt to compensate for the known reducing activity of LDL, ascorbate 
was included in the BSA/copper incubation mixture, but even this failed to promote the 
loss of BSA’s tryptophan residues.  
 There are several possible reasons for the lack of sensitivity exhibited by            
BSA towards cell-mediated protein hydroperoxide formation. Macrophage-mediated 
oxidation of LDL has been suggested to require an initial interaction between the 
lipoprotein and the LDL receptor (Aviram & Rosenblat, 1994). If correct, cell-mediated 
protein hydroperoxide formation on BSA could conceivably be prevented by the 
inability of the albumin protein to associate with the LDL receptor. The relevance of 
this theory is unclear because other groups have indicated that an interaction between 
LDL and its receptor is not essential for macrophage-mediated oxidation (Cathcart       
et al., 1995; Tangirala et al., 1996). Even if these later studies are correct, they do not 
rule out the possibility of a more non-specific interaction between macrophage cells and 
LDL’s lipid component playing an important role in the promotion of oxidation. 
 It is also possible that the failure of THP-1 macrophages to promote the formation of 
BSA hydroperoxides is independent of any BSA-cell association and is, instead, due to 
a lack of a suitable interaction between BSA and transition metals. This is worthy of 
consideration because cells have been suggested to accelerate LDL oxidation by 
maintaining metals in redox active states (Garner & Jessup, 1996). Furthermore, copper 
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is considered to be a more potent mediator of oxidation than iron and this is, at least 
partly, due to its close interaction with the LDL particle (Lynch & Frei, 1995). Copper 
is known to bind albumin tightly (Kocha et al., 1997) and, under certain circumstances, 
is certainly associated with the protein in its redox active form (Samocha-Bonet et al., 
2004). However, incubating BSA with copper alone does not induce a loss of 
tryptophan (Knott et al., 2002) or a significant increase in carbonyl formation (Yan et 
al., 1997). Additional reagents, such as those involved in Fenton chemistry, appear to be 
essential if copper-mediated BSA oxidation is to proceed. While the THP-1 
macrophages represent a likely source of these additional reactants, Ham’s F10 medium 
contains cupric ions at a concentration of only 0.01µM. It is expected that such low 
quantities would be unable to promote significant site-specific damage to the BSA. Iron 
also appears to be a relatively ineffectual oxidant under these circumstances because it 
binds only weakly to BSA (Kocha et al., 1997). Thus, despite iron being present in 
supplemented Ham’s F10 at a concentration of 4.5µM, the possibility of site-directed 
oxidation is virtually non-existent. Iron chelates, including citrate and nitrilotriacetate, 
can increase the oxidative potential of iron towards BSA (Ogino & Okada, 1995) but 
this finding is of little relevance under the conditions of the current study.  
 A third, and most likely, explanation for the lack of protein hydroperoxide formation 
on BSA arises from the theory that lipid-derived radicals are strong initiators of 
apoB100 oxidation. Consequently, the potential exists for these radicals to play an 
equally critical role during the metal-mediated oxidation of other proteins. As a pure 
protein like BSA contains no lipids, it would, by extension, lack susceptibility to any 
protein hydroperoxide formation initiated by radical intermediates of the lipid 
peroxidation chain reaction. Indirect support for this concept arises from a comparison 
of copper-mediated tryptophan loss on BSA and LDL. Under conditions designed to 
limit the difference between these treatments to the presence or absence of lipid, an 
early loss of tryptophan was observed only on LDL (Knott et al., 2002). This led to the 
suggestion that tryptophan modification was a lipid peroxidation-dependent process. A 
more detailed analysis of copper-mediated BSA oxidation confirmed that carbonyl 
formation was also dependent on the presence of lipid (Yan et al., 1997). This increase 
in carbonyls was observed whether using LDL, linoleic acid or a pre-formed 
hydroperoxide like tert-butyl hydroperoxide as the source of lipid. Copper was 
postulated to promote lipid peroxidation and hydroperoxide decomposition, with some 
of the resulting lipid-derived radicals being responsible for initiating BSA oxidation.  
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5.3.4 Effect of 7,8-NP on Macrophage-Mediated LDL Oxidation 
5.3.4.1 7,8-NP Inhibits Protein Hydroperoxide Formation During Macrophage-
Mediated LDL Oxidation 
Given the reactivity of protein hydroperoxides, and their potential to cause additional 
damage, it was important to investigate whether their formation could be inhibited 
during macrophage-mediated LDL oxidation. 7,8-NP has previously been shown to 
inhibit LDL oxidation under cell free conditions, with Gieseg et al. (1995) noting a clear 
protection against lipid peroxidation and vitamin E loss in the presence of copper ions. 
More recently, 7,8-NP has been confirmed to prevent not only lipid peroxidation but 
also protein hydroperoxide formation on LDL during AAPH- and copper-mediated 
oxidation (Gieseg et al., 2003). The peroxidation of LDL lipid in the presence of      
both THP-1 monocytes and THP-1 macrophages is also efficiently inhibited by this 
pteridine (Gieseg & Cato, 2003). 7,8-NP’s protection against THP-1 macrophage-
mediated damage is now shown to extend to the protein component of LDL. Protein 
hydroperoxide formation was inhibited in a concentration-dependent manner that 
paralleled the prevention of lipid peroxidation, as determined by TBARS (Figure 5.10). 
This concentration-dependent effect resulted in the complete protection of both the lipid 
and protein components of LDL by 30µM 7,8-NP. In comparison, THP-1 monocyte-
mediated TBARS formation was completely inhibited on LDL in the presence of only 
5µM 7,8-NP (Gieseg & Cato, 2003). Considering that macrophages are more potent 
inducers of LDL oxidation than the corresponding monocytes (Fuhrman et al., 2004), 
the requirement for a higher 7,8-NP concentration is not unexpected.  
 In addition to preventing damage to the protein and lipid components of LDL, this 
pteridine also spared the loss of large quantities of vitamin E (Figure 5.10c). Thus,    
7,8-NP can be considered to significantly protect the entire LDL particle from THP-1 
macrophage-mediated oxidative attack. A concentration of 30µM 7,8-NP was once 
again shown to provide maximal protection, promoting the retention of approximately 
80-85% of the initial vitamin E concentration. The inability of 7,8-NP to completely 
protect vitamin E has also been noted during earlier LDL oxidation studies (Gieseg & 
Cato, 2003) and may be due to a scavenging competition between the two antioxidants 
for lipid peroxyl radicals. Indeed, 7,8-NP has previously been suggested to protect LDL 
against AAPH- and copper-mediated oxidation by directly competing with vitamin E 
for these lipid peroxyl radicals (Gieseg et al., 1995). 
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5.3.4.2 Mechanism of 7,8-NP-Mediated Protection 
Time course data indicated that 7,8-NP was able to extend the lag phase of both TBARS 
and protein hydroperoxide formation in a concentration-dependent manner, while 
having minimal effect on oxidation rates during the propagation phase (Figure 5.11). 
This agrees with the kinetics observed, in the presence of 7,8-NP, during both AAPH- 
and copper-mediated LDL lipid and protein oxidation (Gieseg et al., 1995; Gieseg et al., 
2003). However, this similarity does not extend to 7,8-NP’s effect on vitamin E 
consumption. While 7,8-NP merely slowed the rate of vitamin E loss during copper-
mediated LDL oxidation (Gieseg et al., 1995), it was able to spare vitamin E almost 
entirely during the early stages of THP-1 macrophage-mediated LDL oxidation (Figure 
5.11c). This sparing effect was concentration-dependent, with increasing quantities of 
7,8-NP completely protecting the vitamin E for increasing periods of time. The 
subsequent loss of vitamin E began slowly in some instances but, by the final stages, 
occurred at rates largely independent of the starting 7,8-NP concentration.  
 The different effects of 7,8-NP on copper-mediated and THP-1 macrophage-
mediated vitamin E loss are most likely due simply to the dissimilar rates of oxidation 
between each of the oxidizing systems and will be discussed in further detail below. 
Nevertheless, it remained possible that the 7,8-NP was inhibiting THP-1 macrophage-
mediated LDL oxidation by mechanism(s) independent of its chain-breaking scavenging 
of the LDL lipid peroxyl radicals. Perhaps this pteridine was able to prevent 
macrophage-mediated LDL oxidation by some, as yet unidentified, direct interaction 
with the cells. Gieseg & Cato (2003) certainly reported a need to pre-incubate the      
7,8-NP with THP-1s for consistent protection. By contrast, the AAPH and copper 
oxidizing systems required a pre-incubation of the 7,8-NP with LDL (Gieseg et al., 
1995).  
 
i) 7,8-NP and TPMET Activity 
TPMET is suggested to play a critical role in macrophage-mediated LDL oxidation 
(Baoutina et al., 2001b) and, as such, it was possible that 7,8-NP could be exerting its 
inhibitory effect via an interaction with this system. Between 75-90% of ferricyanide 
reduction could generally be attributed to THP-1 macrophage TPMET activity, with the 
remainder being due to cell-secreted reductants (eg. Figure 5.16 & Figure 5.17). This 
proportion is in close agreement with the over 81% of ferricyanide reducing activity 
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attributed to the TPMET system during an earlier study involving THP-1 macrophages 
(Baoutina et al., 2001b). By contrast only 40-60% of copper reducing activity could be 
accounted for by TPMET (eg. Figure 5.16 & Figure 5.17). The seemingly higher 
proportion of copper reducing activity in the cell-conditioned medium may be due to the 
ability of BCS (an assay reagent) to alter the redox potential of copper, thereby shifting 
the equilibrium towards greater cupric ion formation (Sayre, 1996). While this can 
affect the measured concentrations of reduced copper, it does not detract from studies 
investigating 7,8-NP’s influence on the cellular reducing activity.  
 It soon became apparent that a pre-incubation with 50µM 7,8-NP had no detectable 
impact on the subsequent activity of either the cell-secreted reductants or the TPMET 
system (Figure 5.16). This was consistently observed by both reduction assays and 
occurred despite the fact that 50µM 7,8-NP is known to significantly inhibit THP-1 
macrophage-mediated LDL oxidation (Figure 5.10 & Figure 5.11). The possibility that 
TPMET activity is inhibited only when continuously exposed to 7,8-NP cannot be 
completely ruled out. Such a study is not feasible due to the strong interference 
experienced by both reduction assays in the presence of micromolar concentrations of 
7,8-NP. Nevertheless, the probability of any significant interaction between 7,8-NP and 
TPMET is extremely unlikely because the continuous exposure of THP-1 macrophages 
to IFN-γ generated nanomolar quantities of pterin (Figure 5.18) but failed to modulate 
TPMET activity (Figure 5.17). While another study did observe an IFN-γ-mediated 
inhibition of TPMET activity (Sun et al., 1996), this disparity may simply be due to the 
use of the HL60 cell line rather than THP-1 macrophages. 
 
ii) 7,8-NP and Radical Scavenging 
The inability of 7,8-NP to inhibit TPMET activity ultimately suggests that, rather than 
modulating macrophage activity, 7,8-NP most likely provides protection against the 
oxidative modification of LDL by scavenging radicals. Further support for this type of 
antioxidant activity arises from the fact that, during THP-1 macrophage-mediated LDL 
oxidation, the 7,8-NP progressively oxidizes to 7,8-XP (Figure 5.12). 7,8-NP loss even 
correlates to the phases of LDL oxidation, with the lag phase ending and the 
propagation phase begining only once most of the 7,8-NP has been consumed.  
 Although the scavenging of LDL lipid peroxyl radicals provides one explanation for 
these kinetics, it remained possible that 7,8-NP’s scavenging activity was instead due to 
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a reaction with cell-associated radicals. Membrane-derived peroxyl radicals represent 
one potential scavenging target because the incubation of cells with ferrous ions, as in 
the current study, has been shown to promote lipid peroxidation on a range of monocyte 
and macrophage cells (Fuhrman et al., 1994; Gieseg et al., 2001b). This peroxidation 
displayed an iron-dose dependence and, while iron levels in the supplemented Ham’s 
F10 are 20-50% of those tested by other studies, some lipid peroxidation in the current 
study is still feasible. Just as critically, cellular lipid peroxides have been found to 
enhance LDL oxidation (Fuhrman et al., 1994; Keidar et al., 1995; Fuhrman et al., 
1997). Thus, it can be envisaged that by protecting macrophages from iron-induced 
peroxidation, 7,8-NP could indirectly protect the LDL particle from oxidative 
modification. This theory is worthy of consideration because 7,8-NP has previously 
been found to prevent iron-induced lipid peroxidation on U937 monocytes (Gieseg       
et al., 2001b). However, the kinetics of 7,8-NP consumption and 7,8-XP formation in 
the presence of THP-1 macrophages do not provide strong support for an interaction 
between 7,8-NP and any cell peroxides that may exist under the conditions of the 
current study (Figure 5.14). If 7,8-NP was scavenging cell-derived radicals, the 
oxidation rate for this pteridine should increase dramatically upon incubation with  
THP-1 macrophages. Instead, the loss of 7,8-NP in the absence of any cells or LDL was 
relatively slow, and the addition of THP-1 macrophages did not speed up this oxidation. 
By contrast, co-incubation with LDL resulted in an increased rate of loss for 7,8-NP, 
and the addition of THP-1 macrophages to this LDL/pteridine incubation mixture 
enhanced 7,8-NP oxidation even further. This latter result is to be expected because 
cells are known to significantly enhance LDL oxidation compared to the corresponding 
cell free conditions. The consumption of 7,8-NP therefore appears to be dependent upon 
the presence of LDL, and the oxidizing capacity of the environment, rather than the 
specific presence of the THP-1 macrophages themselves. 
 Given the above findings, it appears that the distinct trends of vitamin E oxidation 
observed in the current study and the Gieseg et al. (1995) study may simply be due to 
the different oxidizing capacities of the two environments. Sources of this difference 
could range from the degree of oxygen exposure to the use of alternative oxidants and 
incubation media. Copper-mediated cell free LDL oxidation occurred in PBS, subjected 
to continuous swirling in a flask. Cell-mediated LDL oxidation experiments involved 
incubation in Ham’s F10, using plates that were exposed to a constant environment of 
5% carbon dioxide and little motion. Whatever the cause of the different oxidizing 
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capacities, simple rate calculations indicate that 5µM copper was able to support the 
generation of approximately 610 mmoles of protein hydroperoxides per mole of LDL 
per minute during the propagation phase (Gieseg et al., 2003). By contrast, only 110 
mmoles of protein hydroperoxides were formed per mole of LDL every minute during 
THP-1 macrophage-mediated LDL oxidation (Figure 5.11). In the absence of 7,8-NP, 
vitamin E was consumed at a rate of 300 mmole per mole of LDL per minute during 
copper oxidation (not 0.5nM/min as stated in Gieseg et al., 1995). Only 18 mmoles 
were oxidized per mole of LDL every minute during the linear phase of cell-mediated 
vitamin E oxidation (Figure 5.11). Not only do the oxidation rates differ significantly 
between these two studies but the ratio of 7,8-NP to vitamin E also shows large 
variability. The current study is associated with an initial antioxidant ratio of 136 moles 
of 7,8-NP per mole of vitamin E (Figure 5.13b), but Gieseg et al. (1995) used a 
significantly lower ratio of three to four moles of 7,8-NP per mole of vitamin E. 
 7,8-NP and vitamin E have been reported to scavenge peroxyl radicals at 
comparable rates (Oettl et al., 1997) and thus, given the differences above, it appears 
that 7,8-NP is able to more effectively compete for radicals and spare the vitamin E 
from oxidation under conditions associated with the cell studies rather than the copper 
studies. Indeed, 20µM 7,8-NP was observed to decrease almost immediately during 
cell-mediated LDL oxidation while a delay in vitamin E loss was clearly apparent 
(Figure 5.13b). Only after the loss of sufficient quantities of 7,8-NP did vitamin E also 
begin to scavenge the lipid peroxyl radicals and become oxidized. 
 
While all tested concentrations of 7,8-NP showed a protective effect against THP-1 
macrophage-mediated oxidation, the lower concentrations generally portrayed this 
antioxidant effect more efficiently (Figure 5.10 & Figure 5.11). Whether 7,8-NP may be 
exerting a slight pro-oxidant effect by the later stages of incubation with 50µM 7,8-NP 
is unclear and was not further investigated. Nevertheless, the potential for 7,8-NP to 
promote LDL oxidation under various conditions has been noted (Herpfer et al., 2002; 
Greilberger et al., 2004). The result also bears similarities to a study by Herpfer et al. 
(2002). They observed an antioxidant effect in the presence of 150µM 7,8-NP during 
copper-mediated LDL oxidation, but this was weaker compared to the effect of 100µM 
7,8-NP. 
 
 7,8-NP and Macrophage-Mediated LDL Oxidation 168 
  
5.3.4.3 7,8-NP Inhibits Both THP-1 Macrophage- and HMDM-Mediated LDL 
Oxidation 
Regardless of the potential for such pro-oxidant activity at higher pteridine 
concentrations and/or later stages of incubation, the overall activity of 7,8-NP during 
THP-1 macrophage-mediated LDL oxidation is clearly antioxidant in nature. This 
protection was confirmed to span the entire LDL particle and was not restricted to a 
single cell line. 7,8-NP was able to prevent protein hydroperoxide formation, lipid 
peroxidation and vitamin E loss in the presence of the primary HMDMs as well (Figure 
5.24).  
 One point of difference between the two cell types was the antioxidant concentration 
required to completely inhibit cell-mediated LDL oxidation. While 30µM 7,8-NP was 
sufficient for THP-1 macrophages, a minimum concentration of 100µM 7,8-NP was 
required in the presence of HMDMs. The latter experiment required a longer incubation 
time, but this is unlikely to completely account for the differing efficacy of 7,8-NP       
in the two cell systems. Inter-experimental variability meant that different HMDM 
preparations required different incubation times. However, there was no correlation to 
the corresponding concentration of 7,8-NP required for complete protection. 
 The apparently weaker potency of 7,8-NP during HMDM-mediated LDL oxidation 
may be better explained by structural differences betweem these two macrophage types. 
Unlike THP-1 macrophages, HMDM cells are relatively large and lipid-loaded. Cells 
are generally considered to promote LDL oxidation by maintaining transition metals in 
their redox active states. However, the possibility of an interaction between the LDL 
and macrophages does exist (Tangirala et al., 1996). Non-specific interactions between 
LDL lipid and macrophage lipid may be more pronounced in the lipid-loaded HMDMs 
and this could potentially hinder 7,8-NP’s scavenging of LDL lipid peroxyl radicals. As 
discussed in section 3.3.3, the lipid-loaded phenotype may also cause 7,8-NP itself to 
interact or partition with HMDMs. The interaction could occur in such a way that the 
7,8-NP would be unable to scavenge LDL lipid peroxyl radicals as efficiently as it does 
in the presence of THP-1 macrophages.  
 While these issues remain to be clarified, one thing is apparent. The finding that 7,8-
NP can inhibit protein hydroperoxide formation during both THP-1 macrophage- and 
HMDM-mediated LDL oxidation may have far-reaching and beneficial consequences. 
This is because protein hydroperoxides are not inert and, once formed, can consequently 
cause additional damage to a range of substrates including DNA (Gebicki & Gebicki, 
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1999; Luxford et al., 1999), antioxidants (Simpson et al., 1992; Fu et al., 1995)         
and proteins (Gebicki et al., 1995; Davies, 1996a; Soszynski et al., 1996; Hampton      
et al., 2002; Morgan et al., 2002). Thus, by inhibiting protein hydroperoxide formation,      
7,8-NP not only protects the LDL particle but also prevents any adverse reactions that 
may subsequently occur between the reactive protein hydroperoxide moiety and other 
biomolecules.  
 
5.3.5 Effect of IFN-γ on Macrophage-Mediated LDL Oxidation 
5.3.5.1 IFN-γ-Stimulated THP-1 Macrophages Do Not Significantly Inhibit LDL 
Oxidation 
The concentrations of exogenously-supplied 7,8-NP required for effective inhibition of 
macrophage-mediated LDL oxidation are significantly higher than the nanomolar 
quantities released in cell culture upon stimulation of macrophages with IFN-γ (Figure 
5.18; Figure 5.25; Weiss et al., 1992; Weiss et al., 1999; Gieseg & Cato, 2003). While 
this has raised some questions regarding the in vivo relevance of such findings, it is 
nevertheless important to still consider whether the continuous release of 7,8-NP would 
permit more efficient antioxidant activity than a single, bolus addition at the start of      
an experiment. Furthermore, stimulation with IFN-γ alone may not promote maximal 
pterin production in macrophages. Several biomolecules, including TNFα and LPS, 
have previously been shown to enhance neopterin production when co-incubated      
with IFN-γ (Werner-Felmayer et al., 1990; Werner-Felmayer et al., 1995). Although the 
concentration of neopterin generated under these conditions remained in the nanomolar 
range, it is possible that additional, but as yet unidentified, stimulants or combinations 
of stimulants may ultimately raise production further. One research group has also 
questioned whether contact with other cells may be critical for optimizing pterin 
synthesis (Wirleitner et al., 2001; Enzinger et al., 2002a). In vivo, concentrations of up 
to 0.1µM neopterin have certainly been reported in the serum of HIV (Fuchs et al., 
1994) and atherosclerosis (Tatzber et al., 1991) patients while, more recently, neopterin 
has been found to range from nanomolar concentrations up to 1.28µM in inflammatory 
sites (chapter 6). Thus, the potential exists for levels to be even higher in 
microenvironments immediately adjacent to the pterin-synthesizing macrophages. 
Similarly, although intracellular pterin has been detected in the pmole/mg protein range 
after stimulation with IFN-γ (Figure 5.18; Figure 5.25; Werner et al., 1989; Werner-
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Felmayer et al., 1990), it is possible that a more highly concentrated microenvironment 
may exist within the macrophage cells.  
 Given all this, it was deemed worthwhile to investigate whether IFN-γ exerted any 
influence on macrophage-mediated LDL oxidation. While previous studies have 
indicated that IFN-γ can inhibit LDL oxidation in the presence of mouse macrophages 
(Fong et al., 1994), this finding is of little relevance to the current study. The mouse 
macrophage-derived antioxidant activity was attributed to production of nitric oxide 
(Jessup & Dean, 1993; Niu et al., 2000), but human macrophages synthesize 7,8-NP 
rather than nitric oxide upon stimulation with IFN-γ (Werner et al., 1990). Pre-
incubating THP-1 macrophages in RPMI with 500U/ml IFN-γ for 48 hours certainly 
elevated neopterin levels (Figure 5.18). However, a subsequent incubation in ferrous-
supplemented Ham’s F10, containing LDL and fresh IFN-γ, failed to inhibit LDL 
oxidation compared to an unstimulated THP-1 macrophage control (Figure 5.19). This 
lack of protection was not due to an LDL- or iron-mediated inhibition of 7,8-NP 
synthesis. Pterin levels were largely unaffected by incubation with the lipoprotein and, 
although iron has been reported to inhibit neopterin production, this generally requires 
significantly higher concentrations than those used during LDL oxidation studies (Weiss 
et al., 1992).  
 The lack of any significant IFN-γ-mediated protection contrasts with results from 
another study (Gieseg & Cato, 2003). THP-1 macrophages stimulated with IFN-γ 
appeared to slow the rate of vitamin E loss on LDL in that investigation, though a 
significant difference in the extent of lipid peroxidation was apparent at only one      
time point. The slower rate of THP-1 macrophage-mediated LDL oxidation associated 
with this earlier study likely aided detection of such low levels of inhibition. As a 
consequence, experimental modifications were introduced to the current investigation in 
an attempt to create more optimal conditions for detecting any IFN-γ-mediated effect. A 
48 hour pre-incubation of THP-1 macrophages in Ham’s F10, rather than RPMI, not 
only slowed the rate of LDL oxidation (Figure 5.21) but also ensured that no 7,8-NP 
released into the medium during pre-incubation would be lost at the start of the LDL 
incubation. Although protein hydroperoxide and TBARS formation did appear slightly 
slower in the IFN-γ treatment under these conditions, this difference never reached 
significance and was not supported by the vitamin E data (Figure 5.21). Furthermore, 
the trend was not consistently observed, with some experiments showing rates of 
reaction that were identical to those observed in the absence of IFN-γ. The reason for 
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the continued disparity with the Gieseg & Cato (2003) study is unclear but the 
possibility of some unidentified difference existing between the two separate stocks of 
THP-1s cannot be completely ruled out. The plausibility of this concern is highlighted 
by the strong effect of IFN-γ in the presence of another macrophage type, the primary 
HMDMs.  
 
5.3.5.2 IFN-γ-Stimulated HMDMs Strongly Inhibit LDL Oxidation 
In contrast to both THP-1 macrophage studies (Figure 5.21; Gieseg & Cato, 2003),  
IFN-γ-stimulated HMDMs were associated with an intense antioxidant action (Figure 
5.27). Protection extended to the entire LDL particle, with vitamin E loss, protein 
hydroperoxide formation and lipid peroxidation all being inhibited. This inhibition was 
generally of a sufficient strength that the IFN-γ treatment remained in the lag phase after 
LDL from the unstimulated HMDM control had entered the decomposition phase. Just 
as critically, HMDMs incubated with IFN-γ lost no significant viability or metabolic 
activity compared to controls (Figure 5.26). Thus, the lack of oxidation was real and not 
an artefact of the experimental system. Another study has also noted this IFN-γ-
mediated inhibition in the presence of HMDMs and copper but made no attempt to 
explain the results (Hurt-Camejo et al., 1992). 
 Although the IFN-γ-mediated protection against LDL oxidation was always 
detected, the extent of the inhibition did show some variability from one HMDM donor 
to the next. While variable rates of LDL oxidation had previously been observed in the 
presence of unstimulated HMDMs (section 5.3.1), it failed to correlate with the IFN-γ-
stimulated HMDM variability. As a result, this latter variability appears to be caused 
predominantly by differences in donor responsiveness towards IFN-γ rather than any 
differences in the inherent capacity of unstimulated HMDMs to promote LDL 
oxidation. 
 
i) Mechanism of IFN-γ-Mediated Protection 
Despite the fact that IFN-γ induced THP-1 macrophages and HMDMs to synthesize 
similar quantities of neopterin (Figure 5.18 & Figure 5.25), only one of these cells was 
able to significantly inhibit LDL oxidation in the presence of this cytokine. Such a clear 
lack of correlation between neopterin production and antioxidant activity raised serious 
doubts about 7,8-NP’s role in the inhibitory process. Though not definitively studied, 
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IFN-γ has been observed to cause an increase in the area of a number of other peaks 
detected during HPLC pterin analysis (data not shown). Thus, the possibility exists that 
another pterin could be exerting an antioxidant effect. 
 It must also be remembered that IFN-γ is a multifunctional cytokine and has         
the potential to modulate HMDM-mediated LDL oxidation by a number of pterin-
independent mechanisms. As an example, one earlier study also observed an inhibition 
of LDL oxidation in the presence of IFN-γ-stimulated HMDMs (Christen et al., 1994). 
This effect was attributed to IFN-γ’s upregulation of indoleamine 2,3-dioxygenase 
(IDO), a tryptophan degrading enzyme that ultimately results in the generation of         
3-hydroxyanthranilic acid (3-HAA). Although 3-HAA is a potent antioxidant of LDL 
oxidation (Christen et al., 1990; Thomas et al., 1996b), it is not relevant to the current 
study. 3-HAA formation is dependent on the supplementation of Ham’s F10 with 75µM 
tryptophan (Christen et al., 1994), but the Ham’s F10 used in the current study contains 
only an unsupplemented tryptophan concentration of 2.94µM. 
 While the exact source of the IFN-γ-mediated inhibition remains to be determined, it 
does not appear to be an integral component of the HMDMs but is, instead, a secreted 
substance. Medium conditioned by IFN-γ-stimulated HMDMs strongly inhibited LDL 
oxidation, even in the presence of 3µM cupric ions (Figure 5.28). By contrast, 
unstimulated HMDM-conditioned medium supported LDL oxidation at a rate identical 
to the one observed under cell free conditions. This indicates that the pro-oxidant 
activity of the HMDMs is strongly associated with the cells themselves but the 
antioxidant effect is largely, if not entirely, due to cellular secretions. The strength       
of the inhibition caused by cell-secreted products provides further evidence against      
an antioxidant role for 7,8-NP during HMDM-mediated LDL oxidation. The 100µM     
7,8-NP concentration previously shown to be required for complete protection (Figure 
5.24) is several orders of magnitude larger than the nanomolar quantities of pterin 
released into the medium by IFN-γ-stimulated HMDMs (Figure 5.25). 
 In addition to stimulating 7,8-NP and 3-HAA production, IFN-γ has also been 
reported to reduce lipoxygenase activity in macrophages (Fong et al., 1994; Folcik       
et al., 1997). Just like 7,8-NP and 3-HAA, this activity is also not expected to account 
for the IFN-γ-mediated inhibition of LDL oxidation observed in the current study. The 
conditioned medium from unstimulated macrophages possessed no pro-oxidant activity 
that would be susceptible to such down-regulation in the presence of IFN-γ (Figure 
5.28). Furthermore, the unidentified antioxidant is thought to be secreted from HMDMs 
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while 15-lipoxygenase is associated with an intracellular location (Cathcart & Folcik, 
2000).  
 IFN-γ must therefore be inducing the protective effect via a pathway independent of 
the inhibition of lipoxygenase activity and the production of 3-HAA or 7,8-NP, possibly 
one involving the release of a metal-chelating agent. Metal sequestration by macrophage 
cells has certainly been described (Kritharides et al., 1995a; van Reyk et al., 1999). 
While some of this activity was attributed to sequestration within the cells, macrophages 
were also suggested to provide a more antioxidative environment by directly modifying 
the medium (van Reyk et al., 1999). This modification could occur by numerous 
mechanisms, including the secretion of metal chelators.  
 Whatever the source of the antioxidant activity, its release must be enhanced in  
IFN-γ-stimulated HMDMs but not in IFN-γ-stimulated THP-1 macrophages if it is to 
conform to the findings of the current study. Ceruloplasmin represents a classic example 
of this, with synthesis being upregulated strongly by IFN-γ in HMDMs but only weakly 
in THP-1s (Mazumder et al., 1997). As a copper carrier that also possesses ferroxidase 
activity (Fox et al., 2000), this protein initially seems like an ideal source of the IFN-γ-
mediated HMDM antioxidant activity. However, when incubated with cells or reducing 
agents released by cells, ceruloplasmin has also been shown to promote LDL oxidation 
(Ehrenwald et al., 1994; Ehrenwald & Fox, 1996; Fox et al., 2000). While beyond the 
scope of the current study, this issue could be further investigated by confirming the 
relative levels of ceruloplasmin present in the conditioned medium isolated from each 
cell type. As IFN-γ is known to enhance ceruloplasmin production by 20-fold in the 
U937 cell line (Mazumder et al., 1997), a comparative study of LDL oxidation in the 
presence of IFN-γ-stimulated U937s could provide additional, indirect evidence 
regarding ceruloplasmin’s relevance to the oxidative process. More generally, the 
potential for any HMDM-derived metal chelator to inhibit LDL oxidation could be 
investigated by subjecting LDL to a metal-independent form of oxidative stress. The 
peroxyl radical generator, AAPH, represents just such an oxidant and would need to be 
incubated with the LDL in IFN-γ-stimulated HMDM-conditioned medium. A lack of 
protection under these experimental conditions would provide reasonable support for 
the existence of a HMDM-derived metal chelator. By contrast, the detection of 
antioxidant activity in the presence of a metal-independent oxidant would not 
necessarily deny an inhibitory role for metal chelators during LDL oxidation. The range 
of compounds secreted by IFN-γ-stimulated macrophages may simply serve as 
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alternative substrates for radical attack and, as such, represent sacrificial antioxidants of 
the metal-independent oxidation. Care must clearly be taken when interpreting results 
from such experiments. If protein released from IFN-γ-stimulated macrophages served 
as a sacrificial antioxidant, it is expected to be more highly concentrated in the medium 
conditioned by IFN-γ-treated HMDMs than in media conditioned by either control 
HMDMs or IFN-γ-treated THP-1 macrophages. Gel electrophoresis provides one means 
to investigate the existence of such differences. Ultimately, it must also be recalled that 
IFN-γ is a multifunctional cytokine and, as such, could be inhibiting the HMDM-
mediated LDL oxidation by multiple pathways. 
 Although the current investigation found no evidence of antioxidant activity 
associated with the 7,8-NP produced by IFN-γ-stimulated macrophages, the possibility 
of an effect in vivo cannot be eliminated. Atherosclerosis develops over a period of 
decades, and so, with the slower rates of oxidation that are expected to occur in vivo, the 
low but constant production of pterin may have beneficial consequences in such an 
environment. 
 
5.3.6 Summary 
Macrophage-mediated LDL oxidation may play a critical role in the development of 
atherosclerosis. While many studies have investigated such processes, most have 
focussed on lipid rather than protein peroxidation. The finding that protein 
hydroperoxide formation was promoted on the LDL during both THP-1 macrophage- 
and HMDM-mediated oxidation indicates that this process is a general feature of all 
macrophages rather than merely being restricted to one cell type. With approximately 
30-40 protein hydroperoxides being formed per LDL particle at the peak of oxidation, 
this moiety can also be considered a significant consequence of macrophage-mediated 
oxidation. It was produced in greater quantities than other markers of protein oxidation, 
including carbonyls and PB-DOPA. Protein hydroperoxide generation on LDL has 
previously been suggested to involve lipid-derived radicals, and the close parallel 
between protein hydroperoxide formation and lipid peroxidation in the current study 
provides support for this theory. The close parallel further indicates that, like lipid 
peroxidation, protein peroxidation is an early product of LDL oxidation. All this 
suggests that protein hydroperoxides are likely to be generated on LDL in the 
atherosclerotic plaque. 
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 Given the reactivity but relative stability of protein hydroperoxides, this moiety has 
the potential to cause additional damage and may have important implications for 
atherosclerosis. However, there is also the potential to prevent protein hydroperoxide 
generation. An incubation with the pteridine, 7,8-NP, inhibited both THP-1 
macrophage- and HMDM-mediated protein hydroperoxide formation on LDL. This 
occurred in a concentration-dependent manner that paralleled the inhibition of lipid and 
vitamin E oxidation. Thus, 7,8-NP has the capacity to protect the entire LDL particle, 
including the protein component, from cell-mediated oxidative attack. While the 
TPMET system is suggested to be important for macrophage-mediated LDL oxidation 
(Baoutina et al., 2001b), 7,8-NP does not protect the LDL by modulating this activity. 
Instead, it appears to act as a chain-breaking antioxidant by scavenging lipid peroxyl 
radicals in direct competition to the LDL’s vitamin E. A similar mechanism has 
previously been attributed to 7,8-NP during studies of copper- and AAPH-mediated 
LDL oxidation (Gieseg et al., 1995; Gieseg et al., 2003). In support of this radical 
scavenging activity, 7,8-NP was able to extend the lag phase while having a minimal 
impact on the rate of macrophage-mediated LDL oxidation during the propagation 
phase. Such observations can be accounted for by the kinetics of 7,8-NP consumption, 
which was generally completely oxidized to 7,8-XP by the end of the lag phase. 7,8-NP 
oxidation was also shown to be dependent upon the presence of LDL, and the oxidizing 
capacity of the environment, rather than the THP-1 macrophages themselves. 
 Unlike IFN-γ-stimulated THP-1 macrophages, IFN-γ-stimulated HMDMs were 
found to be potent inhibitors of macrophage-mediated LDL oxidation. This contrast was 
observed even though IFN-γ induced both macrophages to produce similar quantities of 
pterin. Just as critically, pterin in the supernatant was only detected at nanomolar levels. 
Despite a single dose of 7,8-NP at these concentrations being insufficient to inhibit LDL 
oxidation, medium conditioned by IFN-γ-treated HMDMs retained the potent 
antioxidant activity. This all suggests that, while the 7,8-NP produced by IFN-γ-
stimulated macrophages did not play a significant role in preventing LDL oxidation in 
the current study, macrophages can nevertheless exhibit antioxidant behaviour under 
certain conditions. The differential effect of IFN-γ on the ability of each macrophage 
cell type to oxidize LDL also provides a renewed warning against extrapolating directly 
from cell lines to primary cells. 
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6 Neopterin and Markers of Oxidation in 
Inflammatory Environments 
6.1 Introduction 
Neopterin is a product of IFN-γ-stimulated macrophages and, as such, has long been 
associated with macrophage activation and inflammation. This relationship has 
highlighted the potential for neopterin to serve as a marker of disease activity. Indeed, 
the correlation between neopterin concentration and disease severity/extent has been 
investigated for numerous infections and diseases, including coronary artery disease 
(CAD).  
 Hospitalized but not non-hospitalized patients with atherosclerosis were shown to 
possess significantly elevated quantities of neopterin compared to healthy controls 
(Tatzber et al., 1991). Even the hospitalized subjects could be further stratified, with 
those exhibiting signs of peripheral occlusions appearing to have higher serum 
neopterin levels than the coronary occlusion patients (Tatzber et al., 1991; Erren et al., 
1999). More comprehensive studies identified a direct correlation between neopterin 
concentrations in the serum and the extent of atherosclerosis. This association remained 
whether monitoring disease progression in the coronary arteries (Gurfinkel et al., 1999), 
or in the carotid artery of a general atherosclerotic population (Weiss et al., 1994) and 
an atherosclerotic subpopulation of haemodialysis patients (Erten et al., 2005). Other 
groups have identified a correlation between serum neopterin levels and the number of 
complex coronary stenoses in patients with either unstable angina (Garcia-Moll et al., 
2000a) or non-ST segment elevation acute coronary syndromes (Avanzas et al., 2004a). 
These same studies, however, failed to find an association between serum neopterin  
and disease extent when measuring other angiographic markers of atherosclerotic 
progression like vessel score. Detecting these correlations therefore appears to be 
dependent on additional factors that range from sample size, to the method for 
determining CAD severity, and even whether neopterin is expressed before or after 
normalization against creatinine. 
 In another negative finding, Schumacher et al. (1992) found no difference in 
neopterin levels between males with either minor or severe CAD. A more 
comprehensive study by the same group several years later reaffirmed this lack of 
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significance, though it was acknowledged that the use of a larger sample size did begin 
to uncover a trend of increasing serum neopterin with increasing CAD (Schumacher et 
al., 1997). It was also acknowledged that neopterin was significantly more concentrated 
in the serum of subjects suffering from acute myocardial infarction compared to both 
healthy controls and patients with stable CAD. This distinction between acute and 
chronic syndromes was contradicted by another group (Auer et al., 2001), but the Auer 
et al. (2001) result appears to be an exception to the general trend. All other studies 
support the Schumacher et al. (1997) findings of serum neopterin levels generally being 
higher in unstable or acute conditions than in stable but chronic forms of CAD (Gupta  
et al., 1997a; Garcia-Moll et al., 2000b; Ilhan et al., 2005). Even neopterin levels in 
urine have been shown to increase significantly in the week following an acute 
myocardial infarction (Melichar et al., 1994). IFN-γ has been detected in atherosclerotic 
plaque (Geng et al., 1995; Frostegard et al., 1999), and sites of plaque rupture/instability 
are associated with high concentrations of macrophages (Bjorkerud & Bjorkerud, 1996). 
Given the mechanism of pterin synthesis, these sites would therefore also be expected  
to represent regions of high neopterin content. Thus, the association with macrophage 
activity provides a simple explanation for the correlations between neopterin and 
adverse cardiac events. 
 The potential also exists for neopterin to differentiate between distinct types of  
acute and unstable coronary syndromes. Patients diagnosed with a non-Q-wave acute 
myocardial infarction have been associated with higher quantities of serum neopterin 
than those diagnosed with unstable angina (Gurfinkel et al., 1999). Another study 
classified 32 women, all diagnosed with unstable angina, into two sub-groups     
(Garcia-Moll et al., 2000b). High serum neopterin levels were associated with women 
who subsequently experienced additional adverse cardiac events. Conversely, lower 
neopterin serum concentrations tended to be observed in women free of such events.  
 Several additional studies have evaluated the prognostic value of neopterin further. 
This pteridine was shown to be predictive of adverse cardiac events in patients who   
had previously suffered a non-Q-wave myocardial infarction (van Haelst et al., 2003)  
or who were diagnosed with hypertension but did not exhibit signs of obstructive    
CAD (Avanzas et al., 2004b). Likewise, higher serum neopterin levels in patients with 
chronic stable angina were associated with a higher risk of adverse cardiac events 
(Avanzas et al., 2005). This ability to predict disease progression in such patients was 
so strong that it remained significant even after adjusting for a range of other potential 
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risk factors, including the presence of complex lesions (Zouridakis et al., 2004). Serum 
neopterin levels were also shown to be predictive of mortality one year after the onset of 
critical limb ischemia in patients with peripheral atherosclerosis (Barani et al., 2005). 
 Although the above associations are all statistically significant, it should be noted 
that the differences in serum neopterin between the control and diseased groups are 
often relatively small. Concentrations may even overlap between the two groups, 
thereby reducing the effectiveness of neopterin as an efficient marker of disease activity 
when assessing individuals rather than populations. What these studies all clearly show, 
however, is the prominence of immune activation during atherosclerosis. By contrast, 
they provide no evidence either for or against an in vivo antioxidant action of 7,8-NP 
(the unoxidized form of neopterin). This is because the previous studies only measured 
pterin in the serum, but the nanomolar (or ng/ml) quantity detected here is, of course, 
likely to be highly diluted compared to neopterin at the original inflammatory site of 
formation. Such a distinction is important because the potential for 7,8-NP to act as an 
antioxidant in vivo will strongly depend upon its concentration at these sites of oxidant 
attack. Admittedly, one study did attempt to gain a more accurate idea of neopterin 
concentrations associated with stable CAD by collecting blood directly from the aortic 
root and coronary sinus (Tanaka et al., 2004). Levels remained in the ng/ml range and 
showed no correlation with disease severity when measured by either extension score or 
clinical score. However, the difference in neopterin levels between these two blood 
collection sites did correlate with atherosclerotic severity when measured by the Gensini 
score. Analysis by this means may therefore have permitted the detection of smaller 
concentration changes than the analysis of peripheral blood, as described for instance, 
by Schumacher et al. (1997). Nevertheless, it still failed to determine the actual 
concentration of neopterin within the local inflammatory environment of the plaque. 
This study also did not attempt to address the question of pterin and antioxidant activity. 
The current study has therefore investigated these issues by measuring total neopterin 
(neopterin plus 7,8-NP) in two inflammatory environments – pus removed from various 
sites of acute inflammation and plaque removed from the carotid artery. In an effort to 
identify any potential antioxidant activity of pterin, markers of oxidation were also 
monitored in each sample and analyzed for the existence of correlations with neopterin. 
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6.2 Results 
6.2.1 Pus 
The nineteen patients, eleven women and eight men, who consented to participate in 
this study had a mean age of 57.8 ± 4.0 years, and a median of 61 years (Table 6.1). All 
presented with symptoms of acute inflammation, though the exact location varied from 
one person to the next. Data regarding each patient’s medical history and prescriptions 
was limited. Nevertheless, the majority did not appear diabetic, with only the patients 
numbered 7 and 10 being listed as possibly diabetic while 11 and 17 were described as 
mildly diabetic (data not shown). It was also known that most patients were prescribed 
antibiotics prior to the removal of pus in an attempt to control any microbial growth at 
the site of inflammation.  
 
 
Table 6.1  General characteristics of patients with acute inflammation. 
Sample 
Number 
Sex Age Location of acute inflammation 
1 Female 89 Gall bladder 
2 Female 69 Anterior abdominal wall 
3 Male 48 Pararectal, lower pelvic region 
4 Male 73 Paracoli, lower pelvic region 
5 Male 68 Right hand side flank 
6 Female 41 Right hand side anterior plural space 
7 Female 24 Fistula/abscess right hand side 
8 Female 43 Gallbladder fossa 
9 Male 61 Peripancreatic 
10 Female 49 Paracoli region 
11 Male 51 Gallbladder fossa 
12 Male 44 Right hand side plural space 
13 Female 64 Pelvis 
14 Male 89 Abdominal cavity 
15 Male 53 Lower abdomen 
16 Female 62 Subphrenic 
17 Female 74 Pelvis 
18 Female 34 Left pelvis 
19 Female 62 Subphrenic 
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6.2.1.1 Neopterin in Pus 
Neopterin (including oxidized 7,8-NP) in the 19 samples of pus was found to range 
between 0.05µM and 1.28µM, with lower and upper quartile concentrations of 0.30µM 
and 0.69µM, respectively (Table 6.2). While individual neopterin levels for each  
patient are listed in Appendix I, a combined analysis of all patients produced a mean of 
0.51 ± 0.07µM neopterin (Table 6.2).  
 Classifying subjects by gender gave an average neopterin concentration of 0.54 ± 
0.07µM for females but 0.45 ± 0.14µM for males at these sites of acute inflammation 
(Figure 6.1). However, the slightly lower neopterin content associated with males was 
not statistically significant. Age also did not appear to be a major determinant of 
neopterin concentrations in the pus. A comparison of these two parameters yielded no 
significant correlation (Figure 6.2).  
 
 
Table 6.2  Statistics for markers of oxidation and inflammation in pus. 
The 19 pus samples were analyzed for PB-DOPA, dityrosine, carbonyls, TBARS, vitamin E and 
neopterin (including oxidized 7,8-NP). Averages and medians, as well as lower and upper quartiles, 
were subsequently calculated for each parameter. See Appendix I for a table showing concentration 
data for each patient. 
Parameter 
 
Mean ± SEM Median (Range) Lower & Upper 
Quartile 
PB-DOPA (µM) 
Dityrosine (µM) 
Carbonyls (µM) 
TBARS (µM) 
Vitamin E (µM) 
Neopterin (µM) 
15.24 ± 4.99 
1.84 ± 1.06 
197.4 ± 37.53 
3.29 ± 0.54 
23.07 ± 3.04 
0.51 ± 0.07 
7.22 (1.86 - 96.9) 
0.20 (0.00 - 19.28) 
164.7 (5.79 - 471.8) 
2.48 (0.81 – 10.06) 
21.89 (2.96 – 46.49) 
0.52 (0.05 – 1.28) 
4.16, 19.27 
0.09, 0.57 
44.07, 359.6 
1.22, 5.27 
11.27, 35.15 
0.30, 0.69 
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Figure 6.1  Effect of sex on neopterin levels at sites of acute inflammation. 
Pus was removed from eleven female patients and eight male patients at sites of acute inflammation 
and measured for neopterin (including oxidized 7,8-NP) via HPLC. 
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Figure 6.2  Effect of age on neopterin levels at sites of acute inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) via HPLC. Neopterin was subsequently compared against the age of 
each corresponding patient. 
 
 
Due to the clinical environment and the health of the patients, it was not possible to 
obtain blood samples for research purposes. However, Christchurch Hospital was able 
to provide data, for 14 of the 19 patients, describing macrophage and white cell numbers 
in the blood. These cells and neopterin are both generally regarded as markers of 
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immune activation. Despite this, no significant correlation was observed between 
neopterin in the pus and macrophage cell counts in the blood (Figure 6.3a). Pus 
neopterin did appear to increase as the concentration of white blood cells increased but, 
with r2=0.20 and p=0.096, this trend also failed to reach significance (Figure 6.3b).  
 
0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.5
1.0
1.5
2.0
2.5
(a)
Neopterin (µM)
M
ac
ro
ph
ag
e 
ce
ll 
co
un
t
(x
10
9 /
L)
 
0.0 0.2 0.4 0.6 0.8 1.0
0
5
10
15
20
25
Neopterin (µM)
W
hi
te
 c
el
l c
ou
nt
(x
10
9 /
L)
(b)
 
Figure 6.3  Relationship between blood cell count and neopterin at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) via HPLC. Blood screening by Christchurch Hospital provided counts 
of (a) macrophage numbers and (b) white cell numbers. 
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If 7,8-NP were to exhibit antioxidant activity at sites of inflammation, it is possible that 
correlations between its oxidation product (neopterin) and various markers of oxidative 
attack would be detectable in the pus. Hydroperoxides were not analyzed due to their 
lack of stability over prolonged periods (Fu et al., 1998) but several other protein 
oxidation products, including PB-DOPA (Figure 6.4), dityrosine (Figure 6.5) and 
carbonyls (Figure 6.6), were able to be monitored. Despite comparing neopterin 
concentrations against all three of these oxidized protein components, no relationship 
was detected. Likewise, the protein concentration in this inflammatory environment 
remained independent of the pus neopterin content (Figure 6.7).  
 Patient 2 possessed the highest concentrations of PB-DOPA, dityrosine and protein. 
However, even removing this outlier from the above analyses did not produce a 
significant association between neopterin and oxidized protein in pus (data not shown). 
 This lack of a correlation with neopterin also extended to TBARS, a lipid oxidation 
product (Figure 6.8). A comparison of TBARS and neopterin levels in the inflammatory 
material yielded a highly insignificant p=0.58 and r2=0.018.  
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Figure 6.4  Relationship between total neopterin and PB-DOPA at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) and PB-DOPA via HPLC.  
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Figure 6.5  Relationship between total neopterin and dityrosine at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) and dityrosine via HPLC.  
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Figure 6.6  Relationship between total neopterin and carbonyls at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) and protein carbonyls via HPLC and spectrophotometer, respectively.  
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Figure 6.7  Relationship between total neopterin and protein at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) and protein via HPLC and spectrophotometer.  
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Figure 6.8  Relationship between neopterin and lipid peroxidation at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) and TBARS via HPLC.  
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 By contrast, a trend between vitamin E and neopterin was identifiable. An increase 
in the pus content of one parameter tended to be associated with a rise in the pus content 
of the other (Figure 6.9a). However, this positive relationship only reached significance 
(p<0.05, r2=0.228) when expressing both vitamin E and neopterin per gram of pus 
protein (Figure 6.9b). 
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Figure 6.9  Relationship between neopterin and vitamin E at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for neopterin 
(including oxidized 7,8-NP) and vitamin E via HPLC. Data is expressed in (a) micromoles per litre 
or (b) micro/nano-moles per gram of protein. A trend line is included to illustrate the correlation. 
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 It should also be noted that vitamin E in the pus was associated with a                
mean concentration of 23.07 ± 3.04µM (Table 6.2). This represents a vitamin E       
level approximately 45 times larger than the corresponding neopterin average of       
0.51 ± 0.07µM. A similar concentration disparity was noted when expressing vitamin   
E and neopterin in moles per gram of protein or when comparing their median values.  
 
6.2.1.2 Comparisons Between Markers of Oxidation in Pus 
In addition to studying the relationships of the various oxidation markers with 
neopterin, it was also possible to investigate associations between the markers 
themselves. A direct comparison of median values for the three protein oxidation 
products revealed that, with a median concentration of 164.7µM and an interquartile 
range between 44.07-359.6µM, carbonyls were present at the highest concentration in 
pus (Table 6.2). PB-DOPA, by comparison, was approximately 23-fold lower and was 
associated with a median and interquartile range of only 7.22µM and 4.16-19.27µM, 
respectively. Dityrosine concentrations were generally even smaller, as shown by the 
median of only 0.20µM and an interquartile range of 0.09-0.57µM. 
 No difference between any of the oxidation parameters and age or gender was 
identified (data not shown), but nine other correlations were detected, while a tenth 
verged on significance. In the case of the latter, the pus protein content (in mg/ml) 
showed a tendency to increase as the micromolar quantity of carbonyls increased. This 
association produced a p value of exactly 0.05 and an r2 Pearson value of 0.22 (data not 
shown). The positive relationship between protein and markers of oxidation was more 
significant for micromolar quantities of PB-DOPA (Figure 6.10), dityrosine (Figure 
6.11) and even TBARS (Figure 6.12). These correlations were strongest for the products 
of protein oxidation, with p<0.001 for both PB-DOPA and dityrosine, and an r2 of 0.821 
and 0.718, respectively. In comparison, TBARS and protein concentrations at the site of 
acute inflammation were significantly associated only by p<0.01 and r2=0.378. Patient 2 
had a strong effect on the above correlations, and significance was lost if this patient’s 
data was removed from analysis (data not shown). 
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Figure 6.10  Correlation between PB-DOPA and protein at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for PB-DOPA and 
protein via HPLC and spectrophotometer, respectively. A trend line is included to illustrate the 
correlation. 
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Figure 6.11  Correlation between dityrosine and protein at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for dityrosine and 
protein via HPLC and spectrophotometer, respectively. A trend line is included to illustrate the 
correlation. 
 
 
 Neopterin and Markers of Oxidation in Inflammatory Environments 189 
  
0 2 4 6 8 10 12
0
50
100
150
200
250
TBARS (µM)
Pr
ot
ei
n 
(m
g/
m
l)
r2=0.378
p<0.01
 
Figure 6.12  Correlation between TBARS and protein at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for TBARS and 
protein via HPLC and spectrophotometer, respectively. A trend line is included to illustrate the 
correlation. 
 
 
 A significant correlation was also apparent between PB-DOPA and dityrosine,      
the two tyrosine oxidation products. With a p<0.001 and r2=0.66, the increase in pus-
associated dityrosine was determined to be proportional to the increase in pus-
associated PB-DOPA (Figure 6.13).  
 Each of the tyrosine oxidation products were, likewise, positively associated with 
the lipid peroxidation marker, TBARS. The relationship between PB-DOPA and 
TBARS was strongest, as verified by p<0.01 and r2=0.443 (Figure 6.14). Nevertheless, 
a statistical comparison of dityrosine and TBARS revealed an association that was also 
significant, with p<0.05 and r2=0.307 (Figure 6.15).  
 It should be noted, however, that the three correlations between PB-DOPA, 
dityrosine and TBARS all lost significance if the outlier from patient 2, corresponding 
to 96.90µM PB-DOPA, 19.28µM dityrosine and 10.06µM TBARS, was removed from 
analysis (data not shown). Significance was also lost if the data was compared on a 
mole per gram of protein basis (data not shown). 
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Figure 6.13  Correlation between PB-DOPA and dityrosine at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for PB-DOPA and 
dityrosine via HPLC. A trend line is included to illustrate the correlation. 
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Figure 6.14  Correlation between TBARS and PB-DOPA at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for TBARS and   
PB-DOPA via HPLC. A trend line is included to illustrate the correlation. 
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Figure 6.15  Correlation between TBARS and dityrosine at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for TBARS and 
dityrosine via HPLC. A trend line is included to illustrate the correlation. 
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Figure 6.16  Correlation between TBARS and vitamin E at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for TBARS and 
vitamin E via HPLC. A trend line is included to illustrate the correlation. 
 
 
 In contrast to the lack of association with neopterin, a couple of oxidation markers 
were shown to correlate negatively with vitamin E. In particular, the TBARS (Figure 
6.16) and PB-DOPA (Figure 6.17a) concentrations both decreased as the quantity of 
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vitamin E increased. Statistical analysis gave p< 0.05 and r2=0.212 for each correlation. 
Once again, the relationship lost significance if the data for patient 2 was excluded from 
analysis (data not shown). The correlation between PB-DOPA and vitamin E could be 
regained, even in the presence of patient 2, after normalizing PB-DOPA against the 
protein content of pus (p<0.05, r2=0.230; Figure 6.17b). 
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Figure 6.17  Correlation between PB-DOPA and vitamin E at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for PB-DOPA and 
vitamin E via HPLC. Vitamin E is expressed in micromoles per litre while PB-DOPA is expressed in 
(a) micromoles per litre or (b) nanomoles per gram of protein. A trend line is included to illustrate 
the correlation. 
 Neopterin and Markers of Oxidation in Inflammatory Environments 193 
  
 Vitamin E could also be correlated to the carbonyl level in the inflammatory 
material, with statistical analysis producing a p<0.01 and r2=0.492 (Figure 6.18). This 
association was unexpectedly observed to be positive, and it remained so, even when 
data was expressed in moles per gram of protein (data not shown).  
 It should be noted that patient two was not included in the carbonyl analysis. When 
spectrophotometrically detecting carbonyl in the pus from this patient, values smaller 
than the baseline absorbance were consistently recorded. 
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Figure 6.18  Correlation between vitamin E and carbonyls at sites of acute 
inflammation. 
Pus was removed from 19 patients at sites of acute inflammation and measured for vitamin E and 
protein carbonyls via HPLC and spectrophotometer, respectively. A trend line is included to 
illustrate the correlation. 
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6.2.2 Plaque 
Plaque was removed from the carotid artery of two patients as part of a pilot study 
aiming to monitor neopterin levels throughout this chronic inflammatory environment. 
Each plaque was therefore subsequently divided into six or seven sections, with each 
piece being analyzed for the presence of neopterin and a range of oxidation markers. 
 The two patients enrolled in this pilot study were both men in their early eighties 
(Table 6.3). Neither was diabetic, both were ex-smokers, but only patient 2 was listed as 
hypertensive. The reported degree of stenosis also differed between the two patients, 
with the first scoring 80% and the second 60-69% when judged by ultrasound. 
Conversely, an inspection of the cross-sections photographed after plaque dissection 
suggested that the carotid artery from patient 1 generally contained less gruel than 
patient 2 (Figure 6.19 & Figure 6.29). Only the last section, number six, appeared 
significantly stenosed in patient 1 while all seven sections of patient 2 were filled with 
gruel. 
 As expected for heart patients, both were prescribed aspirin (Table 6.3). The first 
was also prescribed a drug to treat ulcers and/or gastroesophageal reflux (Omeprazole) 
while the second was prescribed a loop diuretic drug (Frusemide), a hypertensive drug 
(Losartan) and an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) 
reductase (Atorvastatin). 
 
 
Table 6.3  Characteristics of two carotid endarterectomy patients. 
 Patient 1 Patient 2 
Sex Male Male 
Age (years) 80 83 
Smoking Habit Ex-smoker Ex-smoker 
Hypertension No Yes 
Diabetic 
Extent of stenosis 
No 
80% 
No 
60-69% 
Symptoms Stroke,  
Amaurosis fugax 
Amaurosis fugax 
Medication Aspirin, 
Omeprazole 
Aspirin, 
Atorvastatin, 
Frusemide, 
Losartan 
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6.2.2.1 Trends in the Carotid Plaque from Patient 1 
Approximately 28mm of plaque was removed from the right internal carotid artery      
of patient 1 (Figure 6.19). The subsequent dissection created six sections, each 
representing 4-5mm of the plaque length and 0.05-0.328g of plaque weight. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.19  Cross-sections of the internal carotid artery from patient 1. 
The (a) right internal carotid artery was removed from patient 1 and dissected into six segments, 
labelled (b) section one, (c) section two, (d) section three, (e) section four, (f) section five (left) and 
section six (right). This latter section represents the site proximal to the bifurcation. 
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i) Neopterin 
When calculated across all sections, neopterin (including oxidized 7,8-NP) in plaque 1 
averaged a concentration of 0.19 ± 0.10 nmole/g plaque (Figure 6.20). However, with 
five of the six sections ranging only between 0.06 and 0.12 nmole/g plaque, the median 
was restricted to 0.09 nmole/g plaque. This does not detract from the existence of a 
spike in section four, corresponding to a neopterin content of 0.71nmole/g plaque. 
Given a plaque density of approximately 1g/ml, this equates to a peak molar 
concentration of 0.71µM neopterin. 
 Three examples of HPLC neopterin traces for plaque 1 are displayed in Figure 6.21. 
As the standard eluted at 5.158 minutes (data not shown), peak number four 
corresponds to the neopterin in sections three (Figure 6.21a) and four (Figure 6.21b) 
while peak number three corresponds to the neopterin in section five (Figure 6.21c). 
These traces further highlight the large neopterin peak detected in section four 
compared to the significantly lower quantity of neopterin in the surrounding sections. 
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Figure 6.20  Concentration of neopterin in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by HPLC 
for neopterin (including oxidized 7,8-NP). Results are displayed as mean ± SEM of triplicates. 
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1 3.225 3024 
2 4.000 16525 
3 4.967 3702 
4 5.167 6588 
5 8.483 3330 
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Time 
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1 3.225 2845 
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 (c) 
 
Peak 
# 
Retention 
Time 
Area 
1 4.017 33671 
2 4.983 6995 
3 5.150 7706 
4 8.467 4431 
5 10.533 2980 
 
 
 
 
 
 
 
 
 
Figure 6.21  HPLC neopterin traces representative of three sections in plaque 1.  
Homogenized plaque was incubated with TCA and acidic iodine. Neopterin (including oxidized   
7,8-NP) was subsequently detected via HPLC, using excitation and emission wavelengths of 353nm 
and 438nm, respectively, and a mobile phase of 20mM ammonium phosphate (pH 6) with 5% 
methanol. HPLC neopterin traces are presented for (a) section three, (b) section four and (c) section 
five of plaque 1. The peaks corresponding to neopterin occur at (a) peak four, (b) peak four and     
(c) peak three. 
 
 
ii) Protein and Cholesterol 
Protein concentrations per gram of plaque did not vary significantly throughout the first 
five sections of plaque 1 (Figure 6.22). Section six, however, was associated with a 
significant (p<0.001) increase to 117 ± 2.56 mg/g plaque. This represented a jump of 
more than 50% when compared to the protein content in the preceding plaque section. 
 Cholesterol levels, by contrast, showed a gradual rise that finally reached 
significance (p<0.01) from section one by section four (Figure 6.23). This was followed 
by a dramatic 2.3-fold increase in the cholesterol content, at section five, to 76.13 ± 2.68 
µmole/g plaque (p<0.001). A subsequent, and significant, drop to 49.61 ± 2.15 µmole/g 
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plaque (p<0.001) nevertheless remained elevated compared to the first four sections 
(p<0.001 against sections one to three but p<0.01 against section four). 
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Figure 6.22  Concentration of protein in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by the 
BCA protein determination kit for protein. Results are displayed as mean ± SEM of triplicates. 
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Figure 6.23  Concentration of cholesterol in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by 
spectrophotometer for cholesterol. Results are displayed as mean ± SEM of triplicates. 
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iii) Markers of Oxidation 
PB-DOPA levels throughout the six sections of plaque 1 displayed no obvious trend, 
and this remained the case whether expressing protein oxidation in nmoles per gram of 
plaque (Figure 6.24) or nmoles per gram of protein (data not shown). In fact, the 13.48 
± 1.63nmole/g plaque concentration recorded for section one differed significantly only 
from the PB-DOPA content of section two (p<0.05).  
 Excluding section two, all other segments of plaque 1 were found to contain 
detectable quantities of dityrosine (Figure 6.25). Dityrosine concentrations were, 
however, consistently lower than the level of PB-DOPA associated with each respective 
section of plaque (Figure 6.24 & Figure 6.25). In further contrast to PB-DOPA, a 
dityrosine trend was noted. Levels began to increase significantly in the final two 
segments (p<0.001), peaking at 1.29 ± 0.03 nmoles of dityrosine per gram of plaque in 
section six. 
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Figure 6.24  Concentration of PB-DOPA in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by HPLC 
for PB-DOPA. Results are displayed as mean ± SEM of triplicates. 
 
 
 Carbonyls, like dityrosine, did not represent a significant component of section 2 
(Figure 6.26). Excluding this segment, carbonyls showed a general tendency to   
increase along the length of the plaque. A significant elevation above the first segment 
was therefore finally attained in section five, at the maximum concentration of 301.8 ± 
23.15 nmole/g plaque (p<0.05). The subsequent, dramatic decrease (p<0.001) observed 
for section six resulted in a carbonyl content that was lower, but not significantly 
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different, from the section one carbonyl concentration. Despite this drop, carbonyls 
remained more numerous than the PB-DOPA in each of the six sections analyzed 
(Figure 6.24 & Figure 6.26). This difference lacked significance only for the second 
segment of plaque 1. 
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Figure 6.25  Concentration of dityrosine in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by HPLC 
for dityrosine. Results are displayed as mean ± SEM of triplicates. 
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Figure 6.26  Concentration of carbonyls in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by 
spectrophotometer for protein carbonyls. Results are displayed as mean ± SEM of triplicates. 
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 Any trends observed along the atherosclerotic lesion, when measuring the protein 
oxidation products per gram of plaque, remained even after expressing these oxidation 
markers per gram of protein. By contrast, the trends for TBARS and vitamin E appeared 
to depend on the mode of data expression, with variation existing between per gram of 
plaque and per mole of cholesterol analyses. Both normalizations have therefore been 
used to present the TBARS and vitamin E results for plaque 1 and plaque 2. 
 TBARS concentrations in the six sections of plaque 1 only increased significantly 
(p<0.001) in the final two segments when expressing data per gram of plaque (Figure 
6.27a). This resulted in peak TBARS concentrations of 8.77 ± 0.57 nmoles/g plaque and 
8.39 ± 0.32 nmoles/g plaque for sections five and six, respectively. However, when 
compared on a micromole per mole of cholesterol basis, section one was associated with 
the highest TBARS concentration and differed significantly (p<0.001) from all other 
sections (Figure 6.27b). The subsequent decrease was only reversed to a significant 
extent at section five (p<0.01), with a further increase at section six (p<0.001) to a 
concentration that represented 77% of the TBARS content in the first segment. 
 When expressed per gram of plaque, the trend for vitamin E across the six sections 
of plaque 1 displayed similarity with the pattern of cholesterol deposition (Figure 6.23 
& Figure 6.28a). A slow rise in the content of vitamin E reached significance only at 
section four (p<0.001) and was followed by a 1.9-fold increase, to 47.31 ± 0.81 nmole/g 
plaque, in section five (p<0.001). The subsequent decrease in vitamin E at section six 
(p<0.001), nevertheless, remained significantly higher than the concentrations of 
vitamin E in the first three sections (p<0.001) and even in section four (p<0.01).  
 Given the similarity between the cholesterol and vitamin E trends, this latter pattern 
largely disappeared when expressing vitamin E per mole of cholesterol (Figure 6.28b). 
Though not significant, the first three sections now showed a tendency to decrease. 
Furthermore, the segment containing the highest quantity of vitamin E per mole of 
cholesterol was identified as section four, while sections five and six were no longer 
significantly different from section one or each other. 
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Figure 6.27  Concentration of TBARS in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by HPLC 
for TBARS. Data is expressed as (a) nanomoles per gram of plaque and (b) micromoles per mole of 
cholesterol. Results are displayed as mean ± SEM of triplicates. 
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Figure 6.28  Concentration of vitamin E in six sections of plaque 1. 
After dissecting the right internal carotid artery into six sections, each piece was analyzed by HPLC 
for vitamin E. Data is expressed as (a) nanomoles per gram of plaque and (b) micromoles per mole 
of cholesterol. Results are displayed as mean ± SEM of triplicates. 
 
 
6.2.2.2 Trends in the Carotid Plaque from Patient 2 
Approximately 39mm of plaque was removed from the right internal carotid artery of 
patient 2 (Figure 6.29). As this was larger than the plaque from patient 1, it was divided 
into seven sections, each representing 5-6mm of the plaque length and 0.268-0.654g of 
plaque weight.  
 Neopterin and Markers of Oxidation in Inflammatory Environments 205 
  
 Similar to plaque 1, parameters of oxidation and neopterin production were once 
again investigated. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.29  Cross-sections of the internal carotid artery from patient 2. 
The (a) right internal carotid artery was removed from patient 2 and dissected into seven segments, 
labelled (b) section one, (c) section two, (d) section three, (e) section four, (f) section five,              
(g) section six (left) and section seven (right). The sixth section includes the bifurcation. 
(a) (b)
(c) (d)
(e) (f)
(g) 
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i) Neopterin 
When evaluated across all sections, the neopterin (including oxidized 7,8-NP) in   
plaque 2 averaged 0.19 ± 0.02 nmole/g plaque (Figure 6.30). Although a similar mean 
was calculated for plaque 1 (Figure 6.20), the seven segments of plaque 2 were 
associated with a significantly smaller range of neopterin concentrations. This range 
varied only between 0.14-0.27 nmole/g plaque rather than 0.06-0.71 nmole/g plaque.  
 Neopterin peaked in section two of plaque 2 and, given a plaque density of 
approximately 1g/ml, the 0.27 nmole/g plaque concentration would therefore equate to a 
molar value of 0.27µM. The subsequent decline in neopterin levels extended to section 
six before rising again in section seven. However, the neopterin in this last segment still 
remained significantly below the peak concentration detected in section two (p<0.001). 
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Figure 6.30  Concentration of neopterin in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each section was analyzed        
by HPLC for neopterin (including oxidized 7,8-NP). Results are displayed as mean ± SEM of 
triplicates.  
 
 
ii) Protein and Cholesterol 
Protein appeared to be distributed along plaque 2 in a pattern similar to the one 
observed for neopterin (Figure 6.31). In the case of protein, however, the second rise 
was not as pronounced. Section seven was still significantly higher than the preceding 
segment (p<0.05) but was of a concentration more comparable to the protein content    
in section five rather than section one. Nevertheless, the peak protein concentration    
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(97.13 ± 2.24 mg/g plaque) remained associated with section two and also remained 
significantly elevated compared to all other regions of the plaque (p<0.001). 
 The similar distribution patterns for neopterin and protein ensured that, when 
expressed per gram of protein, the neopterin trend largely disappeared (data not shown). 
Section seven continued to be elevated (p<0.001) but all others, including section two, 
showed only minor differences in concentration from the first segment of the plaque. 
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Figure 6.31  Concentration of protein in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each section was analyzed by the 
BCA protein determination kit for protein. Results are displayed as mean ± SEM of triplicates. 
 
 
 Cholesterol was highest in section one (p<0.001) and then proceeded to 
progressively decline in all remaining segments (Figure 6.32). Thus, concentrations 
ranged from a peak of 173.9 ± 9.00 µmole/g plaque in section one to a low of         
24.51 ± 1.16 µmole/g plaque by section seven. It is interesting to note that this low was, 
nevertheless, at a comparable level to the cholesterol concentration in four of the six 
sections of plaque 1 (Figure 6.23).  
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Figure 6.32  Concentration of cholesterol in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each piece was analyzed by 
spectrophotometer for cholesterol. Results are displayed as mean ± SEM of triplicates. 
 
 
 
iii) Markers of Oxidation 
The PB-DOPA in plaque 2 displayed a tendency to decrease from the peak 
concentration, of 15.16 ± 0.43 nmole/g plaque, in section one (Figure 6.33). By section 
four, this gradual decline had reached significance (p<0.01), contrasting with the lack of 
any obvious PB-DOPA trend for plaque 1 (Figure 6.24). One exception to this general 
pattern of reduction was noted in the penultimate section of plaque 2, with a brief 
increase in PB-DOPA that was lower than, though not significantly different from, the 
peak concentration in section one.  
 While PB-DOPA levels were dropping, dityrosine increased significantly (p<0.001)      
in the first three segments of plaque 2 (Figure 6.34). The peak concentration of       
14.64 ± 0.53 nmole/g plaque in section three then dropped dramatically (p<0.001) and 
this decline continued, ultimately resulting in a concentration of 0.49 ± 0.09 nmole/g 
plaque in section seven. Interestingly, four of the six sections of plaque 1 actually 
possessed a smaller amount of dityrosine than the minimum quantity detected in   
plaque 2 (Figure 6.25). 
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Figure 6.33  Concentration of PB-DOPA in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each piece was analyzed by 
HPLC for PB-DOPA. Results are displayed as mean ± SEM of triplicates. 
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Figure 6.34  Concentration of dityrosine in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each piece was analyzed by 
HPLC for dityrosine. Results are displayed as mean ± SEM of triplicates. 
 
 
 Carbonyls were a more abundant protein oxidation product in each section of  
plaque 2 when compared to PB-DOPA and dityrosine (Figure 6.33 to Figure 6.35). The 
carbonyls of plaque 2 were also generally more concentrated than the carbonyls           
of plaque 1 (Figure 6.26 & Figure 6.35). Four of the six sections from the first plaque 
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were found to contain less than the minimum plaque 2 carbonyl concentration of    
217.1 ± 21.70 nmole/g plaque. 
 Although the carbonyl concentration increased and decreased a couple times along 
the length of plaque 2, no strong trend was apparent (Figure 6.35). Indeed, the final 
three sections possessed levels of carbonyls that were not significantly altered from the 
first segment. Even expressing carbonyls in micromoles per gram of protein failed to 
introduce any clearly identifiable pattern of distribution (data not shown).  
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Figure 6.35  Concentration of carbonyls in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each piece was analyzed by 
spectrophotometer for protein carbonyls. Results are displayed as mean ± SEM of triplicates. 
 
 
 TBARS were found to be most concentrated in the first two sections of plaque 2 
when expressing the data per gram of plaque (Figure 6.36a). The subsequent decline 
from this peak of 6-7 nmole/g plaque extended to section six before rising slightly again 
in section seven. Although this final increase was significant compared to the preceding 
section (p<0.001), it nevertheless produced a concentration that represented only 42% 
of the peak TBARS level. Such a pattern contrasts with plaque 1, which contained the 
highest quantity of TBARS in its final two sections (Figure 6.27a). This trend for plaque 
2 also contrasts with the results obtained after normalizing all TBARS data against 
cholesterol (Figure 6.36b). In this case, levels remained low throughout the first six 
sections but increased by 2.7-fold in section seven (p<0.001). 
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Figure 6.36  Concentration of TBARS in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each piece was analyzed by 
HPLC for TBARS. Data is expressed as (a) nanomoles per gram of plaque and (b) micromoles per 
mole of cholesterol. Results are displayed as mean ± SEM of triplicates. 
 
 
 While plaque 1 was associated with no obvious pattern of vitamin E distribution 
after normalization against cholesterol (Figure 6.28b), this lack of trend was only noted 
in plaque 2 when expressing the antioxidant in nanomoles per gram of plaque (Figure 
6.37a). Although the final segment was lower than sections two and four (p<0.001), it 
was not significantly different from the remaining four sections. A trend did appear, 
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however, when expressing the vitamin E of plaque 2 in micromoles per mole of 
cholesterol (Figure 6.37b). This data analysis revealed a general tendency for the 
vitamin E to increase along the length of the plaque and is similar to the distribution of 
vitamin E in plaque 1 when measured on a per gram of plaque, but not on a per mole of 
cholesterol, basis (Figure 6.28).  
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Figure 6.37  Concentration of vitamin E in seven sections of plaque 2. 
After dissecting the right internal carotid artery into seven sections, each piece was analyzed by 
HPLC for vitamin E. Data is expressed as (a) nanomoles per gram of plaque and (b) micromoles per 
mole of cholesterol. Results are displayed as mean ± SEM of triplicates. 
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6.2.2.3 Preliminary Correlations Between Markers of Oxidation and 
Inflammation Along the Length of the Carotid Plaque 
This investigation ultimately aims to compare and identify patterns along the length of 
the plaques and also between the various oxidation parameters. Although the current 
pilot study is too small to permit such trends and correlations to be identified 
conclusively, a few initial associations have been highlighted in Table 6.4. It should be 
noted, however, that these correlations appeared to differ between the two patients and 
to differ, yet again, once the data from both patients was combined. Only the 
dityrosine/protein and cholesterol/TBARS relationships were common to the two 
plaques but even these disappeared during an analysis of the pooled plaque data.  
 The correlations in Table 6.4 were identified using data expressed per gram of 
plaque. When analyzed on a per protein or per cholesterol basis, many of the Table 6.4 
associations were lost and new ones appeared (data not shown). However, given the 
small sample size in this pilot study, these preliminary correlations will not be further 
discussed. 
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Table 6.4  Correlations between markers of oxidation and inflammation along the 
length of plaque. 
Plaque samples from patient 1 and patient 2 were cut into six and seven sections, respectively. Each 
piece was then analyzed for the content of neopterin, protein, cholesterol, PB-DOPA, dityrosine, 
carbonyls, TBARS and vitamin E. Relationships between these parameters were subsequently 
investigated for each individual patient and for the two patients combined, with the data expressed as 
per gram of plaque. All the listed associations are positive and significant, though the level of 
significance may vary and is indicated by * for p<0.05; ** for p<0.01; or *** for p<0.001.  
Correlation p value r2 (Pearson) 
Patient 1 
Dityrosine vs. Protein 
Dityrosine vs TBARS 
Cholesterol vs. TBARS 
Cholesterol vs Vitamin E 
TBARS vs. Vitamin E 
 
Patient 2 
Neopterin vs. Protein 
Neopterin vs. TBARS 
Carbonyl vs. Vitamin E 
PB-DOPA vs Cholesterol 
Dityrosine vs. Protein 
Protein vs. Cholesterol 
Protein vs. TBARS 
Cholesterol vs. TBARS 
 
Combined Patient Data 
Carbonyl vs. Cholesterol 
Carbonyl vs. Vitamin E 
Dityrosine vs. Cholesterol 
Protein vs. TBARS 
Cholesterol vs. Vitamin E 
TBARS vs. Vitamin E 
 
0.019 (*) 
0.023 (*) 
0.025 (*) 
0.001 (**) 
0.029 (*) 
 
 
0.025 (*) 
0.008 (**) 
0.041 (*) 
0.016 (*) 
0.005 (**) 
0.028 (*) 
0.020 (*) 
0.036 (*) 
 
 
0.042 (*) 
0.008 (**) 
0.001 (**) 
0.003 (**) 
0.018 (*) 
0.027 (*) 
 
0.782 
0.762 
0.752 
0.946 
0.737 
 
 
0.668 
0.784 
0.601 
0.718 
0.816 
0.655 
0.696 
0.619 
 
 
0.325 
0.489 
0.627 
0.569 
0.415 
0.372 
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6.3 Discussion 
6.3.1 Neopterin in Pus 
The pus removed from sites of inflammation predominantly constitutes cellular debris, 
leukocytes and plasma infiltrate (Dox et al., 1993). As such, this inflammatory material 
is expected to contain significantly higher concentrations of pterin than serum or urine. 
Healthy people are generally associated with levels of serum neopterin below 10nM 
(Tatzber et al., 1991) while people suffering from infections or various inflammatory 
diseases may contain slightly, though significantly, elevated serum neopterin 
concentrations. In some cases this elevation can be quite pronounced, with quantities 
reaching 0.1µM neopterin in the serum of one or two HIV (Fuchs et al., 1994) and 
atherosclerosis (Tatzber et al., 1991) patients. By contrast, the neopterin in pus averaged 
a concentration of 0.51 ± 0.07µM (Table 6.2), thereby confirming that levels are 
generally higher at the site of inflammation than in serum. Furthermore, the peak 
concentration in this inflammatory material, of 1.28µM neopterin, falls within a range 
comparable to the concentrations of 7,8-NP required to delay copper- and THP-1 
monocyte-mediated LDL oxidation (Gieseg et al., 1995; Gieseg & Cato, 2003). It 
remains possible that microenvironments may exist in the inflammatory material and 
that these may be associated with even higher levels of neopterin.  
 
While one study detected no significant gender difference in serum neopterin (Maloney 
et al., 1997), several others have noted an increased concentration in females compared 
to males (Weiss et al., 1994; Garcia-Moll et al., 2000a). This gender distinction 
remained whether investigating neopterin in healthy subjects or CAD patients. The 
apparent discrepancy with the first study may simply be due to differences in sample 
size. Maloney et al. (1997) analyzed 135 healthy subjects but the equivalent subset in 
the Weiss et al. (1994) study contained 240 people. Sample size may also account for 
the fact that, although a trend towards higher neopterin concentrations in female pus 
was identified, it failed to reach significance (Figure 6.1).  
 Like gender, age has also been suggested to affect the quantity of neopterin in 
serum. Indeed, the positive correlation identified between these two parameters was 
noted in sample groups ranging from insulin-resistant subjects and CAD patients to 
healthy individuals (Ledochowski et al., 1999; Schennach et al., 2002; Tanaka et al., 
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2004; Avanzas et al., 2005; Murr et al., 2005). By contrast, one study of 135 healthy 
people (Maloney et al., 1997) and another using 37 haemodialysis patients (Erten et al., 
2005), failed to detect any association between serum neopterin and age. Likewise, 
neopterin did not appear to significantly increase with age in the 19 pus samples 
analyzed (Figure 6.2). While these apparent discrepancies may be caused by limitations 
in the sample size, the age range of the subjects should also be taken into account. It has 
been suggested that serum neopterin may not increase much between the ages of 18 and 
75, but it is significantly lower in this age group than in people aged over 75 years 
(Hamerlinck, 1999). Given that only two of the pus samples were removed from 
patients older than 75, such differences would not have been adequately highlighted in 
the current study. A further point of consideration regards the theory that neopterin 
levels become elevated as people age due to the development of underlying, and 
unidentified, inflammatory disease processes (Ledochowski et al., 1999; Murr et al., 
2005). As neopterin in the blood is derived from multiple sources, this elevation would 
ultimately be detectable in the serum. By contrast, the pus neopterin measured in the 
current study is produced at a local site of inflammation. It is therefore not likely to be 
affected by the more distant inflammatory events associated with aging. 
 Neopterin is often considered to be a marker of immune activation, raising the 
possibility of a correlation between this pteridine and either macrophages or white   
cells in the bloodstream. Such associations were not significant in the current study 
(Figure 6.3). Nevertheless, a positive trend between neopterin in the pus and white cells 
in the blood was noted, and appeared to be approaching significance (p=0.096). Given a 
sample size larger than 19, a significant correlation may therefore have been detectable. 
Others have tried to identify similar correlations when monitoring serum neopterin. One 
study, involving 50 patients with unstable angina, failed to detect any relationship 
between these parameters (Garcia-Moll et al., 2000a). Meanwhile, another group 
investigated individuals with truncal obesity and did observe a positive correlation 
between serum neopterin and leukocyte levels in the blood (Bozdemir et al., 2006). 
 Numerous studies have investigated the existence of additional associations with 
neopterin. For instance, body mass index (Ledochowski et al., 1999; Bozdemir et al., 
2006), immune activation and metabolism (Erren et al., 1999) and the severity/extent of 
various diseases or infections (Hamerlinck, 1999; Hoffmann et al., 2003) have all been 
monitored against serum neopterin. However, none have attempted to identify the 
relationship between markers of oxidation and neopterin at the site of inflammation.   
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An attempt to remedy this lack of knowledge by analyzing pus revealed that neopterin 
did not exhibit any significant association with either protein content (Figure 6.7) or 
products of protein oxidation (Figure 6.4 to Figure 6.6). Likewise, no correlation was 
detectable between neopterin and a lipid oxidation product like TBARS (Figure 6.8). 
These findings do not provide support for pterins serving as antioxidants at sites of 
acute inflammation. The absence of such correlations could certainly be explained by 
the relationships never existing. Alternatively, the correlations may have been present 
during early stages of inflammation but been subsequently overwhelmed during the 
advanced stages when the pus was finally removed. 
 In contrast to the lack of correlation between neopterin and markers of lipid and 
protein oxidation, an association was able to be identified with vitamin E (Figure 6.9). 
However, even this was only significant when both parameters were expressed relative 
to protein rather than on a molar basis. The reason for this positive association with a 
well-known antioxidant is not known, but it is tempting to speculate that both may be 
fulfilling a similar function in vivo. Nevertheless, it should be noted that the average 
neopterin concentration in the pus of 0.51 ± 0.07µM is significantly lower than the 
average vitamin E concentration of 23.07 ± 3.04µM (Table 6.2). Both compounds are 
suggested to scavenge peroxyl radicals at a comparable rate (Oettl et al., 1997). 
Neopterin would therefore need to act at a different site, or be significantly elevated in a 
microenvironment, if it were to play any significant antioxidant role compared to 
vitamin E in the inflammatory surroundings of pus. Neither possibility was able to be 
investigated in the pus due to the method of isolation and subsequent homogenization of 
this inflammatory material. 
 
6.3.2 Comparisons Between Markers of Oxidation in Pus 
PB-DOPA, dityrosine, protein carbonyls, TBARS and vitamin E were all shown to be 
components of pus. Potential relationships between these different oxidation parameters 
could therefore be investigated. An increase in protein and lipid oxidation products was 
associated with increased pus protein content (Figure 6.10 to Figure 6.12). Thus, as 
expected, the concentration of inflammatory material strongly influences the extent of 
oxidation detected in the pus. 
 A positive relationship between PB-DOPA and dityrosine arises as a consequence of 
their common source of origin (Figure 6.13). Both are products of tyrosine oxidation, 
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with PB-DOPA generated via hydroxylation of a single tyrosine residue and dityrosine 
formed by the cross-linkage of two tyrosyl radicals (Davies et al., 1999). Compared to 
PB-DOPA, the production of dityrosine is therefore more dependent on the rate of 
radical attack. It also requires two tyrosine residues to reside in close proximity. These 
limitations explain why PB-DOPA predominates over dityrosine in pus (Table 6.2) and 
in other inflammatory environments, including atherosclerotic plaque (section 6.3.4; Fu 
et al., 1998; Woods et al., 2003).  
 PB-DOPA is clearly a more common product of oxidation than dityrosine but is, 
conversely, significantly less abundant than protein carbonyls. Carbonyls in the pus 
were, on average, 10-20 times more concentrated than PB-DOPA (Table 6.2). Unlike 
the two markers of tyrosine oxidation, carbonyls are often present as native components 
of protein, and their formation under oxidative conditions is not restricted to a single 
amino acid (Dalle-Donne et al., 2003). Lipid- and sugar-derived aldehydes/ketones are 
also suggested to contribute to the total concentration of protein-associated carbonyls  
by binding to this protein substrate in secondary reactions (Burcham & Kuhan, 1996; 
Davies et al., 1999). 
 PB-DOPA and dityrosine not only correlated with each other in the inflammatory 
environment of the pus but also both shared a relationship with TBARS (Figure 6.14 & 
Figure 6.15). Thus, the increase in oxidative damage to protein appears to be paralleled 
by an increase in lipid peroxidation. It is important to note, however, that these 
relationships are strongly dependent on the protein content of the pus. When PB-DOPA, 
dityrosine and TBARS were expressed relative to protein, all correlations disappeared 
(data not shown). These correlations also lost significance if the outlier attributed to 
patient 2 was removed from analysis. While this does raise concerns regarding the 
strength of the above associations, these findings can still be considered to provide a 
useful starting point for further studies.  
 
In direct contrast to the lack of a relationship between the putative pterin antioxidant 
and oxidized protein or lipid, vitamin E was confirmed to negatively correlate with both 
PB-DOPA and TBARS (Figure 6.16 & Figure 6.17). Although vitamin E is a lipid 
soluble antioxidant, and might therefore be expected to inhibit the formation of TBARS 
more effectively than PB-DOPA, these two associations were actually of a similar 
strength (p<0.05, r2=0.212). Consequently, the potential exists for lipid-derived radicals 
to participate in the generation of PB-DOPA and for the vitamin E to scavenge these 
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radicals and, thus, prevent TBARS as well as PB-DOPA from being produced. A 
similar theory of PB-DOPA formation was proposed to explain the close correlation 
observed between this tyrosine oxidation product and the generation of conjugated 
dienes during AAPH-mediated LDL oxidation (Gieseg et al., 2003). Further support for 
this theory cannot be gained from the current study. As discussed above, a positive 
association between TBARS and PB-DOPA, that was independent of the protein 
content in pus, could not be confirmed.  
 Although vitamin E was negatively associated with the concentration of TBARS 
and PB-DOPA, this was not the case for the other oxidation markers analyzed in pus. 
The lack of a correlation between vitamin E and dityrosine may simply be due to this 
oxidation product being generated independently of the lipid-derived radicals that the 
antioxidant scavenges. Furthermore, dityrosine was generally present only at low levels 
in the pus (interquartile range of 0.09-0.57µM), and this would have severely limited 
any opportunity to observe such a correlation during the analysis of only 19 subjects.  
 The relationship between vitamin E and protein carbonyls was neither neutral nor 
negative but, unexpectedly, positive (Figure 6.18). It has been suggested that, in the 
presence of a sufficiently low radical flux, vitamin E can actually exhibit pro-oxidant 
activities (Bowry et al., 1992; Neuzil et al., 1997). Although this would certainly 
explain the positive association between vitamin E and carbonyls, the negative 
correlations with TBARS and PB-DOPA suggest that a pro-oxidant function for vitamin 
E is not a general feature of the current study. Carbonyls are not simply markers of 
oxidation but also native components of protein. However, the correlation between 
carbonyls and vitamin E could not be accounted for by an increase in the protein content 
of pus. The relationship remained both positive and significant even when carbonyls 
and/or vitamin E were expressed per gram of protein. Carbonyls have been described as 
reasonably stable markers of oxidation (Dalle-Donne et al., 2003) but may still, 
ultimately, undergo further reactions (Davies et al., 1999). Aldehydes may oxidize to 
carboxylic acids while both aldehydes and ketones can react with amines in Schiff base 
reactions, followed by irreversible rearrangements to Amadori products. Perhaps these 
reactions are less favourable in environments associated with higher concentrations of 
antioxidant, thereby resulting in an apparently higher carbonyl concentration and a 
positive association with vitamin E.  
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6.3.3 Neopterin in Plaque  
The atherosclerotic plaque is a site of chronic inflammation, representing a likely source 
of macrophages that are both activated and capable of synthesizing pterin. As a 
consequence, neopterin is expected to be more concentrated in plaque than in serum. 
While numerous studies have analyzed neopterin in the serum, and identified a positive 
relationship with atherosclerosis (Tatzber et al., 1991; Weiss et al., 1994; Gurfinkel      
et al., 1999; Erten et al., 2005), none attempted to study levels within the atherosclerotic 
plaque. The current pilot study has therefore attempted to resolve this gap in knowledge, 
using carotid plaque removed from two donors. By dividing the plaques into sections, it 
has also been possible to determine whether levels vary or remain relatively constant 
throughout the plaque.  
 Neopterin was, indeed, detected in all 13 sections of plaque analyzed, resulting in an 
average concentration of 0.19 nmole/g plaque for each patient (Figure 6.20 & Figure 
6.30). Further analysis of each section from patient 1 revealed relatively low (0.06-0.12 
nmole/g plaque), but consistent, quantities of neopterin in all but one segment. The 
exception, section four, contained a peak concentration of 0.71 nmole/g plaque. This is 
approximately equivalent to 0.71µM neopterin and, although smaller than the maximum 
pus neopterin level of 1.28µM, it still approaches a concentration in the micromolar 
range. Just as critically, these findings confirm that the quantity of neopterin is not 
necessarily homogeneous along the length of the plaque. This makes sense considering 
that macrophages are also known to be distributed unevenly throughout the plaque 
(Bjorkerud & Bjorkerud, 1996; Scott, 2004). These findings therefore also suggest that 
microenvironments, containing even higher quantities of neopterin, may exist within 
certain regions of the plaque. 
 In contrast to patient 1, the seven sections of plaque from patient 2 were associated 
with a much smaller range of neopterin concentrations (0.14-0.27 nmole/g plaque). 
Thus, although neopterin peaked at a significantly elevated level in section two 
compared to the remaining segments, this increase was not as dramatic as that observed 
in plaque 1. A sample size of two is, admittedly, insufficient for making conclusive 
claims regarding neopterin’s deposition along the length of the inflammatory site. 
Nevertheless, this pilot study does indicate that the pattern of neopterin localization in 
plaque is not necessarily comparable between patients. 
 While the patients shared similar demographic data, one major difference was the 
medication being prescribed prior to hospital admission for the carotid endarterectomy. 
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This is of relevance because aspirin (Schroecksnadel et al., 2005) and Atorvastatin 
(Neurauter et al., 2003) have been reported to inhibit neopterin formation in IFN-γ-
simulated macrophages. A clinical study has also shown serum neopterin levels to 
transiently decrease in 10 subjects taking Fluvastatin (van Haelst et al., 2001), while a 
couple of larger studies observed that statins in general were associated with lower 
serum neopterin levels than non-medicated controls (Walter et al., 2003; Avanzas et al., 
2005). Both patients were prescribed aspirin but only patient 2 was taking a statin, 
Atorvastatin (Table 6.3). It is therefore possible that the absence of a large neopterin 
spike in this second patient is due to the anti-inflammatory, neopterin-lowering effects 
of the statin. Larger samples are clearly needed to more adequately investigate this 
theory.  
 The small sample size also prevents neopterin levels in the plaque and pus from 
being conclusively compared. Having acknowledged this, it is interesting to note that 
the average neopterin concentration in the two atherosclerotic plaques is approximately 
40% of the average detected in pus. Such observations hint at a potential difference 
between the chronic inflammatory environment of the plaque and the acute 
inflammation in the pus. At the late stage of atherosclerosis, when the carotid plaques 
were surgically removed, many of the macrophages may have been so lipid-loaded    
and close to death that pterin synthesis was no longer a significant aspect of        
macrophage metabolism. Furthermore, neopterin production is inhibited in IFN-γ-
activated macrophages exposed to iron (Weiss et al., 1992) and the inflammatory 
mediator histamine (Gruber et al., 2000). Both have been suggested to be present         
in plaque, particularly at the advanced stages of the disease (Smith et al., 1992; Lamb  
et al., 1995; Swain & Gutteridge, 1995; Sasaguri & Tanimoto, 2004; Stadler et al., 
2004). 
 In addition to monitoring neopterin’s trend along the length of the plaque, it will 
also ultimately be possible to investigate the existence of correlations between this 
pterin and various markers of oxidation. Identifying these associations was of limited 
success in the current study, due both to the small number of patients sampled and the 
small number of sections obtained for each plaque. Plaque 1 yielded no significant 
relationships while the neopterin in plaque 2 correlated positively with protein and 
TBARS concentrations when expressed per gram of plaque (Table 6.4). Confirming or 
denying the general nature of such correlations will require a sample size much greater 
than the two patients analyzed in the pilot study. 
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6.3.4 Markers of Oxidation in Plaque 
The plaque was homogenized using a procedure previously described by Fu et al. 
(1998). This group confirmed that amino acids were not oxidized as a consequence of 
the homogenization protocol. Thus, oxidation is not expected to be an artefact of 
homogenization in the current study either.  
 As discussed above, the pattern of neopterin localization along the length of the 
plaque was not comparable between the two patients investigated in the current study 
(section 6.3.3). It soon became apparent that this was also the case for each marker of 
oxidation. However, whether such observations are a general feature of atherosclerotic 
plaques will only be known once a larger number of samples have been analyzed.  
 The small sample size has, likewise, prevented correlations between the various 
markers of oxidation in plaque from being reliably identified. Those that appeared in the 
plaque of patient 1 were generally not present in the plaque from patient 2 (Table 6.4). 
This lack of similarity was observed whether measuring PB-DOPA, dityrosine, 
carbonyls and vitamin E relative to plaque weight, protein weight or mole of 
cholesterol.  
 Protein was at a similar level in both patients, with an average concentration across 
the sections of 77.62 ± 8.05 mg/g plaque and 68.06 ± 6.72 mg/g plaque for patient 1 and 
2, respectively (Figure 6.22 & Figure 6.31). This is comparable to the 55.1 mg/g plaque 
determined for protein in an earlier study (Suarna et al., 1995). Despite similar 
averages, however, it should be noted that the protein trend along the plaque was 
slightly different for each patient. 
 Trends were also dissimilar for cholesterol concentration, with a tendency to 
increase towards the bifurcation in plaque 1 but to decrease in the same direction of 
plaque 2 (Figure 6.23 & Figure 6.32). Suarna et al. (1995) did not investigate the 
cholesterol content along the length of the plaque but did determine that, on average, 
free cholesterol was the major lipid component associated with the atherosclerotic 
material of eleven carotid endarterectomy patients. These same subjects had free 
cholesterol concentrations ranging between 0.12 and 1.27mmole/g protein. Although the 
cholesterol assay used in the current study measures both free and esterified forms, the 
average quantity of cholesterol across all sections of plaque 1 and 2 fell within this 
range. Considering that free cholesterol is the predominant lipid component in plaque, 
this finding is not unexpected and it reduces the concern that any products of lipid 
oxidation were significantly interfering in the cholesterol assay. With a mean 
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cholesterol concentration of 0.47 ± 0.11 mmole/g protein (37.15 ± 9.15 µmole/g plaque) 
and 1.29 ± 0.23 mmole/g protein (93.05 ± 21.39 µmole/g plaque) for plaque 1 and 2, 
respectively, it is also apparent that the latter plaque contains an average of 2.5-fold 
more cholesterol than the former. This agrees with the generally more gruel-filled 
appearance noted for the sections of plaque removed from patient 2 compared to   
patient 1 (Figure 6.19 & Figure 6.29).  
 
Products of protein oxidation have been previously detected by other groups in 
homogenized atherosclerotic plaque (Leeuwenburgh et al., 1997b; Fu et al., 1998; 
Upston et al., 2002; Woods et al., 2003). The current study extended these findings by 
demonstrating the existence of PB-DOPA and carbonyls in every section of plaque 
analyzed (Figure 6.24; Figure 6.26; Figure 6.33; Figure 6.35). Even dityrosine was 
present in all but one segment (Figure 6.25 & Figure 6.34).  
 Both pus (section 6.2.1.2) and atherosclerotic plaque (Fu et al., 1998; Woods et al., 
2003) were found to contain PB-DOPA at significantly higher concentrations than 
dityrosine. A similar pattern also tended to be observed in each of the 13 sections of 
plaque analyzed in this pilot study. PB-DOPA remained higher than dityrosine in all 
samples, only losing significance in the second and third sections of plaque 2 due to a 
dramatic elevation in the content of dityrosine. In further agreement with the pus data, 
carbonyls were significantly higher than PB-DOPA and dityrosine in each of the seven 
segments of plaque 2 and all but one segment of plaque 1. Reasons for this trend 
(carbonyls > PB-DOPA > dityrosine) were discussed in section 6.2.1.2, with respect to 
pus, and are likely to be just as applicable for plaque. 
 While investigating the presence of various oxidation markers in the atherosclerotic 
plaque, Wood et al. (2003) estimated that 83% of PB-DOPA and 96% of dityrosine 
were present in the extracellular matrix component (ECM) of the plaque. It seems 
reasonable to expect that PB-DOPA, dityrosine, and even protein carbonyls, may be 
similarly located in the ECM of each section of plaque analyzed in the current study. 
 As stated previously, the trends between the two plaques are not consistent. 
Nevertheless, of the three protein oxidation markers monitored, the dityrosine for both 
patients appeared to display the most pronounced relative change in concentration. This 
general observation shares some similarity with a study by Upston et al. (2002). They 
noted that most tyrosine oxidation products did not vary significantly as the lesion 
severity increased. Dityrosine proved to be the exception and was found to be 
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significantly elevated at advanced stages of atherosclerosis. The current study only 
analyzed advanced lesions, but it could be postulated that regions along the plaque may 
provide a broad analogy to lesions of differing severity. 
 
Oxidized lipids are one of the most commonly studied components of an atherosclerotic 
plaque. Despite such extensive investigations, attempts to identify a relationship 
between lipid oxidation and the extent of atherosclerosis have yielded mixed results. 
One study of 30 carotid plaques found a correlation between plaque instability and 
hydroxyeicosatetraenoic acid (Mallat et al., 1999) but a second study, analyzing 47 
carotid plaques, was unable to confirm this association (Waddington et al., 2003). 
Another group measured TBARS, rather than hydroxyeicosatetraenoic acid, in the 
carotid plaque of 41 endarterectomy patients. They noted a positive association between 
this lipid oxidation product and the likelihood of plaque instability (Nishi et al., 2002). 
Likewise, a positive correlation was shown to exist between the quantity of cholesteryl 
ester hydro(pero)xides in lesions and the severity of coronary atherosclerosis (Upston   
et al., 2002). 
 Relationships have even been identified between atherosclerosis and plasma-
associated lipid hydroperoxides (Kovacs et al., 1997) or TBARS (Bonithon-Kopp et al., 
1997; Salonen et al., 1997). In the latter case, however, Bonithon-Kopp et al. (1997) 
observed a correlation between plasma TBARS and the extent of carotid atherosclerosis 
only in men. By contrast, Salonen et al. (1997) showed a strong association with the 
progression of carotid atherosclerosis by measuring TBARS associated with plasma 
LDL only.  
 Given the small sample size in the current study, it is premature to conclusively 
identify correlations between the concentration of TBARS and atherosclerosis. 
Nevertheless, TBARS was certainly detectable in every segment of plaque analyzed 
(Figure 6.27 & Figure 6.36). Combined with the findings from other groups, this 
suggests that a more complete investigation of correlations between lipid oxidation and 
atherosclerosis may be possible by expanding the pilot study. The concentration of 
TBARS along the length of the plaques could then be compared against various other 
markers of oxidation. 
 
Vitamin E was confirmed to co-exist with lipid oxidation products in each of the         
13 sections of carotid plaque analyzed (Figure 6.28 & Figure 6.37). This agrees with 
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previous plaque studies (Suarna et al., 1995; Niu et al., 1999; Upston et al., 2002), and 
indicates that atherosclerotic lesions are not necessarily antioxidant deficient 
environments. Whether the presence of this antioxidant is a response to oxidative stress 
is currently unclear. It also remains possible that significant amounts of the oxidative 
damage may have occurred in regions lacking suitable quantities of antioxidants. Such 
areas would include microenvironments or sections associated with an early loss of 
antioxidant, followed by a subsequent re-introduction, only after the oxidative damage 
has occurred (Niu et al., 1999). Alternatively, the plaque may represent a site of very 
low radical flux, thereby causing the vitamin E to exert a pro-oxidant activity (Bowry   
et al., 1992; Neuzil et al., 1997). Sampling from the plaque at a single time point makes 
it difficult to distinguish between such possibilities. Nevertheless, once additional 
samples are collected, it will be interesting to determine whether any significant 
relationships exist between vitamin E and the various markers of oxidation that may 
help answer these questions. 
 
6.4 Summary 
Neopterin serves as a marker of immune activation (Hoffmann et al., 2003) and was 
detected in every sample of pus and carotid plaque analyzed. Pus was associated with a 
maximum neopterin concentration in the low micromolar range and contained, on 
average, more pterin than the two atherosclerotic plaque samples. Nevertheless, even 
the neopterin in one section of plaque was found to approach a micromolar level. It 
must also be remembered that the plaque research is merely a pilot study and many 
more samples will be required before strong conclusions, regarding neopterin levels and 
trends in the atherosclerotic plaque, can be identified. 
 The lack of correlation between neopterin and various markers of protein and lipid 
does not support the theory that pterins serve as antioxidants at sites of inflammation. 
However, it remains possible that such correlations were lost by the time the advanced 
stage of inflammation was reached and the patient was admitted to hospital for removal 
of the pus. The positive association between neopterin and the antioxidant, vitamin E, 
suggests that the antioxidant pterin theory cannot be completely discarded. If any 
additional correlations did exist, but were rather weak, a sample size larger than 19 
would likely be required for statistical significance. 
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 Other relationships in the pus indicated that protein oxidation and lipid oxidation 
were positively correlated. Furthermore, and as expected for an antioxidant, the increase 
in vitamin E was associated with a significant decrease in PB-DOPA and TBARS. It 
should be noted, however, that these relationships were all strongly weighted towards 
the sample from patient 2. The pus from this patient consistently contained very high 
levels of oxidized lipid and protein but low quantities of antioxidant. 
 The pilot study of carotid plaques has confirmed the findings of other research 
groups. Markers of protein oxidation (PB-DOPA, dityrosine, carbonyls) and lipid 
oxidation (TBARS) were detected, as was vitamin E. Sample sizes are currently too 
small to permit the conclusive identification of any relationship between these various 
parameters. Nevertheless, a preliminary investigation of the plaque from two patients 
has indicated that antioxidants and products of oxidation are not homogeneous 
throughout the length of the plaque. Concentrations can vary, and the resulting trend is 
not necessarily identical between different patients, even when expressed relative to 
protein or cholesterol rather than plaque weight. 
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7 General Discussion and Conclusions 
A major aim of this thesis was to investigate 7,8-NP’s potential antioxidant activity, 
during both AAPH-induced attack of HMDMs and macrophage-mediated oxidation     
of LDL. The extent of protein hydroperoxide formation in each model, and 7,8-NP’s  
effect on this process, were specifically studied since most previous research has 
focussed on lipid rather than protein peroxidation. 7,8-NP was supplied in a single dose, 
exogenously, as well as continuously from IFN-γ-stimulated macrophages. The 
existence of neopterin (including oxidized 7,8-NP) was also directly measured for the 
first time in two inflammatory environments – pus and atherosclerotic plaque. 
 
7.1 The Prevalence of Protein Hydroperoxides 
Hydroperoxides were shown to form preferentially on lipid rather than protein in 
HMDMs exposed to aqueous peroxyl radicals. This is in striking contrast to what has 
previously been observed during AAPH-induced oxidation of U937 cells (Gieseg et al., 
2000a) and red blood cell membranes (Firth, 2001) and irradiation of mouse myeloma 
cells (Gebicki et al., 2000a; Gebicki et al., 2000b; Du & Gebicki, 2004). Protein was  
the predominant site of peroxidation in these studies. The culture of HMDMs in 10% 
human serum is associated with a dramatic accumulation in PUFA-rich lipid (Garner    
et al., 1997a; Asmis & Jelk, 2000b; Visioli et al., 2000b). Given the susceptibility of 
PUFAs to oxidative attack (Alexander-North et al., 1994), we therefore hypothesize that 
the prevalence of lipid hydroperoxides in the HMDM model is due to the high lipid 
content of these cells. This is of relevance to the atherosclerotic plaque, where 
macrophages also become lipid-loaded. Of further relevance, break-down products of 
lipid hydroperoxides have been detected in plaque samples (Suarna et al., 1995; Niu     
et al., 1999). Peroxyl radical damage should therefore be a significant oxidative stress  
to macrophages in this environment. As such, lipid hydroperoxide formation in   
HMDM cells is likely to represent a significant source of the damage to lipid within 
atherosclerotic plaque. It maybe also be associated with additional adverse 
consequences for the atherogenic process. For instance, macrophages bearing 
peroxidized lipids are suggested to enhance LDL oxidation even in the absence of 
transition metals (Fuhrman et al., 1994).  
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 Lipid hydroperoxide formation and loss of viability were shown to closely correlate, 
indicating that lipid peroxidation may contribute to the AAPH-mediated death of 
HMDM cells. The cytotoxicity of lipid peroxidation is also supported by other studies 
that have noted an increase in cell death upon incubation with lipid hydroperoxides and 
their aldehyde break-down products (Chisolm et al., 1994; Sandstrom et al., 1995; 
Colles et al., 1996; Aoshima et al., 1997; Wang et al., 2000; Choudhary et al., 2002). 
Considering the cytotoxicity of lipid hydroperoxides, much of the peroxidized HMDM 
lipid could ultimately contribute to growth of the necrotic core, providing yet another 
means of adversely affecting the atherogenic process.  
 
Exposure of LDL to macrophages in iron(II)-supplemented Hams F10 was consistently 
shown to result in the formation of 30-40 moles of protein hydroperoxides per mole of 
LDL. This represents 12-15% of the total LDL hydroperoxides and is proportional to 
the protein content in LDL. Protein peroxidation was detected at these significant levels 
whether incubating LDL with the THP-1 macrophage-like cell line or primary HMDM 
cells. Research arising from this thesis therefore indicates that protein hydroperoxides 
are a general consequence of all macrophage-mediated LDL oxidation, rather than 
merely being restricted to one cell type.  
 Kinetic analysis revealed that macrophage-mediated protein hydroperoxide 
formation and lipid peroxidation were closely correlated, with the water-soluble 7,8-NP 
being unable to break this linkage. These findings support the hypothesis that protein 
hydroperoxide formation on the apoB100 of LDL involves lipid-derived radicals 
(Gieseg et al., 2003). The close correlation further indicates that, like lipid peroxidation, 
protein peroxidation can be considered an early product of macrophage-mediated LDL 
oxidation.  
 Although protein hydroperoxide formation is a significant and early consequence of 
macrophage-mediated LDL oxidation, it is not a feature common to all protein-
containing substrates. Exposure of BSA to THP-1 macrophages in iron(II)-
supplemented Hams F10 did not generate any detectable protein hydroperoxides. It 
appears that, under these experimental conditions, the lack of lipid associated with a 
pure protein like BSA limits the peroxidizability of the protein substrate. This result 
also provides further support for the involvement of lipid-derived radicals during 
protein hydroperoxide formation on LDL. 
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 Given the importance of macrophages in atherosclerosis and the susceptibility of 
apoB100 to macrophage-mediated peroxidation, protein hydroperoxides are likely to be 
generated in significant quantities on LDL in the atherosclerotic plaque. In vivo support 
for this claim arises from the discovery of leucine hydroperoxide and valine 
hydroperoxide break-down products in atherosclerotic samples (Fu et al., 1998). Just as 
critically, protein hydroperoxides are known to possess sufficient reactivity to promote 
additional damage (Gebicki, 1997). Protein hydroperoxide formation may therefore 
have important implications in atherogenesis. 
 
7.2 The Antioxidant Activity of 7,8-NP 
While the exact function of 7,8-NP in vivo remains controversial, many studies have 
provided evidence of an antioxidant activity when this pteridine is incubated at 
micromolar concentrations in vitro (Weiss et al., 1993; Horejsi et al., 1996; Wede et al., 
1999; Gieseg et al., 2001a; Gieseg et al., 2001b; Duggan et al., 2002). The current study 
used two different substrates to further investigate this antioxidant role of 7,8-NP. Both 
substrates are considered to be of physiological relevance because they represent 
potential targets of oxidative attack in the inflammatory environments where 7,8-NP 
synthesis is expected to occur. 
 In the first study, concentrations of up to 200µM 7,8-NP were unable to inhibit the 
loss of HMDM viability caused by peroxyl radical attack. This failure to prevent cell 
death was noted even when the rate of radical flux was reduced by half. Thiol oxidation 
and lipid hydroperoxide formation were also unaffected by the presence of 7,8-NP. A 
continuous, endogenous supply of 7,8-NP, produced by IFN-γ-stimulated macrophages, 
was similarly incapable of protecting HMDMs from AAPH-mediated damage. The lack 
of effect contrasts with 7,8-NP’s inhibition of AAPH-induced damage to BSA (Duggan 
et al., 2001), erythrocytes (Gieseg et al., 2001a) and the U937 monocyte cell line 
(Duggan et al., 2002; Baird et al., 2005). Such protection was attributed to 7,8-NP’s 
known ability to efficiently scavenge peroxyl radicals (Oettl et al., 1997). 7,8-NP is 
soluble in water and was therefore also expected to be a potent scavenger of the water-
soluble AAPH peroxyl radicals in the current study. The absence of protection in 
HMDMs may be caused by 7,8-NP and/or AAPH interacting or partitioning with the 
cells in such a way that the 7,8-NP is no longer able to successfully scavenge radicals. 
This interaction/partitioning is likely to arise as a consequence of structural changes that 
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occur to the HMDMs during differentiation in 10% human serum, ultimately resulting 
in a lipid-loaded phenotype.  
 7,8-NP’s lack of effect towards HMDMs exposed to AAPH bears more resemblance 
to the THP-1 monocyte cell line (Baird et al., 2005) than to the U937 monocyte cell line 
(Duggan et al., 2002; Baird et al., 2005). This provides a cautionary tale against 
extrapolating directly from cell lines to primary cells. The results also indicate that    
7,8-NP should be relatively ineffective at preventing HMDM thiol loss, lipid 
peroxidation and death caused by the direct attack of external peroxyl radicals. This is 
particularly relevant in environments like atherosclerotic plaque, where macrophages 
have become lipid-loaded.  
 
In contrast to the oxidized HMDM results, a micromolar dose of 7,8-NP was able to 
effectively prevent macrophage-mediated protein hydroperoxide formation on LDL. 
This protection occurred in a concentration-dependent manner and extended to the 
entire LDL particle, also preventing lipid peroxidation and vitamin E loss. Inhibition 
was observed whether the oxidation was mediated by THP-1 macrophages or HMDMs. 
Further analysis indicated that 7,8-NP did not appear to protect the LDL by modulating 
macrophage activity but, instead, provided protection by scavenging lipid peroxyl 
radicals in direct competition to the LDL’s vitamin E. Evidence for this theory was 
obtained from the kinetic data of macrophage-mediated LDL oxidation and 7,8-NP 
consumption. Cell free LDL oxidation studies have also previously ascribed a lipid 
radical scavenging mechanism to 7,8-NP (Gieseg et al., 1995; Gieseg et al., 2003). 
 Oxidative modification of LDL is a key step in the development of atherosclerosis, 
so 7,8-NP’s ability to inhibit this process could have beneficial consequences. Its 
effectiveness against protein hydroperoxide formation is also of particular interest. 
Protein hydroperoxides are known to possess sufficient reactivity to cause additional 
damage (Gebicki, 1997), but direct cellular defences against them appear to be limited, 
particularly when the protein hydroperoxides are associated with large proteins (Gebicki 
et al., 2002). 7,8-NP therefore has the potential to provide another line of defence 
against protein peroxidation and any adverse reactions that may subsequently occur 
between the reactive protein hydroperoxide moiety and other biomolecules.  
 Although 7,8-NP was a strong antioxidant when added exogenously in micromolar 
quantities, the release of nanomolar pterin from IFN-γ-stimulated macrophages yielded 
contradictory results. Under these conditions, activated THP-1s failed to significantly 
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prevent LDL oxidation but activated HMDMs dramatically inhibited the oxidation of 
protein, lipid and vitamin E in LDL. This HMDM effect did not, however, appear to    
be mediated by 7,8-NP. Medium conditioned by IFN-γ-treated HMDMs retained potent 
antioxidant activity but contained insufficient pterin to account for the strong degree of 
protection. Such findings indicate that, although some IFN-γ-activated macrophages can 
exhibit antioxidant behaviour, 7,8-NP did not play a significant role under the 
conditions of the current study. The disparity between these two macrophage types also 
provides another warning against extrapolating directly from cell lines to primary cells. 
 The contrasting effects of 7,8-NP supplied exogenously, in micromolar amounts, 
and endogenously, in nanomolar quantities, raises questions regarding its in vivo 
relevance as an antioxidant. Antioxidant activity is clearly dependent on both the 
concentration of 7,8-NP and the system being investigated.  
 In vivo, the production of 7,8-NP is expected to occur predominantly at sites of 
inflammation. As pterin had not previously been quantified at such locations, it was 
unclear whether the concentrations in these environments would be sufficient to permit 
any significant antioxidant activity. During this study, neopterin (including oxidized 
7,8-NP) was, for the first time, detected in the inflammatory environments of 19 pus and 
two atherosclerotic plaque samples. An average neopterin concentration of 0.51 ± 
0.07µM was determined for the pus, with peak levels even reaching the low micromolar 
range. Similarly, one section of plaque was found to contain neopterin that approached a 
micromolar concentration. Although not at the levels required for inhibiting the above 
macrophage-mediated LDL oxidations, the peak neopterin concentration in pus is 
comparable to the quantity of 7,8-NP required to delay copper- and THP-1 monocyte-
mediated LDL oxidation (Gieseg et al., 1995; Gieseg & Cato, 2003). It also remains 
possible that, in vivo, the rate of oxidation may be slower and/or microenvironments 
may exist.  
 As part of a preliminary study, it was premature to investigate the existence of 
correlations between neopterin and oxidized protein or lipid in the two atherosclerotic 
plaques. When statistical analysis was applied to the larger pus study, no significant 
relationships were identifiable between neopterin and PB-DOPA, dityrosine, protein 
carbonyls or TBARS. While this lack of association does not support the theory that 
pterins serve as antioxidants at sites of inflammation, it remains possible that such 
correlations were lost by the advanced stage of inflammation associated with the 19 
patients. The positive correlation between neopterin and vitamin E suggests that the 
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antioxidant pterin theory cannot be completely discarded. Nevertheless, it should be 
noted that in pus vitamin E is, on average, 45 times more concentrated than neopterin. 
Both compounds are suggested to scavenge peroxyl radicals at a comparable rate (Oettl 
et al., 1997). Neopterin would therefore need to act at a different site, or be significantly 
elevated in a microenvironment, if it were to play any significant antioxidant role 
compared to vitamin E in the inflammatory surroundings of pus. Neither possibility was 
able to be investigated in the pus due to the method of isolation and subsequent 
homogenization of this inflammatory material. 
 
Results derived from this thesis indicate that both the prevalence of protein 
hydroperoxides, and the ability of 7,8-NP to act as an antioxidant, depend on the system 
under investigation. Neopterin exists in inflammatory environments but, considering the 
lack of protection against AAPH-mediated HMDM oxidation and the concentration 
required to inhibit macrophage-mediated LDL oxidation, strong evidence for an 
antioxidant activity of 7,8-NP in atherosclerotic plaque is currently lacking. 
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Appendix I 
Table A.1  Concentration of protein and protein oxidation markers in 19 samples 
of pus. 
Each sample of pus was analyzed for PB-DOPA, dityrosine, carbonyls and total protein. Carbonyl 
data is not listed for patient 2 because spectrophotometric carbonyl values smaller than the baseline 
absorbance were consistently recorded in the pus from this patient. Samples were analyzed in 
triplicate, with results displayed as mean ± SEM. 
Patient 
Number 
PB-DOPA 
(µM) 
Dityrosine 
(µM) 
Carbonyls 
(µM) 
Protein 
(mg/ml) 
1 6.14 ± 0.68 4.61 ± 0.84 164.8 ± 47.60 66.46 ± 2.92 
2 96.90 ± 4.30 19.28 ± 3.05 / 236.6 ± 7.75 
3 11.67 ± 1.50 0.84 ± 0.04 96.90 ± 8.41 35.01 ± 3.31 
4 5.38 ± 0.83 0.18 ± 0.02 252.1 ±34.40 26.39 ± 1.81 
5 17.83 ± 1.39 0.13 ± 0.02 35.45 ± 4.20 67.91 ± 3.55 
6 31.04 ± 2.75 0.09 ± 0.01 52.68 ± 4.20 59.30 ± 1.42 
7 4.81 ± 0.43 0.05 ± 0.00 336.4 ± 42.51 41.83 ± 3.54 
8 4.16 ± 0.65 0.00 ± 0.00 26.03 ± 6.47 37.91 ± 2.42 
9 10.65 ± 1.27 0.57 ± 0.09 5.79 ± 18.79 47.26 ± 1.91 
10 7.67 ± 1.15 7.10 ± 0.23 454.9 ± 60.00 46.06 ±2.18 
11 2.13 ± 0.13 0.00 ± 0.00 15.00 ± 8.26 20.37 ± 0.22 
12 7.22 ± 0.59 0.42 ± 0.02 382.8 ± 9.37 83.39 ± 4.32 
13 25.86 ± 0.97 0.09 ± 0.01 94.21 ± 3.63 44.54 ± 2.72 
14 19.27 ± 2.56 0.20 ± 0.01 429.2 ± 33.14 66.80 ± 5.72 
15 26.43 ± 2.30 0.39 ± 0.04 471.8 ± 14.86 88.85 ± 0.89 
16 1.86 ± 0.12 0.29 ± 0.01 164.6 ± 10.17 37.50 ± 0.20 
17 2.79 ± 0.14 0.41 ± 0.03 127.0 ± 3.83 51.57 ± 0.95 
18 5.33 ± 0.12 0.17 ± 0.02 263.9 ± 8.92 75.47 ± 2.00 
19 2.51 ± 0.12 0.12 ± 0.01 180.6 ± 4.80 33.45 ± 1.37 
 Appendix I 274 
  
Table A.2  Concentration of TBARS, vitamin E and neopterin in 19 samples of 
pus. 
Each sample of pus was analyzed for TBARS, vitamin E and neopterin (including oxidized 7,8-NP). 
Samples were analyzed in triplicate, with results displayed as mean ± SEM. 
Patient 
Number 
TBARS 
(µM) 
Vitamin E 
(µM) 
Neopterin 
(µM) 
1 0.81 ± 0.10 15.97 ± 1.72 0.69 ± 0.02 
2 10.06 ± 1.04 2.96 ± 0.02 0.07 ± 0.00 
3 3.84 ± 0.22 7.50 ± 0.60 0.30 ± 0.02 
4 1.22 ± 0.18 38.81 ± 1.52 0.40 ± 0.01 
5 2.47 ± 0.05 5.37 ± 0.41 0.69 ± 0.02 
6 1.01 ± 0.02 14.96 ± 0.23 0.58 ± 0.04 
7 4.29 ± 0.06 29.87 ± 0.66 0.65 ± 0.01 
8 1.81 ± 0.07 17.66 ± 1.11 0.05 ± 0.00 
9 5.98 ± 0.04 18.77 ± 0.92 0.42 ± 0.01 
10 1.82 ± 0.00 46.49 ± 2.65 0.52 ± 0.02 
11 5.52 ± 0.21 6.32 ± 0.36 0.07 ± 0.00 
12 3.40 ± 0.17 35.15 ± 0.67 0.37 ± 0.01 
13 5.27 ± 0.11 11.27 ± 0.73 0.89 ± 0.09 
14 0.91 ± 0.03 29.35 ± 1.33 0.10 ± 0.00 
15 5.28 ± 0.21 29.98 ± 0.69 1.28 ± 0.06 
16 2.22 ± 0.00 39.62 ± 0.83 0.64 ± 0.04 
17 0.81 ± 0.26 27.99 ± 0.26 0.86 ± 0.07 
18 3.33 ± 0.12 21.89 ± 1.49 0.50 ± 0.03 
19 2.48 ± 0.08 38.41 ± 0.95 0.54 ± 0.02 
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Appendix II 
The following paper is entitled “Protein Hydroperoxides are a Major Product of Low 
Density Lipoprotein Oxidation During Copper, Peroxyl Radical and Macrophage-
mediated Oxidation”. It includes one figure (Figure 5) that was generated as part of this 
PhD thesis. 
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Damage to apoBlOO on low density lipoprotein (LDL) has
usually been described in terms of lipid aldehyde
derivatisation or fragmentation. Using a modified FOX
assay, protein hydroperoxides were found to form at
relatively high concentrations on apoBlOO during copper,
2,2'-azobis(arnidinopropane) dihydrochloride (AAPH)
generated peroxyl radical and cell-mediated LDL oxi-
dation. Protein hydroperoxide formation was tightly
coupled to lipid oxidation during both copper and
AAPH-mediated oxidation. The protein hydroperoxide
formation was inhibited by lipid soluble ct-tocopherol and
the water soluble antioxidant, 7,8-dihydroneopterin.
Kinetic analysis of the inhibition strongly suggests protein
hydroperoxides are formed by a lipid-derived radical
generated in the lipid phase of the LDL particle during
both copper and AAPH mediated oxidation. Macrophage-
like THP-1 cells were found to generate significant protein
hydroperoxides during cell-mediated LDL oxidation,
suggesting protein hydroperoxides may form in vivo
within atherosclerotic plaques. In contrast to protein
hydroperoxide formation, the oxidation of tyrosine to
protein bound 3,4-dihydroxyphenylalanine (PB-DOPA) or
dityrosine was found to be a relatively minor reaction.
Dityrosine formation was only observed on LDL in the
presence of both copper and hydrogen peroxide. The PB-
DOPA formation appeared to be independent of lipid
peroxidation during copper oxidation but tightly associ-
ated during AAPH-mediated LDL oxidation.
Keywords: Low-density-lipoprotein; Protein-hydroperoxide;
Protein-bound-DOPA; Free-radical; Lipid-peroxidation;
Macrophage; Neopterin
Abbreviations: AAPH, 2,2'azobis(amidinopropane) dihydrochlor-
ide; EDTA, Ethylenediaminetetraacetic acid disodium salt; HPLC,
high performance liquid chromatography, LDL, low density
lipoprotein; PBS, Phosphate buffered saline; PMA, phorbol
12-myristate 13-acetate; PB-DOPA, protein-bound-3,4-dihydroxy-
phenylalanine; TCA, trichloroacetic acid
INTRODUCTION
The oxidation of low density lipoprotein is con-
sidered to be a key process in the development and
progression of atherosclerosis.'1'2' Oxidised LDL is
rapidly taken up by macrophages via the scavenger
receptor, leading to the transformation of the
macrophages to lipid loaded foam cells.'3' In vitro,
LDL oxidation begins with the consumption of
various endogenous antioxidants and is followed by
initiation of the peroxyl radical-mediated chain
reaction, leading to peroxidation of polyunsaturated
fatty acid esters within the LDL particle.'41 Con-
comitantly, the structural integrity of the apoBlOO
protein is lost. Oxidation of the LDL protein moiety
results in the loss of select amino acids/5'6' carbonyl
formation,'7' derivatisation with lipid aldehydes,'81
protein fragmentation15'91 and aggregation through
protein cross-linking.'9'
Free radical-mediated protein oxidation also
results in the formation of two types of reactive
amino acid residues; protein hydroperoxides
and protein bound 3,4-dihydroxyphenylalanine
(PB-DOPA).'10"13' Both reactive groups are known
to form on apoBlOO during LDL oxidation'14'15'
but, unlike protein carbonyls, protein hydroper-
oxides and PB-DOPA can initiate further oxidative
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damage to the protein or surrounding biomole-
cules.™
Protein hydroperoxides are formed when a
hydroxyl or peroxyl radical removes a hydrogen
atom from an amino acid side chain. The resulting
carbon-centred radical may then react with oxygen
and hydrogen ions to form a hydroperoxide on the
amino acid residue.112' Though relatively stable,
protein hydroperoxides readily react with DNA,
oxidising nucleotides'171 and forming protein-DNA
cross-links.1181 Protein hydroperoxides also oxidise
cellular thiols'19' and consume the key cellular
antioxidants ascorbate and glutathione.'10' Protein
hydroperoxides have been shown to form on various
proteins, plasma proteins, lipoproteins and cellular
proteins in living cells.110'15'26'211
PB-DOPA is formed from tyrosine residues by
hydroxyl radical addition to the phenol ring
hydrogen atom, followed by hydroxylation of the
resulting tyrosyl radical.'11' ' As a reducing agent,
PB-DOPA can stimulate further Fenton-mediated
hydroxyl radical production by reducing transition
metal ions.'231 This mechanism appears to be
responsible for PB-DOPA's ability to oxidise
DNA.[24] PB-DOPA has been extensively studied
using pure proteins, and identified in cataract lens125'
and oxidised lipoproteins during copper-mediated
oxidation.1141
Both PB-DOPA and the breakdown products of
protein hydroperoxides have been identified in
atherosclerotic plaques'26' and on ApoB in plasma
from healthy donors.127' However, no study has
addressed the relative significance of PB-DOPA or
protein hydroperoxides during LDL oxidation, nor
demonstrated the formation of either protein
oxidation product during cell-mediated LDL oxi-
dation. In this study we show that protein hydro-
peroxides are a major product of copper ion, peroxyl
radical and cell-mediated LDL oxidation. The lipid
soluble antioxidant, a-tocopherol (vitamin E), and
the water soluble antioxidant, 7,8-dihydroneopterin,
have been used to examine the relationship
between lipid oxidation and protein hydroperoxide
formation during LDL oxidation. 7,8-dihydro-
neopterin is a macrophage-synthesised antioxidant,
which has previously been shown to inhibit lipid
oxidation on LDL and protein hydroperoxide
formation on albumin exposed to peroxyl or
hydroxyl radicals.[2S'29'
MATERIALS AND METHODS
All chemicals and reagents were of AR grade
or better and obtained from the Sigma
Chemical Company (USA) or BDH Chemicals
New Zealand Limited. 7,8-dihydroneopterin was
obtained from Schirck's Laboratories, Switzerland.
2,2'-azobis(amidinopropane) dihydrochloride
(AAPH) was supplied by Aldrich Chemical Com-
pany Inc. Ethylenediaminetetraacetic acid disodium
salt (EDTA) was supplied by BDH chemicals.
All solutions were prepared with high purity
water from a NANOpure ultrapure water system
from Barnstead/Thermolyne (Iowa, USA). Phosph-
ate buffered saline (PBS) (160 mM sodium chloride,
10 mM sodium phosphate buffer pH 7.4), was treated
with chelex-100 resin (BioRad, Richmond, USA) to
remove trace amounts of redox active metal ions.
EDTA-plasma was prepared from blood taken by
venipuncture from healthy female and male donors
(age 20-45 years). The EDTA-plasma from groups of
five donors was pooled and frozen at - 80°C in 0.6%
sucrose for up to 3 months.'30' LDL was prepared by
a single 22 h ultracentrifugation of the pooled EDTA-
plasma using a buoyant density four step discon-
tinuous gradient in a Beckman SW41 rotor.'31' For
oxidation experiments, the LDL was desalted by 24 h
of dialysis with four changes of nitrogen-gassed PBS
containing 0.5 g/1 of chelex-100 resin. The LDL molar
concentration was determined by enzymatic chole-
sterol determination using the "Choi MPR 2" kit
supplied by Roche Chemicals (New Zealand),
assuming an LDL molecular weight of 2.5 MDa and
a cholesterol content of 31.6%.'30)
The a-tocopherol concentration in LDL was
increased by incubating 4 ml of plasma with 40 p-1
of 100 mM a-tocopherol in ethanol under argon gas
for 4h at 37°C with gentle shaking.'32' The LDL was
then purified as described above.
LDL (100 nM) in PBS was oxidised in a glass flask
in the dark at 37°C in a Bioline shaker (Edwards
Instruments Co. Australia), which gently swirled the
flask at 80 rpm.
Protein hydroperoxides were isolated by acid
precipitation and solvent lipid extraction, before
analysis using a modified FOX assay.'21'33'34' The
assay was performed in triplicate, by adding 140 |jd
of 72%w/v trichloroacetic acid (TCA) to lml
samples of LDL (100 nM) and incubating on ice for
lOmin. The protein was pelleted by a 5min
centrifugation at 23,000g, 4°C. The pellet was washed
by vortexing in lml of 1:1 methanol/chloroform
before centrifugation. The resulting pellet was
allowed to dry in air at room temperature for
5 min, before being suspended in 900 ]il of ice cold
50%v/v glacial acetic acid. Fifty microliter each of
5mM ferrous ammonium sulphate and xylenol
orange in 25 mM H2SO4 was added to the protein
suspension. The mixture was incubated at room
temperature for 30 min, during which time ferrous
ions were oxidised to ferric ions by the hydroper-
oxides. Ferric ions are detected by the formation of a
coloured complex with xylenol orange, which is
measured by absorbance at 560 ran against a water
blank. An extinction coefficient of 48,000Mem was
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used to calculate the concentration of protein
hydroperoxide. '33'
For cell-mediated oxidation experiments, 3 ml of
the LDL-containing media was centrifuged at 400g to
eliminate any cellular material. The supernatant was
then incubated with 420 |jd of 72%w/v TCA on ice
for 10 min before centrifugation at 4100# for 15 min at
4CC in thick walled glass centrifuge tubes. The pellet
was washed with chloroform/methanol and assayed
for protein hydroperoxides as described above.
Lipid oxidation was monitored by removing
aliquots of the reaction mixture and measuring the
formation of conjugated dienes by the increase in
absorbance at 234 run.'35-' As the breakdown product
of AAPH absorbs at 234 run, the absorbance of an
incubated AAPH solution was subtracted from the
LDL oxidation mixture.
PB-DOPA and dityrosine were measured by acid
hydrolysis and HPLC analysis, as previously
described.'11'361 The samples were prepared in
triplicate by placing 900 (xl of LDL solution into
glass "Durham" tubes, 50 X 7.5 mm (Samco, USA),
containing 10 (xl of 20mg/ml butylated hydroxy-
toluene (BHT) in methanol, 10 fil of lOOmg/ml
EDTA and 140 |JL1 of 72% TCA. Samples were
incubated on ice for 10 min before centrifugation at
10,000g for 15 min at 4°C. The supernatant was
removed and the pellet washed by vortexing with
500 |xl of 20°C acetone, then 500 |xl of diethyl ether,
with centrifugation between each wash" to pellet the
protein. After drying in air, the sample tubes were
placed in a "picotag hydrolysis vial" (Waters, USA)
and subjected to gas phase acid hydrolysis over 16 h
at 110°C.t;111 Concentration of DOPA and dityrosine
in the hydrolysate was determined by reverse phase
HPLC, with fluorescence detection as previously
described.'36'371 The dityrosine standard was pre-
pared by oxidation of tyrosine with horseradish
peroxidase and purification on DEAE-sephacel
(Sigma).'381 The concentration of the purified
dityrosine was determined by measuring the
absorbance at 315 run, using an extinction coefficient
of £315 = 5080M.'391
Suspension cultures of THP-1 cells were main-
tained in RPMI1640 media, supplemented with 5%
heat inactivated fetal calf serum, lOOU/ml penicillin
and 100 jig/ml streptomycin, in a humidified
incubator with 5% CO2 at 37°C. The cells were
transformed to adherent macrophage-like THP-1
cells, by treatment for 7 days with 100 ng/ml phorbol
12-myristate 13-acetate (PMA), to give a cell density
of 1 X 10s cells/ml in a standard 6 well plate. [4°]
Oxidation experiments were conducted in triplicate,
using Hams F10 media, supplemented with 3 \JM
FeSC>4, after first washing the cells three times in
warm PBS. Filter sterilized LDL was added to the
media to give a final concentration of 40 nM before
incubation for various times at 37°C in 5% CO2.
The results shown are from single experiments,
representative of a minimum of three separate
experiments. The data points shown in the figures
are the means and standard errors of triplicate
analysis taken from a single flask.
RESULTS
The oxidation of 100 nM LDL by 5 |xM copper ions
at 37°C over 2h resulted in the formation of
311 ± 20 moles of total hydroperoxides/mole of
LDL using the standard protein FOX assay with
acid precipitation'33' (data not shown). Removing
lipid from the sample by acid precipitation and
solvent washing, as described in the methods,
reduced the FOX-measured hydroperoxides to 52
protein hydroperoxides per LDL particle. This
equates to 16% of the combined protein and lipid
hydroperoxide value. Unoxidised LDL gave a back-
ground reading of 0.01 absorbance units, which
corresponds to a reading of 2 mole per mole LDL.
Analysis of delipidated and native unoxidised LDL
showed the delipidation procedure did not generate
compounds which reacted in the FOX assay.
Treatment of the oxidised LDL with sodium
borohydride removed all of the FOX-assayed
reactivity generated by the copper oxidation. The
susceptibility to sodium borohydride, and the effect
of acid and solvent washing, confirm the presence
and formation of significantly large levels of protein
hydroperoxides during LDL oxidation.'21' ' The
change from sulphuric acid'33' to 50% glacial acetic
acid to partially solubilise the precipitated apoBlOO
protein is a critical modification of the FOX assay,
which enabled LDL protein hydroperoxides to be
measured. It was also found to be important to keep
the glacial acetic acid on ice before conducting the
FOX assay at room temperature.
Kinetic analysis of the oxidation showed that
protein hydroperoxide formation closely paralleled
the formation of conjugated dienes with both copper
and AAPH-mediated oxidation (Figs. 1 and 2).
No protein or lipid oxidation was observed in the
oxidant-free controls over the same time period. Like
the conjugated dienes formed during lipid peroxi-
dation, the protein hydroperoxide kinetics show a
lag period followed by a rapid formation phase.
In lipid peroxidation this rapid oxidation phase is
usually termed the propagation phase as it is during
this part of the reaction that a lipid radical chain
reaction forms. The maximum protein hydroper-
oxide formation rate with copper ions was calculated
at 1 nM/s while the lipid conjugated diene formation
was calculated at 4.3nM/s. Following the copper-
mediated propagation phase, both protein and lipid
oxidation reached a plateau (Fig. 1A). With AAPH
oxidation, the maximum protein hydroperoxide and
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FIGURE 1 Formation of protein hydroperoxides on LDL.
LDL (100 nM) in PBS was oxidised by either (A) 5 |xM Cu + + or
(B) 1 mM AAPH at 37°C. Protein hydroperoxides were measured
in triplicate by the modified FOX assay and displayed as
mean ± standard error. Conjugated dienes were determined by
measuring the absorbance at 234 run. The data displayed shows
(•) protein hydroperoxide control; (•) protein hydroperoxide
with oxidant, (O) conjugated diene control, (•) conjugated diene
with oxidant.
diene formation rates were 0.3 and 2nM/s,
respectively (Fig. IB).
To determine the possible linkage between the
oxidation of LDL's protein and lipid components, the
effect of a lipid soluble and a water soluble
antioxidant on the oxidation process was investi-
gated. Increasing the a-tocopherol content of LDL,
from 8.5 to 54 a-tocopherol per LDL particle,
doubled the length of the lag phase during copper-
mediated LDL oxidation (Fig. 2A). The additional
a-tocopherol had no significant effect on the
propagation rates of lipid and protein oxidation
and did not disrupt the linkage observed between
protein hydroperoxide and diene formation. During
AAPH-mediated oxidation, the increase in a-
tocopherol caused a dramatic reduction in the
concentration of both dienes and protein hydroper-
oxides. This inhibition was particularly apparent for
the protein hydroperoxides from the 30min time
point onwards (Fig. 2B).
Like a-tocopherol, the presence of the
water soluble antioxidant 7,8-dihydroneopterin
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FIGUEE 2 Effect of a-tocopherol loading on protein
hydroperoxide formation on LDL. (A) Native LDL (lOOnM with
8.5 a-tocopherols per LDL particle) and a-tocopherol-loaded LDL
(lOOnM with 54 a-tocpherols per LDL particle) was incubated
with 5 uM copper at 37°C. (B) Native LDL (lOOnM with 8 o-
tocopherols per LDL particle) and a-tocopherol-loaded LDL
(100 nM with 70 a-tocopherols per LDL particle) was incubated
with 2 mM AAPH at 37°C. Samples were removed at selected time
points for protein hydroperoxide analysis by the modified FOX
assay and lipid oxidation by measurement of the conjugated diene
absorbance at 234 ran. Each protein hydroperoxide value is the
mean ± standard error of three replicates. Blank controls and the
zero time point were subtracted to show the change in oxidation
products over time. The data displayed shows (•) native LDL
protein hydroperoxides; (•) a-tocopherol-loaded LDL protein
hydroperoxides; (•) native LDL dienes; (O) a-tocopherol-loaded
LDL dienes.
lengthened the lag phase but had little impact on
the propagation phase kinetics of dienes and protein
hydroperoxides during copper-mediated oxidation
(Fig. 3A). hi the particular example shown, diene
values did peak much earlier than the hydroper-
oxides during oxidation of the native LDL but this
was not consistently observed. During AAPH
oxidation, the presence of 7,8-dihydroneopterin
caused a lengthening of the lag phase (Fig. 3B).
At first glance, lipid peroxidation appears the most
affected by the 7,8-dihydroneopterin in the propa-
gation phase but close inspection of the data shows
that the presence of 7,8-dihydroneopterin virtually
blocked the formation of dienes during the lag phase.
In the absence of 7,8-dihydroneopterin, 40 dienes per
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FIGURE 3 Effect of water soluble 7,8-dihydxoneopterin on
protein hydroperoxide formation in LDL. LDL (lOOnM) in PBS
was oxidised by either (A) 5 u.M Cu + + or (B) 1 mM AAPH at 37°C
in the presence or absence of 2 |xM 7,8-dihydroneopterin. Samples
were removed at selected time points for protein hydroperoxide
analysis by the modified FOX assay and lipid oxidation by
measurement of the conjugated diene absorbance at 234 run. Each
protein hydroperoxide value is the mean ± standard error of three
replicates. Blank controls and the zero time point were subtracted
to show the change in oxidation products over time. The data
displayed shows (•) native LDL protein hydroperoxides; (•) 7,8-
dihydroneopterin + LDL protein hydroperoxides; (D) native LDL
dienes; (O) 7,8-dihydroneopterin + LDL dienes.
LDL particle had formed at the end of the lag phase
(60min time point) compared to only 12 dienes per
LDL particle at the end of the lag phase in the
presence of 7,8-dihydroneopterin. Protein hydro-
peroxide formation was also reduced by 7,8-
dihydroneopterin during this lag period.
PB-DOPA and dityrosine formation were also
observed during LDL oxidation (Table I). Only PB-
DOPA was observed after a 3h LDL oxidation with
copper alone, while the addition of hydrogen
peroxide resulted in both the detection of dityrosine
and a doubling of PB-DOPA. Hydrogen peroxide
alone was unable to cause the formation of either
tyrosine oxidation product.
The kinetics of PB-DOPA formation during copper
oxidation were significantly different to the rate of
DOPA mmoles/
mole LDL
Dityrosine mmoles/
mole LDL
LDL
LDL + H2O2
LDL + Cu+2
LDL + Cu+2 -hH2O2
0
0
157 ± 20
348 ± 1
0
0
0
70 ±*0.1
LDL (100 nM) was incubated in PBS in the presence and absence of 5(iM
copper chloride or 5 mM hydrogen peroxide at 37°C for 3 h. The zero time
point was subtracted from the value at 3 h of each treatment as there is a
small but significant background level of both oxidation products in LDL
purified from human plasma. The data shown is the mean ± standard error
of three replicates.
diene formation (Fig. 4A). The PB-DOPA continued
to increase well after the peak in diene formation.
In contrast, PB-DOPA formation appeared tightly
coupled to the lipid diene formation during AAPH-
mediated oxidation (Fig. 4B). AAPH-mediated
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FIGURE 4 Formation of PB-DOPA during copper and AAPH-
mediated LDL oxidation. LDL (100 nM) was incubated in PBS at
37°C, with and without either (A) 5 uJv! copper ions or (B) 2m]vf
AAPH. Triplicate samples were removed at the indicated time
points for protein extraction, acid hydrolysis and HPLC analysis
for DOPA. Lipid oxidation was monitored by measuring the
absorbance of the conjugated dienes at 234 nm. No increase in PB-
DOPA or dienes was observed in the oxidant-free controls. Blank
controls and the zero time point were subtracted to show the
change in oxidation products over time. Each PB-DOPA value is
the mean ± standard error of three replicates. The data displayed
shows (•) PB-DOPA; (D) dienes.
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FIGURE 5 LDL (40 nM) was incubated with and without
adherent PMA treated THP-1 cells in iron supplemented Hams
F10 media at 37°C. At the indicated time points, wells were
sampled and analysed for protein hydroperoxides by the modified
FOX assay, and lipid dienes by the absorbance at 234 ran. Each data
point is mean ± standard error of three wells. Blank controls and
the zero time point were subtracted to show the change in
oxidation products over time. Data displayed shows protein
hydroperoxide formation in the presence (•) and (•) absences of
cells. Conjugated dienes are shown in the presence (D) and (O)
absences of cells.
DOPA formation on LDL was unexpected because
hydroxyl btit not peroxyl radicals were believed to
generate PB-DOPA.'10'42' A Fenton-type mechanism,
using hydrogen peroxide generated from AAPH,
was unlikely because the addition of catalase failed
to inhibit PB-DOPA formation. Unlike PB-DOPA, no
dityrosine was generated during either the copper or
AAPH-mediated LDL oxidation. Control exper-
iments confirmed that, in the absence of copper or
AAPH, no significant PB-DOPA or dienes were
detectable (data not shown).
In comparison to the protein hydroperoxide, PB-
DOPA and dityrosine were relatively minor reaction
products. Only one DOPA was detected per 380
protein hydroperoxides (comparing data in Fig. 1
with Table I) and we therefore did not examine the
reaction kinetics of tyrosine oxidation further.
Incubation of LDL with macrophage-like THP-1
cells resulted in the oxidation of both protein and
lipid (Fig. 5). Protein hydroperoxides and dienes
peaked at 6 h, at concentrations of 27 moles per mole
of LDL and 225 moles per mole of LDL, respectively.
A second rise of 234 ran absorbing material was
observed at 24 h, though this is most likely due to
advanced lipid oxidation products which also absorb
at 234ran.351 Protein hydroperoxide and diene
formation both occurred at slower rates in the
absence of cells due to auto-oxidation in the presence
of iron and air.
DISCUSSION
It has long been recognised that damage to the
apoBlOO moiety of LDL is an important consequence
of LDL oxidation.151 In addition to the more classical
types of damage to LDL, we have now clearly shown
that the formation of protein hydroperoxides on the
LDL apoBlOO protein is a significant form of LDL
modification. The maximum, amount of protein
hydroperoxide recorded during copper oxidation
was 79 protein hydroperoxides per LDL particle,
compared with 309 conjugated dienes per particle
(Fig. 2). This protein hydroperoxide concentration is
six times greater than the reported level of protein
carbonyls formed during copper-mediated LDL
oxidation.'7'
Modifying the sample preparation procedure to
include protein precipitation and solvent lipid
extraction enabled the FOX assay to specifically
measure protein hydroperoxides. Degradation of the
FOX-measured protein hydroperoxides by reduction
with sodium borohydride'431 confirmed early work,
which detected protein hydroperoxide in oxidised
LDL using an iodometric assay.'151
Protein hydroperoxide and conjugated diene
formation paralleled each other during both copper
and AAPH-mediated LDL oxidation (Fig. 1). Copper
mediated LDL oxidation appears to involve a
Fenton-like process occurring at specific copper
binding sites on the surface of the LDL particle,
possibly on the apoBlOO.130'441 In contrast, AAPH is a
water soluble peroxyl radical generator, capable of
forming protein hydroperoxides in pure protein
solutions™ and oxidising LDL via the formation of
lipid peroxyl radicals.'451 Despite the differences in
these two radical generating systems, a high level of
similarity was observed in the kinetics of protein
hydroperoxide and diene formation. This suggests
that the oxidation of both moieties was initiated by a
common radical intermediate.
The inability of a-tocopherol and 7,8-NP to uncouple
the oxidation of the lipid and protein components of
LDL during copper and AAPH-mediated oxidation
suggests that radical intermediates of the lipid
peroxidation are responsible for protein hydroperoxide
formation in LDL (Fig. 2). a-Tocopherol's location
within the lipid component of LDL supports a lipid
origin for the radicals responsible for initiating protein
hydroperoxide formation. 7,8-dihydroneopterin and
a-tocopherol inhibit LDL oxidation by competing for
the lipid peroxyl radical during both copper and
AAPH-mediated LDL oxidation.'281 Lipid alkoxyl
radicals are unlikely to be involved in protein
hydroperoxide formation as these radicals predomi-
nate in the latter stages of lipid oxidation, after protein
hydroperoxide formation has peaked. The most likely
lipid radical responsible for protein hydroperoxide
formation on LDL is therefore the chain-propagating
lipid peroxyl radical. The finding that a-tocopherol can
prevent protein hydroperoxide formation on apoBlOO
(Fig. 2), potentially broadens its role to protection of the
entire LDL particle from oxidative insult.
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The lipid soluble antioxidant probucol has also
been shown to protect apoBlOO by inhibiting lipid
peroxidation, carbonyl formation and protein frag-
mentation.17'46' It is possible that a significant part of
this apoBlOO damage results from the breakdown of
protein hydroperoxides. Degradation of hydro-
peroxide on the ct-carbon of model peptides has
been shown to cause fragmentation,' ' while the
decomposition of hydroperoxide on the amino acid
residue side chain generates carbonyl groups.'481 The
amino acids lysine, histidine and proline have been
identified as highly labile in apoBlOO during copper-
mediated LDL oxidation.'51 This loss has previously
been attributed to protein fragmentation or carbonyl
formation. These three amino acids are now known
to also readily form amino acid hydroperoxides
during exposure to hydroxyl radicals.'431 This
suggests that some of the previously described
amino acid loss during LDL oxidation is probably
due to protein hydroperoxide formation. It is
interesting to note that a-tocopherol has also been
shown to inhibit protein fragmentation of apoBlOO
during copper oxidation.'461
It is generally assumed that, because AAPH is
water soluble, AAPH-derived peroxyl radicals will
form in the aqueous phase of a reaction mixture.
As a result, LDL protein hydroperoxides would be
expected to form via direct attack by AAPH peroxyl
radicals in the aqueous phase, as is observed with
albumin.'291 The lipid soluble a-tocopherol should
have had little or no affect on the LDL protein
hydroperoxide formation during our experiments.
Though water soluble, 95% of AAPH can partition
in the lipid phase of SDS-stabilized linoleic acid
micelles. 91 This suggests the majority of the
AAPH peroxyl radicals in our experiments are
forming in the lipid fraction of the LDL particle, not
the aqueous phase. If the AAPH derived radicals
were forming in the aqueous phase, they would
be able to directly attack the ApoB 100 to
form protein hydroperoxide, with out a-tocopherol
having any affect. This model of AAPH-
mediated oxidation is further supported by the
finding that the length of the LDL lag phase is
directly proportional to the concentration of
a-tocopherol, but only during AAPH-mediated
oxidation.'501
Macrophage cells are considered to play a key part
in the modification of LDL within the arterial wall.
The novel finding that cell-mediated LDL oxidation
also generates significant amounts of protein hydro-
peroxides suggests that protein hydroperoxides
could form in atherosclerotic plaques (Fig. 5).
Analysis of atherosclerotic plaque has shown the
presence of hydroxyleucine and hydroxyvaline,
known breakdown products of protein hydroper-
oxides.'261 Considering the known reactivity
of protein hydroperoxides with thiols and
ascorbate,'101 it is possible that they play a role in
plaque formation.
In comparison to protein hydroperoxide for-
mation, oxidative modification of tyrosine does not
appear to constitute a major reaction during the
oxidation of LDL. The concentration observed
during copper-mediated oxidation after 8h was
only one PB-DOPA per five LDL particles (Fig. 4A).
PB-DOPA concentrations have been reported as high
as eight DOPA per LDL particle, but this was only
after 8 days of oxidation.'141 Measurement of amino
acid loss during copper-mediated LDL oxidation
also confirmed tyrosine to be a minor reaction target
during copper-mediated LDL oxidation.
The appearance of PB-DOPA during AAPH-
mediated LDL oxidation was unexpected (Fig. 4B),
as previous studies had shown that only hydroxyl
radicals were capable of initiating DOPA formation
from tyrosine.' ' The strong coupling observed
between the diene and DOPA formation strongly
suggests that the lipid peroxyl radical is involved in
the mechanism. Spin trap studies have shown
peroxyl and alkoxyl radicals can undergo a range
of fragmentation reactions releasing superoxide
radicals, which can dismutate to hydrogen
peroxide.'511 The lack of effect by catalase suggests
that either there is another mechanism leading
to DOPA formation or the reaction site where
the hydrogen peroxide is reacting to form
hydroxyl radicals is not accessable to the catalase
enzyme.
In contrast, during copper-mediated LDL oxi-
dation, the PB-DOPA formation appeared to be
relatively independent of the diene formation
(Fig. 4A). A direct copper/tyrosine interaction rather
than a lipid radical intermediate appears to be
involved, though this has not been observed in our
studies with albumin and copper.'421
Significant dityrosine formation was only
observed under the most oxidative of conditions,
when hydrogen peroxide was added to the
copper/LDL reaction mixture. After 3h of incu-
bation only one dityrosine per 14 LDL particles
was detected (Table I). This may reflect the
requirement of two tyrosyl radicals to occur in
close proximity to each other to form dityrosine.'521
Studies on lens proteins have also found that
hydrogen peroxide has to be present with the copper
ions for dityrosine to be generated by the Fenton
reaction.1531
This study clearly demonstrates that protein
hydroperoxides are a significant product of LDL
oxidation under a variety of oxidation systems,
including cell-mediated oxidation. Others have
clearly shown that protein hydroperoxides are
found in atherosclerotic plaques' 61 and will react to
consume thiols and ascorbate.1121 This raises
the possibility that protein hydroperoxides may
S.P. GIESEG et al.
contribute to some of the pathological behaviour of
oxidised LDL in vivo.
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